Acknowledgements
- Frédéric Pène (Paris)
- Hafid Ait-Oufella (Paris)
- Pierre Asfar (Angers)
- Cécile Aubron (Brest)
- Emmanuel Canet (Nantes)
- Guillaume Carteaux (Créteil)
- Stephan Ehrmann (Tours)
- Jean-Pierre Frat (Poitiers)
- Guillaume Geri (Boulogne-Billancourt)
- Julie Helms (Strasbourg)
- Alexandre Demoule (Paris)
- Saad Nseir (Lille)
- Mehdi Oualha (Paris)
Oral Communications
COK-1 Expiratory muscle weakness quantified by maximal expiratory pressure may be insufficient in predicting critical outcomes in mechanically ventilated patients
Yann Combret1, Guillaume Prieur1, Francis-Edouard Gravier2, Tristan Bonnevie2, Olivier Contal3, Bouchra Lamia1, Clement Medrinal1
1Groupe Hospitalier du Havre, Le Havre, France; 2ADIR Association, Rouen, Fs; 3Haute Ecole de Santé Vaud, Lausanne, Switzerland
Correspondence: Yann Combret (yann.combret@gmail.com)
Outcomes | Low MEP N = 63 | Normal MEP N = 61 | Risk Ratio [95% IC] | p value |
---|---|---|---|---|
Extubation failure, n (%) | 14 (22) | 8 (13) | 1.32 (0.91–1.93) | 0.18 |
Death within 30 days, n (%) | 10 (16) | 5 (8) | 1.37 (0.91–2.06) | 0.19 |
ICU-AW, n (%*) | 32 (64*) | 17 (35*) | 1.82 (1.19–2.77) | 0.003 |
Readmission in ICU within 30 days, n (%) | 1 (2) | 1 (2) | 0.98 (0.24–3.98) | 0.98 |
COK-2 Consequences of ICU acquired weakness: a systematic review and meta-analysis
Clement Medrinal1, Yann Combret2, Roger Hilfiker3, Nadine Aroichane4, Tristan Bonnevie5, Francis-Edouard Gravier5, Guillaume Prieur1, Olivier Contal6, Bouchra Lamia7
1Le Havre Hospital, ICU Department. Normandie University, UNIROUEN, UPRES EA3830-GRHV, Institute for Research and Innovation in Biomedicine (IRIB), Le Havre, France; 2Le Havre Hospital, ICU Department. Research and Clinical Experimentation Institute (IREC), Pulmonology, ORL and Dermatology, Louvain Catholic University, Brussels, Le Havre, France; 3University of Applied Sciences and Arts Western Switzerland Valais (HES-SO Valais-Wallis), School of Health Sciences, Leukerbad, Leukerbad, Switzerland; 4IFMK de Rouen, Rouen, France; 5ADIR Association Normandie University, UNIROUEN, UPRES EA3830-GRHV, Institute for Research and Innovation in Biomedicine (IRIB), Bois Guillaume, France; 6University of Applied Sciences and Arts Western Switzerland (HES-SO), Lausanne, Switzerland; 7Le Havre Hospital, Pulmonology Department. Normandie University, UNIROUEN, UPRES EA3830-GRHV, Institute for Research and Innovation in Biomedicine (IRIB), Le Havre, France
Correspondence: Clement Medrinal (medrinal.clement.mk@gmail.com)
COK-3 Accuracy of diaphragm ultrasound to predict weaning outcome during spontaneous breathing trial: a meta-analysis
Aymeric Le Neindre1, Francois Philippart1, Marta Luperto2, Johan Wormser1, Johanna Morel3, Serge Aho2, Silvia Mongodi4, Francesco Mojoli4, Belaid Bouhemad2
1Groupe Hospitalier Paris Saint-Joseph, Paris, France; 2CHU de Dijon, Dijon, France; 3CHU Henri Mondor, Créteil, France; 4Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Correspondence: Aymeric Le Neindre (aymeric.leneindre@gmail.com)
CO-01 Risk factors for candidemia: a prospective matched case–control study
Julien Poissy1, Lauro Damonti2, Anne Bignon3, Nina Khanna4, Matthias Von Kietzell5, Katia Boggian5, Dionysios Neofytos6, Fanny Vuotto7, Valerie Coiteux8, Florent Artru9, Stefan Zimmerli2, Jean-Luc Pagani10, Thierry Calandra11, Boualem Sendid12, Daniel Poulain12, Christian Van Delden6, Frédéric Lamoth13, Oscar Marchetti11, Pierre-Yves Bochud11
1Intensive Care Department, University hospital of Lille, Lille, France; 2Department of Infectious Diseases, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland; 3Surgical Intensive Care Unit. University hospital of Lille, Lille, France; 4Division of Infectious Diseases and Hospital Epidemiology, University Hospital of Basel, Basel, Switzerland; 5Department of Infectious Diseases, Cantonal Hospital of Saint Gallen, Saint Gallen, Switzerland; 6Infectious diseases, University Hospital of Geneva, Geneva, Switzerland; 7Infectious Diseases Department, University hospital of Lille, Lille, France; 8Hematological Disorders Department, University Hospital of Lille, Lille, France; 9Digestive Intensive Care Department, University Hospital of Lille, Lille, France; 10Intensive Care Department, University hospital of Lausanne, Lausanne, Switzerland; 11Infectious Diseases Department, University Hospital of Lausanne, Lausanne, Switzerland; 12Laboratory of Mycology and Parasitology, University Hospital of Lille, Lille, France; 13Microbiology Institute, University Hospital of Lausanne, Lausanne, Switzerland
Correspondence: Julien Poissy (julien_poissy@hotmail.fr)
CO-02 A stronger signal of ART-123 efficacy in patients with sepsis associated coagulopathy enrolled into the SCARLET Trial in France
Bruno François1, Maud Fiancette2, Julie Helms3, Emmanuelle Mercier4, Jean-Baptiste Lascarrou5, Xavier Wittebole6, Amanda Radford7, Toshihiko Kayanoki7, Kosuke Tanaka7, David Fineberg7, Jean-Louis Vincent8
1Réanimation polyvalente/Inserm CIC 1435/Inserm UMR 1092, CHU Dupuytren, Limoges, France; 2Médecine Intensive Réanimation, Centre Hospitalier Départemental Vendée, La Roche-Sur-Yon, France; 3Université de Strasbourg (UNISTRA), Faculté de Médecine; Hôpitaux universitaires de Strasbourg, Médecine Intensive-Réanimation, Nouvel Hôpital Civil, Strasbourg, France; 4Médecine Intensive Réanimation/CRICS-TRIGGERSEP, CHRU de Tours, Tours, France; 5Service de Médecine Intensive Réanimation, CHU de Nantes, Nantes, France; 6Department of Critical Care Medicine, Clinique universitaire St Luc, Université Catholique de Louvain, Brussels, Belgium; 7Asahi Kasei Pharma America, Waltham, UNITED STATES; 8Department of Intensive Care, Erasme Hospital, Universite Libre de Bruxelles, Brussels, Belgium
Correspondence: Bruno François (b.francois@unilim.fr)
CO-03 Use and impact of aminoglycoside empirical therapy in extended spectrum beta-lactamase enterobacteriaceae bloodstream infections in intensive care unit
Lucie Benetazzo, Pierre-Yves Delannoy, Olivier Leroy, Olivier Robineau, Agnes Meybeck
CH Tourcoing, Tourcoing, France
Correspondence: Lucie Benetazzo (lucie.benetazzo@gmail.com)
CO-04 Impact of a restrictive antibiotic policy on the emergence of extended-spectrum ß-lactamase producing Enterobacteriaceae (ESBL-E) in the ICU. A quasi-experimental observational study
Christophe Le Terrier1, Marco Vinetti1, Régine Richard1, Bruno Jarrige2, Sébastien Breurec3, Michel Carles1, Guillaume Thiery1
1CHU Guadeloupe Intensive Care Unit, Pointe-À-Pitre, France; 2CHU Guadeloupe Hospital Infection Control Department, Pointe-À-Pitre, France; 3CHU Guadeloupe Microbiology unit, Pointe-À-Pitre, France
Correspondence: Christophe Le Terrier (christophe.clt@orange.fr)
2014 | 2015 | p | |
---|---|---|---|
N patients | 1009 | 1067 | |
N patients with ICU stay > 48 h | 767 (76.0%) | 826 (77.4%) | 0.45 |
Age (years) | 55.5 (19.9%) | 54.7 (19.6%) | 0.38 |
SAPS II mean ± SD | 42 ± 24 | 40 ± 25 | 0.01 |
All patient’s ICU length of stay > 48 h | n = 767 | n = 826 | |
SAPS II mean ± SD | 42 ± 21 | 40 ± 21 | 0.08 |
Sepsis (community or acquired) | 374 (48.8%) | 320 (38.7%) | < 0.0001 |
Catecholamines administrated in septic patients | 170 (22.2%) | 151 (18.3%) | 0.06 |
Primary outcome | |||
ICU-acquired ESBL-E | 145 (18.9%) | 92 (11.1%) | < 0.0001 |
Secondary outcomes | |||
ESBL-E infections | 60 (7.8%) | 37 (4.5%) | 0.005 |
All-cause ICU mortality | 215 (28.0%) | 184 (22.3%) | 0.01 |
All-cause hospital mortality | 256 (33.4%) | 226 (27.4%) | 0.01 |
ICU length of stay, days median ± IQR | 6 [4–12] | 5 [4–10] | 0.02 |
Patients who did not receive antibiotic therapy | 332 (43.3%) | 440 (53.5%) | < 0.0001 |
Number of patients receiving antibiotics | n = 435 | n = 386 | < 0.0001 |
Antibiotics administrated | |||
Amoxicillin | 29 (6.7%) | 67 (17.6%) | < 0.0001 |
Amoxicillin/ clavulanic acid | 122 (88.0%) | 69 (17.9%) | < 0.0001 |
Piperacillin/tazobactam | 169 (38.9%) | 18 (4.7%) | < 0.0001 |
Cefotaxime/Ceftriaxone (C3G) | 196 (45.1%) | 162 (42%) | 0.37 |
Cefoxitin (cephamycin) | 6 (1.4%) | 34 (8.8%) | < 0.0001 |
Ceftazidime | 19 (4.4%) | 40 (10.4%) | < 0.0001 |
Cefepim | 7 (1.6%) | 18 (4.3%) | 0.01 |
Carbapenem | 54 (12.4%) | 14 (4.7%) | < 0.0001 |
Antibiotics targeting anaerobic pathogens* | 379 (87.1%) | 171 (37.5%) | < 0.0001 |
CO-05 Awake venoarterial extracorporeal membrane oxygenation in cardiogenic shock: a propensity score matched analysis
Santiago Montero1, Florent Huang2, Juliette Chommeloux2, Nicolas Brechot2, Pierre Demondion3, Guillaume Franchineau2, Guillaume Hekimian2, Romain Persichini4, Charles-Edouard Luyt2, Guillaume Lebreton3, Alain Combes2, Matthieu Schmidt2
1Hospital Germans Trias i Pujol, Acute Cardiovascular Care Unit, Cardiology, Universitat Autònoma de Barcelona, Barcelona, Spain; 2Assistance Publique–Hôpitaux de Paris, Pitié–Salpêtrière Hospital, Medical Intensive Care Unit, 75651 Paris Cedex 13, France; 3Assistance Publique–Hôpitaux de Paris, Pitié–Salpêtrière Hospital, Thoracic and Cardiovascular department, 75651 Paris Cedex 13, France; 4Medical–Surgical Intensive Care Unit, CHU de La Réunion, Felix-Guyon Hospital, Saint Denis, La Réunion, France
Correspondence: Santiago Montero (monteroaradas@gmail.com)
CO-06 Impact of pulmonary hypertension on post heart transplant outcome
Cyrielle Desnos1, Guillaume Coutance1, Mathieu Kerneis1, Amandine Baptiste2, Guillaume Lebreton3, Charles-Edouard Luyt4, Alain Combes4, Shaida Varnous1, Nicolas Brechot4
1Cardiology department, La Pitié Salpêtrière hospital, Paris, France; 2Biostatistics and public health department, La Pitié Salpêtrière hospital, Paris, France; 3Cardio-thoracic surgery department, La Pitié Salpêtrière hospital, Paris, France; 4Intensive care unit, Cardiology institute, La Pitié Salpêtrière hospital, Paris, France
Correspondence: Cyrielle Desnos (cyrielle.desnos@wanadoo.f)
CO-07 Hemodynamic and microcirculation evaluation of Vasopressin versus Norepinephrine in a porcine model of refractory cardiac arrest resuscitated by venous-arterial ECMO
Thomas Klein1, Caroline Fritz1, Daniel Grandmougin2, Yihua Liu2, Sophie Orlowski3, Tran N’guyen4, Eliane Albuisson5, Bruno Lévy1
1Service de Réanimation Médicale Brabois, CHRU Nancy, Pôle Cardio-Médico-Chirurgical, INSERM U1116 Vandoeuvre-Les-Nancy, France; 2Service de Chirurgie Cardiaque Brabois, CHRU Nancy, Pôle Cardio-Médico-Chirurgicale, INSERM U1116, Vandoeuvre-Les-Nancy, France; 3Service de Biochimie, Pôle Laboratoires, CHRU Nancy Central, Nancy, France; 4Ecole de chirurgie, Faculte de Médecine, Université de Lorraine, Vandoeuvre-Les-Nancy, France; 5Plateforme d’aide à la recherche clinique (PARC-UMDS), Hôpital de Brabois, CHRU Nancy, Vandoeuvre-Les-Nancy, France
Correspondence: Thomas Klein (thomas090@outlook.fr)
CO-08 Veno-arterial Extracorporeal Membrane Oxygenation flow or Dobutamine to increase microcirculation for Refractory Cardiogenic Shock
Juliette Chommeloux1, Santiago Montero2, Guillaume Franchineau1, Alain Combes1, Matthieu Schmidt1
1Assistance Publique–Hôpitaux de Paris, Pitié–Salpêtrière Hospital, Medical Intensive Care Unit, 75651 Paris Cedex 13, France; 2Acute and intensive cardiovascular care unit, department of cardiology, hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Correspondence: Juliette Chommeloux (juliette.chommeloux@gmail.com)
CO-09 Weaning from noninvasive ventilation and high flow nasal cannula in patients with severe bronchiolitis
Julie Cassibba1, Anne Ego2, Isabelle Pin1, Guillaume Mortamet3
Service de pédiatrie, CHU de Grenoble, Grenoble, France; 2Département de santé publique, CHU de Grenoble, Grenoble, France; 3Service de réanimation pédiatrique, CHU de Grenoble, Grenoble, France
Correspondence: Julie Cassibba (jcassibba@chu-grenoble.fr)
CO-10 Influenza-associated encephalitis: a French multicentric retrospective study in pediatric intensive care units
Pierre CLEUZIOU1, Florence RENALDO1, Sylvain RENOLLEAU2, Isabelle DESGUERRE2, Etienne JAVOUHEY3, Pierre TISSIERES4, Pierre-Louis LEGER5, Stéphane DAUGER1, Michael LEVY1
1Hôpital Robert Debré-APHP, Paris, France; 2Hôpital Necker Enfants Malades-APHP, Paris, France; 3Hôpitaux de Lyon, Lyon, France; 4Hôpital du Kremlin-Bicêtre-APHP, Le Kremlin Bicêtre, France; 5Chef de service de la réanimaton pédiatrique de l’hôpital Trousseau, Paris, France
Correspondence: Pierre Cleuziou (pierre.cleu@gmail.com)
CO-11 Population pharmacokinetics of Cefazolin in critically ill children infected with methicillin-sensitive Staphylococcus aureus
Elodie Salvador, Mehdi Oualha, Emmanuelle Bille, Olivier Bustarret, Agathe Béranger, Guillaume Geslain, Florence Moulin, Julie Toubiana, Sihem Benaboud, Sylvain Renolleau, Jean-Marc Tréluyer, Déborah Hirt
Necker Hospital, Paris, France
Correspondence: Elodie Salvador (elodie.salvador@aphp.fr)
CO-12 Factors influencing unplanned extubations in a pediatric intensive care unit: a 9-year prospective study
Guillaume Geslain, Jeanne Mayeur, Michael Levy, Géraldine Poncelet, Fleur Le Bourgeois, Arielle Maroni, Camille Dollat, Jérôme Naudin, Stéphane Dauger, Maryline Chomton, Anna Deho
Pediatric Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Robert Debre University Hospital, Université de Paris, Paris, France
Correspondence: Guillaume Geslain (guillaume.geslain@aphp.fr)
Total number of accidental extubations n = 102 | |
---|---|
Age < 2 years | 68/102 (67.1%) |
Use of sedation | 80/100 (80.0%) |
Patients described as agitated | 35/96 (36.5%) |
Presence of physical restraints | 90/98 (91.8%) |
Nasally inserted endotracheal tube | 47/101 (46.5%) |
Cuffed endotracheal tube | 53/92 (57.6%) |
Unknown circumstances (no staff at bedside) | 55/102 (53.9%) |
Re-intubation rate | 59/97 (60.8%) |
Median nurse to patient ratio | 1:2.29 |
CO-13 Score for the risk of acquisition of pressure ulcer in the ICU: Data from the Pressure Study
Philippe Michel1, Gwenaëlle Jacq1, Gregoire Muller1, Guillaume Decormeille1, Atika Youssoufa1, Laurent Poiroux1, Brigitte Barrois2, Nadia Aissaoui1, Saber Davide Barbar1, Florence Boissier1, David Grimaldi1, Sami Hraiech1, Nicholas Heming1, Bertrand Hermann1, Jean-FrançOis Llitjos1, Lamia Besbes1, Jean-Baptiste Lascarrou1, Gaël Piton1
1CERC, Paris, France; 2Association PERSE, Paris, France
Correspondence: Philippe Michel (philippe@docteur-michel.fr)
CO-14 Effect of short incitement to follow social media to improve knowledge of scientific literature by intensive care trainees
Jean-Baptiste Lascarrou1, Stephan Ehrmann2, Maelle Martin1, Pierre Potier1, Jean-Marie Castillo3, Jean Reignier1, Emmanuel Canet1
1Médecine Intensive Réanimation, Nantes, France; 2Médecine Intensive Réanimation, Tours, France; 3General Practionner, Nantes, France
Correspondence: Jean-Baptiste Lascarrou (jeanbaptiste.lascarrou@chu-nantes.fr)
Group 1 Already on Twitter (n = 16) | Group 2 Randomized Twitter (n = 31) | Group 3 Randomized Control (n = 30) | P | |
---|---|---|---|---|
Number or respondents | 10 | 24 | 28 | 0.29 |
Opening of a Twitter account | – | 21 | 1 | – |
Knowledge of #FOAMed resource Sci-Hub Unpaywall Kopernio PubMed Central | 10 0 2 5 | 22 0 0 13 | 28 0 0 14 | 0.29 - 0.02 0.94 |
Self-declaration of article knowledge | 4 [2–5] 3.6 ± 1.4 | 4[3–5] 3.5 ± 1.3 | 4 [2.5–4] 3.4 ± 1.3 | 0.85 |
Global score of article knowledge (1 point for each good answer to primary outcome) | 4 [3–5] 3.9 ± 0.9 | 4 [2.5–4] 3.5 ± 1.2 | 3 [2–4] 3.1 ± 0.9 | 0.09 |
At least one abstract read | 9 | 21 | 23 | 0.89 |
At least one article read | 8 | 10 | 15 | 0.11 |
At least one article discussed | 9 | 20 | 20 | 0.45 |
At least one article discussed on Twitter | 0 | 0 | 0 | – |
CO-15 Construction of a stress scale specific to intensive care units: the PS-ICU scale
Alicia Fournier1, Florent Lheureux2, Maria Cruz Martin Delgado3, Maria Grazia Bocci4, Alessia Prestifilippo5, Amélie Anota6, Pierre Aslanian7, Guillaume Besch8, Jean-Michel Constantin9, Jean-Pierre Quenot10, Belaid Bouhemad11, Gilles Capellier12, Alexandra Laurent1
1Department of psychology, University of Burgundy, Dijon, France; 2Department of psychology, University of Franche-Comté, Besançon, France; 3Hospital Universitario Torrejón en Torrejón de Ardoz, Madrid, Spain; 4Department of anesthesiology and intensive care medicine, Fondazione Policlinico Universitario Agostino Gemelli—IRCCS, Roma, Italy; 5Psychologist, Private practice, Roma, Italy; 6Methodology and quality of life unit in oncology, Centre hospitalier régional universitaire de Besançon, Besançon, France; 7Department of intensive care medicine, CHUM, Montréal, Canada; 8Surgical intensive care unit, Centre hospitalier régional universitaire de Besançon, Besançon, France; 9Anesthesiology critical care and perioperatrive medicine, Hôpital La Pitié Salpêtrière, Paris, France; 10Department of intensive care medicine, Centre hospitalier régional universitaire de Dijon, Dijon, France; 11Surgical intensive care unit, Centre hospitalier régional universitaire de Dijon, Dijon, France; 12Department of intensive care medicine–samu 25, Centre hospitalier régional universitaire de Besançon, Besançon, France
Correspondence: Alicia Fournier (alicia.fournier@u-bourgogne.fr)
CO-16 Are Intensive Care Residents more exposed to Anxiety/Depression?
Mehdi Marzouk1, Manel Lahmar2, Zeineb Hammouda2, Islem Ouanes2, Fahmi Dachraoui2, Lamia Besbes2, Fekri Abroug2
1Service de Réanimation Centre Hospitalier de Béthune, Beuvry, France; 2Service de Réanimation Polyvalente. CHU F.Bourguiba, Monastir, Tunisia
Correspondence: Mehdi Marzouk (docmehdi.marzouk@gmail.com)
CO-17 Outcome of adult sickle cell patients admitted in ICU: national retrospective study in French ICUs
Maïté Agbakou1, Noelle Brule2, Morgane Pere3, Emmanuel Canet2, Jean Reignier2, Jean-Baptiste Lascarrou2
1Service de médecine intensive réanimation, CHU Nantes, Nantes, France; 2CHU Nantes, Service De Médecine Intensive Réanimation, Chu Nantes, France; 3Plateforme de Méthodologie et Bistastistiques, direction de la recherche, CHU Nantes, Nantes, France
Correspondence: Maïté Agbakou (maite.agbakou@gmail.com)
CO-18 In-Hospital Mortality-Associated Factors of Thrombotic Antiphospholipid Syndrome Patients Requiring Intensive Care Unit Admission
Marc Pineton De Chambrun1, Romaric Larcher2, Frédéric Pene3, Laurent Argaud4, Julien Mayaux5, Rémi Coudroy6, Elie Azoulay7, Yacine Tandjaoui-Lambiotte8, Stanislas Faguer9, Charles-Edouard Luyt1, Alain Combes1, Zahir Amoura10
1Sorbonne Université, APHP, Hôpital La Pitié–Salpêtrière, Institut de Cardiométabolisme et Nutrition (ICAN), Service de Médecine Intensive-Réanimation, Paris, France; 2Service de Médecine Intensive-Réanimation, Hôpital Lapeyronie, Centre Hospitalier Universitaire (CHU) de Montpellier PhyMedExp, Université de Montpellier, INSERM, CNRS, Montpellier, France; 3Service de Médecine Intensive-Réanimation, Hôpital Cochin, Hôpitaux Universitaires Paris Centre, APHP & Université Paris Descartes, Paris, France; 4Service de Médecine Intensive-Réanimation, Hôpital Edouard-Herriot, Hospices Civils de Lyon, Lyon, France; 5APHP, Hôpital La Pitié–Salpêtrière, Service de Pneumologie, Médecine Intensive et Réanimation Médicale, Département R3S, Paris, France; 6Service de Médecine Intensive-Réanimation, INSERM CIC1402, Groupe ALIVE, Université de Poitiers, CHU de Poitiers, Poitiers, France; 7Service de Médecine Intensive-Réanimation, Hôpital Saint-Louis, APHP, Paris, France; 8Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, APHP, HUPSSD, Bobigny, France; 9Département de Néphrologie et Transplantation d’Organes, Unité de Réanimation, Centre de Référence des Maladies Rénales Rares, Hôpital Rangueil, CHU de Toulouse, Toulouse, France; 10Sorbonne Université, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital La Pitié–Salpêtrière, Institut E3M, Service de Médecine Interne 2, Centre de Référence National Lupus Systémique, Syndrome des Anticorps Anti-phospholipides et Autres Maladies Auto-Immunes Systémiques Rares, Paris, France
Correspondence: Marc Pineton de Chambrun (marc.dechambrun@gmail.com)
CO-19 Coagulation disorders in critically ill HLH patients: a prospective study
Sandrine Valade1, Michaël Darmon1, Amélie Launois2, Bérangère Joly2, Jehane Fadlallah3, Lionel Galicier3, Claire Fieschi3, Lara Zafrani1, Virginie Lemiale1, Anne Claire Lepretre4, Adrien Mirouse1, Jean-Jacques Tudesq1, Agnès Veyradier2, Elie Azoulay1, Eric Mariotte1
1Saint-Louis Hospital, Medical ICU, Paris, France; 2Hematology Department and Research Unit EA3518, Institute of Hematology, French Reference Center for Thrombotic Microangiopathies, Lariboisière Hospital, University Paris Diderot, Paris, France; 3Department of Clinical Immunology, Saint-Louis Hospital, Paris, France; 4Saint-Louis Hospital, Transfusion Department, Etablissement Français Du Sang, Paris, France
Correspondence: Sandrine Valade (sandrine.valade@aphp.fr)
CO-20 Thrombotic thrombocytopenic purpura related neurological manifestations: clusters at presentation and long-term prognosis
Adrien Mirouse1, Stéphane Legriel2, Sylvie Chevret1, Agnès Veyradier1, Lionel Galicier1, Lara Zafrani1, Eric Mariotte1, Elie Azoulay1
1Hôpital Saint-Louis, Paris, France; 2Centre Hospitalier de Versailles, Le Chesnay, France
Correspondence: Adrien Mirouse (adrien.mirouse@aphp.fr)
Outcome | Cluster 1 n = 47 | Cluster 2 n = 22 | Cluster 3 n = 39 | p-value |
---|---|---|---|---|
Month 3 (n = 108) | ||||
Relapse | 4 (9%) | 0 (0%) | 1 (3%) | 0.43 |
Alive | 47 (100%) | 22 (100%) | 37 (95%) | 0.0001 |
GOS 5 | 44 (98%) | 13 (65%) | 21 (60%) | < 0.0001 |
Motor deficiency | 0 (0%) | 4 (20%) | 8 (24%) | 0.0006 |
Cognitive impairment | 0 (0%) | 6 (30%) | 9 (27%) | < 0.0001 |
Month 6 (n = 105) | ||||
Relapse | 2 (5%) | 1 (5%) | 2 (6%) | 1.00 |
Alive | 44 (100%) | 22 (100%) | 36 (92%) | < 0.0001 |
GOS 5 | 44 (100%) | 15 (68%) | 23 (69%) | < 0.0001 |
Motor deficiency | 0 (0%) | 5 (26%) | 6 (19%) | 0.0008 |
Cognitive impairment | 0 (0%) | 4 (21%) | 7 (23%) | 0.001 |
Year 1 (n = 94) | ||||
Relapse | 4 (10%) | 1 (5%) | 1 (4%) | 0.86 |
Alive | 40
(100%) | 19 (100%) | 27 (77%) | 0.0002 |
GOS 5 | 40 (100%) | 15 (79%) | 20 (57%) | < 0.0001 |
Motor deficiency | 0 (0%) | 2 (11%) | 4 (15%) | 0.021 |
Cognitive impairment | 0 (0%) | 2 (11%) | 7 (26%) | 0.001 |
CO-21 Relationship between diaphragm thickening fraction and transdiaphragmatic pressure in healthy and mechanically ventilated patients: a breath by breath analysis
Thomas Poulard1, Quentin Fossé2, Jean-Luc Gennisson3, Marie-Cécile Niérat2, Jean-Yves Hogrel1, Thomas Similowski2, Alexandre Demoule2, Damien Bachasson1, Martin Dres2
1Institute of Myology, Neuromuscular Investigation Center, Neuromuscular Physiology Laboratory, Paris, France; 2AP-HP, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Service de Pneumologie, Médecine Intensive et Réanimation, (Département “R3S”), Paris, France; 3Imagerie par Résonance Magnétique Médicale et Multi-Modalités (IR4M), CNRS UMR8081, Université Paris-Saclay, Orsay, France
Correspondence: Thomas Poulard (t.poulard@institut-myologie.org)
CO-22 Accuracy of clinical estimation of the respiratory effort under pressure support ventilation
Samuel Tuffet, François Perier, Anne-Fleur Haudebourg, Nicolas De Prost, Keyvan Razazi, Armand Mekontso Dessap, Guillaume Carteaux
Réanimation médicale CHU Henri Mondor, Créteil, France
Correspondence: Samuel Tuffet (samuel.tuffet@hotmail.fr)
CO-23 Influence of body mass index on respiratory mechanics in acute respiratory distress syndrome: a multicenter cohort study
Rémi Coudroy1, Jean-Luc Diehl2, Damien Vimpere3, Nadia Aissaoui3, Romy Younan3, Clotilde Bailleul3, Amélie Couteau-Chardon3, Aymeric Lancelot3, Emmanuel Guérot3, Chen Lu4, Laurent Brochard4
1Poitiers Hospital, Poitiers, France; 2Assitance Publique Hopitaux de Paris, Paris, France; 3Georges Pompidou European Hospital, Paris, France; 4Interdepartmental Division of Critical Care Medicine, Toronto, Canada
Correspondence: Rémi Coudroy (r.coudroy@yahoo.fr)
CO-24 Impact of tidal volume during the “transition period” following neuromuscular blockade cessation in ARDS: an observational study
Safaa Nemlaghi1, Anne-Fleur Haudebourg2, François Perier2, Nicolas De Prost2, Keyvan Razazi2, Guillaume Voiriot1, Muriel Fartoukh1, Armand Mekontso Dessap2, Guillaume Carteaux2
1Médecine Intensive Réanimation, Hôpital Tenon, Paris, France; 2Réanimation Médicale, CHU Henri Mondor, Créteil, France
Correspondence: Safaa Nemlaghi (safaa.nemlaghi@gmail.com)
CO-25 Impact of Perioperative Anemia and red blood Cells Transfusion on post-operative complications after oncological surgery
Xavier Chapalain1, Yves Ozier1, Catherine Le Niger2, Olivier Huet1, Cécile Aubron3
1Department of anesthesiology and intensive care unit, CHRU de Brest Hôpital de la Cavale Blanche, Brest, France; 2Haemovigilance Unit, CHRU de Brest, Brest, France; 3Medical Intensive Care unit, CHRU de Brest, Brest, France
Correspondence: Xavier Chapalain (xavier.chapalain@chu-brest.fr)
CO-26 Impact of blood products transfusions on the susceptibility to ICU-acquired infections in septic shock
Edwige Péju1, Jean-FrançOis Llitjos1, Jean-Paul Mira1, Jean-Daniel Chiche1, Alain Cariou1, Julien Charpentier1, Matthieu Jamme2, Frédéric Pene1
1Centre Hospitalier COCHIN (APHP), Paris, France; 2Centre Hospitalier TENON (APHP), Paris, France
Correspondence: Edwige Péju (edwigepeju@gmail.com)
CO-27 Exploring the microvascular impact of Red Blood Cell Transfusion in intensive care unit patients
Geoffroy Hariri1, Simon Bourcier1, Zora Marjanovic2, Jérémie Joffre1, Jeremy Lemarie3, Jean-Rémi Lavillegrand1, Dominique Charue3, Thomas Duflot4, Naike Bige1, Jean-Luc Baudel1, Eric Maury1, Mohamad Mohty2, Bertrand Guidet1, Jeremy Bellien5, Olivier Blanc-Brude3, Hafid Ait-Oufella1
1Medecine intensive Reanimation, Hôpital Saint-Antoine, Paris, France; 2Service d’hématologie, Hôpital Saint-Antoine, Paris, France; 3Inserm U970, Paris, France; 4Inserm U1096, Rouen, France; 5Medecine Inserm U1096, Rouen, France
Correspondence: Geoffroy Hariri (geoffroyhariri@hotmail.com)
CO-28 Effectiveness of a transfusion protocol to reduce the inappropriate use of red blood cell transfusions in critically ill patients: a before and after study
Eric Thiry, Eloïse Natalis, Deeba Ali, Julien Guntz, Philippe Devo, Pierre Demaret
chc liège, liège, belgium
Correspondence: Eric Thiry (eric.thiry@chc.be)
CO-29 Effect of extracorporeal CO2 removal on right ventricular function in patients with acute respiratory distress syndrome: the ECCO2Rea pilot study
Suzanne Goursaud, Xavier Valette, Julien Dupeyrat, Cedric Daubin, Damien Du Cheyron
CHU de Caen Normandie, Service de Réanimation Médicale, 14000 Caen, France
Correspondence: Suzanne Goursaud (goursaud.suzanne@wanadoo.fr)
CO-30 Typology of Published Randomized Controlled Trials in Critically Ill Patients with Acute Respiratory Failure
Guillaume Dumas1, Sylvie Chevret2, Marine le Corre3, Elie Azoulay1
1Medical Intensive Care Unit, Saint-Louis University Hospital, Paris, France; 2ECSTRA team, Biostatistics and clinical epidemiology, UMR 1153 (center of epidemiology and biostatistic Sorbonne Paris Cité, CRESS), INSERM, Paris Diderot University, Paris, France; 3Department of Anesthesiology and Critical Care, Groupe Hospitalier Pitié-Salpêtrière Charles Foix, Paris, France
Correspondence: Guillaume Dumas (dumas.guillaume1@gmail.com)
CO-31 Impact of radiation therapy exposure on outcome of cancer patients admitted in an intensive care unit for acute respiratory failure
Lucile Martin1, Michaël Darmon2, Virginie Lemiale2, Alexandre Demoule3, Frédéric Pene4, Anne-Pascale Meert5, Achille Kouatchet6, djamel MOKART7, Fabrice Bruneel8, Elie Azoulay2, Martine Nyunga1
1Centre Hospitalier de Roubaix, Roubaix, France; 2Hôpital Saint-Louis, Paris, France; 3Hôpital Pitié-Salpêtrière, Paris, France; 4Hôpital Cochin, Paris, France; 5Institut Jules Bordet, Brussels, Belgium; 6Centre Hospitalier Régional Universitaire, Angers, France; 7Institut Paoli Calmettes, Marseille, France; 8Hôpital André Mignot, Versailles, France
Correspondence: Lucile Martin (lucile.martin.lm@gmail.com)
CO-32 Benefit-to-risk balance of bronchoalveolar lavage in the critically ill. A prospective, multicenter cohort study
Toufik Kamel1, Julie Helms2, Ralf Janssen-Langenstein3, Achille Kouatchet4, Antoine GUILLON5, Jeremy Bourenne6, Damien Contou7, Christophe Guervilly8, Rémi Coudroy9, Marie-anne Hoppe10, Jean-Baptiste Lascarrou11, Jean-Pierre Quenot12, Gwenhael Colin13, Paris Meng14, Jerome Roustan15, Christophe Cracco16, Mai-anh Nay1, Thierry Boulain1
1Centre Hospitalier Régional d’Orléans, Service de Médecine Intensive Réanimation, Orléans, France; 2CHU de Strasbourg-Hôpital Civil, Service de Réanimation Médicale, Strasbourg, France; 3Médecine Intensive Réanimation, Hôpital de Haute pierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; 4CHU d’Angers, Service de Réanimation Médicale et de Médecine Hyperbare, Angers, France; 5CHRU de Tours-Hôpital Bretonneau, Service de Réanimation Polyvalente, Tours, France; 6Médecine Intensive Réanimation, Réanimation des Urgences, Hôpital La Timone, Marseille, France; 7CH d’Argenteuil, Service de Réanimation Polyvalente, Argenteuil, France; 8Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, Médecine Intensive Réanimation, Marseille, France; 9Médecine Intensive et Réanimation, CHU de Poitiers, Poitiers, France; 10CH de La Rochelle-Hôpital Saint-Louis Service de Réanimation Polyvalente, La Rochelle, France; 11Service de Médecine Intensive Réanimation, CHU de Nantes, Hôtel Dieu, Nantes, France; 12CHU de Dijon-Complexe du Bocage, Dijon, France; 13CHD Vendée–Hôpital de la Roche-sur-Yon, La Roche-Sur-Yon, France; 14Hôpital Raymond Poincaré, APHP, Service de Médecine intensive Réanimation, Garches, France; 15Centre hospitalier de Montauban, service de réanimation polyvalente, Montauban, France; 16CH d’Angoulême Service de Réanimation Polyvalente, Angoulême, France
Correspondence: Toufik Kamel (toufik.kamel@chr-orleans.fr)
CO-33 Meningitis is a rare complication of critically ill patients with severe pneumococcal community-acquired pneumonia
Paul Jaubert, Julien Charpentier, Jean-Daniel Chiche, Frédéric Pene, Alain Cariou, Guillaume Savary, Marine Paul, Jean-Paul Mira, Mathieu Jozwiak
Cochin, Paris, France; 2 Mignot, Versailles, France
Correspondence: Paul Jaubert (paul.jaubert@gmail.com)
CO-34 Acute varicella zoster encephalitis admitted to the ICU: a French multicentric cohort
Adrien Mirouse1, Romain Sonneville2, Keyvan Razazi3, Sybille Merceron4, Laurent Argaud5, Naike Bige6, Stanislas Faguer7, Pierre Perez8, Guillaume Geri9, Claude Guérin5, Anne-Sophie Moreau10, Laurent Papazian11, René Robert12, François Barbier13, Frédérique Ganster14, Julien Mayaux15, Elie Azoulay1, Emmanuel Canet16
1Hôpital Saint-Louis, Paris, France; 2Hôpital Bichat, Paris, France; 3Hôpital Henri Mondor, Créteil, France; 4Hôpital André Mignot, Le Chesnay, France; 5CHU de Lyon, Lyon, France; 6Hôpital Saint-Antoine, Paris, France; 7CHU de Toulouse, Toulouse, France; 8CHU de Nancy, Nancy, France; 9Hôpital Cochin, Paris, France; 10CHU de Lille, Lille, France; 11CHU de Marseille, Marseille, France; 12CHU de Poitiers, Poitiers, France; 13CHU de Orléans, Orléans, France; 14CH de Mulhouse, Mulhouse, France; 15Hôpital Pitié-Salpêtrière, Paris, France; 16CHU de Nantes, Nantes, Frances
Correspondence: Adrien Mirouse (adrien.mirouse@aphp.fr)
CO-35 Comparative analysis of host responses to septic and non-septic shock
Fabrice Uhel1, Brendon Scicluna1, Lonneke van Vught1, Olaf Cremer2, Marc Bonten3, Marcus Schultz4, Tom van der Poll1
1Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; 2Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, Netherlands; 3Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands; 4Department of Intensive Care Medicine, and Laboratory of Experimental Intensive Care and Anesthesiology (L·E·I·C·A), Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
Correspondence: Fabrice Uhel (fabrice.uhel@gmail.com)
CO-36 HepatoDengue: Severity and outcome of acute hepatitis in Dengue Fever in New Caledonia
Mathieu Série1, Darless Clausse1, Marine Noel1, Paul Abraham1, Carole Forfait2, Sophie Gaimard1, Delphine Betton1
1CHT, Nouméa, France; 2DASS, Nouméa, France
Correspondence: Mathieu Série (mathieuserie@aol.com)
CO-37 Long-term prognosis after ICU discharge in kidney transplant recipients
Romain Arrestier1, Nathanael Lapidus2, Xavier Monnet3, Muriel Fartoukh4, Armand Mekontso Dessap5, Philippe Grimbert6, Antoine Durrbach7, Eric Rondeau8, Matthieu Jamme9
1Medical Intensive Care Unit, Henri Mondor University Hospital, Assistance Publique-Hôpitaux de Paris, Créteil, France; 2Sorbonne University, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique IPLESP, Public Health Department, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; 3Service de réanimation médicale, Hôpital de Bicêtre. Université Paris-Sud, Faculté de médecine Paris-Sud, Inserm UMR S 999, Le Kremlin-Bicêtre, France; 4AP-HP, Hôpital Tenon, Service de Réanimation médico-chirurgicale Faculté de médecine Sorbonne Université Groupe de Recherche Clinique CARMAS, Collégium Gallilée, UPEC, Paris, France; 5Service de Réanimation Médicale, Hôpitaux Universitaires Henri Mondor-Albert Chenevier, Assistance Publique-Hôpitaux de Paris. Groupe de Recherche Clinique CARMAS, Université Paris-Est Créteil, IMRB, Créteil, France; 6AP-HP, Nephrology and Renal Transplantation Department, Institut Francilien de Recherche en Néphrologie et Transplantation (IFRNT), Groupe Hospitalier Henri-Mondor/Albert-Chenevier Université Paris-Est-Créteil, DHU, VIC, IMRB, Equipe 21, INSERM U 955, Créteil, France; 7Nephrology Service, Centre Hospitalier de Bicetre UMRS1197, INSERM, Villejuif University Paris Sud, Orsay, Le Kremlin Bicêtre, France; 8Kidney transplant department, Tenon Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France; 9Service de Réanimation Médico-Chirurgicale, CHI Poissy/Saint-Germain-en-Laye, Poissy, France
Correspondence: Romain Arrestier (romain.arrestier@gmail.com)
CO-38 Outcome of septic patients with augmented renal clearance after community-acquired infection
Romain Courcelle, Diego Castanares, Pierre-François Laterre, Philippe Hantson
Departement of intensive care unit, Cliniques Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
Correspondence: Romain Courcelle (romcourcelle@hotmail.com)
CO-39 Transition from Acute Kidney Injury to recovery: A cohort study
Moustafa Abdel-Nabey, Etienne Ghrenassia, Eric Mariotte, Sandrine Valade, Virginie Lemiale, Lara Zafrani, Elie Azoulay, Michaël Darmon
Hopital Saint-Louis, Paris, France
Correspondence: Moustafa Abdel-Nabey (moustafa.abdelnabey@gmail.com)
CO-40 Attributable mortality and host response alterations associated with transient and persistent acute kidney injury in critically ill patients with sepsis
Fabrice Uhel1, Hessel Peters-Sengers1, Fahimeh Falah1, Brendon Scicluna1, Lonneke van Vught1, Marc Bonten2, Olaf Cremer 3, Marcus Schultz4, Tom van der Poll1
1Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands; 2Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, Netherlands; 3Department of Intensive Care Medicine, University Medical Center Utrecht, Utrecht, Netherlands; 4Department of Intensive Care Medicine, and Laboratory of Experimental Intensive Care and Anesthesiology (L·E·I·C·A), Amsterdam University Medical Centers, location Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands
Correspondence: Fabrice Uhel (fabrice.uhel@gmail.com)
CO-41 In-hospital cardiac arrest in intensive care units: evolution of patient profile, management and outcomes from 1997 to 2015
Clotilde Bailleul1, Etienne Puymirat1, Philippe Aegerter2, Bertrand Guidet1, Alain Cariou1, Nadia Aissaoui1
1APHP, Paris, France; 2APHP, Boulogne-Billancourt, France
Correspondence: Clotilde Bailleul (clotilde.bailleul@aphp.fr)
CO-42 Can the cahp score help to predict the mode of death post cardiac arrest?
Marine Paul1, Sarah Benghanem2, Stéphane Legriel1, Florence Dumas3, Alain Cariou2
1Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, Le Chesnay, France; 2Intensive Care Unit Cochin hospital, Paris, France; 3Emergency Department, Cochin hospital, Paris, France
Correspondence: Marine Paul (marine.1604@hotmail.fr)
CO-43 Neuron-Specific Enolase as a Predictor of Death or Poor Neurological Outcome After Out-of-Hospital Cardiac Arrest in patient with nonshockable rhythm
Arnaud-Félix Miailhe1, Alain Cariou2, Gwenhael Colin3, Jean-Pierre Quenot4, Didier Thevenin5, Nicolas Pichon6, Sylvie Vimeux7, Thierry Boulain8, Jean-Pierre Frat9, Elisabeth Coupez10, Stéphane Legriel11, Amélie le Gouge12, Bruno Giraudeau12, François Desroys du Roure13, Jean-Baptiste Lascarrou14
1Medical Intensive Care Unit, University Hospital Center, Nantes, France; 2Medical Intensive Care Unit, Cochin University Hospital Center, Paris, France; 3Medical Intensive Care Unit, District Hospital Center, La Roche Sur Yon, France; 4Medical Intensive Care Unit, University Hospital, Dijon, France; 5Medical-Surgical Intensive Care Unit, General Hospital Center, Lens, France; 6University Hospital Center, Limoge, France; 7General Hospital Center, Montauban, France; 8Regional Hospital Center, Orleans, France; 9University Hospital Center, Poitiers, France; 10Medical Intensive Care Unit, University Hospital, Clermont Ferrand, France; 11Medical Intensive Care Unit, General Hospital, Versailles, France; 12INSERM CIC1415, CHRU de Tours, Tours, France; 13Biological unit, District Hospital Center, La Roche Sur Yon, France; 14Medecine Intensive Reanimation, University Hospital Center, Nantes, France
Correspondence: Arnaud-Félix Miailhe (flexmiailhe@hotmail.com)
CO-44 Long-term disabilities in awakened survivors of out-of-hospital cardiac arrest: the Hanox study
Charles-Edouard Luyt1, Alain Cariou2, Nicolas Deye3, Emmanuel Guérot4, Julien Mayaux1, Romain Sonneville5, Pascale Pradat-Diehl1, Anne Peskine1
1Pitié-Salpêtrière Hospital, Paris, France; 2Cochin Hospital, Paris, France; 3Lariboisière Hospital, Paris, France; 4Georges Pompidou European Hospital, Paris, France; 5Bichat Hospital, Paris, France
Correspondence: Charles-Edouard Luyt (charles-edouard.luyt@aphp.fr)
CO-45 Non-inferiority study in pediatric cardiac surgery compared a short 24-h antibiotic prophylaxis with 48-h protocol
Jeanne Bordet, Lucie Petitdemange
CHU Strasbourg, Strasbourg, France
Correspondence: Jeanne Bordet (jeanne.bordet.pro@gmail.com)
CO-46 Management of pediatric acute liver failure with extra corporeal therapies
Megan Nallet-Amate1, Benoit Colomb1, Etienne Javouhey2
1Neonatal and Pediatric Intensive Care Unit, Department of Pediatrics, Dijon, Burgundy University, Dijon, France; 2Pediatric Intensive Care Unit, Department of Pediatrics, Lyon-Bron, Claude Bernard University, Lyon, France
Correspondence: Megan Nallet-Amate (megan.amate@gmail.com)
CO-47 An automated modified Wood’s clinical asthma score to strengthen respiratory severity assessment in big data
Sally Al Omar1,2, Alex Lepage-Farrell1,2, Atsushi Kawaguchi1,2,3, Gabriel Masson1,4, Philippe Jouvet1,2, Guillaume Emeriaud1,2
1Pediatric Intensive Care Unit, Sainte-Justine Hospital, Montreal, Canada; 2Department of Pediatrics, Université de Montréal, Montreal, Canada; 3Department of Pediatrics, University of Ottawa, Ottawa, Canada; 4Department of Anesthesiology and Intensive Care Medicine, University Hospital of Lille, Lille, France
Correspondence: Sally Al Omar (sally.alomar@gmail.com)
CO-48 The experience of parents of critically ill children during their stay in a French paediatric intensive care unit
Clémentine Fort, Etienne Javouhey, Fabienne Bordet
Hôpital Femme Mère Enfant, Lyon, France
Correspondence: Clémentine Fort (clementine.fort@chu-lyon.fr)
CO-49 Study of gastrointestinal dysfunction in ventilated adults with shock
Paul Decamps1, Amélie le Gouge2, Julie Boisramé-Helms3, Laurent Brisard4, Jean-Baptiste Lascarrou5, Nadia Anguel6, Laurent Argaud7, Karim Asehnoune8, Pierre Asfar9, Anne Bretagnol10, Hoang-nam Bui11, Emmanuel Canet12, Daniel da Silva13, Michaël Darmon14, Vincent Das15, Jérôme Devaquet16, Michel Djibre17, Maïté Garrouste18, Stéphane Gaudry19, Olivier Gontier20, Claude Guerin21, Bertrand Guidet22, Christophe Guitton23, Jean-Etienne Herbrecht24, Jean-Claude Lacherade25, Philippe Letocart26, Frédéric Martino27, Emmanuelle Mercier28, Jean-Paul Mira29, Saad Nseir30, Gaël Piton31, Jean-Pierre Quenot32, Jack Richecoeur33, Jean-Philippe Rigaud34, René Robert35, Carole Schwebel36, Michel Sirodot37, Didier Thevenin38, Jean Reignier1
1Service de Médecine Intensive-Réanimation, CHU de Nantes, Nantes, France; 2CIC INSERM 1415, Hôpital Bretonneau, Tours, France; 3Medical Intensive Care Unit, Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg, Strasbourg, France; 4CHU de Nantes, Hôpital Laennec, Département d’Anesthésie et Réanimation, Nantes, France; 5Médecine Intensive Réanimation, Chu De Nantes, Nantes, France; 6Medical Intensive Care Unit, CHU de Bicêtre, Assistance Publique-Hôpitaux de Paris (AP-HP), Le Kremlin-Bicêtre, Paris, France; 7Medical Intensive Care Unit, Hospices Civils de Lyon, Hôpital Edouard Herriot, Lyon, France; 8Surgical Intensive Care Unit, Hotel Dieu, CHU de Nantes, Nantes, France; 9Medical Intensive Care and Hyperbaric Oxygen Therapy Unit, Centre Hospitalier Universitaire Angers, Angers, France; 10Medical Intensive Care Unit, CHR Orléans, Orléans, France; 11Medical Intensive Care Unit, Hôpital Pellegrin, CHU Bordeaux, Bordeaux, France; 12Médecine Intensive Réanimation, CHU de Nantes, Nantes, France; 13Medical-Surgical Intensive Care Unit, Centre Hospitalier de Saint-Denis, Saint-Denis, France; 14Medical-Surgical Intensive Care Unit, University Hospital, Saint Etienne, Saint Etienne, France; 15Medical-Surgical Intensive Care Unit, Centre Hospitalier Intercommunal André Grégoire, Montreuil, France; 16Medical-Surgical Intensive Care Unit, Hôpital Foch, Suresnes, Suresnes, France; 17Medical-Surgical Intensive Care Unit, Tenon University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; 18Medical-Surgical Unit, Hôpital Saint-Joseph, Paris, France; 19Medical-Surgical Intensive Care Unit, Hôpital Louis Mourier, Assistance Publique-Hôpitaux de Paris (AP-HP), Colombes, France; 20Medical-Surgical Intensive Care Unit, Hôpital de Chartres, Chartres, France; 21Medical Intensive Care Unit, Groupement Hospitalier Nord, Hospices Civils de Lyon, Lyon, France; 22Medical Intensive Care Unit, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; 23Medical-Surgical Intensive Care Unit, Hôpital du Mans, Le Mans, France; 24Medical Intensive Care Unit, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, France; 25Médecine Intensive Réanimation, Centre Hospitalier Départemental de la Vendée, La Roche sur Yon, France; 26Medical-Surgical Intensive Care Unit, Hôpital Jacques Puel, Rodez, France; 27Medical-Surgical Intensive Care Unit, CHU de Pointe-à-Pitre, Pointe-à-Pitre, France; 28Médecine Intensive Réanimation, Hôpital Bretonneau, CHU Tours, Tours, France; 29Intensive Care Unit, Cochin University Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France; 30Medical Intensive Care Unit, CHU Lille, Lille, France; 31Intensive Care Unit, CHRU Besançon, Besançon, France; 32Medical-Surgical Intensive Care Unit, François Mitterrand University Hospital, Dijon, France; 33Medical-Surgical Intensive Care Unit, Hôpital de Beauvais, Beauvais, France; 34Medical-Surgical Intensive Care Unit, Hôpital de Dieppe, Dieppe, France; 35Medical Intensive Care Unit, CHU Poitiers, Poitiers, France; 36Medical Intensive Care Unit, CHU Albert Michallon Grenoble, Grenoble, France; 37Medical-Surgical Intensive Care Unit, Centre Hospitalier Annecy-Genevois, Metz-Tessy, France; 38Medical-Surgical Intensive Care Unit, Centre Hospitalier Docteur Schaffner, Lens, France
Correspondence: Paul Decamps (paul.decamps@hotmail.fr)
CO-50 Incidence and risk factors of upper digestive tract ischemia after Out-of-Hospital Cardiac Arrest, the ENTRACT study
David Grimaldi1, Stéphane Legriel2, Nicolas Pichon3, Philippe Colardelle2, Sarah Leblanc4, Florence Canoui-Poitrine5, Omar Ben Hadj Salem6, Gregoire Muller7, Nicolas de Prost8, Sofia Herrmann9, Sophie Marque10, Aurore Baron10, Bertrand Sauneuf11, Jonathan Messika12, Jacques Creteur13, Jean pierre Bedos14, Fabio Taccone13, Emmanuelle Boutin5, Alain Cariou6
1USI Hôpital Erasme, Bruxelles, Belgium; 2CH Versailles, Le Chesnay, France; 3CHU Dupuytren, Limoges, France; 4Gastro-enterologie CHU Cochin, Paris, France; 5Biostatistique CHU henri Mondor, Creteil, France; 6CHU Cochin, Paris, France; 7MIR CH Orléans, Orléans, France; 8CHU Henri Mondor, Creteil, France; 9Gastroentérologie CH Orléans, Orléans, France; 10Réanimation CH Sud Francilien, Corbeil, France; 11Réanimation CH Public du Cotentin, Cherbourg, France; 12Réanimation CHU Louis Mourier, Colombes, France; 13USI Hôpital Erasme, ULB, Bruxelles, Belgium; 14Réanimation CH Versailles, Le Chesnay, France
Correspondence: David Grimaldi (david.grimaldi@erasme.ulb.ac.be)
CO-51 Severe acute cholangitis in French ICUs: a retrospective multicenter study. ICUte Cholangitis group
Jean-Rémi Lavillegrand1, Emmanuelle Mercier-des-Rochettes1, Claire Pichereau2, Gaël Piton3, Baron Elodie4, Frédéric Pene4, Idriss Razach5, Merad Monchi6, Damien Contou7, Gabriel Preda8, Chloe Molliere9, Arnaud Galbois9, Arnaud-felix Miailhe10, Jean Regnier10, Raphael Favory11, Guillaume Dumas12, Hafid Ait-Oufella1
1Réanimation, Hopital Saint-Antoine, Paris, France; 2Réanimation, CH de Poissy, Poissy, France; 3Réanimation, CHU Besançon, Besançon, France; 4Réanimation, Hopital Cochin, Paris, France; 5Réanimation, CH de fontainebleau, Fontainebleau, France; 6Réanimation, CH de Melun, Melun, France; 7Réanimation, CH V Dupouy, Argenteuil, France; 8Réanimation, CH de Saint-Denis, Saint-Denis, France; 9Réanimation, CH Claude gallien, Qincy Sous Senart, France; 10Réanimation, CHU de Nantes, Nantes, France; 11Réanimation, Hopital Salengro, Lille, France; 12Réanimation, CHU Saint-Antoine, Paris, France
Correspondence: Jean-Rémi Lavillegrand (JRLavillegrand@gmail.com)
CO-52 Liver transplantation for critically ill cirrhotic patients
Thierry Artzner1, Baptiste Michard1, Emmanuel Weiss2, Louise Barbier3, Zaid Noorah4, Jean-Claude Merle4, Catherine Paugam2, Claire Francoz2, Francois Durand2, Olivier Soubrane2, Tasneem Pirani5, John O’grady5, Nigel Heaton5, Eleni Theocharidou5, William Bernal5, Ephrem Salame3, Helene Barraud3, Petru Bucur3, Francois Lefebvre1, Lawrence Serfaty1, Camille Besch1, Philippe Bachellier1, Francis Schneider1, Eric Lavesque4, François Faitot1
1Hôpital de Hautepierre, Strasbourg, France; 2Hôpital Beaujon, Clichy, France; 3Hôpital Trousseau, Tours, France; 4Hôpital Henri Mondor, Créteil, France; 5King’s College Hospital, London, UK
Correspondence: Thierry Artzner (thierry.artzner@gmail.com)
CO-53 Does Echocardiography Improve Clinical Outcomes in Shock States?
Habiba Hemamid, Mosbah Nabil, Abdelmalek Hakimi
CHU de Sétif, Setif, ALGERIA
Correspondence: Habiba Hemamid (habibahemamid@yahoo.com)
CO-54 Prognostic assessment of left ventricular diastolic and systolic function during septic shock
Philippe Vignon1, Cyril Charron2, Marine Goudelin3, Annick Legras4, Michel Slama5, Gwenael Prat6, Stein Silva7, David Vandroux8, Gregoire Muller9, Bruno Lévy10, Florence Boissier11, Bruno Evrard3, Xavier Repessé2, Julien Maizel5, Guillaume Geri2, Julie Leger12, Antoine Vieillard-Baron2
1Réanimation polyvalente/Inserm CIC 1435/Inserm UMR 1092, CHU Dupuytren/Université de Limoges, Limoges, France; 2Médecine Intensive Réanimation, CHU Ambroise Paré, APHP, Boulogne Billancourt, France; 3Réanimation polyvalente/Inserm CIC1435, CHU Dupuytren, Limoges, France; 4Médecine Intensive Réanimation, CHU Bretonneau, Tours, France; 5Réanimation médicale, CHU Amiens, Amiens, France; 6Réanimation médicale, CHU Brest, Brest, France; 7Réanimation polyvalente, CHU Purpan, Toulouse, France; 8Réanimation polyvalente, CHU Félix Guyon, Saint Denis De La Réunion, France; 9Réanimation polyvalente, CHR d’Orléans, Orléans, France; 10Réanimation médicale, Hôpitaux de Brabois, CHU de Nancy, Vandoeuvre-Lès-Nancy, France; 11Réanimation médicale, CHU La Milétrie, Poitiers, France; 12Inserm CIC 1415, CHU Bretonneau, Tours, France
Correspondence: Philippe Vignon (philippe.vignon@unilim.fr)
CO-55 Perfusion index: a non-invasive way to detect the effects of the end-expiratory occlusion test in critically ill patients
Alexandra Beurton, Francesco Gavelli, Jean-Louis Teboul, Nello De Vita, Xavier Monnet
Service de médecine intensive-réanimation, Hôpital de Bicêtre, Hôpitaux universitaires Paris-Saclay, Assistance publique—Hôpitaux de Paris, Inserm UMR S_999, Université Paris-Su, Le Kremlin-Bicêtre, France
Correspondence: Alexandra Beurton (alexandra.beurton@aphp.fr)
CO-56 Mini and micro fluid challenge predicts preload responsiveness in critically ill patients
Nello de Vita, Francesco Gavelli, Jean-Louis Teboul, Arthur Pavot, Rui Shi, Xavier Monnet
Service de médecine intensive-réanimation, Hôpital de Bicêtre, Hôpitaux universitaires Paris-Saclay, Assistance publique—Hôpitaux de Paris, Inserm UMR S_999, Université Paris-Sud, Le Kremlin-Bicêtre, France
Correspondence: Nello de Vita (Nellodevita@hotmail.com)
CO-57 Impact of diaphragm dysfunction on cardiac function and lung aeration during weaning
Emmanuel Rozenberg, Elise Morawiec, Julien Mayaux, Julie Delemazure, Thomas Similowski, Alexandre Demoule, Martin Dres
AP-HP. Sorbonne Université, Hôpital Pitié-Salpêtrière, Service de Pneumologie, Médecine intensive—Réanimation (Département “R3S”), F-75013, Paris, France
Correspondence: Emmanuel Rozenberg (emmanuelrozenberg@gmail.com)
CO-58 Shear wave elastography, a new tool for diaphragmatic qualitative assessment in critically ill patients
Yassir Aarab1, Aurelien Flatres2, Fanny Garnier1, Romaric Larcher1, David Chapeau1, Kada Klouche1, Pascal Etienne3, Gilles Subra4, Samir Jaber5, Nicolas Molinari6, Lucie Gamon6, Stefan Matecki2, Boris Jung1
1Medical Intensive Care Unit, Montpellier University and Montpellier Teaching Hospital, Montpellier, France; 2INSERM U1046, CNRS UMR9214, Université de Montpellier, Montpellier, France; 3Laboratoire Charles Coulomb (L2C), University of Montpellier, CNRS, Montpellier, France; 4Institut des Biomolécules Max Mousseron (IBMM), UMR5247 CNRS, ENSCM, Université de Montpellier, Montpellier, France; 5Saint Eloi Anesthesiology and Critical Care Medicine, Montpellier University and Montpellier Teaching Hospital, Montpellier, France; 6Biostatistics Department, Montpellier University and Montpellier Teaching Hospital, Montpellier, France
Correspondence: Yassir Aarab (y-aarab@f-montpellier.fr)
CO-59 ICU-acquired weakness but not diaphragm dysfunction strongly impacts long-term survival of critically ill patients
Clément Saccheri, Elise Morawiec, Julie Delemazure, Julien Mayaux, Bruno-Pierre Dubé, Thomas Similowski, Alexandre Demoule, Martin Dres
Service de Pneumologie, Médecine intensive Réanimation, Hôpital Pitié Salpêtrière, Groupe hospitalier universitaire APHP. Sorbonne Université, Paris, France
Correspondence: Clément Saccheri (clement.saccheri@gmail.com)
CO-60 Role of limb weakness on extubation outcome among patients at high-risk of reintubation in the ICU
Arnaud Thille1, Florence Boissier1, Michel Muller2, Albrice Levrat2, Gaël Bourdin3, Sylvène Rosselli3, Jean-Pierre Frat1, Rémi Coudroy1, Emmanuel Vivier3
1CHU de Poitiers, Médecine Intensive Réanimation ALIVE research group INSERM CIC 1402, Poitiers, France; 2Centre Hospitalier Annecy Genevoix, Réanimation Polyvalente, Metz-Tessy, France; 3Centre Hospitalier Saint Joseph Saint Luc, Réanimation Polyvalente, Lyon, France
Correspondence: Arnaud Thille (aw.thille@gmail.com)
CO-61 Lung bacteriobiota but not mycobiota predicts day 28 mortality among critically ill influenza patients
Renaud Prével1, Raphaël Enaud2, Alexandre Massri3, Erwan Begot1, Laurent Villeneuve4, Fabien Beaufils2, Marie-Edith Lafon5, Camille Ciccone5, Patrick Berger2, Alexandre Boyer1, Laurence Delhaes6, Didier Gruson1
1CHU Bordeaux, Medical Intensive Care Unit, Bordeaux, France; 2Inserm U1045 Centre de Recherche Cardio-thoracique, Bordeaux, France; 3Intensive Care Unit, CH Francois Mitterrand, Pau, France; 4Bacteriology laboratory, CH Francois Mitterrand, Pau, France; 5CHU Bordeaux, Virology laboratory, Bordeaux, France; 6CHU Bordeaux, Mycology laboratory, Bordeaux, France
Correspondence: Renaud Prével (renaud.prevel@hotmail.fr)
CO-62 Pathway mapping of leukocyte transcriptome in influenza patients reveals distinct pathogenic mechanisms associated with progression to severe infection
Yoann Zerbib1, Emily Jenkins2, Maryam Shojaei2, Anthony Mclean2, Klaus Schughart3, Benjamin Tang2
1Department of medical Intensive Care, Amiens University Hospital, Amiens, France; 2Department of Intensive Care Medicine, Nepean Hospital, Sydney, Australia; 3Helmholtz Centre for Infection Research, Braunschweig, Germany
Correspondence: Yoann Zerbib (zerbib.yoann@chu-amiens.fr)
CO-63 Herpes Simplex Virus and Cytomegalovirus reactivation among severe ARDS patients under veno-venous ECMO
Sami Hraiech1, Eline Bonnardel2, Christophe Guervilly1, Jean-Marie Forel1, Melanie Adda1, Gabriel Parzy1, Guilhem Cavaille1, Benjamin Coiffard1, Laurent Papazian1
1Service de Médecine Intensive-Réanimation, APHM, Hôpital Nord, Marseille, France; 2Magellan Medico-Surgical Center, South Department of Anaesthesia and Critical Care, Bordeaux, France
Correspondence: Sami Hraiech (sami.hraiech@ap-hm.fr)
CO-64 Comparison of RSV and influenza infection in ICU patients-the CAPTIF study
Charlotte Vandueren1, Benjamin Zuber2, Eve Garrigues3, Antoine Gros4, Nicolas Epaillard5, Guillaume Voiriot6, Yacine Tandjaoui-Lambiotte7, Jean-Baptiste Lascarrou8, Florence Boissier9, Virginie Lemiale10, Damien Contou11, Sami Hraiech12, Anne-Pascale Meert13, Bertrand Sauneuf14, Aline Munting15, Sylvie Ricome16, Guillaume Geri3, Jonathan Messika17, Gregoire Muller18, Julien Coussement19, David Grimaldi20
1USI, Hôpital Erasme, ULB, Bruxelles, Belgium; 2Réanimation Hôpital Foch, Suresnes, France; 3Réanimation Hôpital Ambroise Paré, Boulogne, France; 4CH Versailles, Le Chesnay, France; 5Réanimation Hôpital Saint Antoine, Paris, France; 6Réanimation Hôpital Tenon, Paris, France; 7Réanimation Hôpital Avicennes, Bobigny, France; 8MIR CHU Nantes, Nantes, France; 9MIR CHU Poitiers, Poitiers, France; 10Réanimation Hôpital Saint Louis, Paris, France; 11Réanimation CH Argenteuil, Argenteuil, France; 12Réanimation Hôpital Nord-APHM, Marseille, France; 13USI, Hôpital BORDET, ULB, Bruxelles, Belgium; 14Réanimation CH Public du Cotentin, Cherbourg, France; 15CHU UCL Namur, Godinne, Belgium; 16Réanimation CH Aulnay, Aulnay S/bois, France; 17Réanimation Hôpital Louis Mourier, Colombes, France; 18CH Orleans, Orleans, France; 19Maladies Infectieuses, Hôpital Erasme, ULB, Bruxelles, Belgium; 20USI Hôpital Erasme ULB, Bruxelles, Belgium
Correspondence: Charlotte Vandueren (chavandueren@yahoo.fr)
CO-65 Epidemiology and 1-year functional outcome of ICU-admitted stroke patients
Benoit Brassart, Ahmed El Kalioubie, Saad Nseir
Université Lille, Centre Hospitalier Universitaire Lille, Lille, France
Correspondence: Benoit Brassart (brassart.benoit@gmail.com)
CO-66 Association of reason for endotracheal intubation with long-term survival in acute stroke patients requiring mechanical ventilation
Etienne de Montmollin1, Nicolas Terzi2, Claire Dupuis3, Maïté Garrouste4, Daniel da Silva5, Michaël Darmon6, Virginie Laurent7, Guillaume Thiery8, Johanna Oziel9, Guillaume Marcotte10, Marc Gainnier11, Shidasp Siami12, Benjamin Sztrymf13, Christophe Adrie14, Jean Reignier15, Romain Sonneville1, Jean-François Timsit1
1Medical and Infectious Diseases Intensive Care Unit, Bichat-Claude Bernard Hospital, Paris, France; 2Medical Intensive Care Unit, Grenoble University Hospital, La Tronche, France; 3Medical Intensive Care Unit, Gabriel Montpied University Hospital, Clermont-Ferrand, France; 4Medical Unit, French British Hospital, Levallois-Perret, France; 5Intensive Care Unit, Delafontaine Hospital, Saint-Denis, France; 6Medical Intensive Care Unit, Saint-Louis Hospital, Paris, France; 7Intensive Care Unit, André Mignot Hospital, Le Chesnay, France; 8Intensive care Unit, Hôpital Nord, Saint-Etienne, France; 9Intensive Care Unit, Avicenne Hospital, Bobigny, France; 10Surgical Intensive Care Unit, Edouard Herriot Hospital, Lyon, France; 11Intensive Care Unit, La Timone Hospital, Marseille, France; 12Intensive Care Unit, Sud-Essonne Hospital, Etampes, France; 13Intensive Care Unit, Antoine Béclère Hospital, Clamart, France; 14Physiology department, Cochin Hospital, Paris, France; 15Medical Intensive Care Unit, Nantes University Hospital, Nantes, France
Correspondence: Etienne de Montmollin (edemontmollin@gmail.com)
CO-67 Association between targeted temperature management and long-term neurological prognosis: insights from two large datasets from France and north-America
Jean-Baptiste Lascarrou1, Florence Dumas2, Wulfran Bougouin3, Frankie Beganton4, Nadia Aissaoui5, Richard Chocron2, Nicolas Deye5, Daniel Jost6, Stéphane Legriel7, Lionel Lamhaut8, Antoine Vieillard-Baron9, Eloi Marijon10, Xavier Jouven4, Alain Cariou5
1Médecine Intensive Réanimation, Nantes, France; 2Emergency Department, Paris, France; 3Medical Surgical Intensive Care Unit, Massy, France; 4INSERM, Paris, France; 5Médecine Intensive Réanimation, Paris, France; 6Brigade Sapeurs Pompiers Paris, Paris, France; 7Medical Surgical Intensive Care Unit, Versailles, France; 8Medical Intensive Care Unit, Paris, France; 9Médecine Intensive Réanimation, Boulogne Billancourt, France; 10Cardiology Department, Paris, France
Correspondence: Jean-Baptiste Lascarrou (jeanbaptiste.lascarrou@chu-nantes.fr)
CO-68 Cost-utility analysis of different treatments for acute ischaemic stroke: a Belgian, micro-costing health technology assessment
Evi Mellebeek1, Anouk Lesenne2, Jef Grieten1, Alain Wibail3, Ludovic Ernon3, Luc Stockx3, Elly Vandermeulen3, Pascal Vanelderen4, Joris Vundelinckx5, Sofie van Cauter3, Jill Grondelaers3, Elke Panis3, Dieter Mesotten4
1KU Leuven/ZOL Genk, Genk, Belgium; 2Universiteit Gent/ZOL Genk, Gent, Belgium; 3ZOL Genk, Genk, Belgium; 4Universiteit Hasselt/ZOL Genk, Genk, Belgium; 5ZOL Genk, Genk, Belgium
Correspondence: Evi Mellebeek (evimellebeek503@hotmail.com)
Flash communications
F-001 A Systematic Echography During Intubation Procedure to Predict Cardiovascular Collapse (EPIC)
Vanessa Jean-Michel1, Gwenael Prat2, Pierre Bailly2, James Benis3, Montaine Lefevre4, Pierre-Yves Egreteau4, Christophe Giacardi5, Cécile Aubron2, Erwan L’her2
1CH de Tourcoing, Tourcoing, France; 2CHRU de La Cavale Blanche, Brest, France; 3CH de Quimper, Quimper, France; 4CH de Morlaix, Morlaix, France; 5HIA Clermont Tonnerre, Brest, France
Correspondence: Vanessa Jean-Michel (vanessa.jeanmichel@gmail.com)
F-002 Heart rate variability as an indicator of outcome in the ICU? A prospective cohort
Laetitia Bodenes, Victoire Pateau, Julien Dolou, Quang-Thang N’guyen, Erwan L’her
Service de Medecine Intensive et Réanimation, CHRU de Brest, Brest, France
Correspondence: Laetitia Bodenes (Laetitia.bodenes@chu-brest.fr)
F-003 A mouse model of ischemic stroke in impaired glucose tolerance condition induced by chronical exposure of High Fat Diet
Coline Grisotto, David Couret
Service neuroréanimation, CHU Sud Reunion, Saint-Pierre, France
Correspondence: Coline Grisotto (grisottocoline@yahoo.fr)
F-004 Does metformin act as a protective drug after a massive ischemia reperfusion induced by cardiac arrest? A survival study
Barthélémy Vallee1, Amélie Rolle1, Romain Rozier2, Frédéric Martino1, Jean-Ehrland Ricci2, Bertrand Pons1, Michel Carles1
1CHU Guadeloupe, Les Abymes, France; 2Equipe 3-INSERM U1065-Université Nice Sophia Antipolis (UNS), Nice, France
Correspondence: Barthélémy Vallee (barthelemy.vallee@chu-guadeloupe.fr)
F-005 Ischemic and hemorrhagic complications of patients on venoarterial-extracorporeal membrane oxygenation for cardiogenic shock post myocardial infarction
Paul Masi, Maxence Le Guyader, Charles-Edouard Luyt, Guillaume Franchineau, Loïc Le Guennec, Simon Bourcier, Nicolas Brechot, Matthieu Schmidt, Alain Combes, Guillaume Hekimian
Réanimation Médicale Pitié Salpétrière, Paris, France
Correspondence: Paul Masi (paul.masi@aphp.fr)
F-006 The endoplasmic reticulum stress expression under cardiopulmonary bypass: the relationship with organ failure
Zoé Demailly1, Thomas Clavier1, Vincent Richard2, Fabienne Tamion1
1Department of medical critical care-Rouen university hospital, Rouen, France; 2UMR inserm 1096 Endothelium, Valvulopathy & Heart Failure, Rouen, France
Correspondence: Zoé Demailly (lulu.demailly@gmail.com)
F-007 Acute mesenteric ischemia in patients under mechanical support by veno-arterial ECMO
Marie Renaudier1, Quentin De Roux1, Wulfran Bougouin2, Johanna Boccara1, Baptiste Dubost1, Antonio Fiore1, Aurélien Amiot1, Olivier Langeron1, Nicolas Mongardon1
1CHU Henri Mondor, Créteil, France; 2Hôpital Privé Jacques Cartier, Massy, France
Correspondence: Marie Renaudier (Mrenaudier@aol.com)
Characteristics | All ECMO (n = 150) | AMI (n = 14) | No AMI (n = 136) | p |
---|---|---|---|---|
Age (years) | 58 (48–69) | 57 (47–70) | 58 (48–68) | 0.82 |
VA-ECMO for medical reason | 85 (57) | 6 (43) | 79 (58) | 0.21 |
Refractory cardiac arrest | 39 (26) | 5 (36) | 34 (25) | 0.28 |
Intra-aortic balloon pump | 28 (19) | 3 (21) | 25 (18) | 0.73 |
Delay between admission and VA-ECMO (days) | 0 (0–1) | 0 (0–2) | 0 (0–1) | 0.27 |
SAPS II | 54 (38–70) | 56 (45–73) | 53 (38–70) | 0.47 |
Lactate level at day 0 (mmol/L) | 5.2 (3–9.1) | 7.8 (2.6–10.2) | 5.1 (3–9.1) | 0.49 |
Vasoactive-Inotropic Score | 70 (34–139) | 136 (51–238) | 70 (34–129) | 0.05 |
Renal replacement therapy in the first 5 days | 47 (32) | 9 (64) | 38 (28) | 0.01 |
Highest norepinephrine dose in the first 5 days (µg/kg/min) | 1.0 (0.5–2.0) | 2.3 (1.4–3.0) | 1.0 (0.5–1.9) | 0.01 |
Second shock in the first 5 days | 76 (51) | 12 (86) | 64 (47) | 0.009 |
Enteral nutrition in the first 5 days | 128 (88) | 10 (71) | 118 (90) | 0.06 |
ICU mortality | 84 (56) | 14 (100) | 70 (51) | < 0.001 |
F-008 Comparison of pleural and esophageal pressure in supine and prone position in a porcine model of acute respiratory distress syndrome
Nicolas Terzi1, Sam Bayat1, Norbert Noury2, Jean-Pierre Giliberto3, Sylvie Roulet3, Emanuele Turbil4, Walide Habre3, Claude Guérin2
1CHUGA, Grenoble, France; 2Université de Lyon, Lyon, France; 3Université de Genève, Genève, Switzerland; 4Université de Sassarie, Sassarie, Italy
Correspondence: Nicolas Terzi (nterzi@chu-grenoble.fr)
F-009 A systematic bench assessment of automatic tube compensation provided by intensive care unit ventilators
Nicolas Terzi1, Louis-Marie Galerneau1, Zakaria Riad2, Emanuele Turbil3, Carole Schwebel1, Claude Guérin2, Bruno Louis4
1Médecine Intensive Réanimation, Grenoble, France; 2Médecine Intensive Réanimation, Lyon, France; 3Médecine Intensive Réanimation, Sassari, Italy; 4INSERM UMR 955 Eq13, Créteil, France
Correspondence: Nicolas Terzi (nterzi@chu-grenoble.fr)
F-010 Impact of the mechanical power and its components on mortality in patients with ARDS: a post hoc analysis of a controlled randomized study
Radj Cally1, Claude Guérin2, Arnaud Gacouin3, Gilles Perrin1, Anderson Loundou1, Samir Jaber4, Jean-Michel Arnal5, Dider Perez6, Jean-Marie Seghboyan7, Jean-Michel Constantin8, Jean-Yves Lefrant9, Gwenael Prat10, Antoine Roch1, Laurent Papazian1, Jean-Marie Forel1
1AP-HM, Marseille, France; 2CHU de Lyon, Lyon, France; 3CHU de Rennes, Rennes, France; 4CHU de Montpellier, Montpellier, France; 5Centre Hospitalier de Toulon, Toulon, France; 6Centre Hospitalier de Lons-le-Saunier, Lons-Le-Saunier, France; 7Hôpital Européen, Marseille, France; 8CHU de Clermont-Ferrand, Clermont-Ferrand, France; 9CHU de Nîmes, Nimes, France; 10CHU de Brest, Brest, France
Correspondence: Radj Cally (radj.cally@yahoo.fr)
F-011 A physiological systematic review and meta-analysis on positive end expiratory pressure-induced lung recruitment in patients with acute respiratory distress syndrome
Emanuele Turbil1, Louis-Marie Galerneau2, Antonia Koutsoukou3, Jean Jacques Rouby4, Jean Dellamonica5, Carole Schwebel2, Nicolas Terzi2, Claude Guérin6
1University of Sassari, Sassari, Italy; 2C.H.U de Grenoble, La Tronche, France; 3University of Athens Medical School, Athens, GREECE; 4La Pitié Salpétrière Hospital, Paris, France; 5CHU de Nice, Nice, France; 6Hôpital de la croix rousse, Lyon, France
Correspondence: Emanuele Turbil (emanuele.turbil@gmail.com)
F-012 Early effects of mechanical ventilation on diaphragm function and its influence on weaning
Ahlem Trifi, Farah Ben Lamine, Cyrine Abdennebi, Foued Daly, Yosr Touil, Sami Abdellatif, Salah Ben Lakhal
Medical ICU, la Rabta hospital, Faculty of Medicine of Tunis, Tunis, Tunisia
Correspondence: Ahlem Trifi (trifiahlem2@gmail.com)
F-013 Shear wave elastography for assessing diaphragm activity in mechanically ventilated patients
Quentin Fossé1, Thomas Poulard2, Jean-Yves Hogrel2, Jean-Luc Gennisson3, Thomas Similowski1, Alexandre Demoule 1, Marie Cécile Niérat4, Damien Bachasson2, Martin Dres1
1Service de Pneumologie, Médecine Intensive Réanimation, Pitié Salpétrière, GH Universitaire APHP-Sorbonne Université, Paris, France; 2Institut de Myologie, Paris, France; 3IR4M, Orsay, France; 4INSERM UMRS1158 Neurophysiologie respiratoire expérimentale et clinique, Paris, France
Correspondence: Quentin Fossé (quentin.fosse@gmail.com)
F-014 Inspiratory effort can be measured during spontaneous breathing at the bedside: illustration of feasibility
Davy Cabrio, Filippo Bongiovanni, Philippe Eckert, Lise Piquilloud
CHUV, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Correspondence: Davy Cabrio (cabriodavy@gmail.com)
F-015 Innate T cells during severe pneumonia and Acute Respiratory Distress Syndrome
Youenn Jouan1, Chloé Boisseau2, Antoine Guillon1, Yonatan Perez1, Pierre-François Dequin1, Mustapha Si-Tahar2, Christophe Paget2
1Service de Médecine Intensive Réanimation, Tours, France; 2INSERM U1100, Tours, France
Correspondence: Youenn Jouan (youenn.jouan@gmail.com)
F-016 A dominant circulating PD-1/2B4 CD8+ T-cells pattern at day 1 correlates with mortality but not with secondary infections in septic patients admitted to the ICU
Damien Guinault1, Marie-Laure Nicolau-Travers2, Stein Silva3, Arnaud Del Bello1, Olivier Cointault1, Edith Hourcastagnou3, David Rousset3, Laurence Lavayssiere1, Marie-Béatrice Nogier1, Arnaud Mari3, Nassim Kamar1, François Vergez2, Stanislas Faguer1
1Département de Néphrologie et Transplantation d’Organes, CHU de Toulouse, Toulouse, France; 2Laboratoire d’Hématologie-Immunologie, CHU de Toulouse, Toulouse, France; 3Département d’Anesthésie et Réanimation-Réanimation Médicale, CHU de Toulouse, Toulouse, France
Correspondence: Damien Guinault (guinault.d@chu-toulouse.fr)
F-017 Comparison of one-year outcome of severe community-acquired bacterial or viral pneumonia and pneumonia of unidentified etiology
Frédéric Sangla1, Pierre-Emmanuel Marti2, David Legouis2, Amélie Brebion3, Pierre Saint-Sardos4, Alexandre Lautrette5, Mireille Adda5, Bruno Pereira6, Bertrand Souweine5
1CHU de Clermont-Ferrand, Clermont-Ferrand, France; 2Service de Soins Intensifs adultes, Hopitaux Universitaires de Genève, Genève, Switzerland; 3Laboratoire de Virologie, CHU Clermont-Ferrand, CNRS, Université Clermont Auvergne, Clermont-Ferrand, France; 4Laboratoire de Bactériologie, CHU Clermont-Ferrand, CNRS, INSERM, Université Clermont Auvergne, Clermont-Ferrand, France; 5Service de Médecine Intensive et réanimation, CHU Clermont-Ferrand, CNRS, Université Clermont Auvergne, Clermont-Ferrand, France; 6Département de Biostatistique, CHU Clermont-Ferrand, Clermont-Ferrand, France
Correspondence: Frédéric Sangla (fred.sangla@gmail.com)
F-018 Interest of UNYVERO multiplex PCR (CURETIS) for BAL rapid microbiologic and antibiotic susceptibility documentations in immunocompromised patients under antibiotic therapy
Jean-Luc Baudel1, Jacques Tankovic2, Redouane Dahoumane2, Salah Gallah2, Laurent Benzerara2, Jean-Remy Lavillegrand1, Razach Abdallah1, Geoffroy Hariri1, Naike Bige1, Hafid Ait-Oufella1, Nicolas Veziris2, Eric Maury1, Bertrand Guidet1
1Service de Réanimation Médicale, Hôpital Saint-Antoine, Paris, France; 2Service de Bactériologie, Hôpital Saint-Antoine, Paris, France
Correspondence: Jean-Luc Baudel (jean-luc.baudel@aphp.fr)
F-019 Do not underestimate RSV pneumonia among critically ill patients
Erwan Begot1, Suzanne Champion1, Charline Sazio1, Benjamin Clouzeau1, Alexandre Boyer1, Hoang-Nam Bui1, Marie-Edith Lafon2, Camille Ciccone2, Julia Dina3, Didier Gruson1, Renaud Prével1
1CHU Bordeaux, Medical intensive care unit, Bordeaux, France; 2CHU Bordeaux, Virology laboratory, Bordeaux, France; 3National Reference Center for Measles Mumps and Rubella, CHU de Caen, Caen, France
Correspondence: Erwan Begot (erwan.begot@chu-bordeaux.fr)
F-020 Determinants of respiratory distress from seawater drowning: a prospective observational study from seven intensive care units on the French Riviera
Alexandre Robert1, Denis Doyen2, Pierre-Marie Bertrand3, Michel Kaidomar1, Nicolas Clement3, Nicolas Bele1, Nihal Martis2, Hervé Quintard4, Hervé Hyvernat2, Gilles Bernardin2, Jean Dellamonica2
1Fédération des réanimations du Var Est, Fréjus-Draguignan, France; 2Médecine Intensive Réanimation, Hôpital l’Archet 1, CHU de Nice, Nice, France; 3Médecine Intensive Réanimation, CH de Cannes, Cannes, France; 4Réanimation polyvalente, Hôpital Pasteur 2, CHU de Nice, Nice, France
Correspondence: Alexandre Robert (alex_robert@hotmail.fr)
F-021 Impact of Extra-Corporeal Membrane Oxygenation (ECMO) support on piperacillin exposure in septic patients: a case–control study
Pierre Fillatre1, Florian Lemaitre2, Nicolas Nesseler3, Matthieu Schmidt4, Sebastien Besset4, Yoann Launey5, Adel Maamar6, Pierre Daufresne7, Erwan Flecher8, Yves Le Tulzo9, Jean-Marc Tadié9, Pierre Tattevin9
1Service de Réanimation Polyvalente, Saint Brieuc, France; 2Service de Pharmacologie-CHU Pontchaillou, Rennes, France; 3Service de Réanimation de Chirurgie Thoracique et de Chirurgie Vasculaire-CHU Pontchaillou, Rennes, France; 4Service de Réanimation Médicale-CHU La Pitié Salpétrière, Paris, France; 5Service de Réanimation Chirurgicale-CHU Pontchaillou, Rennes, France; 6Service de Maladies Infectieuses et de Réanimation Médicale-CHU Pontchaillou, Rennes, France; 7Service d’hématologie-CHU Pontchaillou, Rennes, France; 8Service de Chirurgie Thoracique et de Chirurgie Vasculaire-CHU Pontchaillou, Rennes, France; 9Service de Maladies Infectieuses et de Réanimation Médicale-CHU Pontchaillou, Rennes, France
Correspondence: Pierre Fillatre (pierrefillatre@hotmail.com)
F-022 End-of-life management strategies the opinion of Tunisian intensivists in the Vincent lambert’s case
Meriem Fatnassi1, Hela Maamouri1, Nassereddine Foudhaili1, Nozha Brahmi1
1Service de réanimation toxicologique et polyvalente centre Mahmoud Yaacoub, Tunis, Tunisia
Correspondence: Meriem Fatnassi (merifatnassi@gmail.com)
F-023 Impact of a visual support dedicated to prognosis of patients on symptoms of stress of family members
Pascal Beuret1, Gabrielle Burelli1, Arthur Vincent1, Jeremy Mallard1, Sarah Meffre1, Alizee Maarek1, Sixtine Bonnet1, Jerome Morel2
1Réanimation polyvalente/Centre hospitalier, Roanne, France; 2Réanimation polyvalente B/CHUI, Saint Etienne, France
Correspondence: Pascal Beuret (pascal.beuret@ch-roanne.fr)
F-024 Sedation practice and discomfort during withdrawal of mechanical ventilation in critically ill patients at End-of-Life: a post hoc analysis of a multicenter study
René Robert1, Amélie Le Gouge2, Jean Reignier3
1Université de Poitiers, Poitiers, France/Inserm CIC 1402, ALIVE, service de Médecine Intensive Réanimation, Poitiers, France; 2Inserm CIC 1415, Tours, Tours, France; 3Université de Nantes, Nantes, France
Correspondence: René Robert (r.robert@chu-poitiers.fr)
F-025 Post-death meeting for relatives of ICU deceased patients: a way to alleviate grief symptoms?
Thibault Dekeyser, Dominique Malacrino, Caroline Sejourne, Marie-Christine Dufossez, Mehdi Marzouk, Imen Rahmani, Laura Lstiburek, Christophe Vinsonneau
Service de Médecine Intensive Réanimation, Centre hospitalier de Béthune Germon et Gauthier, 62408, Béthune, France
Correspondence: Thibault Dekeyser (thibault.dekeyser@live.fr)
F-026 The pediatric intensivist’s position when confronted to parents opposed to termination of life-sustaining treatments on their child
Delphine Brown, Marcel-Louis Viallard, Laure de Saint-Blanquat, Agathe Béranger, Lucie Derauglaudre, Marion Gregnon, Sylvain Renolleau, Marie-France Mamzer, Laurent Dupic
Necker, Paris, France
Correspondence: Delphine Brown (delphine.brown@aphp.fr)
F-027 Advance directives: a general overview
Ameni Abidi, Hela Maamouri, Meriem Fatnassi, Takoua Khzouri, Nozha Brahmi
Service de réanimation toxicologique et polyvalente, Centre Mahmoud Yaacoub d’assistance médicale urgente, Tunis, Tunisia
Correspondence: Ameni Abidi (drabidiameni@gmail.com)
F-028 Development of a hemodialysis model in rats with septic acute kidney injury
Nicolas Benichou, Stéphane Gaudry, Sandrine Placier, Juliette Hadchouel, Alexandre Hertig, Christos Chatziantoniou, Didier Dreyfuss
French National Institute of Health and Medical Research (INSERM), UMR_S1155, Remodeling and Repair of Renal Tissue, Hôpital Tenon, F-75020, Sorbonne Université, Paris, France
Correspondence: Nicolas Benichou (nico.benichou@gmail.com)
RRT type | Arterio-venous hemodialysis |
---|---|
Anesthesia | Isoflurane gas |
Vascular access | Carotid artery, femoral vein |
Anticoagulation | Heparinized saline 100 UI/ml: 1 ml at the beginning |
Extracorporeal circuit volume | Approx. 0.7 ml (without dialyzer), 1.3 ml (with dialyzer) |
Priming | NaCl 0.9% (no transfusion) |
Hemodialyzer (membrane) | MicroKros® (Spectrum Lab), surface 20 cm2, 50 kDa pores, 20 cm length, fiber inner diameter 0.5 mm |
Blood flow | 1 ml/min, controlled with a peristaltic pump |
Duration | 120 min |
F-029 Incidence and renal prognosis of positive antibiotic associated crystalluria in infective endocarditis patients
Matthieu Jamme1, Leopold Oliver2, Julien Ternacle2, Raphael Lepeule3, Sovannarith San2, Amina Moussafeur2, Antonio Fiore4, Nicolas Mongardon5, Michel Daudon6, Pascal Lim2, Emmanuel Letavernier6
1Renal ICU and Kidney Transplantation, Tenon university hospital, APHP, Paris, France; 2Cardiology, Mondor university hospital, APHP, Creteil, France; 3Infectious mobile unit, Mondor university hospital, APHP, Creteil, France; 4Heart surgery, Mondor university hospital, APHP, Creteil, France; 5Surgical ICU Mondor university hospital, APHP, Creteil, France; 6Physiology unit, Tenon university hospital, APHP, Paris, France
Correspondence: Matthieu Jamme (mat.jamme@gmail.com)
F-030 Cytogenetic Abnormalities and Risk for Acute Kidney Injury in Critically Ill Patients with Acute Myeloid Leukemia (AML)
Inna Mohamadou1, Michaël Darmon1, Swann Bredin1, Emmanuel Canet1, Lara Zafrani1, Etienne Lengline1, Achille Kouatchet2, Alexandre Demoule3, Pierre Perez4, Frédéric Pene5, Djamel Mokart6, Christine Lebert1, Fabrice Bruneel7, Emmanuel Raffoux1, Virginie Lemiale1, Elie Azoulay1
1Hôpital Saint-Louis, Paris, France; 2CHU de Poitiers, Poitiers, France; 3Hôpital de la Pitié Salpêtrière, Paris, France; 4CHRU Nancy Brabois, Nancy, France; 5Hôpital Cochin, Paris, France; 6Institut Paoli-Calmettes, Marseille, France; 7Hôpital André Mignot, Versailles, France
Correspondence: Inna Mohamadou (inna.m@hotmail.fr)
F-031 Do Renal Resistive Index (RRI) measurement predict renal function evolution in critically ill patients with stage 2 Acute Kidney Injury (AKI)?
Patricia Wiesen, Didier Ledoux, Paul Massion, Benoit Misset
CHU Liège-Soins Intensifs, Liege, Belgium
Correspondence: Patricia Wiesen (p.wiesen@chuliege.be)
Clinical data | n/p (%) Median (p25; p75) | n/p (%) Median (p25; p75) | ||
---|---|---|---|---|
(n = 57) | Systolic arterial pressure (mmHg) | 108 (102; 130) | 114 (104; 130) | P = 0.536 |
(n = 57) | Diastolic arterial pressure (mmHg) | 63 (55; 70) | 53 (47; 61) | P = 0.004 |
(n = 57) | Mean arterial pressure (mmHg) | 79 (72; 88) | 74 (65; 83) | P = 0.101 |
(n = 56) | Central venous pressure (mmHg) | 8 (4; 10) | 9 (7; 13) | P = 0.256 |
(n = 25) | Cardiac output | 4.9 (4.0; 7.4) | 4.6 (3.3; 5.5) | P = 0.379 |
(n = 57) | Cardiac frequency (b/min) | 96 (87; 108) | 80 (70; 90) | P = 0.004 |
(n = 57) | Vasopressor requirement | 8/18 (44.4%) | 18/39 (46.2%) | P = 0.904 |
(n = 57) | Inotropic requirement | 0/18 (0%) | 6/39 (15.4%) | P = 0.162 |
Laboratory | Haemoglobin (g/dl) | 9.2 (8.3; 10.1) | 9.3 (8.1; 10.6) | P = 0.718 |
(n = 57) | White Blood count (/mm3) | 9905 (7850; 16,730) | 12,490 (9000; 16,000) | P = 0.643 |
(n = 57) | CRP (mg/l) | 139 (40; 263) | 69 (34; 171) | P = 0.345 |
(n = 57) | Na (mmol/l) | 144 (139; 146) | 140 (138; 145) | P = 0.235 |
(n = 57) | Cl (mmol/l) | 102 (98; 107) | 102 (96; 105) | P = 0.104 |
(n = 57) | K (mmol/l) | 3,8 (3.6; 4.2) | 4.39 (3.79; 4.8) | P = 0.019 |
(n = 56) | PO4 (mmol/l) | 1.05 (0.84;
1.37) | 1.27 (1.0; 1.68) | P = 0.078 |
(n = 57) | Creatinine Kinase (UI/l) | 64 (27; 205) | 132 (49; 336) | P = 0.042 |
(n = 57) | Albumin (g/l) | 32 (29; 35) | 32 (28; 34) | P = 0.580 |
(n = 47) | Δ urea (mg/dl) | − 13.5 (− 21; − 2) | 5 (− 37; 34)) | P = 0.459 |
(n = 47) | Δ creatinine (mg/dl) | − 0.18 (− 0.43; − 0.09) | − 0.15 (− 0.65; 0.19) | P = 0.902 |
(n = 37) | Cumulated fluid balance D3 (ml) | 2217 (1083; 4086) | − 1314 (− 2821; 46) | P = 0.017 |
(n = 57) | Diuretics | 5/18 (27.8%) | 12/39 (30.7%) | P = 1 |
Prognosis (n = 56) | RRT | 1/18 (6%) | 9/39 (22.5%) | P = 0.146 |
F-032 Doppler based resistive index measurement in ICU patients and influence of inter-operator variability: Results of a multicenter cohort study
Jean Jacques Tudesq1, David Schnell2, Marie Reynaud3, Stéphane Rouleau2, Ferhat Meziani4, Alexandra Boivin4, Mourad Benyamina5, Francois Vincent6, Alexandre Lautrette7, Christophe Leroy7, Yves Cohen8, Matthieu Legrand5, Jerome Morel3, Jeremy Terreaux3, Aurelie Bourmaud9, Michaël Darmon5
1Saint-Louis University Hospital, Paris, France; 2Angouleme Hospital, Angouleme, France; 3Saint-Etienne Hospital, Saint-Etienne, France; 4Strasbourg Hospital, Strasbourg, France; 5Saint-Louis Hospital, Paris, France; 6Montfermeil Hospital, Montfermeil, France; 7Clermont-Ferrand Hospital, Clermont-Ferrand, France; 8Avicenne Hospital, Bobigny, France; 9Robert Debre Hospital, Paris, France
Correspondence: Jean Jacques Tudesq (jean-jacques.tudesq@aphp.fr)
F-033 Echocardiographic follow-up of right ventricular dysfunction is the best way to evaluate cardiorenal syndrome (CRS) in ICU
Mario Geneix1, Sebastien Moschietto2, Antoine Frouin2, Fanny Depeyre2, Thibault Dupont3, Florent Montini2
1CH Timone, Marseille, France; 2CH Henri Duffaut, Avignon, France; 3CHU Kremlin Bicêtre, Paris, France
Correspondence: Mario Geneix (mario.geneix@gmail.com)
F-034 Is citrate required for heparin-free intermittent hemodialysis in critically ill patients?
Chloé Medrano, Olivier Cointault, Laurence Lavayssiere, Marie-Béatrice Nogier, Nassim Kamar, Stanislas Faguer
Département de Néphrologie et transplantation d’organes, Toulouse, France
Correspondence: Chloé Medrano (chloemedrano@hotmail.fr)
F-035 Assessment of diaphragmatic function in mechanically ventilated children using the neuromuscular efficiency index
Benjamin Crulli, Guillaume Emeriaud
Pediatric intensive care unit, Department of pediatrics, CHU Sainte Justine, Université de Montréal, Montreal, Canada
Correspondence: Benjamin Crulli (benjamin.crulli@umontreal.ca)
F-036 Efficacy and safety of dexmedetomidine as sole sedation for children undergoing MRI in comparison to general anesthesia: a single-center retrospective study (DEX-IRM)
Hélène Lepeltier1, Arnaud Lepetit2, Maxime Gauberti3, Clément Escalard3, Anne Lesage2, David Brossier4, Isabelle Goyer5
1CHU CAEN, Département de pédiatrie, Caen, France; 2CHU CAEN, Département d’anesthésie, Caen, France; 3CHU CAEN, Département de radiologie, Caen, France; 4CHU CAEN, Département de réanimation pédiatrique, Caen, France; 5CHU CAEN, Département de pharmacie, Caen, France
Correspondence: Hélène Lepeltier (helene.lepeltier@orange.fr)
F-037 Incidence of withdrawal syndrome after sedation/analgesia in a surgical pediatric intensive care units using the Withdrawal Assessment Tool-1 (WAT-1) score
Pauline Ponsin1, Guillaume Geslain2, Chloé Tridon1, Charline Riaud1, Nicolas Robin1, Alina Lazarescu1, Gilles Orliaguet1
1Department of anaesthesia and intensive care, Assistance Publique-Hôpitaux de Paris, Necker-Enfants Malades Hospital, Paris, France; 2Pediatric Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Robert Debre University Hospital Université de Paris, Paris, France
Correspondence: Pauline Ponsin (pauline_2014@hotmail.com)
WAT-1 ≥ 3 (n = 23) | WAT-1 < 3 (n = 23) | p | |
---|---|---|---|
Duration of opioids (d) | 6.0 (4.9; 5.0) | 4.0 (3.0; 5.5) | 0.006 |
Total dose of opioids (µg/kg equivalent sufentanil) | 41.7 (30.9; 127.6) | 17.25 (132.0; 35.9) | < 0.001 |
Duration of BZD infusion (d) | 5.0 (5.0; 9.0) | 4.0 (3.0; 5.5) | 0.006 |
Total dose of BZD (mg/kg equivalent midazolam) | 33.2 (20.8; 58.9) | 14.0 (5.6; 20.4) | < 0.001 |
Length of mechanical ventilation (d) | 9.0 (6.5; 13.0) | 5.0 (4.0; 7.0) | < 0.001 |
Length of stay in the PICU (d) | 13.0 (10.0; 23.0) | 9.0 (5.0; 10.5) | < 0.001 |
Data presented as median (range). BZD: benzodiazepine, d: days, PICU: pediatric intensive care unit. A p value < 0.05 was considered statistically significant. |
F-038 Automatic Real-time Classification of the Validity of Intracranial Pressure Signals Recorded by Ventricular Drain Using a Machine Learning Method
Sally Al Omar1, Floriane Cannet2, Gabriel Masson3, Philippe Jouvet1, Guillaume Emeriaud1
1CHU Sainte-Justine, Montreal, Canada; 2Polytech Marseille, Marseille, France; 3University Hospital of Lille, Lille, France
Correspondence: Sally Al Omar (sally.alomar@gmail.com)
F-039 Epidemiology and prognosis of acute encephalitis in pediatric intensive care unit
Hélène Lienard1, Jérôme Naudin1, Florence Renaldo2, Fleur Le Bourgeois1, Anna Deho1, Maryline Chomton1, Géraldine Poncelet2, Guillaume Geslain2, Stéphane Dauger1, Michael Levy1
1Pediatric Intensive Care Unit, Hôpital Robert-Debré, Assistance Publique Hôpitaux de Paris, Paris, France; 2Pediatric Neurology, Hôpital Robert-Debré, Assistance Publique Hôpitaux de Paris, Paris, France
Correspondence: Hélène Lienard (lienardhelene@gmail.com)
F-040 Prognostic value of cerebral oxymetry in critically ill children undergoing extracorporeal membrane oxygenation
Meryl Vedrenne-Cloquet, Raphaël Lévy, Judith Chareyre, Manoëlle Kossorotoff, Sylvain Renolleau, Marion Grimaud
Hôpital Necker-Enfants Malades, Paris, France
Correspondence: Meryl Vedrenne-Cloquet (meryl_vedrenne@yahoo.fr)
F-041 Cerebral autoregulation impairment is associated with acute neurological events during pediatric extracorporeal membrane oxygenation
Nicolas Joram1, Erta Beqiri2, Stefano Pezzato3, Pierre Bourgoin1, Alexis Chenouard1, Jean-Michel Liet1, Marek Czosnyka2, Pierre-Louis Leger4, Peter Smielewski2
1Pediatric Intensive Care Unit, University hospital of Nantes, Nantes, France; 2Division of academic Neurosurgery, Department of clinical neurosciences, Addensbrooke ‘s Hospital, University of Cambridge, Cambridge, UK; 3Pediatric Intensive Care Unit, IRCCS Giannina Gaslini Institute, Genoa, Italy; 4Pediatric Intensive Care Unit, Trousseau University Hospital, Paris, France
Correspondence: Nicolas Joram (nicolas.joram@chu-nantes.fr)
F-042 Protective mechanisms of pharmacologic preconditioning against myocardial ischemia reperfusion injury: role of Bcl-2 family proteins
Romain Rozier1, Rachel Paul-Bellon1, Elodie Villa2, Amélie Rolle3, Marc Aimé Raucoules4, Jean-Ehrland Ricci1, Michel Carles3
1Université Côte d’Azur-CHU Nice-C3M INSERM U1065 Equipe 3, Nice, France; 2Feinberg School of Medicine, Northwestern University, IL, Chicago, USA; 3CHU Point-à-Pitre, Point-À-Pitre, France; 4CHU Nice-Université Côte d’Azur, Nice, France
Correspondence: Romain Rozier (romainrozier13@gmail.com)
F-043 Early sepsis worsens outcome in experimental ischemic stroke despite recanalization
Thomas Rambaud1, Lucas Di Meglio1, Adrien Cogo1, Veronique Ollivier1, Mialitiana Solo Nomenjanahary1, Sébastien Dupont1, Yacine Boulaftali1, Nathalie Kubis2, Benoit Ho Tin Noe1, Mikael Mazighi3, Romain Sonneville4
1INSERM U 1148 laboratory for vascular translationnal science, Paris, France; 2INSERM U 1148 laboratory for vascular translationnal science/Service de Physiologie Clinique-Explorations Fonctionnelles, AP-HP, Hôpital Lariboisière, Paris, France; 3INSERM U 1148 laboratory for vascular translationnal science/Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris, France; 4INSERM U 1148 laboratory for vascular translationnal science/medical and infectious intensive care unit, Bichat hospital, aphp, Paris, France
Correspondence: Thomas Rambaud (rambaud.t@gmail.com)
Outcome | Sham + placebo | Sham + LPS | t-MCAO + placebo | t-MCAO + LPS | 4 group comparison |
---|---|---|---|---|---|
Death or Hemorrhagic transformation at 24 h | 0% [0–42%] (0/5) | 0% [0–42%] (0/5) | 6% [3–27%] (1/17) | 50% [25.3–74.6%] (6/12) | p = 0.03 |
Death at 24 h | 0% [0–42%] (0/5) | 0% [0–42%] (0/5) | 6% [3–27%] (1/17) | 33% [14–61%] (4/12) | p = 0.03 |
Hemorrhagic transformation at 24 h | 0% [0–42%] (0/5) | 0% [0–42%] (0/5) | 0% [0–18%] (0/17) | 25% [9–53%] (3/12) | p = 0.01 |
F-044 Extracellular vesicles as a marker of lung injury after cardiac surgery with cardiopulmonary bypass
William Allali1, Erwan Dumontet, Murielle Gregoire, Mathieu Lesouhaitier, Arnaud Gacouin, Sebastien Biedermann, Erwan Flecher, Karin Tarte, Jean-Marc Tadié
1CHU Rennes, Rennes, France
Correspondence: William Allali (William.ALLALI@chu-rennes.fr)
F-045 Prone positioning decreases macrophage recruitment in ventral lung regions of animals with experimental acute respiratory distress syndrome
Laurent Bitker1, Nicolas Costes2, Didier Le Bars2, Maciej Orkisz3, Mehdi Mezidi1, Nazim Benzerdjeb4, Jean Christophe Richard1
1Médecine Intensive-Réanimation, hôpital de la Croix Rousse, Hospices Civils de Lyon, Lyon, France; 2CERMEP-Imagerie du vivant, Lyon, France; 3CREATIS, Lyon, France; 4Service d’anatomo-pathologie, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Lyon, France
Correspondence: Laurent Bitker (laurent.bitker@chu-lyon.fr)
F-046 Plasma exosomes as promising biomarkers for Acute Respiratory Distress Syndrome
Gilles Parzibut, Julien Guiot
CHU-Sart Tilman, Liège, Belgium
Correspondence: Gilles Parzibut (g.parzibut@gmail.com)
F-047 Assessment of red blood cell deformability in patients with diabetic ketoacidosis
Dorian Leroy1, Bruno Sirault2, Patrick Biston1, Karim Zouaoui Boudjletia3, Michael Piagnerelli1
1Intensive Care. CHU-Charleroi. Université Libre de Bruxelles., 6042-Charleroi, Belgium; 2Internal Medicine. CHU-Charleroi. Université Libre de Bruxelles., 6042-Charleroi, Belgium; 3Experimental Medicine Laboratory. CHU-Charleroi. Université Libre de Bruxelles., 6110-Montigny-Le-Tilleul, Belgium
Correspondence: Dorian Leroy (Dorian.Leroy@ulb.ac.be)
F-048 Description of the early hemodynamic profile of septic patients assessed by focused echocardiography in the Emergency Department
Thomas Lafon1, Pauline Feydeau2, Alexandra Appert-Decle3, Mathilde Hadj3, Vincent Bigrat2, Vincent Legarcon3, Marine Goudelin4, Bruno Evrard4, Ana Catalina Hernandez Padilla5, Arthur Baisse3, Philippe Vignon6
1Service d’Accueil des Urgences/Inserm CIC 1435, CHU Dupuytren, Limoges, France; 2SAMU/SMUR, CHU Dupuytren, Limoges, France; 3Service d’Accueil des Urgences, CHU Dupuytren, Limoges, France; 4Réanimation polyvalente, CHU Dupuytren, Limoges, France; 5Inserm CIC 1435, CHU Dupuytren, Limoges, France; 6Réanimation polyvalente/Inserm CIC 1435/Inserm UMR 1092, CHU Dupuytren/Université de Limoges, Limoges, France
Correspondence: Thomas Lafon (thomas.lafon@chu-limoges.fr)
F-049 Right ventricular failure in septic shock Characterization, incidence and impact on fluid-responsiveness
Guillaume Geri1, Amélie Prigent2, Xavier Repessé2, Marine Goudelin3, Gwenael Prat4, Bruno Evrard3, Cyril Charron1, Philippe Vignon3, Antoine Vieillard-Baron1
1Ambroise Paré Hospital, Boulogne-Billancourt, France; 2Ambroise Paré Hospital, medical ICU, APHP, Boulogne-Billancourt, France; 3CHU Limoges, Limoges, France; 4CHU Brest, Brest, France
Correspondence: Guillaume Geri (guillaume.geri@aphp.fr)
F-050 Weaning failure of cardiac origin in high-risk patients: role of the fluid balance
Marine Goudelin1, Pauline Champy2, Jean-Bernard Amiel1, Bruno Evrard1, Anne-Laure Fedou1, Thomas Daix3, Bruno François3, Philippe Vignon3
1Réanimation polyvalente, CHU Dupuytren, Limoges, France; 2Anesthésie secteur digestif et urologie, CHU Dupuytren, Limoges, France; 3Réanimation polyvalente/Inserm CIC 1435/Inserm UMR 1092, CHU Dupuytren, Limoges, France
Correspondence: Marine Goudelin (marine.goudelin@chu-limoges.fr)
1st SBT failed | 2nd SBT succeeded | p | |
---|---|---|---|
Before SBT | |||
E, cm/s | 102 (85–149) | 84 (67–127) | 0.017 |
E/A | 1.65 (1.17–2.66) | 1.33 (0.83–2.09) | 0.139 |
DTE, ms | 103 (92–134) | 133 (103–184) | 0.139 |
E/E’ | 8.9 (5.9–13.1) | 7.3 (5.0–10.4) | 0.028 |
End of SBT | |||
E, cm/s | 122 (93–168) | 100 (85–122) | 0.009 |
E/A | 2.45 (1.05–3.64) | 1.54 (0.88–2.31) | 0.009 |
DTE, ms | 81 (71–128) | 130 (97–133) | 0.093 |
E/E’ | 9.3 (7.5–12.6) | 7.7 (6.2–9.9) | 0.047 |
Weight and fluid balance | |||
Weight difference (admission), kg | + 1.6 (− 2.1/+ 6.5) | − 5.0 (− 9.5/− 1.7) | 0.005 |
Cumulated fluid balance, ml | + 146 (− 2654/+ 4434) | − 2224 (− 7056/+ 100) | 0.005 |
F-051 Measurement site accuracy of inferior vena cava diameters to predict fluid responsiveness in spontaneously breathing patients
Morgan Caplan, Julien Goutay, Perrine Bortolotti, Thierry Onimus, Raphael Favory, Sébastien Préau
CHRU Lille, Lille, France
Correspondence: Morgan Caplan (Morgan.Caplan@gmail.Com)
F-052 Search for trans-thoracic echocardiography predictive criteria of hemodynamic instability during intermittent hemodialysis in critically ill patients
Maxime Leclerc, Benoit Courteille, Cedric Daubin, Julien Dupeyrat, Suzanne Goursaud, Aurelie Joret, Toufiq Rhanem, Xavier Valette, Damien Cheyron
CHU Caen Côte de Nacre, Caen, France
Correspondence: Maxime Leclerc (leclerc.maxime@hotmail.fr)
F-053 Global longitudinal strain is the best transthoracic echocardiography parameter of left and right ventricular systolic function in critically ill patients
Pierre Dupland, Ariane Gavaud, Frédéric Pene, Jean-Daniel Chiche, Jean-Paul Mira, Alain Cariou, Mathieu Jozwiak
Service de Médecine Intensive Réanimation, Hôpitaux universitaires Paris-Centre, Hôpital Cochin, Paris, France
Correspondence: Pierre Dupland (pierre.dupland@gmail.com)
F-054 The Applicability of Fluid Responsiveness Indices in Circulatory failure (AFRIC study)
Rui Shi, Nello De Vita, Francesco Gavelli, Jean-Louis Teboul, Arthur Pavot, Xavier Monnet
Service de médecine intensive-réanimation, Hôpital de Bicêtre, Hôpitaux universitaires Paris-Saclay, Assistance publique—Hôpitaux de Paris, Inserm UMR S_999, Université Paris-Sud, Le Kremlin-Bicêtre, France
Correspondence: Rui Shi (shiruidingding@hotmail.com)
F-055 Sleep Apnea Syndrome in hypercapnic respiratory failure: prevalence and validation of screening scores
Fadoua Houri, Wiem Nouira, Hedia Ben Ahmed, Zeineb Hammouda, Manel Lahmar, Fekri Abroug, Lamia Besbes
CHU F.Bourguiba, Monastir, Tunisia
Correspondence: Fadoua Houri (hourifadwa@gmail.com)
F-056 Extracorporeal CO2 Removal in acute exacerbation of COPD not responding to non-invasive ventilation: a single center experience
Daniel Silva1, Rita Serbouti2, Laurent Laine1, Nathalie Memain1, Vincent Ioos1, Mathilde Lermuzeaux1, Camille Legouy1, Morgan Benais1, Luis Ferreira1, Jérôme Aboab1
1Médecine Intensive Réanimation-Centre Hospitalier de Saint-Denis, Saint-Denis, France; 2Fresenius Medical Care France, Fresnes, France
Correspondence: Daniel Silva (daniel.silva@mac.com)
F-057 High-Flow Nasal nebulization of Salbutamol during severe acute exacerbation of Chronic Obstructive Pulmonary Disease
Clément Beuvon1, Nicolas Marjanovic1, Rémi Coudroy1, Christophe Rault1, Vanessa Bironneau1, Xavier Drouot1, René Robert1, Arnaud Thille1, Jean-Pierre Frat1
1CHU de Poitiers, Poitiers, France
Correspondence: Clément Beuvon (cbeuvon@hotmail.fr)
F-058 T-piece versus sub-therapeutic pressure support for weaning from invasive mechanical ventilation in patients with chronic obstructive pulmonary disease: a comparative prospective study
Amira Jamoussi, Fatma Jarraya, Samia Ayed, Takoua Merhabene, Jalila Ben Khelil, Mohamed Besbes
Abderrahmen Mami Hospital, Tunis, Tunisia
Correspondence: Amira Jamoussi (dr.amira.jamoussi@gmail.com)
F-059 The incidence of laryngo-tracheal lesions in tracheotomized patients in Post Intensive Care Rehabilitation Unit
Laurence Donetti, Dominique Kaminski, Mohamed Laissi, Jean-Claude Marchal, Pascal Meyer, Karim Nssair, Gérald Choukroun
CH Forcilles, Ferolles Attilly, France
Correspondence: Laurence Donetti (laurdonetti@gmail.com)
Lesions | Number of patients |
---|---|
Epiglottis edema | 25 |
Arytenoides edema | 43 |
Vocal cords edema | 10 |
Vocal cords nodule | 1 |
Vocal cords posterior notch | 2 |
Larynx abnormal sensibility | 19 |
Larynx abnormal mobility | 18 |
F-060 Which score to predict NIV failure in Hypercapnic Respiratory Failure: HACOR score vs ROX index
Wiem Nouira, Zeineb Hammouda, Syrine Maatouk, Hedia Ben Ahmed, Amir Bedhaifi, Yed Maatouk, Fadoua Houri, Fekri Abroug, Lamia Besbes
CHU F.Bourguiba, Monastir, Tunisia
Correspondence: Wiem Nouira (wiemnouira1@gmail.com)
F-061 Characteristics and outcome of patients managed for difficult weaning in a weaning and rehabilitation care unit
Sarah Makoudi, Julie Delemazure, Martin Dres, Alexandre Demoule, Elise Morawiec
Unité de soins de rééducation post réanimation Service de Pneumologie, Médecine Intensive, Paris, France
Correspondence: Sarah Makoudi (smmakoudi@gmail.com)
F-062 Hemodynamic impact of High-dose Insulin Euglycemic Therapy in calcium channel blockers poisoning
Julien Goutay1, Erika Parmentier-Decrucq1, Olivier Nigeon2, Julien Poissy1, Daniel Mathieu1, Thibault Duburcq1
1CHU de Lille, Pôle de Réanimation, Hôpital Salengro, Lille, France; 2CH de Lens, Service de Réanimation, Lens, France
Correspondence: Julien Goutay (julien.goutay@gmail.com)
F-063 Liver Dysfunction and Ketamine use in critically ill patients with ARDS: a Post Hoc analysis of the ACURASYS study
Florence Daviet1, Benjamin Coiffard1, Arnaud Gacouin2, Gilles Perrin3, Anderson Loundou4, Samir Jaber5, Jean-Michel Arnal6, Dider Perez7, Jean-Marie Seghboyan8, Jean-Michel Constantin9, Jean-Yves Lefrant10, Claude Guérin11, Gwenael Prat12, Jean-François Timsit13, Antoine Roch1, Laurent Papazian1, Jean-Marie Forel1
1Médecine Intensive Réanimation, Service du Pr PAPAZIAN, Hôpital Nord, Marseille, France; 2Service des maladies infectieuses et réanimation médicale, hôpital Pontchaillou, centre hospitalier universitaire de Rennes, Rennes, France; 3Réanimation des Urgences et Medicale, CHU la Timone 2, Marseille, France; 4Unité d’Aide Méthodologique à la Recherche Clinique-Assistance Publique-Hôpitaux de Marseille, Marseille, France; 5Département d’Anesthésie-Réanimation, hôpital Saint-Éloi, Montpellier, France; 6Service de Réanimation Polyvalente, Hôpital Sainte Musse, Toulon, France; 7Service de Réanimation-USC, Hôpital Lons-le-Saunier, Lons-Le-Saunier, France; 8Réanimation Hopital Européen, Marseille, France; 9Department of Perioperative Medicine, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France; 10Department of Anaesthesiology, Critical Care and Emergency Medicine, CHU de Nîmes, Nimes, France; 11Réanimation Médicale Hôpital de la Croix Rousse, Lyon, France; 12Medical Intensive Care Unit, Cavale Blanche University Hospital, Brest, France; 13Medical and Infectious Diseases ICU (MI2), Bichat Hospital, Paris, France
Correspondence: Florence Daviet (florence.daviet@ap-hm.fr)
F-064 Cardiovascular complications following Ciguatera fish poisoning in the French West Indies—A case series
Dabor Resiere1, Florentin Jonathan2, Mahi Zacharia2, Papa Gueye2, Hatem Kallel3, Hossein Mehdaoui1
1Department of Critical Care, University Hospital of Martinique, Fort-De-France, France; 2University Hospital of Martinique, Fort-De-France, France; 3Intensive Care Unit, Cayenne General hospital, Cayenne, 97300, French Guiana, France
Correspondence: Dabor Resiere (dabor.resiere@chu-martinique.fr)
F-065 Acute organophosphate poisoning
Fahd Moussaid, Reda Elhadrami, Hamza Elhamzaoui, Taoufik Abouelhassan
Emergency department, University Hospital Mohamed VI, Marrakec, MOROCCO
Correspondence: Fahd Moussaid (fahdmoussaid5@gmail.com)
OP | Patient percentage |
---|---|
Rodenticides | 80% |
Malathion | 5% |
Cockroach trap | 10% |
Baygon pesticide | 5% |
F-066 Long-term exposure to Sargassum-seaweed pollution in the French Caribbean Islands: clinical consequences and outcome
Dabor Resiere1, Ruddy Valentino1, Rishika Banydeen2, Jonathan Florentin1, Papa Gueye1, Alain Blateau3, Hatem Kallel4, Bruno Megarbane5, Remi Neviere1, Hossein Mehdaoui1
1Department of Critical Care, University Hospital of Martinique, F-97200 Fort-de-France, France; 2Department of Epidemiology & Methodology, University Hospital of Martinique, F-97200 Fort-de-France, France; 3ARS Martinique, Fort-De-France, France; 4Intensive Care Unit, Cayenne General Hospital, Cayenne, 97300 French Guiana, France; 5Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS1144, Paris, France
Correspondence: Dabor Resiere (dabor.resiere@chu-martinique.fr)
F-067 Prognosis value of acute liver dysfunction after out-of-hospital cardiac arrest
Marie-Charlotte Delignette1, Thomas Baudry1, Marie Simon1, Flavie Lavigne1, Eric Bonnefoy-Cudraz2, Laurent Argaud1, Martin Cour1
1Médecine Intensive Réanimation-Hôpital Edouard Herriot, Lyon, France; 2USIC-Hôpital Louis Pradel, Lyon, France
Correspondence: Marie-Charlotte Delignette (marie-charlotte.delignette@chu-lyon.fr)
F-068 Using neuron-specific-enolase (NSE) for prediction of severe brain damage after cardiac arrest: insights from the Parisian Registry
Guillaume Savary1, Antonin Ginguay2, Phuong-Nhi Bories2, Paul Jaubert1, Ariane Gavaud1, Elodie Baron1, Pierre Dupland1, Jean-Paul Mira1, Florence Dumas3, Alain Cariou1
1Medical Intensive Care Unit, Cochin Hospital, APHP, Centre—Université de Paris, Paris, France; 2Biochimie, Cochin Hospital, APHP, Centre—Université de Paris, Paris, France; 3Emergency Department, Cochin University Hospital, APHP, Paris, France
Correspondence: Guillaume Savary (guillaume.savary@aphp.fr)
F-069 Availability of psychologists in French-speaking intensive care units
Jean-Baptiste Lascarrou1, Saber Davide Barbar2, Florence Boissier3, Guillaume Decormeille4, Nicholas Heming5, Bertrand Hermann6, Sami Hraiech7, Gwenaëlle Jacq8, Jean-FrançOis Llitjos6, Lamia Besbes9, Laurent Poiroux10, Xavier Monnet11, Gaël Piton12
1Medical Intensive Care Unit, Nantes, France; 2Medical Intensive Care Unit, Nîmes, France; 3Medical Intensive Care Unit, Poitiers, France; 4Medical Surgical Intensive Care Unit, Toulouse, France; 5Medical Intensive Care Unit, Garches, France; 6Medical Intensive Care Unit, Paris, France; 7Medical Intensive Care Unit, Marseilles, France; 8Medical Surgical Intensive Care Unit, Versailles, France; 9Medical Intensive Care Unit, Monastir, Tunisia; 10Medical Intensive Care Unit, Angers, France; 11Medical Intensive Care Unit, Le Kremlin-Bicêtre, Francel; 12Medical Intensive Care Unit, Besançon, France
Correspondence: Jean-Baptiste Lascarrou (jeanbaptiste.lascarrou@chu-nantes.fr)
n = 197 ICUs | P | |
---|---|---|
Presence of a psychologist | 89 (54%) | |
Presence of a psychologist | ||
Public hospital | 71/162 (44%) | 0.34 |
Private hospital | 18/33 (54%) | |
Unknown | 2 | |
Presence of psychologist | ||
Adult ICU | 80/185 (43%) | 0.006 |
Pediatric ICU | 9/10 (90%) | |
Presence of a psychologist according to the opening of the ICU | ||
< 8 h | 39/79 (49%) | 0.58 |
> 8 h | 21/45 (46%) | |
24 h | 29/71 (41%) |
F-070 Should Intermediate care units and intensive care units be 2 separate units?
Juliette Audibert, Adel Ben Salah, Alexandre Conia, Olivier Gontier, Mouldi Hamrouni, Cecile Jourdain, Benedicte Mauchien, Pierre Kalfon
Hôpitaux de Chartres, Chartres, France
Correspondence: Juliette Audibert (juliettesouhaid@gmail.com)
F-071 Evaluation of an early post-ICU discharge consult program on handoff quality
Camille Vissac1, Cécilia Tabra1, Rusel Leon1, Marina Axus1, Morgane Commereuc1, Frédérique Schortgen1, Jerome Cecchini1
1Réanimation et surveillance continue adulte, Hôpital intercommunal de Créteil, Créteil, France
Correspondence: Camille Vissac (camille.vissac@chicreteil.fr)
F-072 Patients’ perceptions of quality of life after ICU discharge
Danielle Prevedello, Claire Steckelmacher, Marianne Devroey, Jean-Charles Preiser
Hopital Erasme, Bruxelles, Belgium
Correspondence: Danielle Prevedello (danielle.prevedello@gmail.com)
F-073 Post-traumatic stress disorder after discharge from an acute medical unit
Basma lahmer1, naoufel madani1,2, jihane belayachi1,2, redouane abouqal1,2
1Acute Medical Unit, Ibn Sina University Hospital, Rabat, Morocco; 2Laboratory of Biostatistics, Clinical, and Epidemiological Research, Faculty of medicine and pharmacy—university Mohammed V, 10000, Rabat, Morocco
Correspondence: Basma lahmer (basma.lahmer.93@gmail.com)
F-074 Quadriceps strength of critically ill patients: how weak are they?
Anne Meunier, Jean-Louis Croisier, Isabelle Kellens, Benoit Misset, Jean Joris, Anne-Françoise Rousseau
University Hospital of Liège, Liège, Belgium
Correspondence: Anne Meunier (anne.meunier@student.uliege.be)
F-075 Healthcare trajectories before and after critical illness: population-based insight on diverse patients clusters
Youenn Jouan1, Leslie Grammatico-Guillon2, Antoine Guillon1, Stephan Ehrmann1
1Service de Médecine Intensive Réanimation, CHU de Tours, Tours, France; 2Service d’Information Médicale, d’Epidémiologie et d’Economie de la Santé, Tours, France
Correspondence: Youenn Jouan (youenn.jouan@gmail.com)
F-076 Prehospital triage in severely traumatized children: experience of a French regional trauma system
Jordan Porteaud1, Guillaume Mortamet2, Francois-Xavier Ageron3, Pierre Bouzat1
1Département d’anesthésie, CHU de Grenoble, Grenoble, France; 2Service de réanimation pédiatrique, CHU de Grenoble, Grenoble, France; 3CH Annecy, Annecy, France
Correspondence: Jordan Porteaud (jporteaud@chu-grenoble.fr)
F-077 Glomerular filtration rate estimation formulas for assessing piperacillin clearance in critically ill children
Agathe Béranger1, Sihem Benaboud2, Saïk Urien3, Thao Nguyen Khoa4, Inès Gana2, Julie Toubiana5, Yi Zheng2, Fabrice Lesage6, Sylvain Renolleau8, Déborah Hirt2, Jean-Marc Treluyer2, Mehdi Oualha1
1Réanimation pédiatrique, Necker Enfants Malades, Paris, France; 2Pharmacologie clinique, Cochin, Paris, France; 3URC, Cochin-Tarnier, Paris, France; 4Biochimie générale, Necker Enfants Malades, Paris, France; 5Pédiatrie générale, Necker Enfants Malades, Paris, France; 6Réanimation pédiatrique, Necker, Paris, France
Correspondence: Agathe Béranger (agathe.beranger@gmail.com)
F-078 Acute pancreatitis in the pediatric intensive care unit: French retrospective study
Elsa Amouyal1, Julie Sommet1, Jerome Rambaud2, Anna Deho1, Jérôme Naudin1, Michael Levy1, Géraldine Poncelet1, Fleur Le Bourgeois1, Guillaume Geslain1, Arielle Maroni1, Stéphane Dauger1, Maryline Chomton1
1Robert Debré Hospital, Paris, France; 2Trousseau Hospital, Paris, France
Correspondence: Elsa Amouyal (elsa_amouyal@hotmail.com)
F-079 Therapeutic plasma exchange for immunologic disorders: a well-tolerated and safe process for pediatric life-threatening conditions
Jean-Sebastien Diana, Sandra Manceau, Tioka Rabeony, Caroline Elie, Anne-Marine Lenzotti, Valerie Jolaine, Melodie Aubart, Pierre Tremolieres, Nadege Salvi, Christine Bodemer, Brigitte Bader-Meunier, Christine Barnerias, Franck Iserin, Christophe Chardot, Florence Lacaille, Sylvain Renolleau, Remi Salomon, Francois Lefrere, Mehdi Oualha, Marianne Delville, Laurent Dupic
APHP, Paris, France
Correspondence: Jean-Sebastien Diana (jean-sebastien.diana@aphp.fr)
F-080 Epidemiology and risk factors of infections on catheters with implantable chamber in the pediatric population
Yacine Benhocine
University hospital nedir mohamed, Tizi-Ouzou, ALGERIA
Correspondence: Yacine Benhocine (yacine001@yahoo.fr)
F-081 Effect of a compliant bundled care on severity and mortality in children with severe sepsis hospitalized in PICU. Retrospective analysis of the DIABACT III study
Camille Beaucourt1, Fleur Lorton2, Elise Launay2, Florent Baudin3, Christèle Gras-Leguen2, Etienne Javouhey4
1CHRU Jean Minjoz, Besancon, France; 2Hôpital Mère Enfant, Nantes, France; 3Hôpital Femme Mère Enfant, Bron, France; 4Hôpital Femme Mère Enfant, Lyon, France
Correspondence: Camille Beaucourt (camille.beaucourt91@gmail.com)
F-082 Epidemiology of nosocomial infections with extended-spectrum β-lactamase producing gram-negative bacilli in a neonatal and paediatric Tunisian intensive care unit
Ahmed Ayari1, Asma Bouziri1, Ahmed Hajji1, Shatila Hadj Hassine1, Assaad Louati1, Khaled Menif1, Aïda Borgi1, Nejla Ben Jaballah1
1Service de Réanimation Pédiatrique Polyvalente/Bechir Hamza Children’s Hospital of Tunis, Tunis, Tunisia
Correspondence: Ahmed Ayari (Ahmed.alayari@gmail.com)
F-083 Serum phosphate variation precedes acute kidney injury in Tumor Lysis Syndrome
Marie Lemerle1, Aline Schmidt2, Valérie Thepot-Seegers3, Achille Kouatchet1, Valérie Moal4, Mélina Raimbault5, Corentin Orvain2, Jean-Francois Augusto6, Julien Demiselle1
1CHU Angers, Médecine intensive réanimation, Angers, France; 2CHU Angers, Maladie du sang, Angers, France; 3CHU Angers-ICO, Angers, France; 4CHU Angers, Pharmacie, Angers, France; 5CHU Angers, LABORATOIRE de Biochimie, Angers, France; 6CHU Angers, néphrologie dialyse transplantation, Angers, France
Correspondence: Marie Lemerle (marielemerle@yahoo.fr)
F-084 Chimeric Antigen Receptor T Cell-related toxicities requiring ICU admission: a single-centre experience
Clara Sortais1, Amélie Seguin2, Thomas Gastinne1, Amandine Le Bourgeois1, Steven Le Gouill1, Jean-Baptiste Lascarrou3, Charlotte Garret3, Maelle Martin3, Arnaud-Felix Miailhe3, Helene Migueres3, Laura Crosby3, Olivier Zambon3, Jean Reignier3, Emmanuel Canet3
1Service d’Hématologie Clinique/CHU de Nantes, Nantes, France; 2Service de Médecine Intensive Et Réanimation/CHU de Nantes, Nantes, France; 3Service de Médecine Intensive Et Réanimation/CHU de Nantes, Nantes, France
Correspondence: Clara Sortais (clara.sortais@chu-nantes.fr)
F-085 Pediatric Intensive Care Unit (PICU) management after Tisagenlecleucel (CTL019 Chimeric Antigen Receptor T Cell Therapy) infusion for B-Cell Acute Lymphoblastic Leukemia (ALL): experience of the first pediatric French patients
Jérôme Naudin1, Arthur Felix2, Maryline Chomton1, Michael Levy3, Marie-Emilie Dourthe4, Delphine Chaillou4, Karima Yakouben4, André Baruchel5, Stéphane Dauger3
1Service de réanimation pédiatrique-CHU Robert Debré-APHP, Paris, France; 2Institut Gustave Roussy, Villejuif, France; 3Service de réanimation pédiatrique-CHU Robert Debré-APHP-Université de Paris, Paris, France; 4Service d’hématologie pédiatrique-CHU Robert Debré-APHP, Paris, France; 5Service d’hématologie pédiatrique-CHU Robert Debré-APHP-Université de Paris, Paris, France
Correspondence: Jérôme Naudin (jerome.naudin@aphp.fr)
F-086 CAR-T cell therapy in ICU patients: a single-center experience
Sandrine Valade1, Eric Mariotte1, Virginie Lemiale1, Lara Zafrani1, Adrien Mirouse1, Yannick Hourmant1, Jean Jacques Tudesq1, Asma Mabrouki1, Igor Theodose1, Catherine Thieblemont2, Nicolas Boissel2, Michaël Darmon1, Elie Azoulay1
1APHP, Saint Louis Hospital, Medical ICU, Paris, France; 2APHP, Saint Louis Hospital, Hematology, Paris, France
Correspondence: Sandrine Valade (sandrine.valade@aphp.fr)
F-087 5-Fluorouracil-induced encephalopathy: a French national survey
Alice Boilève1, Laure Thomas2, Coralie Coccini3, Agnès Le-Lillo Louët4, Louise Gaboriau5, Laurent Chouchana6, Michel Ducreux1, David Malka1, Valérie Boige1, Antoine Hollebecque1, Dominique Hillaire-Buys3, Mathieu Jozwiak7
1Département de Médecine Oncologique, Institut Gustave Roussy, Villejuif, France; 2Centre Régional de PharmacoVigilance, Assistance Publique des Hôpitaux de Paris, Hôpitaux Universitaires Paris-Est, Hôpital Henri Mondor, Créteil, France; 3Centre Régional de PharmacoVigilance, Hôpital Universitaire de Montpellier, Montpellier, France; 4Centre Régional de PharmacoVigilance, Hôpital Européen George Pompidou, Paris, France; 5Centre Régional de PharmacoVigilance, Assistance Publique des Hôpitaux de Paris, Hôpitaux Universitaires Paris-Centre, Hôpital Européen Georges Pompidou, Lille, France; 6Centre Régional de PharmacoVigilance, Assistance Publique des Hôpitaux de Paris, Hôpitaux Universitaires Paris-Centre, Hôpital Cochin, Paris, France; 7Service de Médecine Intensive Réanimation, Assistance Publique des Hôpitaux de Paris, Hôpitaux Universitaires Paris-Centre, Hôpital Cochin, Paris, France
Correspondence: Alice Boilève (alice.boileve@gmail.com)
F-088 Immune related adverse events: a retrospective look into the future of oncology in the intensive care unit
Adrien Joseph1, Annabelle Stoclin2, Antoine Vieillard-Baron3, Guillaume Geri3, Jean-Marie Michot4, Olivier Lambotte5, Elie Azoulay6, Virginie Lemiale6
1U1138, INSERM, Equipe 11 labellisée Ligue Nationale Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France; 2Département d’anesthésie-réanimation, Institut Gustave Roussy, Villejuif, France; 3Service de réanimation médico-chirurgicale, Hôpital Ambroise Paré, Assistance Publique Hôpitaux de Paris, Boulogne Billancourt, France; 4Département d’innovations thérapeutiques et d’essais précoces (DITEP), Institut Gustave Roussy, Villejuif, France; 5Service de médecine interne et immunologie clinique, Hôpital Bicêtre, Assistance Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France; 6Service de réanimation médical, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France
Correspondence: Adrien Joseph (adrien.joseph@hotmail.fr)
F-089 Tyrosin kinase inhibitor: an effective tool against lung cancer involvement responsible for acute respiratory failure in ICU
Yanis Akrour1, Yacine Tandjaoui-Lambiotte1, Boris Duchemann2, Frederic Gonzalez3, Annabelle Stoclin4, Fadwa El Kouari5, Aude Gibelin6, Paul Jaubert7, Anne-Sophie Moreau8, Florent Wallet9, Etienne De Montmollin10, Damien Contou11, Nicolas Dufour12, Romain Persichini13, Marc Pineton De Chambrun5, Alexandre Lautrette14, Anne Oppenheimer15, Yves Cohen16, Stéphane Gaudry16
1Réanimation médico-chirurgicale, CHU Avicenne, APHP, Bobigny, France; 2Oncologie, CHU Avicenne, APHP, Bobigny, France; 3Réanimation, Institut Paoli Calmette, Marseille, France; 4Réanimation, Institut Gustave Roussy, Villejuif, France; 5Réanimation, CHU Pitié-Salpêtrière, APHP, Paris, France; 6Réanimation, CHU Tenon, APHP, Paris, France; 7Réanimation, CHU Cochin, APHP, Paris, France; 8Réanimation, CHRU, Lille, France; 9Réanimation, CHU Lyon, Lyon, France; 10Réanimation, CHU Bichat, APHP, Paris, France; 11Réanimation, Argenteuil, France; 12Réanimation, CH Réné Dubos, Pontoise, France; 13Réanimation, CHU de la Réunion, Saint Denis De La Réunion, France; 14Réanimation, CHU, Clermont-Ferrand, France; 15EA 7285 Research Unit ‘Risk and Safety in Clinical Medicine for Women and Perinatal Health’, Versailles-Saint-Quentin University, Clamart, France; 16Réanimation, CHU Avicenne, APHP, Bobigny, France
Correspondence: Yanis Akrour (akrour.yanis92@gmail.com)
F-090 Center effect in intubation risk in critically-ill immunocompromised patients with acute hypoxemic respiratory failure
Guillaume Dumas
1Service de Médecine intensive-réanimation, Hôpital Saint-Louis, Paris APHP, Inserm UMR 1153, Paris, France
Correspondence: Guillaume Dumas (dumas.guillaume1@gmail.com)
F-091 The impact of Influenza on 28-day survival in ARDS non-trauma patients
Mathieu Lesouhaitier, Jean-Marc Tadié, Aurélien Frérou, Sonia Rafi, Claire Lhommet, Adel Maamar, Yves Le Tulzo, Arnaud Gacouin
CHU Rennes, Rennes, France
Correspondence: Mathieu Lesouhaitier (mathieu.lesouhaitier@chu-rennes.fr)
F-092 Acute Respiratory Distress Syndrome: Acute Respiratory Distress Syndrome among French Army. Retrospective analysis about war casualties on fifteen years study
Johan Schmitt1, Mathieu Boutonnet2, Goutorbe Philippe1, Raynaud Laurent3, Cyril Carfantan4, Antoine Luft5, Pierre Pasquier2, Eric Meaudre1, Julien Bordes1
1Military Teaching Hospital Saint Anne, Toulon, France; 2Military Teaching Hospital Percy, Paris, France; 3Tropical Medecine Institute’s French Health Army Service, Marseille, France; 4Military Medical Service, Ventiseri, France; 5French Army Health Service Direction, Paris, France
Correspondence: Johan Schmitt (schmitt.johan83@gmail.com)
F-093 Title: Acute respiratory failure due to Pneumocystis with or without acute respiratory distress syndrome requiring ICU admission
Laure Folliet, Jean-Christophe Richard, Damien Dupont, Meja Rabodonirina, Laurent Argaud, Vincent Piriou, Thomas Rimmele, Claude Guérin
HCL, Lyon, France
Correspondence: Laure Folliet (laure.folliet@chu-lyon.fr)
F-094 Impact of bronchoalveolar lavage in mechanically ventilated patients: an electrical impedance tomography—based study
Guillaume Franchineau, Paul Masi, Nicolas Brechot, Guillaume Hekimian, Loïc Le Guennec, Simon Bourcier, Charles-Edouard Luyt, Alain Combes, Matthieu Schmidt
Médecine Intensive-Réanimation, CHU Pitié-Salpêtrière, Paris, France
Correspondence: Guillaume Franchineau (gfranchineau@gmail.com)
F-095 Effect of transesophageal echocardiography on tracheal microaspiration and ventilator-associated pneumonia in intubated critically-ill patients: a multicenter prospective observational study
François Bagate1, Anahita Rouze2, Farid Zerimech3, Florence Boissier4, Vincent Labbe5, Keyvan Razazi1, Guillaume Carteaux1, Saad Nseir2, Armand Mekontso Dessap1
1CHU Henri Mondor, Service de Médecine Intensive Réanimation, Créteil, France; 2CHU Lille, Service de Médecine Intensive Réanimation, Lille, France; 3CHU Lille, Centre de Biologie Pathologie, Lille, France; 4CHU Poitiers, Service de Médecine Intensive Réanimation, Poitiers, France; 5CHU Tenon, Service de réanimation polyvalente, Paris, France
Correspondence: François Bagate (francois.bagate@aphp.fr)
F-096 Severe Chest Trauma as a Risk Factor of Post-Traumatic Pulmonary Embolism in the ICU
Mariem Dlela1, Yassmine Kammoun2, Olfa Turki1, Kamilia Chtara1, Mounir Bouaziz1
1Habib Bourguiba hospital, Sfax, Tunisia; 2Hedi Chaker hospital, Sfax, Tunisia
Correspondence: Mariem Dlela (mariem241090@gmail.com)
F-097 Impact of pulmonary and non-pulmonary sepsis on susceptibility to secondary bacterial pneumonia: a pivotal role for the alveolar macrophage?
Jean-FrançOis Llitjos1, Zakaria Ait Hamou1, Christophe Rousseau1, Matthieu Benard1, Hugues Vicaire1, Clémence Martin2, Pierre-Régis Burgel2, Jean-Paul Mira3, Jean-Daniel Chiche3, Maha Zohra Ladjemi1, Frédéric Pene3
1INSERM U1016, Institut Cochin, 22 rue Méchain, 75014, Paris, France; 2Service de pneumologie, hôpital Cochin, Paris and INSERM U1016, Institut Cochin, 22 rue Méchain, 75014, Paris, France; 3Médecine Intensive-Réanimation, hôpital Cochin, Paris and INSERM U1016, Institut Cochin, 22 rue Méchain, 75014, Paris, France
Correspondence: Jean-FrançOis Llitjos (jllitjos@gmail.com)
F-098 Local signs at insertion site and prediction of catheter-related infections in short-term central venous and arterial catheters in the ICU. Individual findings from 4 multicenter randomized controlled trials
Niccolo Buetti1, Stephane Ruckly1, Jean-Christophe Lucet1, Olivier Mimoz2, Bertrand Souweine3, Jean-François Timsit1
1INSERM IAME DESCID, Paris, France; 2Services des Urgences Adultes and SAMU 86, Centre Hospitalier Universitaire de Poitiers, Poitiers, France; 3Medical ICU, Gabriel-Montpied University Hospital, Clermont-Ferrand, France
Correspondence: Niccolo Buetti (niccolo.buetti@gmail.com)
F-099 Epidemiology and Outcomes of Pneumococcal meningitis with Sepsis in France
Claire Dupuis1, Michael Thy1, Bruno Mourvillier1, Lila Bouadma1, Stephane Ruckly2, Anne Perozziello3, Damien Van-Gysel4, Etienne de Montmollin1, Romain Sonneville1, Jean-François Timsit1
1Réanimation médicale et infectieuse, CHU Bichat, AP-HP, Paris, France; 2UMR 1137 IAME Team Descide, Paris, France; 3UMR 1137-IAME Team 5–DeSCID, Paris, France; 4Département d’Informations Médicales, CHU Bichat, APHP Paris, Paris, France
Correspondence: Claire Dupuis (cdup83@gmail.com)
F-100 Poor outcome associated with Mucormycosis in critically-ill hematological patients: Results of a multicenter study
Matthieu Jestin1, Adrien Mirouse1, Jean-Jacques Tudesq1, Yannick Hourmant1, Fabrice Bruneel2, Julien Mayaux3, Martin Murgier4, Frédéric Pene5, Eric Mariotte6, Virginie Lemiale6, Lara Zafrani6, Elie Azoulay6, Michaël Darmon6, Sandrine Valade6
1Service de Médecine Intensive et Réanimation, Hôpital Saint-Louis, Paris, France; 2Service de réanimation médico-chirurgicale, Centre hospitalier de Versailles, Le Chesnay, France; 3Service de Pneumologie, Médecine Intensive et Réanimation, Hôpital Universitaire Pitié-Salpêtrière, Paris, France; 4Service de Réanimation polyvalente, Centre hospitalo-universitaire de Saint-Etienne, Saint-Etienne, France; 5Service de Médecine Intensive et Réanimation, Hôpital Cochin, AP-HP, Paris, France; 6Service de Médecine Intensive et Réanimation, Hôpital Saint-Louis, Paris, France
Correspondence: Matthieu Jestin (m_jestin56@hotmail.com)
F-101 Prediction of clinical phenotypes with biomarkers during presumed sepsis: a non-supervised analysis of the Captain cohort
Benoit Misset1, François Philippart2, Virginie Moucadel3, Mariana Parlato4, Catherine Fitting5, Jean-Pierre Bedos6, Jean-Luc Diehl7, Olfa Hamzaoui8, Djillali Annane9, Didier Journois7, Jean-Marc Cavaillon5, Joël Coste7
1CHU Sart-Timan, Liège, Belgium; 2GHPSJ, Paris, France; 3Biomérieux, Lyon, France; 4Inserm, Paris, France; 5Pasteur Institute, Paris, France; 6CH, Versailles, France; 7APHP, Paris, France; 8APHP, Clamart, France; 9APHP, Garches, France
Correspondence: Benoit Misset (benoit.misset@chuliege.be)
F-102 Pro-adrenomedullin and Procalcitonin serial levels in predicting infection relapse or superinfection and outcome in ICU—a post hoc analysis of the PRORATA biobank
Lila Bouadma1, Tiphaine Robert1, Charles-Edouard Luyt2, Philippe Montravers3, Carole Schwebel4, Stephane Ruckly1, Jean-François Timsit1
1Hôpital Bichat Claude Bernard, Paris, France; 2Hôpital de la Pitié Salpêtrière, Paris, France; 3Hôpital Michallon, Paris, France; 4Hôpital Michallon, Grenoble, France
Correspondence: Lila Bouadma (lila.bouadma@aphp.fr)
F-103 Performance of repeated (1-3)-β-d-glucan measures, a post hoc analysis of the EMPIRICUS Randomized Clinical Trial
Claire Dupuis1, Clément Le Bihan1, Muriel Cornet2, Stephane Ruckly3, Carole Schwebel2, Lila Bouadma1, Elie Azoulay4, Jean-François Timsit1
1Réanimation médicale et infectieuse, CHU Bichat, APHP, Paris, France; 2Mycologie-Parasitologie, CHU Grenoble, Grenoble, France; 3UMR 1137, IAME, équipe Descide, Université de Paris, Paris, France; 4Réanimation médicale, CHU Saint Louis, APHP, Paris, France
Correspondence: Claire Dupuis (cdup83@gmail.com)
F-104 Prehospital measurement of lactatemia and blood culture drawing for septic shock
Barbara Alves, Benoit Vivien, Romain Jouffroy
Anesthesia and Intensive Care Unit—SAMU 75—Assistance Publique des Hôpitaux de Paris –Necker Enfants Malades Hospital, Paris, France
Correspondence: Barbara Alves (brb.alv@gmail.com)
F-105 Head Injury Imaging-Timing is Critical
Mufaddal Jivanjee
1London North West Healthcare NHS Trust, London, UK
Correspondence: Mufaddal Jivanjee (mufaddal.jivanjee@nhs.net)
F-106 Does continuous insufflation of oxygen without intubation improve mortality after cardiac arrest?
Arnaud Gaillard, Cécile Ricard, Guillaume Berthet, Olivier Baptiste, Vincent Peigne
Haute Savoie Fire Department, Meythet, France
Correspondence: Arnaud Gaillard (arnaud.gaillard@sdis74.fr)
F-107 Can New Wearable Technology significantly increase the Efficacy Cardiopulmonary Resuscitation? A controlled, randomized trial testing
Michele Musiari1, Samuele Ceruti2, Roberta Sonzini3, Luciano Anselmi4, Andrea Saporito4, Xavier Capdevila5, Tiziano Cassina6
1Hôpital Fribourgeois Regional (HFR), Fribourg, Switzerland; 2Hôpitaux Universitaires de Genève, Genève, Switzerland; 3Clinica Luganese, Lugano, Switzerland; 4Ente Ospedaliero Cantonale, Bellinzona, Switzerland; 5Centre Hôspitalier Universitaires, Montpellier, France; 6CardioCentro Ticino, Lugano, Switzerland
Correspondence: Michele Musiari (michelemusiari@bluewin.ch)
F-108 Early DiaGnosis of Anoxic brain injury for Resuscitated patients (EDGAR): value of continuous aEEG, quantitative automated pupillometry and Cardiac Arrest Hospital Prognosis (CAHP) score for early neurologic prognosis after adult cardiac arrest
Sébastien Gette, Rostane Gaci, Guillaume Louis, Cyril Cadoz, Damien Barraud, Boris Glavnik, Guillaume Jay, Julie Larde, Nicolas le Berre, Nouchan Mellati, Emmanuel Novy, Jessica Perny, Adeline Perrein, Yoann Picard, Kevin Podrez, Béatrice Schnitzler, Christophe Goetz, Serge Le Tacon
Hôpital Mercy CHR Metz-Thionville, Metz, France
Correspondence: Sébastien Gette (s.gette@chr-metz-thionville.fr)
F-109 Impact of delayed specialized advice on the quality of care at the emergency department
Hadil Mhadhbi, Meher Arafa, Mounir Hagui
ED HMPIT, Tunis, Tunisia
Correspondence: Hadil Mhadhbi (hadil.mhadhbi@gmail.com)
F-110 Hypnosis to reduce anxiety and pain during prolonged ICU stay for Guillain-Barré syndrome (GBS)
Sylvie Calvat1, Sylvie Colombani2, Christophe Cracco1, Charles Lafon1, Stéphane Rouleau1, David Schnell1
1Centre Hospitalier d’Angoulême, Angoulême, France; 2Institut Bergonié, Bordeaux, France
Correspondence: Sylvie Calvat (sylvie.calvat@ch-angouleme.fr)
F-111 Resuscitation Hypnosis: Benchmarks for Effective Practice
Gwenael Prat1, Anne Renault1, Christelle Teiten1, Montaine Lefevre2, Erwan L’her1
1Medical Intensive care unit, CHRU Brest, Brest, France; 2Medical Intensive care unit, CH Morlaix, Morlaix, France
Correspondence: Gwenael Prat (gwenael.prat@chu-brest.fr)
F-112 Effect of a musical intervention during central venous catheterization in an intensive care unit: the MUSIC CAT prospective randomized pilot study
Sophie Jacquier, Brice Sauvage, Gregoire Muller, Thierry Boulain, Mai-Anh Nay
CHR, Orléans, France
Correspondence: Sophie Jacquier (sophie.jacquier@chr-orleans.fr)
F-113 Sleep in non-intubated patients admitted to ICU for acute respiratory failure: A prospective observational monocenter study
Damien Marie1,2, Stephanie Barrau1,2, Clément Beuvon1,2, Faustine Reynaud1,2, Adrien Pépin-Lehalleur1,2, Christophe Rault1,3, Jean-Claude Meurice1,4, Rémi Coudroy1,2, Jean-Pierre Frat1,2, René Robert1,2, Xavier Drouot1,3, Arnaud Thille1,2
1INSERM CIC 1402, Groupe ALIVE, Université de Poitiers, Poitiers, France; 2Réanimation Médicale, CHU de Poitiers, Poitiers; 3Neurophysiologie Clinique et Explorations Fonctionnelles, CHU de Poitiers, Poitiers; 4Pneumologie, CHU de Poitiers, Poitiers
Correspondence: Damien Marie (damien.marie01@gmail.com)
F-114 Evaluation of Association of Secondary Brain Insults and Outcome in Convulsive Status Epilepticus: a Post Hoc Analysis of the Hybernatus Trial
Candice Fontaine1, Virginie Lemiale2, Matthieu Resche-Rigon2, Maleka Schenck3, Jonathan Chelly4, Thomas Geeraerts5, Aicha Hamdi6, Christophe Guitton7, Ferhat Meziani8, Jean-Yves Lefrant9, Bruno Mégarbane10, Hervé Mentec11, Cendrine Chaffaut2, Alain Cariou12, Stéphane Legriel1
1Centre Hospitalier de Versailles, Le Chesnay, France; 2Centre Hospitalier Universitaire Saint Louis, Paris, France; 3Hôpitaux Universitaires de Strasbourg-Hôpital de Hautepierre, Strasbourg, France; 4Centre Hospitalier de Melun, Melun, France; 5Centre Hospitalier Universitaire de Toulouse, Toulouse, France; 6Centre Hospitalier De Montreuil, Montreuil, France; 7Centre Hospitalier du Mans, Le Mans, France; 8Hopitaux Universitaires de Strasbourg-Nouvel Hopital Civil, Strasbourg, France; 9Hopital Universitaire de Nimes, Nimes, France; 10Centre Hospitalier Universitaire Lariboisiere, Paris, France; 11Centre Hospitalier d’Argenteuil, Argenteuil, France; 12Centre Hospitalier Universitaire Cochin, Paris, France
Correspondence: Candice Fontaine (candicefontaine@yahoo.com)
F-115 Acute stroke admitted to the ICU: prognosis and functional outcome
Thibaut Carval1, Charlotte Garret1, Benoit Guillon2, Amélie Seguin1, Maelle Martin1, Arnaud-Felix Miailhe1, Hélène Migueres1, Olivier Zambon1, Laura Crosby1, Jean-Baptiste Lascarrou1, Jean Reignier1, Emmanuel Canet1
1Medical ICU, Nantes, France; 2Neurology department, Nantes, France
Correspondence: Thibaut Carval (thibautcarval@hotmail.com)
F-116 Hemorrhagic brain injuries in critical care units: a systematic review of prognostic models
Jeanne Simon-Pimmel1, Yohann Foucher1, Maxime Leger2, Fanny Feuillet3, Laetitia Bodet-Contentin4, Raphaël Cinotti5, Denis Frasca6, Etienne Dantan1
1INSERM UMR 1246 SPHERE, Nantes University, Tours University, Nantes, France; 2Medical Intensive Care, Angers University Hospital, Angers, France; 3INSERM UMR 1246 SPHERE, Nantes University, Tours University-Biostatistics and Methodology Unit, Nantes University Hospital, Nantes, France; 4Intensive Care Unit, Tours University Hospital, Tours, France; 5Anaesthesia and critical care department, Nantes University Hospital, Nantes, France; 6Anaesthesia and critical care department, Poitiers University Hospital, Poitiers, France
Correspondence: Jeanne Simon-Pimmel (jeanne.pimmel@gmail.com)
F-117 RETRACT System: a computerized 3D video analyzing system for the monitoring of respiratory retraction signs in children
Haythem Rehouma1, Gabriel Masson2, Sandrine Essouri2, Rita Noumeir3, Philippe Jouvet2
1École de Technologies Supérieure (ETS) of Montreal (QC) Canada, Montreal, Canada; 2CHU Sainte-Justine (CHUSJ), Mother and Child University Hospital Center, Montréal, Canada, Montreal, Canada; 3École de Technologies Supérieure (ETS) of Montreal (QC) Canada, Montreal, Canada
Correspondence: Haythem Rehouma (rhoumahaythem@gmail.com)
F-118 Design and evaluation of a training support for pediatric tracheostomy care
Thibault Lassalle, Thomas Sagardoy, Astrid Botte
CHU Bordeaux, Bordeaux, France
Correspondence: Thibault Lassalle (thibaultlassalle40@gmail.com)
F-119 Nurse-driven non-invasive ventilation weaning protocol in severe bronchiolitis in PICU is feasible and safe
Camille Guillot, Mathilde Periot-Jarry
Hopital Jeanne de Flandre-CHU Lille, Lille, France
Correspondence: Camille Guillot (cami.guillot@gmail.com)
F-120 Weaning from Non-Invasive Ventilation and High-Flow Nasal Cannula therapy in acute bronchiolitis in infants—A survey of practice in French-speaking countries
Marie Suzanne1, Isabelle Pin1, Guillaume Mortamet2
1Service de pédiatrie, CHU de Grenoble, Grenoble, France; 2Service de réanimation pédiatrique, CHU de Grenoble, Grenoble, France
Correspondence: Marie Suzanne (msuzanne@chu-grenoble.Fr)
F-121 Prone positioning for severe pediatric acute respiratory distress syndrome: an observational study in four French intensive care units
Laura Labro, Jerome Rambaud
Pediatric and neonatal intensive care unit, Armand-Trousseau hospital, Sorbonne university, Paris, France
Correspondence: Laura Labro (laura.glt@wanadoo.fr)
F-122 Extracorporeal membrane oxygenation (ECMO) for immunocompromised children with acute respiratory distress syndrome (ARDS): a French ECMO center cohort
Jerome Rambaud, Blandine Robert
Pediatric and neonatal intensive care unit, Armand-Trousseau hospital, Sorbonne university, Paris, France
Correspondence: Jerome Rambaud (jerome.rambaud@aphp.fr)
F-123 Impact of establishment of a pediatric mobile ECMO team
Géraldine Poncelet1, Mathieu Genuini1, Jérôme Naudin1, Pierre-Louis Leger2, Guillaume Geslain1, Arielle Maroni1, Maryline Chomton1
1Réanimation et surveillance continue pédiatriques, CHU Robert Debré, Paris, France; 2Réanimation et surveillance continue pédiatriques, CHU Armand Trousseau, Paris, France
Correspondence: Géraldine Poncelet (geraldine.poncelet@aphp.fr)
E-posters
P-001 The Use of ICU Resources in Metastatic Breast Cancer
Guillaume Beinse1, Jean-Jacques Tudesq1, Luis Teixeira2, Edith Borcoman1, Adrien Mirouse1, Yannick Hourmant1, Asma Mabrouki1, Michaël Darmon1, Virginie Lemiale1, Elie Azoulay1
1Medical ICU, Saint-Louis Hospital, AP-HP, Paris, France; 2Breast diseases unit, Saint-Louis Hospital, AP-HP, Paris, France
Correspondence: Guillaume Beinse (guillaume.beinse@gmail.com)
P-002 Factors associated with survival of patients with solid cancer alive after intensive care unit (ICU) discharge between 2005 and 2013
Hubert Gheerbrant1, Jean-François Timsit2, Nicolas Terzi1, Stephane Ruckly3, Mathieu Laramas1, Matteo Giaj Levra1, Emmanuelle Jacquet1, Loic Falque1, Denis Moro-Sibilot1, Anne-Claire Toffart1
1CHU Grenoble Alpes, Grenoble, France; 2APHP, Paris, France; 3OutcomeRea, Bobigny, France
Correspondence: Hubert Gheerbrant (hgheerbrant@chu-grenoble.fr)
P-003 Initiation of chemotherapy within ICU: a retrospective study
Maxence Chicoisneau, Lieveke Ameye, Marianne Paesmans, Jean-Paul Sculier, Anne-Pascale Meert
Institut Jules Bordet, Brussels, Belgium
Correspondence: Maxence Chicoisneau (Maxence.Chicoisneau@ulb.ac.be)
P-004 Adequacy and prognosis of ICU admission or denial in critically ill onco-hematology patients
Wafa Zarrougui1, Emna Ennouri1, Tarek Ben Ahmed2, Khaoula Meddeb1, Radhouane Toumi1, Amal Baccari1, Imen Ben Saida1, Mohamed Boussarsar1
1Medical Intensive Care Unit, Farhat Hached University Hospital. Université de Sousse, Faculté de médecine de Sousse, LR No LR12SP09. Heart Failure, Sousse, Tunisia; 2Department of medical oncology, Farhat Hached University Hospital, Sousse, Tunisia
Correspondence: Wafa Zarrougui (wafa.zarrougui91@gmail.com)
P-005 Characteristics and Outcomes of Critically Ill Cancer Patients admitted to a Tunisian Intensive Care Unit
Imen Ben Saida1, Hela Kallal1, Yosri Ben Ali1, Nesrine Fraj1, Wafa Zarrougui1, Imtinene Belaid2, Mohamed Boussarsar1
1Medical intensive care unit, Farhat Hached hospital, Université de Sousse, Faculté de Médecine de Sousse, UR No LR12SP09. Heart Failure, Sousse, Tunisia; 2Oncology department, Farhat Hached hospital, Université de Sousse, Faculté de Médecine de Sousse, Sousse, Tunisia
Correspondence: Imen Ben Saida (imen.bensaida@yahoo.com)
P-006 Prognosis and mortality risk factors of denied onco-hematology patients for ICU admission
Emna Ennouri1, Wafa Zarrougui1, Tarek Ben Ahmed2, Khaoula Meddeb1, Radhouane Toumi1, Amal Triki1, Imen Ben Saida1, Mohamed Boussarsar1
1Medical Intensive Care Unit, Farhat Hached University Hospital. Université de Sousse, Faculté de médecine de Sousse, LR No LR12SP09. Heart Failure, Sousse, Tunisia; 2Department of medical oncology, Farhat Hached University Hospital., Sousse, Tunisia
Correspondence: Emna Ennouri (m.na.ennouri@gmail.com)
P-007 Influence of underlying hematological malignancy grade on outcome of critically ill hematological patients
Pablo Pagliarani, Vincent Rebiere, Lara Zafrani, Virginie Lemiale, Djamel Mokart, Alexandre Demoule, Martine Nyunga, Achille Kouatchet, Frédéric Pene, Michaël Darmon, Elie Azoulay
APHP, Paris, France
Correspondence: Pablo Pagliarani (pablopagliarani@gmail.com)
P-008 Pulmonary embolism in ICU of the CHU of ORAN: retrospective study about 22 cases
Soulef Bousbia, Soumia Benbernou, Nabil Ghomari, Houria Djebli
Faculté de medecine d’Oran, Oran, ALGERIA
Correspondence: Soulef Bousbia (bsoulef90@gmail.com)
P-009 Pulmonary embolism feature in patients with Guilliain Barre syndrom
Olfa Turki, Rezk Gorbel, Mariem Dlela, Najeh Baccouche, Abir Bouattour, Mabrouk Bahloul, Mounir Bouaziz
HABIB BOURGUIBA University Hospital, Sfax, Tunisia
Correspondence: Olfa Turki (olfa.turki.rea@gmail.com)
P-010 Acute respiratory distress syndrome among burns in Tunisia: state of play and prognosis
Wael Chemli, Lilya Debbiche, Hana Fredj, Sarra Ben Zarrouk, Hana Benali, Manel Ben Saad, Amel Mokline, Amenallah Messaadi
Burns intensive care unit, CTGB, Ben Arous, Tunisia
Correspondence: Wael Chemli (wchemli90@gmail.com)
P-011 Risk factors and outcomes of aspiration pneumonia
Oussama Jaoued, Makni Saba, Abid Emna, Sik Ali Habiba, Fekih Hassen Mohamed, Elatrous Souheil
Hôpital Taher sfar, Mahdia, Tunisia
Correspondence: Oussama Jaoued (oussamajaoued@gmail.com)
P-012 Hyperoxia in intensive care: impact on morbidity and mortality
Rim Jemmeli, Samia Ayed, Amira Jamoussi, Dhouha Lakhdhar, Jalila Ben Khelil, Mohamed Besbes
Abderrahmen Mami Hospital, Ariana, Tunisia
Correspondence: Rim Jemmeli (rimjemmeli@gmail.com)
P-013 Experience of the practice of prone position in patients with acute respiratory distress syndrome in intensive care (CHU Oran)
Nabil Ghomari, Soumia Benbernou, Djebli Houria
Faculté de medecine d’Oran, Oran, Algeria
Correspondence: Nabil Ghomari (nabilghomari@hotmail.fr)
P-014 Impact of Cannula Size on Clinical Outcomes in Venovenous Extracorporeal Membrane Oxygenation
Julien Goutay, Nicolas Cousin, Thibault Duburcq, Erika Parmentier-Decrucq
CHU de Lille, Pôle de Réanimation, Hôpital Salengro, Lille, France
Correspondence: Julien Goutay (julien.goutay@gmail.com)
P-015 Colonization with carbapenemase-producing Gram-negative bacilli in burn patients in Tunisia
Sonia Ben Behi1, Sarra Dhraief1, Hana Fredj2, Lilya Debbiche2, Amenallah Messaadi2, Lamia Thabet1
1Centre de Traumatologie et des Grands Brûlés de Ben Arous-Laboratoire de biologie médicale et banque du sang, Ben Arous, Tunisia; 2Centre de Traumatologie et des Grands Brûlés de Ben Arous-Service de réanimation des brûlés, Ben Arous, Tunisia
Correspondence: Sonia Ben Behi (benbehi.sonya@gmail.com)
P-016 Evaluation of Antifungal Therapy in Burn ICU
Selma Abid, Hana Fredj, Amel Mokline, Bahija Gasri, Manel Ben Saad, Amenallah Messaadi
Intensive Burn Care Departement, Burn and Trauma Center-Tunis, Tunisia, Ben Arous, Tunisia
Correspondence: Selma Abid (darly2910@gmail.com)
P-017 Epidemiology of candidemia in a medical ICU: a 12-years retrospective study
Salma Klaii1, Ahlem Trifi2, Aicha Kallel1, Foued Daly2, Yosr Touil2, Sami Abdellatif2, Kalthoum Kallel1, Salah Ben Lakhal2
1Parasitology/Mycology laboratory, la Rabta hospital, Faculty of Medicine of Tunis, Tunis, Tunisia; 2Medical ICU, la Rabta hospital, Faculty of Medicine of Tunis, Tunis, Tunisia
Correspondence: Salma Klaii (kalai.salma89@gmail.com)
P-018 Necrotizing soft-tissue infections in the intensive care unit: a retrospective hospital-based study
Kais Regaieg, Sabrine Nakaa, Arnaud Mailloux, Madjid Boukari, Johana Cohen, Dany Goldgran-Toledano
Groupe hospitalier intercommunal Le Raincy-Montfermeil, Montfermeil, France
Correspondence: Kais Regaieg (kais.regaieg@gmail.com)
P-019 Bacteriological profile and antimicrobial susceptibility of isolated bacteria in a burn intesive care unit in Tunisia
Karim Mechri1, Sarra Dhraief1, Emna Hammami1, Amel Mokline2, Kawther Faleh2, Amenallah Messaadi2, Lamia Thabet1
1Centre de Traumatologie et des Grands Brûlés de Ben Arous-Laboratoire de biologie médicale et banque du sang, Ben Arous, Tunisia; 2Centre de Traumatologie et des Grands Brûlés de Ben Arous-Service de réanimation des brûlés, Ben Arous, Tunisia
Correspondence: Karim Mechri (karimmechri91@gmail.com)
P-020 Prognostic factors of community-acquired peritonitis
Khalid Khaleq, Amine Zerhouni, Driss Elhammoudi, Rachid El Harrar
CHU Ibn Rochd, Casablanca, Morocco
Correspondence: Khalid Khaleq (khaleq20@gmx.fr)
P-021 Bloodstream infections caused by KPC-producing bacteria
Sabrine Bradai, Kamilia Chtara, Basma Mnif, Karama Bouchaala, Mabrouk Bahloul, Mounir Bouaziz
University of Sfax, Sfax, Tunisia
Correspondence: Sabrine Bradai (sabrine.bradai2@gmail.com)
Empiric antibiotic | Number | Adapted antibiotic | Number |
---|---|---|---|
Cefotaxime Tigecycline | 1 1 | Amikacin Fosfomycin Tigecycline | 1 1 1 |
Imipenem + colistin Imipenem + amikacin Amoxicillin/clavulanic acid +amikacin Ciprofloxacin + colistin Tigecycline + colistin Tigecycline + ciprofloxacin Fosfomycin + amikacin Piperacillin/tazobactam + ciprofloxacin Piperacillin/tazobactam + colistin | 4 2 1 1 1 1 1 1 1 | Imipenem + colistin Tigecyline + colistin Bactrim + amikacin Ciprofloxacin + tygecycline Tygecycline + colistin Fosfomycin + amikacin Piperacillin/tazobactam + ciprofloxacin Piperacillin/tazobacta + coli Piperacillin/tazobactam + fosfomycin Imipenem + tygecycline | 4 2 1 1 1 1 1 1 1 1 |
Imipenem + colistin + ciprofloxacin Imipenem + colistin +fosfo Imipenem + colistin + tigecycline Imipenem + colistin + vancomycin Tigecycline + rifampicin + ciprofloxacin | 1 1 1 1 1 | Imipenem + Bactrim + colistin Piperacillin/tazobactam + amikacin + colistin | 1 1 |
No use of empiric antibitic | 0 | KPC not treated | 0 |
P-022 Incidence of healthcare-associated infections in a Tunisian intensive care unit
Rania Ammar Zayani, Farah Zouari, Yousfi Mounir, Mariem Dlela, Chokri Ben Hamida, Mounir Bouaziz
Faculty of medecine, University of Sfax, Sfax, Tunisia
Correspondence: Rania Ammar Zayani (rania.ammarzayani@gmail.com)
P-023 Prognostic factors of digestive oncological emergencies in the elderly
Khalid Khaleq, Karima Mourabit, Fatimazahra Bensardi, Rachid Al Harrar, Aziz Fadil
Faculté de médecine et de pharmacie Université Hassan II/CHU Ibnou Rochd, Casablanca, Morocco
Correspondence: Khalid Khaleq (khaleq20@gmx.fr)
-
Epidemiological, concerning age and gender.
-
Clinical parameters including risk factors, history, general condition of the patient and physical examination.
-
Paraclinical parameters, interesting biological data and imaging.
-
Medical and surgical therapeutics.
-
Postoperative follow-up.
-
Treatment results.
P-024 Usefulness of shock index for prehospital triage of septic shock by the SAMU regulation
Romain Jouffroy1, Anastasia Saade1, Pascal Philippe1, Papa Gueye2, Emmanuel Bloch-Laine3, Patrick Ecollan4, Benoit Vivien1
1Department of Anesthesia & Intensive Care Unit, SAMU, Hôpital Necker-Enfants Malades, Paris, France; 2Prehospital Medical System, SAMU de Martinique, University Hospital Pierre Zobda Quitman, Martinique, Fort-De-France, France; 3Emergency department, hospital Cochin 24 rue du Faubourg Saint-Jacques 75014 Paris France and emergency department—SMUR, Hospital Hôtel-Dieu, Paris, France; 4Intensive Care Unit, SMUR, Pitie Salpetrière Hospital, Paris, France
Correspondence: Romain Jouffroy (romain.jouffroy@gmail.com)
P-025 Clinical impact of Atrial Fibrillation in patients hospitalized for diabetic ketoacidosis at Emergency Department
Nadia Zaouak, Yosra Yahya, Khedija Zaouche, Abdelwahab Mghirbi, Radhia Boubaker, Hamida Maghraoui, Kamel Majed
Emergency Department of La Rabta teaching hospital, Tunis, Tunisia
Correspondence: Nadia Zaouak (zaouak.nadia@yahoo.fr)
P-026 Prehospital shock index to assess mortality of septic shock
Romain Jouffroy1, Jean-Pierre Tourtier2, Papa Gueye3, Emmanuel Bloch-Laine4, Vincent Bounes5, Guillaume Debaty6, Josiane Boularan7, Benoit Vivien1
1Department of Anesthesia & Intensive Care Unit, SAMU, Hôpital Necker-Enfants Malades, Paris, France; 2Paris Fire Brigade, Teaching military hospital Bégin, Paris, France; 3Prehospital Medical System, SAMU de Martinique, University Hospital Pierre Zobda Quitman, Martinique, Fort-De-France, France; 4Emergency department, hospital Cochin 24 rue du Faubourg Saint-Jacques 75014 Paris France and emergency department—SMUR, Hospital Hôtel-Dieu, Paris, France; 5SAMU 31, Toulouse University Hospital, Toulouse, France; 6SAMU 38, Grenoble University Hospital, Grenoble, France; 7SAMU 31, Castres Hospital, Castres, France
Correspondence: Romain Jouffroy (romain.jouffroy@gmail.com)
P-027 Ultrasound guidance and the set up of central venous catheters in emergency situations
Walid Sellami
Département d’anesthésie réanimation, LR12DNO1, Hôpital militaire de Tunis, Tunis, Tunisia
Correspondence: Walid Sellami (drsellamiwalid@yahoo.fr)
P-028 Neuromyelitis optica attacks treatment assessment and analysis
Hossein Mehdaoui, Maeva le Goic, Ruddy Valentino, Cyrille Chabartier, Jean-Louis Ferge, Dabor Resiere, Shazima Vally, Emmanuelle Guerin, Agathe Chaplain, Marie Sabia, Ronan Hinaut, Philippe Cabre
University hospital of Martinique, Fort-De-France, France
Correspondence: Hossein Mehdaoui (hossein.mehdaoui@chu-martinique.fr)
Age | 45 ± 17 |
---|---|
Sex ratio (F/M) | 3.0 (18/6) |
Acute myelitis | 15 (62.5%) |
Optic neuritis | 16 (66%) |
AQP4 Antibodies | 12 (52%) |
MOG Antibodies | 4 (17%) |
Seronegative patients | 7 (30%) |
Pulse steroid administration | 16 (66.7%) |
Pulse steroid administration delay | 7.5 ± 7.7 d |
Plasma exchange | 22 (91%) |
Plasma exchange delay | 16.1 ± 10.8 d |
Deaths | 5 (20.8%) |
P-029 Guillain-Barré syndrome in Intensive Care Unit: a 10 years experience
Olfa Turki, Rezk Gorbel, Mariem Dlela, Hela Kallal, Kamilia Chtara, Mabrouk Bahloul, Mounir Bouaziz
Habib Bourguiba University Hospital, Sfax, Tunisia
Correspondence: Olfa Turki (olfa.turki.rea@gmail.com)
P-030 Medical treatment of immediate post partum hemorrhage
Janati Adnane, Lina Berrada, Amine Mohamed Amine
Obstetric intensive care unit, Casablanca, MOROCCO
Correspondence: Janati Adnane (adnanejanati@gmail.com)
P-031 Predicting outcome in ICU trauma patients with AKI
Mariem Dlela, Kamilia Chtara, Farah Zouari, Mabrouk Bahloul, Mounir Bouaziz
Habib bourguiba hospital, Sfax, Tunisia
Correspondence: Mariem Dlela (mariem241090@gmail.com)
P-032 Predictors of post-traumatic AKI in the ICU
Mariem Dlela, Farah Zouari, Olfa Turki, Mabrouk Bahloul, Mounir Bouaziz
Habib bourguiba hospital, Sfax, Tunisia
Correspondence: Mariem Dlela (mariem241090@gmail.com)
P-033 Prevalence and risk factors of hypotension associated with preload-dependence during continuous renal replacement therapy in critically ill patients
Guillaume Chazot, Laurent Bitker, Mehdi Mezidi, Hodane Yonis, Louis Chauvelot, Paul Chabert, Laure Folliet, Jean-Christophe Richard
Service de Médecine Intensive Réanimation. Hôpital de la Croix-Rousse. Hospices Civils de Lyon, Lyon, France
Correspondence: Guillaume Chazot (guillaume.chazot@chu-lyon.fr)
P-034 Comparison of the RIFLE, AKIN, CK and KDIGO criteria to predict acute renal failure and mortality in critically ill patients
Rania Ammar Zayani, Emna Ennouri, Karama Bouchaala, Sabrine Bradai, Chokri Ben Hamida, Mounir Bouaziz
Faculty of medecine, university of sfax, Sfax, Tunisia
Correspondence: Rania Ammar Zayani (rania.ammarzayani@gmail.com)
P-035 Renal replacement therapy in a Medical Intensive Care Unit: Prognosis and challenges
Ghalia Boubaker1, Asma El Hadhri1,2, Khaoula Meddeb1, Wafa Zarrougui1, Emna Ennouri1, Amal Triki1, Imen Ben Saida1, Imed Chouchene1, Mohamed Boussarsar1
1Medical intensive care unit farhat hached university hospital, Université de Sousse, Faculté de Médecine de Sousse, LR No LR12SP09. Heart Failure, Sousse, Tunisia; 2Hospital hygiene unit, Farhat Hached University Hospital, Sousse, Tunisia
Correspondence: Ghalia Boubaker (boubaker15ghalia@gmail.com)
P-036 Sepsis induced acute kidney injury: incidence, risk factors and prognostic impact in critically ill patients
Karama Bouchaala, Rania Ammar Zayani, Chokri Ben Hamida, Mabrouk Bahloul, Mounir Bouaziz
Habib bourguiba university hospital, Sfax, Tunisia
Correspondence: Karama Bouchaala (karamamnif@gmail.com)
P-037 Is augmented renal clearance a predictor of morbidity and mortality in severely burned patients?
Somai Mehdi, Amel Mokline, Laajili Achref, Kawther Faleh, Hager Zouari, Hana Fredj, Manel Ben Saad, Amenallah Messaadi
Centre de traumatologie et des grands brulés, Tunis, Tunisia
Correspondence: Somai Mehdi (mehdi.somai.87@gmail.com)
P-038 Post-traumatic acute renal failure in critically ill patients: risk factors
Rania Ammar Zayani, Karama Bouchaala, Yousfi Mounir, Kamilia Chtara, Mabrouk Bahloul, Chokri Ben Hamida, Mounir Bouaziz
Faculty of Medicine, University of Sfax, Tunisia, Sfax, Tunisia
Correspondence: Rania Ammar Zayani (rania.ammarzayani@gmail.com)
P-039 Velocity time integral in transcranial doppler (TCD) in healthy controls (C) versus ICU patients (P) for detection of cerebral blood flow (CBF) abnormalities
Jack Richecoeur1, Danièle Combaux1, Anne Sagnier1, Romain Mercier1, Nathalie Verrier1, Romain Debock1, Marie-Anais Bastide1, Cecile Caplin1, Chloe Soulignac1, Jean-Louis Dubost2, Bruno Gelee2, David Luis1
1CH Simone Veil, Beauvais, France; 2CH Rene Dubos, Pontoise, France
Correspondence: Jack Richecoeur (jack.richecoeur@gmail.com)
C (n=38) | P (n=38) | p | |||
---|---|---|---|---|---|
MAP mmHg | 95.00 | (89.00–98.00) | 79 | (65.50–64.50) | < 0.001 |
ITVao cm | 21.50 | (19.50–30.00) | 16 | (13.90–18.75) | < 0.001 |
ITVMCA cm | 50.80 | (44.00–60.00) | 30.30 | (22.93–39.55) | < 0.001 |
Vs cm/s | 90.70 | (57.00–104.0) | 84.30 | (52.58–109.50) | 0.11 |
Vd cm/s | 40.30 | (35.00–50.00) | 31.32 | (20.50–43.68) | 0.03 |
Vm cm/s | 58.50 | (54.70–66.15) | 43.96 | (28.38–60.95) | 0.01 |
IR | 0.55 | (0.500–0.587) | 0.591 | (0.5160–0.690) | NS |
IP | 0.88 | (0.726–1.01) | 0.900 | (0.729–1.240) | NS |
P-040 Habituation to the auditory startle reflex is a new sign of minimally conscious state
Bertrand Hermann1, Amina Ben Salah1, Mélanie Valente2, Lionel Naccache3
1Université Paris Descartes, Paris, France; 2Institut du Cerveau et de la Moelle Epinière, Paris, France; 3Sorbonne Université, Paris, France
Correspondence: Bertrand Hermann (bertrand.hermann@gmail.com)
P-041 Teaching the basics of bedside electroencephalography to critical care staffs: a prospective multicentre study
Stéphane Legriel1, Gwenaëlle Jacq1, Amandine Lalloz2, Guillaume Geri3, Pedro Mahaux3, Cedric Bruel4, Sandie Brochon4, Benjamin Zuber5, Cécile Andre5, Krystel Dervin6, Mathilde Holleville6, Alain Cariou2
1Centre Hospitalier de Versailles, Le Chesnay, France; 2Hôpitaux Universitaires Paris Centre-Cochin, Paris, France; 3Hôpital Ambroise Paré, Boulogne, France; 4Groupe hospitalier Paris Saint Joseph, Paris, France; 5Hôpital Foch, Suresnes, France; 6Hôpitaux Universitaires Paris Nord Val de Seine-Beaujon, Clichy, France
Correspondence: Stéphane Legriel (slegriel@ch-versailles.fr)
P-042 Prognostic factors for stroke in CHU Oran emergency department
Houria Djebli, Soumia Benbernou, Nabil Ghomari
Faculte de médecine d’Oran, Oran, Algeria
Correspondence: Houria Djebli (djeblihouria@yahoo.fr)
P-043 The clinical and progressive aspects of cerebral venous thromboses at the Oran hospital and university center
Mourad Goulmane
Oran Hospital and University Center, Oran, Algeria
Correspondence: Mourad Goulmane (goulmane.mourad@univ-oran1.dz)
P-044 Analysis on prognostic factors of patients with ruptured intracranial aneurysm in intensive care unit
Karim Badaoui, Rachid Cherkab, Chafik El Kettani, Barrou Lahoucine
CHU ibn Rochd, Casablanca, Morocco
Correspondence: Karim Badaoui (karimbadaoui61@gmail.com)
This study (2012/2019) | Rivero Rodriguez et al. (2005–2014) | Jaja et al. (2015) | Meneghelli et al. (2016) | Charpentier et al. (1999) | Qureshi et al. (1999) | Spatenkova et al. (2017) | |
---|---|---|---|---|---|---|---|
Age | p = 0.31 | p = 0.023 | p = 0.008 | ||||
Sexe | p = 0.0067 | ||||||
Atcdshta | p = 0.0001 | P < 0.01 | |||||
GCS | p < 0.01 | p = 0.014 | |||||
Fever | p = 0.02 | ||||||
Wfns score | p < 0.01 | p = 0.0021 | p = 0.05 p < 0.001 | p = 0.025 | |||
Hunt et Hess | p = 0.05 | p = 0.000 | |||||
Fisher ¾ | p = 0.003 p = 0.02 | p = 0.0008 | |||||
Anterior aneurismal location | p = 0.000 | ||||||
Dysnatremia | p = 0.037 p = 0.019 | p = 0.0073 | p = 0.0083 | P = 0.001 p < 0.01 | |||
Vasospasm | p = 0.0000 | p = 0.001 | |||||
Hydrocephalus | p = 0.0039 | p=0.011 | |||||
Prolongated ventilation | p = 0.003 p = 0.02 | ||||||
Rebleeding | p = 0.0019 | ||||||
Post-operative deficit | p = 0.03 | ||||||
Onset time of surgery | p < 0.01 |
P-045 Decompressive hemicraniectomy in malignant middle cerebral artery infarction about 20 cases
Rania Ammar Zayani, Karama Bouchaala, Kamilia Chtara, Yousfi Mounir, Mabrouk Bahloul, Chokri Ben Hamida, Mounir Bouaziz
Faculty of Medicine, University of Sfax, Sfax, Tunisia
Correspondence: Rania Ammar Zayani (rania.ammarzayani@gmail.com)
P-046 Prediction of outcome after acute stroke: comparison of CT-DRAGON score and a simplified score
Anouk Lesenne1, Jef Grieten1, Alain Wibail1, Ludovic Ernon1, Luc Stockx1, Patrick Wouters2, Elly Vandermeulen1, Sam Van Boxstael1, Pascal Vanelderen1, Sven Van Poucke1, Joris Vundelinckx1, Sofie Van Cauter1, Dieter Mesotten1
1Ziekenhuis Oost-Limburg Genk, Genk, Belgium; 2Universiteit Gent/Universitair Ziekenhuis Gent, Gent, Belgium
Correspondence: Anouk Lesenne (anouk.lesenne@ugent.be)
Favourable outcome (%) | Miserable outcome (%) | |
---|---|---|
CT-Dragon score | ||
Misclassification rate | 29 | 13 |
Sensitivity | 67 | 10 |
Specificity | 74 | 100 |
Simplified score | ||
Misclassification rate | 26 | 14 |
Sensitivity | 77 | 23 |
Specificity | 73 | 97 |
P-047 Adherence to GOLD 2017 guidelines treatment recommendations in critically ill COPD patients
Imen Ben Saida, Hela Kallal, Sana Rouis, Wessem Ammar, Nesrine Fraj, Wafa Zarrougui, Rym Chelbi, Mohamed Boussarsar
Medical intensive care unit, farhat hached hospital, Université de Sousse, Faculté de Médecine de Sousse, UR N° LR12SP09.Heart Failure, Sousse, Tunisia
Correspondence: Imen Ben Saida (imen.bensaida@yahoo.com)
P-048 Use of video-Airtraq in difficult intubation situation: experience of Tizi-Ouzou University Hospital
Yacine Benhocine
Tizi-Ouzou University Hospital, Tizi-Ouzou, Algeria
Correspondence: Yacine Benhocine (yacine001@yahoo.fr)
P-049 Added-value of clinical pharmacist (CP) in intensive care unit (ICU)?
Justine Lemtiri, Elodie Matusik, Fabien Lambiotte, Hatem Boughanmi, Emilie Herbez, Etienne Cousein, Nabil El Beki
Centre hospitalier de Valenciennes, Valenciennes, France
Correspondence: Justine Lemtiri (lemtiri-j@ch-valenciennes.fr)
PI | Solicitations | |
---|---|---|
Number | 2458 | 1272 |
Main distribution | Inappropriate way and administration: 20% Underdosing/overdosing: 16.8% Drug not indicated: 15% Non-compliance with the recommendations: 14.6% Indication not treated: 12.4% | Therapeutic strategy: 20% Antibiotherapy: 16% Dosage: 14.5% Computerized prescription: 10% Administration: 7% |
Acceptance | 89% (2197/2458) | – |
CLEO scale impact (by the French Society of Clinical Pharmacy) | Vital/major clinical impact: 373/1764 (21%) Average clinical impact: 765/1764 (43%) Economic impact: 270/1764 (15%) | – |
P-050 Experience of young internal doctors in learning of placement of central venous lines echo guided in emergency department CHU ORAN (Algeria)
Soulef Bousbia, Soumia Benbernou, Nabil Ghomari, Houria Djebli
Faculté de medecine d’oran, Oran, Algeria
Correspondence: Soulef Bousbia (bsoulef90@gmail.com)
P-051 Learning emergency procedures at the faculty of medicine and pharmacy in Marrakech: medical simulation model
Fahd Moussaid, Youssef Bouidir, Hamza Elhamzaoui, Taoufik Abouelhassan
Emergency Department, University Hospital Marrakech, Marrakech, MOROCCO
Correspondence: Fahd Moussaid (fahdmoussaid5@gmail.com)
P-052 NEWS, Heart Rate Variability and iROX: predictor of poor outcomes in ICU patient under spontaneous ventilation?
Nicolas Ferrière, Laetitia Bodenes, Victoire Pateau, Julien Dolou, Erwan L’her
CHRU Brest, Brest, France
Correspondence: Nicolas Ferrière (nicolas.ferriere@chu-brest.fr)
P-053 Which optimal dose of enoxaparine in burn patients
Sarra Dhraief, Kawther Faleh, Meriem Oueslati, Hana Fredj, Amel Mokline, Lamia Thabet, Hana Benali, Selma Abid, Lilya Debbiche, Amenallah Messaadi
Department of Clinical Biology, Burn and Trauma Center–Tunis, Tunisia, Ben Arous, Tunisia
Correspondence: Sarra Dhraief (dhraiefsarra@gmail.com)
P-054 Outcomes in critically ill patients non admitted in the intensive care unit from the emergency department
Hadil Mhadhbi, Khedija Zaouche, Hamida Maghraoui, Yosra Yahya, Kamel Majed
Emergency Department la Rabta, Tunis, Tunisia
Correspondence: Hadil Mhadhbi (hadil.mhadhbi@gmail.com)
P-055 SIRS is still useful in the sepsis-3 era
Abderrahim Achouri, Hadil Mhadhbi, Khedija Zaouche, Hamida Maghraoui, Radhia Boubaker, Kamel Majed
University Hospital Center of Rabta in Tunis, Tunis, Tunisia
Correspondence: Abderrahim Achouri (achouryabderrahim@gmail.com)
qSOFA ≥ 2 | SIRS ≥ 2 | |
---|---|---|
Septic shock (%); p value | 24% (< 0.001) | 29% (0.02) |
Odds ratio [95% IC] | 15.143 [4.191–54.715] | 1.409 [1.237–1.605] |
AUC [95% IC] | 0.772 [0.676–0.868] | 0.593 [0.478–0.707] |
Sensitivity | 0.89 | 1 |
Specificity | 0.65 | 0.19 |
Positive predictive value (PPV) | 0.46 | 0.29 |
Negative predictive value (NPV) | 0.94 | 1 |
P-056 Predictors of mortality in septic shock in intensive care
Mohamed Lazraq, Sabah Benhamza, Youssef Miloudi, Abdelhak Bensaid, Najib Elharrar
Hôpital 20 aout 1953, CHU ibn rochd, Casablanca, Morocco
Correspondence: Mohamed Lazraq (mohamed_lz@hotmail.com)
P-057 Molecular characterization of carbapenemase-producing Enterbacteriaceae in trauma and burn center in Tunisia
Mehdi Gaddas, Sarra Dhraief, Karim Mechri, Imen Jami, Amenallah Messaadi, Lamia Thabet
1Centre de Traumatologie et des Grands Brûlés de Ben Arous-Laboratoire de biologie médicale et banque du sang, Ben Arous, Tunisia; 2Centre de Traumatologie et des Grands Brûlés de Ben Arous-Service de réanimation des brûlés, Ben Arous, Tunisia
Correspondence: Mehdi Gaddas (gaddasmehdi@icloud.com)
P-058 Proteus mirabilis infections in intensive care unit
Sabrine Bradai, Karama Bouchaala, Fatma Zouari, Basma Mnif, Kamilia Chtara, Mounir Bouaziz
University of Sfax, Sfax, Tunisia
Correspondence: Sabrine Bradai (sabrine.bradai2@gmail.com)
Empiric antibiotic | Number | Percentage (%) | Adapted antibiotic | Number | Percentage (%) |
---|---|---|---|---|---|
Imipenem Colistin Gentamicin Cefotaxime | 8 1 1 3 | 22.2 2.8 2.8 8.3 | Imipenem Cefotaxime Colistin Piperacillin/tazobactam Amikacin Gentamycin | 2 2 2 2 1 1 | 5.6 5.6 5.6 5.6 2.8 2.8 |
Imipenem + gentamicin Imipenem + amikacin Imipenem + colistin Tigecycline + colistin Amoxicillin/clavulanic acid + amikacin Ciprofloxacin + colistin Ciprofloxacin + rifampicin Imipenem + bactrim Cefotaxime + metronidazol Cefotaxime + ciprofloxacin | 4 3 2 2 1 1 1 1 1 1 | 11.1 8.3 5.6 5.6 2.8 2.8 2.8 2.8 2.8 2.8 | Imipenem + gentamicin Imipenem +amikacin Imipenem + tygecycline Imipenem + colistin Tygecycline + colistin Ciprofloxacin + gentamicin Ciprofloxacin + tygecycline Ciprofloxacin + imipenem Cefotaxime + gentamicin Colistine + Amikacin Ertapenem + gentamycin Piperacillin/tazobactam + fosfomycin | 5 4 2 1 1 1 1 1 1 1 1 1 | 13.9 11.1 8.3 5.6 5.6 5.6 2.8 2.8 2.8 2.8 2.8 2.8 |
Colistin + rifampicin + Ciprofloxacin Colistin + vancomycin + metronidazol Imipenem + gentamicin + tygecycline | 1 1 1 | 2.8 2.8 2.8 | Ceftazidime + amikacin + colistine Piperacillin/tazobactam + ciprofloxacin + colistin Piperacillin/tazobactam + Imipenem + levofloxacine | 1 1 1 | 2.8 2.8 2.8 |
No use of empiric antibiotic | 3 | 8.3 | P. mirabilis not treated | 3 | 8.3 |
P-059 Eosinopenia in sepsis
Kaoutar El Fakhr, Habibou Hassane Mahamane Rabiou, Abdeljabbar Marhfour, Boubaker Charra
CHU Ibn rochd, Casablanca, Morocco
Correspondence: Kaoutar El Fakhr (kaoutarelfakhr2013@gmail.com)
P-060 Impact of multiplex PCR on antibiotic prescription in ICU patients with community acquired-pneumonia
Marion Giry, Déborah Boyer, Manuel Etienne, Dorothée Carpentier, Steven Grange, Christophe Girault, Fabienne Tamion, Gaetan Beduneau
1Réanimation médicale, CHU de Rouen, Rouen, France; 2Maladies infectieuses et tropicales, CHU de Rouen, Rouen, France
Correspondence: Marion Giry (marion.giry7@gmail.com)
P-061 Discrepancies exist between medical and paramedical ICU health workers’ opinions on a mandatory vaccination for influenza
Renaud Prével1, Raphaël Enaud2, Erwan Begot1, Alexandre Massri3, Chloé Gisbert-Mora4, Patrick Berger5, Cédric Carrié6, Hugues De Courson7, Alexandre Boyer1, Didier Gruson1
1CHU Bordeaux, Medical Intensive Care Unit, Bordeaux, France; 2Inserm U1045 Centre de Recherche Cardio-thoracique, Bordeaux, France; 3Intensive Care Unit, CH Francois Mitterrand, Pau, France; 4Intensive Care Unit, CH Cote Basque, Bayonne, France; 5Inserm U1045 Centre de Recherche Cardio-thoracique, Bordeaux, France; 6CHU Bordeaux, Surgical and Trauma Intensive Care Unit, Anesthesiology and Critical Care Department, Bordeaux, France; 7CHU Bordeaux, Neuro Intensive Care Unit, Anesthesiology and Critical Care Department, Bordeaux, France
Correspondence: Renaud Prével (renaud.prevel@hotmail.fr)
P-062 Predictive mortality factors of severe influenza A in intensive care: experience of a tunisian referral center
Amira Jamoussi1, Samia Ayed1, Hamdi Doghri1, Takoua Merhabene1, Amine Slim2, Jalila Ben Khelil1, Mohamed Besbes1
1Medical Intensive Care Unit, Abderrahmen Mami Pneumology Hospital, Ariana, Tunis, Tunisia; 2Virology Unit, Microbiology Laboratory, National Influenza Centre, Charles Nicolle’s Hospital, Tunis, Tunisia
Correspondence: Amira Jamoussi (dr.amira.jamoussi@gmail.com)
P-063 Antibiotherapy of peritonitis in intensive care: impact of the 2015 SFAR recommendations and interest of an adapted antibiotherapy
Adrien Krings, Hugues Georges, Pierre-Yves Delannoy, Olivier Leroy
Centre hospitalier Gustave Dron, Tourcoing, France
Correspondence: Adrien Krings (adrienkrings@yahoo.fr)
P-064 Epidemiological profile and antibiotic susceptibility of Acinetobacter baumannii isolates in a trauma and burn center in Tunisia
Emna Hammami, Sarra Dhraief, Mehdi Gaddas, Sonia Ben Behi, Amenallah Messaadi, Lamia Thabet
Centre de Traumatologie et des Grands Brûlés de Ben Arous-Laboratoire de biologie médicale et banque du sang, Ben Arous, Tunisia
Correspondence: Emna Hammami (emnahammami1993@gmail.com)
P-065 Multicentric satisfaction survey of aScope Bronchosampler™, a new sampling accessory for aScope™4 Broncho
Emmanuel Novy1, Claude Meistelman1, Clement Fournier2, Gilles Dhonneur3, Julien Pottecher4
1CHRU NANCY, Vandoeuvre Les Nancy, France; 2CHRU Lille, Lille, France; 3Institut Curie, Paris, France; 4HUS Strasbourg, Strasbourg, France
Correspondence: Emmanuel Novy (e.novy@chru-nancy.fr)
In comparison to existing method how do you rate aScope BronchoSampler | − | − | Equal/acceptable | + | ++ |
---|---|---|---|---|---|
Device assembly | 0 (0%) | 2 (4%) | 5 (11%) | 15 (31%) | 26 (54%) |
Suction capacity | 0 (0%) | 3 (6%) | 19 (40%) | 16 (33%) | 10 (21%) |
Sampling quality | 0 (0%) | 1 (2%) | 19 (40%) | 17 (35%) | 11 (23%) |
Sampling volume | 0 (0%) | 3 (6%) | 23 (48%) | 13 (27%) | 7 (15%) |
Sampling process simplification | 1 (2%) | 5 (11%) | 2 (4%) | 25 (52%) | 15 (31%) |
Reducing risk of loss or contamination sample | 0 (0%) | 6 (13%) | 3 (6%) | 25 (52%) | 14 (29%) |
Overall perception: the quality and functionality | 0 (0%) | 0 (0%) | 8 (17%) | 19 (39%) | 21 (44%) |
P-066 Epidemiological profile and antibiotic susceptibility of Staphylococcus aureus isolates in a trauma and burn center in Tunisia
Karim Mechri1, Sarra Dhraief1, Hana Fredj2, Kawther Faleh2, Amenallah Messaadi2, Lamia Thabet1
1Centre de Traumatologie et des Grands Brûlés de Ben Arous-Laboratoire de biologie médicale et banque du sang, Ben Arous, Tunisia; 2Centre de Traumatologie et des Grands Brûlés de Ben Arous-Service de réanimation des brûlés, Ben Arous, Tunisia
Correspondence: Karim Mechri (karimmechri91@gmail.com)
P-067 Interest of procalcitonin in intensive care (about 120 cases)
Amine Raja, Mohamed Elaiassi, Boubaker Charra
Medical Resuscitation Department of the University Hospital of Casablanca, Casablanca, Morocco
Correspondence: Amine Raja (raja.amine2@gmail.com)
P-068 Worldwide clinical practices in perioperative antibiotic therapy for lung transplantation
Benjamin Coiffard1, Eloi Prud’homme2, Sami Hraiech2, Nadim Cassir3, Laurent Papazian2
1Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, Médecine Intensive Réanimation, Marseille, France; 2APHM, Hôpital Nord, Médecine Intensive Réanimation, Marseille, France; 3Aix Marseille Univ, APHM, IHU-Méditerranée Infection, Marseille, France, Marseille, France
Correspondence: Benjamin Coiffard (bcoiffard.aphm@gmail.com)
P-069 Use of aminoglycosided in a French pediatric hospital: a retrospective study
Séverine Manen1, Cécile Bost-Bru1, Sébastien Chanoine2, Guillaume Mortamet3
1Service de pédiatrie, CHU de Grenoble, Grenoble, France; 2Département de pharmacie, CHU de Grenoble, Grenoble, France; 3Service de réanimation pédiatrique, CHU de Grenoble, Grenoble, France
Correspondence: Séverine Manen (smanen@chu-grenoble.fr)
P-070 Blood exchange transfusion in severe pertussis: mortality risk factors
Ahmed Ayari, Rim Ouerfelli, Ahmed Hajji, Shatila Hadj Hassine, Assaad Louati, Asma Bouziri, Khaled Menif, Aïda Borgi, Nejla Ben Jaballah
Service de Réanimation Pédiatrique Polyvalente/ Bechir Hamza Children’s Hospital of Tunis, Tunis, Tunisia
Correspondence: Ahmed Ayari (Ahmed.alayari@gmail.com)
P-071 Pneumocystis pneumonia in a pediatric intensive care unit: a retrospective study from 2006 to 2019
Arielle Maroni, Stéphane Dauger, Camille Dollat, Jérôme Naudin, Anna Deho, Géraldine Poncelet, Michael Levy, Fleur Le Bourgeois, Guillaume Geslain, Maryline Chomton
Hospital Robert DEBRE-Pediatric Intensive Care Unit, Paris, France
Correspondence: Arielle Maroni (arielle.maroni@aphp.fr)
P-072 Prevalence of Staphylococcus aureus health care-associated infections among carriers and associated risk factors in a pediatric intensive care unit
Perrine See1, Stéphane Bonacorsi2, Jérôme Naudin1, Anna Deho1, Géraldine Poncelet1, Catherine Doit2, Fleur Le Bourgeois1, Maryline Chomton1, Stéphane Dauger1, Michael Levy1
1Réanimation et surveillance continu pédiatriques, Hôpital Robert-Debré, APHP, Paris, France; 2Microbiologie, Hôpital Robert-Debré, APHP, Paris, France
Correspondence: Perrine See (perrinesee@aol.com)
P-073 Acinetobacter baumannii nosocomial infections in pediatric intensive care unit at Casablanca Ibn Rochd Hospital
Samira Kalouch, Khalid Yakini, Wissal Aissaoui, Abdelaziz Chlilek
CHU ibn rochd casablanca, Casablanca, Morocco
Correspondence: Samira Kalouch (dr.kalouch@gmail.com)
P-074: Postoperative treatment with vancomycin in children with liver or combined liver-kidney transplantation
Mehdi Oualha1, Hélène Yager1, Delphine Callot2, Mathieu Genuini3, Julie Toubiana2, Agathe Béranger1, Florence Lacaille1, Romain Berthaud1, Christophe Chardot1, Carole Hennequin1, Anais Brassier1, Sihem Benaboud1, Sylvain Renolleau1
1Hôpital Necker enfants malades, Paris, France; 2Hôpital Cochin, Paris, France; 3Hôpital Robert Debré, Paris, France
Correspondence: Mehdi Oualha (mehdi.oualha@aphp.fr)
P-075 Early bacterial infections after pediatric liver transplantation in the era of multiresistant bugs: a 9-year retrospective experience
Agathe Béranger1, Carmen Capito2, Florence Lacaille3, Agnès Ferroni4, Naïm Bouazza5, Muriel Girard3, Mehdi Oualha1, Sylvain Renolleau1, Dominique Debray3, Christophe Chardot2, Pierre Frange4, Florence Moulin1
1Réanimation pédiatrique, Necker Enfants Malades, Paris, France; 2Chirurgie viscérale pédiatrique, Necker Enfants Malades, Paris, France; 3Hépatologie pédiatrique, Necker Enfants Malades, Paris, France; 4Microbiologie clinique, Necker Enfants Malades, Paris, France; 5URC, Cochin-Necker Enfants Malades, Paris, France
Correspondence: Agathe Béranger (agathe.beranger@gmail.com)
Variables, n (%) or median [IQR] | Infected patients, n = 67 (47%) | Non-infected patients, n = 75 (53%) | Univariate p | Multivariate analysis | |
---|---|---|---|---|---|
OR (95% CI) | p | ||||
Preoperative data | |||||
Age (years) | 1.75 [0.9–6.3] | 3.5 [1.3–9.7] | 0.02 | ||
Weight (kg) | 11 [8-19] | 14.4 [9–28.3] | 0.009 | 0.96 (0.9–0.99) | 0.03 |
Male gender | 37 (55%) | 37 (49%) | NS | ||
Malnutrition | 22 (33%) | 28 (37%) | NS | ||
Biliary atresia | 37 (55%) | 39 (52%) | NS | ||
Previous abdominal surgeries | 49 (73%) | 47 (63%) | NS | ||
High-emergency waiting list | 25 (37%) | 24 (32%) | NS | ||
Graft/recipient weight ratio (%) | 2.9 [1.6-4] | 2.7 [1.8-3.3] | NS | ||
Intra-operative data | |||||
Serum lactate (mmol.L−1) | 3.8 [3–5.5] | 3.9 [3.1–4.9] | NS | ||
Transfusion volume (TBVR*) | 2.3 [1.3–3.9] | 1.4 [0.8–2.2] | 0.001 | 1 (0.9–1.2) | NS |
Cold ischemia time (hours) | 8.3 [7.3–9.3] | 8.1 [6.5–9.1] | NS | ||
Presence of prosthetic mesh | 30 (45%) | 16 (21%) | 0.005 | 2.4 (1.1–5.4) | 0.046 |
Postoperative data | |||||
Surgical complications | 23 (34%) | 18 (24%) | NS | ||
Acute rejection | 30 (45%) | 30 (40%) | NS |
P-076 B-lactams in critically ill children with renal failure and continuous renal replacement therapy: dosing and exposure
Mehdi Oualha, Benjamin Prim, Déborah Hirt, Saoussen Krid, Inès Gana, Fabrice Lesage, Romain Berthaud, Sihem Benaboud, Jean-Marc Tréluyer, Sylvain Renolleau
Necker Hospital, Paris, France
Correspondence: Mehdi Oualha (mehdi.oualha@aphp.fr)
P-077 Oncological digestive emergencies profile and become
Khalid Khaleq, Wafaa Eddouissi, Fatimazahra Bensardi, Rachid Al Harrar
Faculté de médecine et de pharmacie/ CHU ibnou Rochd, Casablanca, MOROCCO
Correspondence: Khalid Khaleq (khaleq20@gmx.fr)
P-078 Outcome of intracranial hemorrhage in patients with acute leukemia: results of a retrospective cohort study
Yannick Hourmant, Sandrine Valade, Adrien Mirouse, Jean Jacques Tudesq, Asma Mabrouki, Eric Mariotte, Virginie Lemiale, Lara Zafrani, Michaël Darmon, Elie Azoulay
Hôpital Saint Louis -APHP-Médecine intensive et réanimation, Paris, France
Correspondence: Yannick Hourmant (yannick.hourmant@aphp.fr)
P-079 Sinusoidal obstruction syndrome in critically ill patients in the era of defibrotide (ISOS study): results of a retrospective cohort study
Pierre-Edouard Debureaux1, Michaël Darmon1, Naike Bige2, Anne-Sophie Moreau3, Djamel Mokart4, Guillaume Morel5, Claire Lacan5, Pierre Perez6, Frédéric Pene7, Achille Kouatchet8, Muriel Picard9, Martin Murgier10, Julien Mayaux11, Emmanuel Canet12, Elie Azoulay1, Sandrine Valade1
1Medical Intensive Care Unit, Saint Louis Hospital, Paris, France; 2Medical Intensive Care Unit, Saint Antoine Hospital, Paris, France; 3Critical Care Center, CHU de Lille, Lille, France; 4Critical Care Center, IPC, Marseille, France; 5Intensive Care Unit, CHU Strasbourg, Strasbourg, France; 6Medical Intensive Care Unit, Brabois University Hospital, Nancy, France; 7Medical Intensive Care Unit, Cochin Teaching Hospital, Paris, France; 8Medical Intensive Care Unit, Angers Teaching hospital, Angers, France; 9Department of Intensive Care, IUCT-Oncopôle, Toulouse, France; 10Medical-Surgical Intensive Care Unit, Saint-Priest-en-Jarez Hospital, Saint Etienne, France; 11Medical ICU, Pitié-Salpêtrière Hospital, Paris, France; 12Médical Intensive Care Unit, Centre Hospitalier Universitaire-Nantes, Nantes, France
Correspondence: Pierre-Edouard Debureaux (hemato.debureaux@gmail.com)
P-080 Etiology and outcome of acute respiratory failure in critically Ill immunocompromised and neutropenia: Retrospective analysis of a prospective multicenter multinational dataset
Djamel Mokart1, Michaël Darmon2, Achille Kouatchet3, Massimo Antonelli4, Martin Balik5, Andreas Barratt-Due6, Philippe Bauer7, Gaston Burghi8, Alexandre Demoule9, David Grimaldi10, Ignacio Martin Loeches11, Geeta Mehta12, Victoria Metaxa13, Saad Nseir14, Anders Perner15, Peter Pickkers16, Jean Reignier17, Jordi Rello18, Peter Schellongowski19, Marcio Soares20, Miia Valkonen21, Andry Van De Louw22, Virginie Lemiale2, Elie Azoulay2
1Réanimation, Institut Paoli-Calmettes, Marseille, France; 2Réanimation médicale Hôpital Saint Louis, Paris, France; 3Réanimation médicale CHU Angers, Angers, France; 4Agostino Gemelli University Hospital, Università Cattolica del Sacro Cuore, Rome, Italy; 5Department of Anesthesiology and Intensive Care Medicine, Charles University in Prague and General University Hospital, Prague, Republic Czech; 6Department of Emergencies and Critical Care, Oslo University Hospital, Oslo, Norway; 7Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, USA; 8Terapia Intensiva, Hospital Maciel, Montevideo, Uruguay; 9Réanimation médicale Hôpital Pitié Salpetrière, Paris, France; 10Department of Intensive Care, Hôpital Erasme, Université Libre de Bruxelles, Brussels, Belgium; 11Department of Intensive Care Medicine, Trinity College, Dublin, Ireland; 12Department of Medicine and Interdepartmental Division of Critical Care Medicine, Sinai Health System, University of Toronto, Toronto, Canada; 13King’s College Hospital, London, UK; 14Critical Care Center, CHU Lille, School of Medicine, University of Lille, Lille, France; 15Department of Intensive Care, Rigshospitalet, University of Copenhagen, Copenhagen, Danmark; 16The Department of Intensive Care Medicine (710), Radboud University Medical Center, Nijmegen, Netherlands; 17Medical Intensive Care Unit, Hôtel Dieu-HME University Hospital of Nantes, Nantes, France, Nantes, France; 18CIBERES, Universitat Autonòma de Barcelona, European Study Group of Infections in Critically Ill Patients (ESGCIP), Barcelona, Spain; 19Department of Medicine I, Medical University of Vienna, Vienna, Austria; 20The Department of Critical Care and Graduate Program in Translational Medicine, Rio De Janerio, Brazil; 21Division of Intensive Care Medicine, Department of Anesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; 22Division of Pulmonary and Critical Care, Penn State University College of Medicine, Hershey, USA
Correspondence: Djamel Mokart (mokartd@ipc.unicancer.fr)
P-081 Hepatic dysfunction in critically ill patients with hematologic malignancies: an underestimated life-threatening situation
Magali Bisbal1, Michaël Darmon2, Colombe Saillard3, Virginie Lemiale2, Frédéric Pene4, Achille Kouatchet5, Vincent Mallet6, Charlotte Mouliade6, Alexandre Demoule7, Francois Vincent8, Martine Nyunga9, Fabrice Bruneel10, Anne Renault11, Christine Lebert12, Anne-Pascale Meert13, Dominique Benoit14, Rebecca Hamidfar15, Merce Jourdain16, Elie Azoulay2, Djamel Mokart1
1Réanimation, Institut Paoli-Calmettes, Marseille, France; 2Réanimation médicale, Hôpital Saint Louis, Paris, France; 3Hématologie, Institut Paoli-Calmettes, Marseille, France; 4Médecine intensive Réanimation, Hôpital Cochin, Paris, France; 5Réanimation, CHU Angers, Angers, France; 6Hépatologie médicale, Hôpital Cochin, Paris, France; 7Médecine intensive Réanimation, hôpital Pitié Salpêtrière, Paris, France; 8Réanimation, Hôpital Avicenne, Paris, France; 9Réanimation, CH ROUBAIX, Roubaix, France; 10Réanimation, CH Versailles, Versailles, France; 11Réanimation médicale, CHU Brest, Brest, France; 12Réanimation médicale, CH La Roche-sur-Yon, La Roche-Sur-Yon, France; 13Institut Jules Bordet, Bruxelles, Belgium; 14Ghent University Hospital, Gent, Belgium; 15Réanimation, CHU Grenoble, Grenoble, France; 16Réanimation, Hôpital Roger Salengro, CHU Lille, Lille, France
Correspondence: Magali Bisbal (bisbalm@ipc.unicancer.fr)
OR | 95% CI | p | |
---|---|---|---|
Hepatic Charlson comorbidity Performance status > 1 Acute respiratory failure at ICU admission Mechanical ventilation during ICU stay Renal replacement therapy during ICU stay Chemotherapy initiated at ICU admission | 11.669 2.138 2.227 4.836 2.341 0.225 | 1.366–99.719 1.036–4.412 1.029–4.822 2.235–10.463 1.082–5.067 0.064–0.791 | 0.025 0.040 0.042 < 0.0001 0.031 0.020 |
P-082 CT findings and association with outcome of critically ill patients with hematological malignancies, acute respiratory failure and respiratory virus detection
Amazigh Aguersif1, Marion Jaffro1, Audrey Fernandez1, Alexandre Nguyen1, Emilie Berard1, Sihem Bouharaoua1, Jean Michel Mansuy1, Catherine Mengelle1, Guillaume Morel2, Cyril Cadoz3, Laura Platon4, Alexis Ferre5, Camille Verlhac6, Nahema Issa7, Laurent Argaud8, Guillaume Geri9, Danielle Reuter10, Stein Silva1, Muriel Picard11
1CHU DE TOULOUSE, Toulouse, France; 2CHU DE STRASBOURG, Strasbourg, France; 3CHU DE METZ, Metz, France; 4CHU DE MONTPELLIER, Montpellier, France; 5CH DE VERSAILLES, Versailles, France; 6CHU DE CLERMONT-FERRAND, Clermont-Ferrand, France; 7CHU DE BORDEAUX, Bordeaux, France; 8HOSPICES CIVILS DE LYON, Lyon, France; 9APHP, AMBROISE PARE, Paris, France; 10Ch Sud Francilien, Corbeil-Essonnes, France; 11IUCT-ONCOPOLE, Toulouse, France
Correspondence: Amazigh Aguersif (aguersif.a@chu-toulouse.fr)
P-083 High-dose methotrexate in ICU patients: a retrospective study
Sandrine Valade1, Lara Zafrani1, Eric Mariotte1, Virginie Lemiale1, Guillaume Dumas1, Lauriane Goldwirt2, Adrien Mirouse1, Yannick Hourmant1, Jean Jacques Tudesq1, Asma Mabrouki1, Elie Azoulay1, Michaël Darmon1
1Medical ICU, Saint Louis hospital, Paris, France; 2Department of Pharmacology, Saint Louis hospital, Paris, France
Correspondence: Sandrine Valade (sandrine.valade@aphp.fr)
P-084 Life-threatening complications following high-dose methotrexate and role of glucarpidase
Chloé Medrano1, Lucie Oberic2, Suzanne Tavitian2, Florent Puisset3, Caroline Protin4, Sophie Perriat3, Muriel Picard4, Francoise Huguet2, Sarah Bertoli2, Christian Recher2, Stanislas Faguer1
1Department of Nephrology and Organ Transplantation-Intensive Care Unit, University Hospital of Toulouse, Toulouse, France; 2Service d’Hématologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; 3Service de Pharmacologie, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France; 4Service de Réanimation, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France
Correspondence: Chloé Medrano (chloemedrano@hotmail.fr)
P-085 Impact of infection on hepatic encephalopathy during cirrhosis
Khaoula Ben Ismail, Sana Khedher, Ameni Khaled, Nassereddine Foudhaili, Mohamed Salem
USI Digestif-service de gastroenterologie-EPS Charles Nicolles.Tunis–Tunisie., Tunisia, Tunisia
Correspondence: Khaoula Ben Ismail (khaoula87@hotmail.fr)
P-086 Lactulose vs. polyethylene glycol electrolyte solution for treatment of hepatic encephalopathy
Khaoula Ben Ismail, Sana Khedher, Ameni Khaled, Nassereddine Foudhaili, Mohamed Salem
USI Digestif-service de gastroenterologie-EPS Charles Nicolles.Tunis –Tunisie., Tunisia, Tunisia
Correspondence: Khaoula Ben Ismail (khaoula87@hotmail.fr)
P-087 Acute pancreatitis and pregnancy
Janati Adnane, Lina Berrada
Obstetric intensive care unit, Casablanca, Morocco
Correspondence: Janati Adnane (adnanejanati@gmail.com)
P-088 Selecting patients with decompensated cirrhosis and acute-on-chronic liver failure (ACLF) admitted to the intensive care unit for liver transplantation
Sophie-Caroline Sacleux, Elise Lemaitre, Marc Boudon, Philippe Ichaï, Didier Samuel, Faouzi Saliba
AP-HP Hôpital Paul-Brousse, Centre Hépato-Biliaire, Liver Intensive Care Unit, Villejuif, France
Correspondence: Sophie-Caroline Sacleux (sophie-caroline.sacleux@aphp.fr)
P-089 Interest of body composition analysis in CT in cirrhotic patients with septic shock
Caroline Lemaitre1, Steven Grange2, Mathieu Devilder3, Dorothée Carpentier2, Gaetan Beduneau2, Christophe Girault2, Fabienne Tamion2, Celine Savoye Collet3
1Hepato-gastroenterology Unit, CHU ROUEN, Rouen, France; 2Medical Intensive Care Unit, CHU ROUEN, Rouen, France; 3Radiology Unit, CHU ROUEN, Rouen, France
Correspondence: Caroline Lemaitre (caro.lemaitre@wanadoo.fr)
P-090 Comparative study between superinfection of necrosis lapses in post-ERCP pancreatitis and other etiologies of pancreatitis
Rachid Jabi, Mohammed Bouziane
CHU Mohammed VI, Oujda, Morocco
Correspondence: Rachid Jabi (jabirachid@gmail.com)
P-091 Determinants of early morbidity and mortality after liver transplantation from a retrospective cohort of 229 patients
Gautier Nitel, Aghiles Hamroun, Anne Bignon, Gilles Lebuffe
CHRU Lille, Lille, France
Correspondence: Gautier Nitel (gautier.nitel@gmail.com)
P-092 Usefulness of systematic blood culture under veno-arterial ECMO
Quentin De Roux1, Marie Renaudier1, Wulfran Bougouin2, Johanna Boccara1, Baptiste Dubost1, Vincent Fihman3, Raphael Lepeule3, Antonio Fiore4, Jean-Winoc Decousser3, Olivier Langeron1, Nicolas Mongardon1
1Service d’anesthésie-réanimation chirurgicale, réanimation chirurgicale cardio-vasculaire, DMU CARE, Assistance Publique des Hôpitaux de Paris (APHP), Hôpitaux Universitaires Henri Mondor, Créteil, France; 2Réanimation polyvalente, Hôpital Privé Jacques Cartier, Massy, France; 3Service de microbiologie-bactériologie-hygiène, Assistance Publique des Hôpitaux de Paris, Centre Hospitalier Universitaire Henri Mondor, Créteil, France; 4Service de chirurgie cardiaque, Assistance Publique des Hôpitaux de Paris, Centre Hospitalier Universitaire Henri Mondor, Créteil, France
Correspondence: Quentin De Roux (deroux.q@gmail.com)
P-093 Catheterization and fungal infection risk
Nabil Mosbah, Habiba Hemamid, Abdelmalek Hakimi
CHU Sétif, Sétif, ALGERIA
Correspondence: Nabil Mosbah (mosbahnabil05@gmail.com)
P-094 Molecular characterization and resistance profile of emergent extensively drug-resistant bacteria in burn patients
Emna Hammami1, Sarra Dhraief1, Hana Fredj2, Sajida Sboui2, Amenallah Messaadi2, Lamia Thabet1
1Centre de Traumatologie et des Grands Brûlés de Ben Arous-Laboratoire de biologie médicale et banque du sang, Ben Arous, Tunisia; 2Centre de Traumatologie et des Grands Brûlés de Ben Arous-Service de réanimation des brûlés, Ben Arous, Tunisia
Correspondence: Emna Hammami (emnahammami1993@gmail.com)
P-095 Stenotrophomonas maltophilia infections in intensive care unit: clinical features, management and outcome
Myriam Kallel, Samia Ayed, Amira Jamoussi, Dhouha Lakhdhar, Jalila Ben Khelil, Mohamed Besbes
Abderrahmen Mami Hospital, Ariana, Tunisia
Correspondence: Myriam Kallel (myriamkallel1991@gmail.com)
P-096 Incidence and prognostic impact of thrombocytopenia in septic shock: a prospective study
Rania Ammar Zayani, Karama Bouchaala, Sabrine Bradai, Chokri Ben Hamida, Mabrouk Bahloul, Mounir Bouaziz
Habib bourguiba university hospital, Sfax, Tunisia
Correspondence: Rania Ammar Zayani (rania.ammarzayani@gmail.com)
P-097 Epidemiological profile and antibiotic susceptibility of Pseudomonas aeruginosa isolates in a trauma and burn center in Tunisia
Mehdi Gaddas1, Sarra Dhraief1, Karim Mechri1, Imen Jami2, Amenallah Messaadi2, Lamia Thabet1
1Centre de Traumatologie et des Grands Brûlés de Ben Arous-Laboratoire de biologie médicale et banque du sang, Ben Arous, Tunisia; 2Centre de Traumatologie et des Grands Brûlés de Ben Arous-Service de réanimation des brûlés, Ben Arous, Tunisia
Correspondence: Mehdi Gaddas (gaddasmehdi@icloud.com)
P-098 Acinetobacter baumanii: therapeutic impasse
Sabah Benhamza, Mohamed Lazraq, Abdelhak Bensaid, Youssef Miloudi, Najib El Harrar
Réanimation de l’hôpital du 20 Août, Casablanca, Morocco
Correspondence: Sabah Benhamza (benhamzasabah5@gmail.com)
P-099 Clinical variables predicting intensive care unit transfer and death in patients with suspected infection managed at the emergency department
Hadil Mhadhbi, Khedija Zaouche, Abdelwahab Mghirbi, Radhia Boubaker, Kamel Majed
Emergency Department la Rabta, Tunis, Tunisia
Correspondence: Hadil Mhadhbi (hadil.mhadhbi@gmail.com)
P-100 Diaphragmatic contractile function between supine position versus prone position in ventilated patients
Ahlem Trifi, Cyrine Abdennebi, Foued Daly, Asma Mehdi, Yosr Touil, Sami Abdellatif, Salah Ben Lakhal
Medical ICU la Rabta hospital, Tunis, Tunisia
Correspondence: Ahlem Trifi (trifiahlem2@gmail.com)
P-101 Assessment of aerosol delivery during mechanical ventilation of a simulated adult tracheostomy patient
Barry Murphy, Andrew O’sullivan, Mary Joyce, Gavin Bennett, Elena Fernandez Fernandez, Amy Tatham, Ronan Macloughlin
Aerogen Ltd., Galway, Ireland
Correspondence: Barry Murphy (Bmurphy@aerogen.com)
% Aerosol dose Average ± SD | |||
---|---|---|---|
VMN | JN | P-value | |
On inspiratory limb | 24.52 ± 1.03 | 12.95 ± 0.21 | 0.0037 |
On dry side of humidifier | 32.62 ± 1.10 | 20.97 ± 1.51 | 0.0004 |
P-value | 0.0100 | 0.0127 |
P-102 An international survey on practice in use of automatic tube compensation mode during mechanical ventilation in Intensive Care units
Emanuele Turbil1, Louis-Marie Galerneau2, Nicolas Terzi2, Claude Guérin3
1University of Sassaria, Sassaria, Italy; 2Medecine Intensive Reanimation, Grenoble, France; 3Medecine Intensive Reanimation, Lyon, France
Correspondence: Emanuele Turbil (emanuele.turbil@gmail.com)
P-103 Assessment of respiratory effort based on the analysis of the ventilator waveforms: a machine learning approach
Samuel Tuffet1, Bruno Louis2, Yvon Deplante3, François Perier1, Anne-Fleur Haudebourg1, Nicolas De Prost1, Keyvan Razazi1, Armand Mekontso Dessap1, Guillaume Carteaux1
1Réanimation Médicale CHU Henri Mondor, Créteil, France; 2INSERM U955 Equipe 13, Créteil, France; 3GRC CARMAS UPEC, Créteil, France
Correspondence: Samuel Tuffet (samuel.tuffet@hotmail.fr)
P-104 Oesophageal pressure measurement in intubated patients by intensive care units nurses: the ON educational study
Maëva Campfort, Flavie Laurioux, Pierre-Yves Olivier, Lise Piquilloud, Alain Mercat, Francois Beloncle
MIR, CHU d’Angers, Angers, France
Correspondence: Maëva Campfort (maevacampfort@aol.com)
P-105 Weaning from mechanical ventilation in burns: Which weaning test in clinical practice?
Kawther Faleh, Hana Fredj, Houda Maayoufi, Amel Mokline, Imen Jami, Manel Ben Saad, Amenallah Messaadi
Intensive Burn Care Departement, Burn and Trauma Center, Ben Arous, Tunisia
Correspondence: Kawther Faleh (kaouther_1@yahoo.fr)
P-106 Role of chest wall expiratory flow limitation and airway closure in patients with acute respiratory distress syndrome
Nicolas Terzi1, Louis-Marie Galerneau1, Mehdi Mezidi2, Emanuele Turbil3, Hodane Yonis2, Loredana Baboi2, Bruno Louis4, Carole Schwebel1, Claude Guérin2
1Médecine Intensive Réanimation, CHU Grenoble Alpes, Grenoble, France; 2Médecine Intensive Réanimation, CHU de Lyon, Lyon, France; 3University of Sassaria, Sassaria, Italy; 4INSERM 955, Créteil, France
Correspondence: Nicolas Terzi (nterzi@chu-grenoble.fr)
EFL | P value (versus 0.50) | AC | P value (versus 0.50) | |
---|---|---|---|---|
Edyn,cw/Edyn,L | 0.90 (0.85–0.94) | < 0.001 | 0.61 (0.54–0.68) | 0.013 |
Est,cw/Est,L | 0.75 (0.54–0.90) | 0.011 | 0.55 (0.34–0.75) | 0.75 |
Est,cw/Est,L_aop | 0.90 (0.62–0.99) | < 0.001 | 1.00 (0.86–1.00) | < 0.001 |
P-107 Anesthesia outside operating room in pediatrics
Ihssan Mehrez, Adnane Berdai, Said Belmekadem, Mustapha Harandou
CHU HASSAN II, Fes, Morocco
Correspondence: Ihssan Mehrez (mehrez.ihssan@gmail.com)
P-108 Umbilical vein catheterization through Wharton’s jelly: a possibility for a fast and safe way to deliver treatments in the delivery room?
Suzanne Borrhomée
Hôpital René Dubos, France
Correspondence: Suzanne Borrhomée (suzanne.borrhomee@gmail.com)
P-109 Cerebral Vascular Stroke (CVA) in children
Choubeila Guetteche
Universitary hospital center, Constantine, ALGERIA
Correspondence: Choubeila Guetteche (cguetteche@gmail.com)
P-110 High glucose intake and glycemic level in postoperative liver transplantation for children with inherited metabolic disorders of protein intoxication
Mehdi Oualha, Victoire Thenot, Marion Grimaud, Anais Brassier, Pascale De Lonlay, Fabrice Lesage, Florence Lacaille, Christophe Chardot, Laurent Dupic, Sylvain Renolleau
Necker Hospital, Paris, France
Correspondence: Mehdi Ouahla (mehdi.oualha@aphp.fr)
P-111 Acute cellular rejection in first month after pediatric liver transplantation: rate and risk factors
Pauline Adnot, Laure Cohen, Florence Moulin, Mehdi Oualha, Muriel Girard, Stephanie Chhun, Christophe Chardot, Sylvain Renolleau, Marion Grimaud
Hôpital Necker Enfants Malades, Paris, France
Correspondence: Pauline Adnot (pauline.adn@gmail.com)
P-112 Dexmedetomidine sedation for pediatric MRI: a retrospective cohort from a French pediatric intensive care unit
Hélène Lepeltier1, Maxime Gauberti2, Arnaud Lepetit3, Charlotte Roulland1, Alexandre Frugier3, David Brossier4, Isabelle Goyer5
1CHU CAEN, Département de pédiatrie, Caen, France; 2CHU CAEN, Département de radiologie, Caen, France; 3CHU CAEN, Département d’anesthésie, Caen, France; 4CHU CAEN, Département de réanimation pédiatrique, Caen, France; 5CHU CAEN, Département de pharmacie, Caen, France
Correspondence: Hélène Lepeltier (helene.lepeltier@orange.fr)
P-113 Evaluation of simulresp©: a simulation software of child and teenager cardiorespiratory physiology
David Brossier1, Olivier Flechelles2, Michael Sauthier1, Guillaume Emeriaud1, Bernard Guillois3, Philippe Jouvet1
CHU Sainte Justine, Montréal, Canada; 2CHU de Martinique, Fort De France, France; 3CHU de Caen, Caen, France
Correspondence: David Brossier (david_brossier@yahoo.fr)
P-114 Place of tracheotomy in pediatric resuscitation
Samira Kalouch, Khalid Yakini, Wissal Aissaoui, Abdelaziz Chlilek
CHU IBN ROCHD Casablanca, Casablanca, Morocco
Correspondence: Samira Kalouch (dr.kalouch@gmail.com)
P-115 Aspiration pneumonia and drug overdose requiring invasive ventilation: impact of a care protocol on the antibiotic prescription
Gurvan Le Bouar1, Pierre-Louis Declercq2, Medhi Bousta3, Jean-Baptiste Michot4, Jean-Philippe Rigaud2, Laurie Lagache3, Olivier Delastre4, Déborah Boyer5, Samia Boubeche5, Dorothée Carpentier5, Thomas Clavier5, Elsa Demarest1, Christophe Girault5, Jean Glenisson5, Elise Godeau5, Steven Grange5, Damiano Cerasuolo6, Fabienne Tamion5, Gaetan Beduneau5
1Medical-Surgical Intensive Care Unit, District Hospital Center, Évreux, France; 2Medical-Surgical Intensive Care Unit, District Hospital Center, Dieppe, France; 3Medical-Surgical Intensive Care Unit, District Hospital Center, Le Havre, France; 4Medical-Surgical Intensive Care Unit, District Hospital Center, Elbeuf, France; 5Medical Intensive Care Unit, Rouen University Hospital, Rouen, France; 6Unit of biostatistics, Rouen University Hospital, Rouen, France
Correspondence: Gurvan Le Bouar (gurvan.lbk@hotmail.fr)
P-116 Impact of hyperoxemia on mortality during septic shock: retrospective study on the MIMIC-III database
Benjamin Popoff, Bertrand Dureuil, Benoit Veber, Thomas Clavier
Département d’Anesthésie Réanimation, CHU de Rouen, Université de Rouen Normandie, Rouen, France
Correspondence: Benjamin Popoff (benjamin.popoff@chu-rouen.fr)
P-117 Impact of multiplex PCR (Filmarray TM) on the diagnosis and adequacy of initial therapy in HCAP/HAP/VAP hospitalized in ICU: a pilot monocenter study
Jonathan Pehlivan1, Camille D’humieres1, Juliette Patrier1, Lila Bouadma1, Manon Lejeune2, Clement Lebihan1, Laurence Armand-Lefrevre2, Jean-François Timsit3
1Bichat RMI, Paris, France; 2Bichat microbiologie, Paris, France; 3APHP Bichat Paris, Paris, France
Correspondence: Jonathan Pehlivan (jonathan.pehlivan@gmail.com)
P-118 How to improve the post-operative antibiotics prescription after major pancreatic surgery? A retrospective cohort study
Matthieu Petit, Guillaume Geri, Elsa Salomon, Frédérique Peschaud, Antoine Vieillard-Baron, Xavier Repessé
APHP-hôpital Ambroise Paré, Boulogne-Billancourt, France
Correspondence: Matthieu Petit (matthieu-petit@hotmail.fr)
P-119 Care paths of pneumococcal meningitis with sepsis in France: a retrospective analysis of a French medico-administrative (PMSI) database
Michael Thy1, Claire Dupuis1, Bruno Mourvillier2, Lila Bouadma1, Stephane Ruckly3, Anne Perozziello3, Damien Van-Gysel4, Etienne De Montmollin1, Romain Sonneville1, Jean-François Timsit1
1Réanimation médicale et infectieuse, Paris, France; 2Réanimation médicale, CHU Reims, Reims, France; 3UMR 1137, IAME, équipe Descide, Université de Paris, Paris, France; 4Département d’informations médicales, CHU Bichat, APHP, Paris, France
Correspondence: Michael Thy (michael245thy@gmail.com)
1stICU | Interm2ndICU | ward2ndICU | IntermOnly | Pval (all) | Pval 1stICU versus ward2ndICU | |
---|---|---|---|---|---|---|
Cases | 636 | 153 | 362 | 61 | . | |
Characteristics of the patient | ||||||
Age > 65 y.o. | 244 (38.36) | 76 (49.67) | 171 (47.24) | 26 (42.62) | 0.01 | < 0.01 |
Hospital stay characteristics | ||||||
Academic institution | 292 (45.91) | 81 (52.94) | 189 (52.21) | 22 (36.07) | 0.03 | 0.06 |
Severity of the patients | ||||||
Kidney organ failure | 259 (40.72) | 62 (40.52) | 139 (38.4) | 16 (26.23) | 0.16 | 0,47 |
Respiratory organ failure | 614 (96.54) | 152 (99.35) | 352 (97.24) | 22 (36.07) | < 0.01 | 0.55 |
Septic shock | 620 (97.48) | 149 (97.39) | 350 (96.69) | 36 (59.02) | < 0.01 | 0.46 |
Coma | 400 (62.89) | 89 (58.17) | 217 (59.94) | 13 (21.31) | < 0.01 | 0.36 |
Purpura | 49
(7.7) | 11 (7.19) | 19 (5.25) | 5 (8.2) | 0.50 | 0.14 |
Codes for identification of pneumococcal infection | ||||||
Pneumococcal pneumonia (J13) | 151 (23.74) | 34 (22.22) | 81 (22.38) | 9 (14.75) | 0.45 | 0.62 |
Pneumococcal septicemia(A403) | 173 (27.2) | 51 (33.33) | 111 (30.66) | 22 (36.07) | 0.24 | 0.24 |
Outcomes | ||||||
Hospital length of stay, median (IQR) | 21 [9; 39] | 26 [15; 43] | 23 [10; 46] | 16 [11; 28] | < 0.01 | 0.22 |
ICU length of stay, median (IQR) | 11 [5; 21] | 12 [6; 21] | 10 [4; 22] | 1 [0; 4] | < 0.01 | 0.29 |
Discharge to home | 184 (28.93) | 34 (22.22) | 86 (23.76) | 32 (52.46) | < 0.01 | 0.08 |
Hospital mortality | 253 (39.78) | 67 (43.79) | 186 (51.38) | 8 (13.11) | < 0.01 | < 0.01 |
Cost(€), median (IQR) | 21,783 [13,197; 33,774] | 27,653 [17,262; 41,659] | 22,584 [14,013; 37,245] | 12,067 [8398; 18,355] | < 0.01 | 0,19 |
P-120 Protective effects of landiolol against sepsis-induced atrial fibrillation in mice: preliminary results
Romaric Larcher1, Jerome Thireau2, Jeremy Fauconnier2, Sarah Colombani2, Alain Lacampagne2, Kada Klouche1
1Médecine intensive-Réanimation, CHU de Montpellier INSERM, CNRS, PhyMedEx, Université de Montpellier, Montpellier, France; 2INSERM, CNRS, PhyMedEx, Université de Montpellier, Montpellier, France
Correspondence: Romaric Larcher (r-larcher@chu-montpellier.fr)
Sham (n = 10) | Septic (n = 10) | Septic + landiolol (n = 10) | |
---|---|---|---|
EKG recording before transesophageal stimulation | |||
Heart rate (bpm), mean ± SD | 362 ± 27 | 502 ± 30 | 465 ± 21 |
Sinus cycle length (ms), mean ± SD | 167 ± 12 | 118 ± 9 | 130 ± 7 |
P wave (ms),
mean ± SD | 11 ± 2 | 17 ± 2 | 8 ± 2 |
PR interval (ms), mean ± SD | 40 ± 5 | 43 ± 6 | 42 ± 5 |
QRS duration (ms), mean ± SD | 10 ± 1 | 9 ± 1 | 9 ± 1 |
QT interval (ms), mean ± SD | 15 ± 2 | 15 ± 2 | 15 ± 3 |
QTc (ms), mean ± SD | 37 ± 4 | 43 ± 8 | 40 ± 13 |
EKG recording after transesophageal stimulation | |||
Atrial fibrillation, n (%) | 0 (0%) | 7 (70%) | 2 (20%) |
P-121 Quantifying carriage of extended-spectrum beta-lactamase-producing enterobacteriaceae and subsequent ICU acquired infection in French Guiana
Hatem Kallel1, Claire Mayence1, Caroline Dupuy1, Cyrille Mathien1, Stephanie Houcke1, Dabor Resiere2, Hommel Didier1
1CH Cayenne, Cayenne, France; 2CHU Martinique, Fort De France, France
Correspondence: Hatem Kallel (hatem.kallel@ch-cayenne.fr)
P-122 Vancomycin serum concentration after 48 h of administration: a 3 years survey in an intensive care unit
Nicolas Perin1, Claire Roger1, Laurent Muller1, Jean-Yves Lefrant1, Jason A. Roberts2
1CHU Caremeau Nîmes, Nîmes, France; 2CHU Caremeau Nîmes, Nîmes, France
Correspondence: Nicolas Perin (perinnico.1@gmail.com)
P-123 Psychiatric profile of patients hospitalized in intensive care unit for suicide attempt
Jihene Guissouma1, Meriem Ksouri1, Hatem Ghadhoune1, Habib Brahmi1, Yesmine Garbaa1, Hana Benali1, Rawnak Houli1
Hôpital Habib Bougatfa, Bizerte, Tunisia
Correspondence: Jihene Guissouma (bahri.jihene@yahoo.fr)
P-124 Impact of hyperglycemia in severe scorpion envenomation
Oussama Jaoued, Yosri Ben Ali, Gharbi Rim, Sik Ali Habiba, Fekih Hassen Mohamed, Elatrous Souheil
Hôpital Taher Sfar, Mahdia, Tunisia
Correspondence: Oussama Jaoued (oussamajaoued@gmail.com)
P-125 Fatal poisoning in south Tunisia: a 12 years study
Wiem Ben Amor, Narjess Karray, Malek Zribi, Karim Derbel, Zouhir Hammami, Mabrouk Bahloul, Mounir Bouaziz, Samir Maatoug
1Forensic departement Habib Bourguiba University Hospital, Sfax, Tunisia; 2Reanimation departement Habib Bourguiba University Hospital, Sfax, Tunisia
Correspondence: Wiem Ben Amor (wiembenamar@yahoo.fr)
P-126 Severe acute poisoning by organophosphate pesticides: report of 18 cases at the Oran hospital and university center
Mourad Goulmane
Hospital and university center of Oran, Oran, Algeria
Correspondence: Mourad Goulmane (goulmane.mourad@univ-oran1.dz)
P-127 Factors of gravity of ecstasy poisoning : 2 years experience in a toxicology hospital in Tunis
Hela Maamouri, Meriem Fatnassi, Hend Allouche, Nozha Brahmi
Service de réanimation toxicologique et polyvalente Centre Mahmoud Yaacoub, Tunis, Tunisia
Correspondence: Hela Maamouri (helamaamouri@yahoo.fr)
P-128 The viper envenomations
Nissrine Tajellijiti, Youssef Bouidir, Fahd Moussaid, Youssef Elouardi, Mohamed Khallouki
Surgical resuscitation department, university hospital, Marrakech, Morocco
Correspondence: Nissrine Tajellijiti (dr.nissrina.taj5555@gmail.com)
P-129 Drug-induced hyperammonaemia: data from VigiBase, the WHO database
Nicolas Weiss, Joe Elie Salem, Benedicte Lebrun-Vignes, Kevin Bihan, Marika Rudler, Charlotte Bouzbib, Philippe Sultanik, Dominique Thabut
Sorbonne Université, Paris, France
Correspondence: Nicolas Weiss (nicolas.weiss@aphp.fr)
Substances | n | IC 0.25 | Serious adverse events, n | Serious adverse events, % | Fatal adverse events, n | Fatal adverse events, % |
---|---|---|---|---|---|---|
Valproic acid | 1260 | 6.86 | 768 | 61 | 54 | 4 |
Fluorouracil | 221 | 4.27 | 213 | 96 | 20 | 9 |
Topiramate | 96 | 4.33 | 65 | 68 | 0 | 0 |
Oxaliplatin | 74 | 2.53 | 68 | 92 | 12 | 16 |
Asparaginase | 71 | 5.09 | 50 | 70 | 6 | 8 |
Levofolinic acid | 51 | 5.44 | 51 | 100 | 6 | 12 |
Paracetamol | 48 | 0.95 | 38 | 79 | 16 | 33 |
Tacrolimus | 37 | 1.80 | 36 | 97 | 25 | 68 |
Levetiracetam | 35 | 2.21 | 25 | 71 | 3 | 9 |
Carbamazepine | 35 | 1.48 | 24 | 69 | 0 | 0 |
Bevacizumab | 34 | 1.43 | 34 | 100 | 3 | 9 |
Methotrexate | 33 | 0.43 | 31 | 94 | 11 | 33 |
P-130 Out-of-hospital cardiac arrest due to smoke inhalation: characteristics and outcomes
Christophe Allouache, Nicholas Heming, Virginie Maxime, Bernard Clair, Pierre Moine, Djillali Annane
Raymond Poincaré hospital, Garches, France
Correspondence: Christophe Allouache (allouache.christophe@outlook.com)
P-131 Diagnostic and prognosis values of cerebrospinal fluid analysis after cardiac arrest
Marine Paul1, Sarah Benghanem2, Sybille Merceron1, Hugo Bellut1, Anne Roche1, Mikhael Giabicani1, Florence Dumas3, Amandine Henry4, Paul Jaubert2, Fabrice Bruneel1, Jean Pierre Bedos1, Alain Cariou2, Stéphane Legriel1
1Intensive Care Unit, Centre Hospitalier de Versailles-Site André Mignot, Le Chesnay, France; 2Intensive Care Unit, Cochin Hospital, Paris, France; 3Emergency Department, Cochin Hospital, Paris, France; 4Microbiology Department, Centre Hospitalier de Versailles-Site André Mignot, Le Chesnay, France
Correspondence: Marine Paul (marine.1604@hotmail.fr)
P-132 Epidemiological, clinical, prognostic aspects of severe brain injuries in Yaoundé (Cameroon)
Roddy Stephan Bengono Bengono, Albert Ludovic Amengle, Junette Arlette Metogo Mbengono, Agnès Esiene, Paul Owono Etoundi, Jacqueline Ze Minkande
Faculty of medicine and Biomedical Sciences, University of Yaounde 1, Yaoundé, Cameroon
Correspondence: Roddy Stephan Bengono Bengono (rodbeng@yahoo.fr)
P-133 Predictors of outcome in ICU patients with severe blunt chest trauma
Mariem Dlela1, Abir Bouattour1, Yassmine Kammoun2, Olfa Turki1, Mounir Bouaziz1
1Habib bourguiba hospital, Sfax, Tunisia; 2Hedi chaker hospital, Sfax, Tunisia
Correspondence: Mariem Dlela (mariem241090@gmail.com)
P-134 Early hyperglycaemia in traumatic brain injury: about 380 cases
Tayssir El Haj, Kamilia Chtara, Rania Ammar Zayani, Sabrine Bradai, Mabrouk Bahloul, Mounir Bouaziz
University of Sfax, Sfax, Tunisia
Correspondence: Tayssir El Haj (tayssir_elhaj@yahoo.com)
P-135 Management of traumatic pneumothorax
Dalila Bougdal, Souhila Sadat, Dalila Zeghdoud
Hôpital Salim Zemirli, Alger, ALGERIA
Correspondence: Dalila Bougdal (dalilabougsrlf@gmail.com)
P-136 Management of cervical spine trauma at the CHU Sylvanus Olympio (SO) in Lome
Tabana Mouzou, Pilakimwe Egbohou, Pikabalou Tchetike
Anesthesia-Reanimation Service of Chu Sylvanus Olympio, Lomé, TOGO
Correspondence: Tabana Mouzou (essohanam2020@gmail.com)
P-137 Fat embolism syndrome post-traumatic report of 24 cases
Mediouni Karim, Amine Raja, Aziz Bouhouri, Alharrar Rachid
University hospital IBN ROCHD Casablanca, Casablanca, Morocco
Correspondence: Mediouni Karim (Mediouni_karim@hotmail.com)
P-138 Post-trauma fat embolism syndrome
Naila Boukoub, Mouna El Idrissi, Taha Hounain, Sara Maaroufi, Youssef Elouardi
Surgical ICU Department, Ibn Tofail Hospital, Marrakech, Morocco
Correspondence: Naila Boukoub (naila.boukoub@edu.uca.ac.ma)
P-139 Sedation-analgesia among elderly patients in Intensive care unit: about 30 cases
Maha Hammami, Kamilia Chtara, Olfa Turki, Najeh Baccouche, Mabrouk Bahloul, Mounir Bouaziz
University of Sfax, Sfax, Tunisia
Correspondence: Maha Hammami (dr.hammamimaha@yahoo.fr)
P-140 Causes and risk factors of death of patients admitted in two intensive care units in Yaoundé (Cameroon)
Roddy Stephan Bengono Bengono, Junette Arlette Metogo Mbengono, Albert Ludovic Amengle, Agnès Esiene, Paul Owono Etoundi, Jacqueline Ze Minkande
Faculty of Medicine and Biomedical Sciences, University of Yaoundé 1, Yaoundé, Cameroon
Correspondence: Roddy Stephan Bengono Bengono (rodbeng@yahoo.fr)
P-141 Journal club in a French ICU: a drop in the ocean of medical literature. Description and clinical impact of 1712 articles read over a 12-year period (2007-2019)
Damien Contou1, Marina Thirion2, Olivier Pajot1, Gaëtan Plantefeve4, Hervé Mentec1
1Centre Hospitalier Victor Dupouy, Argenteuil, France; 2Centre Hospitalier du Bassin de Thau, Sète, France
Correspondence: Damien Contou (damien.contou@ch-argenteuil.fr)
P-142 Evolution and prognostic factors of patients aged 80 and over admitted to surgical ICU
Gautier Nitel, Anne Bignon, Eric Kipnis
CHU Lille, Lille, France
Correspondence: Gautier Nitel (gautier.nitel@gmail.com)
P-143 Assessing patient safety culture perception in the intensive care unit in Tunisia
Oussama Jaoued, Chaoueh Sabrina, Sik Ali Habiba, Wael Chemli, Gharbi Rim, Fekih Hassen Mohamed, Elatrous Souheil
Hôpital Taher Sfar, Mahdia, Tunisia
Correspondence: Oussama Jaoued (oussamajaoued@gmail.com)
P-144 Use of the simplified acute physiology score II (SAPS II) at the Emergency Department
Hadil Mhadhbi, Khedija Zaouche, Yosra Yahya, Abdelwahab Mghirbi, Kamel Majed
Emergency Department la Rabta, Tunis, Tunisia
Correspondence: Hadil Mhadhbi (hadil.mhadhbi@gmail.com)
P-145 Outcomes of very elderly (≥ 80 years) critical-ill patients in a tunisian medical intensive care unit
Oussama Jaoued, Chaoueh Sabrina, Sik Ali Habiba, Yosri Ben Ali, Fekih Hassen Mohamed, Elatrous Souheil
Hôpital Taher Sfar, Mahdia, Tunisia
Correspondence: Oussama Jaoued (oussamajaoued@gmail.com)
P-146 Assessing the need for a rapid response system: patterns of deteriorating ward patients admitted to the ICU and of Chain of Care
Myrtille Gaudel1, Mathilde Masson2, Johanna Temime1, Nicolas Van Grunderbeeck1, Clément Delpierre1, Charles Detollenaere1, Julien Marc1, Didier Thevenin1
Centre Hospitalier de Lens, Lens, France; 2Centre Hospitalier d’Arras, Arras, France
Correspondence: Myrtille Gaudel (myrtille.gaudel@gmail.com)
P-147 Forty year-old and under critically ill patients dying early after admission despite full intensive care: epidemiology, clinical characteristics and financial impact over 12 years
Clémence Perrin, Guillaume Morel, Florence Fagot-Gandet, Valentin Morandeau, Claire Lacan, Pierrick Le Borgne, Vincent Castelain, Francis Schneider
Médecine Intensive Réanimation, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
Correspondence: Clémence Perrin (clemenceperrin@ymail.com)
P-148 Blood transfusion: modalities and risks -Intensive care unit A1-
Ihssan Mehrez, Abdelkrim Shimi, Ali Derkaoui, Mohhamed Khatouf
CHU HASSAN II, Fes, Morocco
Correspondence: Ihssan Mehrez (mehrez.ihssan@gmail.com)
P-149 Value of the CURB-65 score in predicting ICU admission and in-hospital mortality in patients with sepsis
Hadil Mhadhbi, Yosra Yahya, Abderrahim Achouri, Khedija Zaouche, Kamel Majed
Emergency Department la Rabta, Tunis, Tunisia
Correspondence: Hadil Mhadhbi (hadil.mhadhbi@gmail.com)
P-150 Impact of comorbidities on outcomes in sepsis in emergency department
Abderrahim Achouri, Hadil Mhadhbi, Khedija Zaouche, Hamida Maghraoui, Radhia Boubaker, Kamel Majed
University Hospital Center Rabta of Tunis, Tunis, Tunisia
Correspondence: Abderrahim Achouri (achouryabderrahim@gmail.com)
P-151 Micafungin population PK analysis in critically ill patients receiving continuous veno-venous hemofiltration or continuous veno-venous hemodiafiltration
1CHU Nîmes, Nîmes, France; 2University of Queensland, Brisbane, Australia
Correspondence: Nicolas Garbez (nicolas.garbez@umontpellier.fr)
Ann. Intensive Care 2020, 10(Suppl 1):P-151
P-152 Amikacin pharmacokinetic/pharmacodynamic (PK/PD) in intensive care unit: is a 25 mg/kg daily dose really insufficient?
Elsa Logre1, Maya Enser1, Sébastien Tanaka2, Marie Dubert3, Aurore Claudinon4, Nathalie Grall5, Hervé Mentec1, Philippe Montravers6, Olivier Pajot1
1Réanimation polyvalente, CH Argenteuil, Argenteuil, France; 2Réanimation chirurgicale, CHU Bichat et Université de la Réunion, INSERM UMR1188 Diabète, Saint-Denis de la Réunion, Paris, France; 3Maladies infectieuses et tropicales, CHU Bichat, Paris, France; 4Microbiologie, CH Argenteuil, Argenteuil, France; 5Microbiologie, CHU Bichat, Paris, France; 6Réanimation chirurgicale, CHU Bichat, Paris, France
Correspondence: Elsa Logre (elsa.logre@gmail.com)
P-153 Performance of qSOFA for identifying patients with suspected infection at risk of adverse outcomes during a review by an intensivist
Maïté Agbakou1, Seydou Goro2, Axelle Dupont2, Jean-Baptiste Lascarrou1, Charlotte Garret1, Amelie Seguin1, Maelle Martin1, Arnaud-Felix Miailhe1, Helene Migueres1, Olivier Zambon1, Laura Crosby1, Jean Reignier1, Jerome Lambert2, Emmanuel Canet1
1Service de médecine intensive réanimation, CHU Nantes, Nantes, France; 2Service de biostatistique et information Médicale, Hôpital Saint Louis, APHP, Paris, France
Correspondence: Maïté Agbakou (maite.agbakou@gmail.com)
P-154 Accuracy of SOFA, qSOFA, SIRS criteria and lactate level in predicting mortality of infected ICU patients
Ahlem Trifi1, Cyrine Abdennebi2, Foued Daly1, Yosr Touil1, Sami Abdellatif1, Salah Ben Lakhal1
1Medical ICU, la Rabta hospital, Faculty of Medicine of Tunis, Tunis, Tunisia; 2Medical ICU la Rabta hospital, Tunis, Tunisia
Correspondence: Ahlem Trifi (trifiahlem2@gmail.com)
P-155 Use of qSOFA score for predicting prognosis in patients admitted with decompensated liver cirrhosis
Khaoula Ben Ismail, Sana Khedher, Ameni Khaled, Nassereddine Foudhaili, Mohamed Salem
USI Digestif-service de gastroenterologie-EPS Charles Nicolles.Tunis –Tunisia, Tunisia, Tunisia
Correspondence: Khaoula Ben Ismail (khaoula87@hotmail.fr)
P-156 Angioedema associated with thrombolysis for ischemic stroke: analysis of a case-control study
Clara Vigneron1, Aldéric Lécluse2, Thomas Ronzière3, Sonia Alamowitch4, Olivier Fain1, Nicolas Javaud5
1Médecine Interne, Centre de Référence associé sur les angiœdèmes à kinines (CRéAk), Hôpital Saint-Antoine, APHP, Paris, France; 2Neurologie, CHU Angers, Angers, France; 3Neurologie, CHU Pontchaillou, Rennes, France; 4Neurologie, Hôpital Saint-Antoine, APHP, Paris, France; 5Urgences, Centre de Référence associé sur les angiœdèmes à kinines (CRéAk), Hôpital Louis Mourier, APHP, Colombes, France
Correspondence: Clara Vigneron (claravigneron@hotmail.fr)
P-157 Outcome of patients with inflammatory bowel diseases admitted to the intensive care unit: a multicenter retrospective study of 76 patients
Romaric Larcher, Fanny Garnier, Matthieu Amalric, Vincent Brunot, Laura Platon, Yassir Aarab, Guillaume Pineton De Chambrun, Jonathan Charbit, Samir Jaber, Boris Jung, Kada Klouche
Médecine intensive–Réanimation, Hôpital Lapeyronie, CHU de Montpellier, Montpellier, France
Correspondence: Romaric Larcher (r-larcher@chu-montpellier.fr)
P-158 Carboxyhemoglobin level is a reliable diagnosis biomarker of hemolytic anemia in intensive care unit
Geoffroy Hariri, Kyann Hodjat-Panah, Laurene Blum, Jean-Rémi Lavillegrand, Idriss Razach, Naike Bige, Jean-Luc Baudel, Bertrand Guidet, Eric Maury, Hafid Ait-Oufella
Médecine Intensive-Réanimation, Hôpital Saint-Antoine, Paris, France
Correspondence: Geoffroy Hariri (geoffroyhariri@hotmail.com)
P-159 Thrombocytopenia in intensive care: still not easy
Amine Raja, Mohamed Elaiassi, Maghfour Abdejabbar, Boubaker Charra
1The medical resuscitation department (27) of Ibn Rochd University Hospital in Casablanca, Casablanca, MOROCCO
Correspondence: Amine Raja (raja.amine2@gmail.com)
P-160 CAPS criteria fail to identify most severely-ill thrombotic antiphospholipid syndrome patients requiring intensive care unit admission
Marc Pineton De Chambrun1, Romaric Larcher2, Frédéric Pene3, Laurent Argaud4, Alexandre Demoule5, Rémi Coudroy6, Elie Azoulay7, Yacine Tandjaoui-Lambiotte8, Stanislas Faguer9, Alain Combes1, Charles-Edouard Luyt1, Zahir Amoura10
1Sorbonne Université, APHP, Hôpital La Pitié–Salpêtrière, Institut de Cardiométabolisme et Nutrition (ICAN), Service de Médecine Intensive-Réanimation, Paris, Paris, France; 2Service de Médecine Intensive-Réanimation, Hôpital Lapeyronie, Centre Hospitalier Universitaire (CHU) de Montpellier PhyMedExp, Université de Montpellier, INSERM, CNRS, Montpellier, France; 3Service de Médecine Intensive-Réanimation, Hôpital Cochin, Hôpitaux Universitaires Paris Centre, APHP & Université Paris Descartes, Paris, France; 4Service de Médecine Intensive-Réanimation, Hôpital Edouard Herriot, Hospices Civils de Lyon, Lyon, France; 5APHP, Hôpital La Pitié–Salpêtrière, Service de Pneumologie, Médecine Intensive et Réanimation Médicale, Département R3S Sorbonne Université, INSERM UMRS1158, Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France; 6Service de Médecine Intensive-Réanimation, INSERM CIC1402, groupe ALIVE, Université de Poitiers, CHU de Poitiers, Poitiers, France; 7Service de Médecine Intensive-Réanimation, Hôpital Saint-Louis, APHP, Paris, France; 8Service de Réanimation Médico-Chirurgicale, Hôpital Avicenne, APHP, HUPSSD, Bobigny, France; 9Département de Néphrologie et Transplantation d’organes-Unité de Réanimation, Centre de Référence des Maladies Rénales Rares, Hôpital Rangueil, CHU de Toulouse, Toulouse, France; 10Sorbonne Université, Assistance Publique-Hôpitaux de Paris (APHP), Hôpital La Pitié–Salpêtrière, Institut E3M, Service de Médecine Interne 2, Centre de Référence National Lupus Systémique, Syndrome des Anticorps Anti-phospholipides et autres maladies auto-immunes systémiques rares, Parisf, France
Correspondence: Marc Pineton De Chambrun (marc.dechambrun@gmail.com)
P-161 Anemia in intensive care unit
Sabah Benhamza, Afak Nsiri, Rachid Al Harrar
Surgical emergency resuscitation service of Ibn Rochd University Hospital, Casablanca, Morocco
Correspondence: Sabah Benhamza (benhamzasabah5@gmail.com)
P-162 Severe viral myopericarditis associated with anti-RNA polymerase III autoantibodies: a new entity
Marc Pineton De Chambrun1, Jean-Luc Charuel2, Guillaume Hekimian1, François Lifermann3, Isabelle Melki4, Charles-Edouard Luyt1, Alain Combes1, Zahir Amoura5
1Sorbonne Université, APHP, Hôpital La Pitié–Salpêtrière, Institut de Cardiométabolisme et Nutrition (ICAN), Service de Médecine Intensive-Réanimation, Paris, France; 2Sorbonne Université, APHP, Hôpital La Pitié–Salpêtrière, Laboratoire d’Immunochimie, Département d’Immunologie, Paris, France; 3Centre Hospitalier de Dax, Service de Médecine Interne, Dax, France; 4Université Paris Diderot, APHP, Hôpital Robert-Debré, Service de Pédiatrie Générale, Paris, France; 5Sorbonne Université, Assistance Publique–Hôpitaux de Paris (APHP), Hôpital La Pitié–Salpêtrière, Institut E3M, Service de Médecine Interne 2, Centre de Référence National Lupus Systémique et SAPL et autres maladies auto-immunes, Paris, France
Correspondence: Marc Pineton De Chambrun (marc.dechambrun@gmail.com)
P-163 Gastrointestinal manifestations in severe thrombotic microangiopathies
Eric Mariotte1, Lara Zafrani1, Sandrine Valade1, Virginie Lemiale1, Adrien Mirouse1, Jean Jacques Tudesq1, Yannick Hourmant1, Agnès Veyradier2, Bérangère Joly2, Lionel Galicier1, Jehane Fadlallah1, Michael Darmont1, Elie Azoulay1
1Hôpital Saint Louis, APHP, Paris, France; 2Hôpital Lariboisière, APHP, Paris, France
Correspondence: Eric Mariotte (eric.mariotte@aphp.fr)
P-164 Study of tolerance and complications of therapeutic plasma exchanges at Rennes University Hospital between 2011 and 2017, the COMPLASMA study
Valentin Coirier1, Mathieu Lesouhaitier1, Florian Reizine1, Adel Maamar1, Arnaud Gacouin1, Yves Le Tulzo1, Jean-Marc Tadié1, Christophe Camus1
Rennes University Hospital, Rennes, France
Correspondence: Valentin Coirier (valentin.coirier@gmail.com)
P-165 Arrhythmia-induced cardiogenic shock on VA-ECMO: reduction or atrio-ventricular node ablation allow recovery
Guillaume Hekimian, Nicolas Paulo, Nicolas Brechot, Estelle Gandjbakhch, Xavier Waintraub, Matthieu Schmidt, Ania Nieszkowska, Paul Masi, Guillaume Franchineau, Simon Boursier, Loïc Le Guennec, Guillaume Lebreton, Alain Combes, Charles-Edouard Luyt
Hôpital Pitié-Salpêtrière, Paris, France
Correspondence: Guillaume Hekimian (guillaume.hekimian@aphp.fr)
Overall population, n = 35 | Non survivors, n = 11 | Survivors, n = 24 | p | |
---|---|---|---|---|
Age–year | 48 [39–60] | 59
[41–65] | 27 [39–53] | 0.21 |
Known non ischemic cardiomyopathy | 14 (40) | 9 (81.8) | 5 (20.8) | 0.002 |
Known paroxystic atrial fibrillation | 10 (28.6) | 6 (54.5) | 4 (16.7) | 0.04 |
Type of supraventricular arrythmia—no. (%) | ||||
Atrial fibrillation | 27 (77.1) | 8 (72.7) | 19 (79.2) | 0.69 |
Atrial flutter | 3 (8.6) | 2 (18.2) | 1 (4.2) | 0.23 |
Atrial tachycardia | 2 (5.7) | 0 | 2 (8.3) | 0.99 |
Junctional tachycardia | 3 (8.6) | 1 (9.1) | 2 (3) | 0.99 |
Successful sustained reduction after amiodarone load and/or electric shock | 12 (34.3) | 1 (9.1) | 11 (45.8) | 0.003 |
SOFA score | 10 [7–13] | 12 [8–14] | 10 [7–12] | 0.29 |
Mechanical ventilation—no. (%) | 30 (85.7) | 10 (90.9) | 20 (83.3) | 0.99 |
Renal replacement therapy—no. (%) | 15 (42.9) | 9 (81.8) | 6 (25) | 0.003 |
Inotrope Score | 29 [11–80] | 67 [11–173] | 20 [12–63] | 0.29 |
Heart Rate before ECMO—beats/min | 150 [140–168] | 140 [120–150] | 158 [140–175] | 0.01 |
Lactate—mmol/L | 7.9 [4.3–11.3] | 7.2 [4.1–10.5] | 8 [4.3–11.4] | 0.61 |
NT Pro BNP—pg/mL | 8503 [3283–16,899] | 20,019 [14,250–34,534] | 4741 [2521–8503] | 0.0005 |
Left ventricular ejection fraction—% | 10 [10–15] | 10 [10–15] | 10 [10–15] | 0.83 |
ECMO duration | 11 [7–17] | 11 [5–12] | 12 [8–18] | 0.29 |
Recovery | 20 (57) | 2 (18.2) | 18 (75) | 0.003 |
Bridge to LVAD | 2 (5.7) | 0 | 2 | 0.99 |
Bridge to transplantation | 4 (11.4) | 0 | 4 | 0.28 |
P-166 Transpulmonary thermodilution detects rapid and reversible increases in lung water induced by positive end-expiratory pressure in acute respiratory distress syndrome
Francesco Gavelli, Jean-Louis Teboul, Xavier Monnet
Service de médecine intensive-réanimation, Hôpital de Bicêtre, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, F-94270 France, Le Kremlin-Bicêtre, France
Correspondence: Francesco Gavelli (Francesco.gavelli@uniupo.it)
P-167 Diagnostic and pronostic value of procalcitonin and C-Reactive-Protein in patients undergoing extracorporeal membrane oxygenation support
Vincent Liu, Natacha Rousse, Antoine Lamer, Elena Madalina Nodea, Guillaume Gantois, André Vincentelli, Emmanuel Robin, Mouhammed Moussa
Réanimation chirurgicale cardiovasculaire, Institut Coeur-Poumon, CHU Lille, Lille, France
Correspondence: Vincent Liu (vincent.liu@hotmail.fr)
P-168 Does the infusion speed impact the haemodynamic effect of a fluid bolus in septic shock patients? A pharmacodynamic study
Arthur Pavot, Francesco Gavelli, Jean-Louis Teboul, Rui Shi, Nello De Vita, Xavier Monnet
Hôpital de Bicêtre, Le Kremlin-Bicêtre, France
Correspondence: Arthur Pavot, (pavot.arthur@gmail.com)
P-169 PROtocolized Care to Reduce HYpotension after Spinal Anaesthesia (ProCRHYSA randomized trial): final results
Samuele Ceruti1, Mathieu Favre2, Silvia Bosio3, Bruno Minotti4, Marco Spagnoletti5, Michele Musiari6, Andrea Saporito7
1Hôpitaux Universitaires de Genèvetaux, Genève, Switzerland; 2Hôpitaux Universitaires de Genève, Genève, Switzerland; 3Clinica Luganese, Lugano, Switzerland; 4Kantonsspital St. Gallen, St. Gallen, Switzerland; 5Clinica Luganese, Lugano, Switzerland; 6Hôpital Fribourgeois Regional (HFR), Fribourg, Switzerland; 7Ente Ospedaliero Cantonale, Bellinzona, Switzerland
Correspondence: Samuele Ceruti (samuele.ceruti@me.com)
P-170 Does the end-expiratory occlusion test predict preload responsiveness? A systematic review and meta-analysis
Francesco Gavelli, Rui Shi, Jean-Louis Teboul, Xavier Monnet
Hôpital de Bicêtre, Le Kremlin-Bicêtre, France
Correspondence: Francesco Gavelli (francesco.gavelli@uniupo.it)
P-171 Acute kidney injury and risk of pulmonary embolism in patients with septic shock
Rania Ammar Zayani, Karama Bouchaala, Hela Kallal, Chokri Ben Hamida, Mounir Bouaziz
Habib bourguiba university hospital, Sfax, Tunisia
Correspondence: Rania Ammar Zayani (rania.ammarzayani@gmail.com)
P-172 Extravascular lung water levels and kinetics are associated with mortality: a systematic review and meta-analysis
Francesco Gavelli, Rui Shi, Jean-Louis Teboul, Xavier Monnet
Service de médecine intensive-réanimation, Hôpital de Bicêtre, Hôpitaux Universitaires Paris-Sud, Le Kremlin-Bicêtre, F-94270 France, Le Kremlin-Bicetre, France
Correspondence: Francesco Gavelli (Francesco.gavelli@uniupo.it)
P-173 The rheumatic mitral stenosis in intensive care: epidemiology, clinical and feature management
Fahd Moussaid, Abir Abardazzou, Hamza Elhamzaoui, Taoufik Abouelhassan
Emrgency departement, University Hospital, Marrakech, MOROCCO
Correspondence: Fahd Moussaid (fahdmoussaid5@gmail.com)
P-174 Prognostic value of C-reactive protein and quick SOFA in patients with sepsis at the Emergency Department
Hadil Mhadhbi, Khedija Zaouche, Abderrahim Achouri, Hamida Maghraoui, Kamel Majed
Emergency Department la Rabta, Tunis, Tunisia
Correspondence: Hadil Mhadhbi (hadil.mhadhbi@gmail.com)
P-175 Usefulness of the C reactive protein in prognosis assessment of patients with sepsis and septic shock at Emergency Department
Nadia Zaouak, Yosra Yahya, Khedija Zaouche, Radhia Boubaker, Abdelwahab Mghirbi, Hamida Maghraoui, Kamel Majed
Emergency Department of La Rabta Teaching Hospital, Tunis, Tunisia
Correspondence: Nadia Zaouak (zaouak.nadia@yahoo.fr)
P-176 Procalcitonin (PCT) kinetics in septic burn patients
Sarra Dhraief1, Sajida Sboui2, Karim Mechri1, Amel Mokline2, Lamia Thabet1, Hana Fredj2, Lilya Debbiche2, Wael Chemli2, Bahija Gasri2, Amenallah Messaadi2
1Departement of Clinical Biology, Burn and Trauma Center–Tunis, Tunisia, Ben Arous, Tunisia; 2Intensive Burn Care Departement, Burn and Trauma Center-Tunis, Tunisia, Ben Arous, Tunisia
Correspondence: Sarra Dhraief (dhraiefsarra@gmail.com)
P-177 Epidemiological profile and antibiotic susceptibility of blood culture isolates from burn patients in Tunisia
Mehdi Gaddas1, Sarra Dhraief1, Emna Hammami1, Amel Mokline2, Amenallah Messaadi2, Lamia Thabet1
1Centre de Traumatologie et des Grands Brûlés de Ben Arous-Laboratoire de biologie médicale et banque du sang, Ben Arous, Tunisia; 2Centre de Traumatologie et des Grands Brûlés de Ben Arous-Service de réanimation des brûlés, Ben Arous, Tunisia
Correspondence: Mehdi Gaddas (gaddasmehdi@icloud.com)
P-178 Epidemiological profile and antibiotic susceptibility of blood culture isolates in an intensive care unit in Tunisia
Karim Mechri, Sarra Dhraief, Mehdi Gaddas, Emna Hammami, Sonia Ben Behi, Lamia Thabet
Centre de Traumatologie et des Grands Brûlés de Ben Arous-Laboratoire de biologie médicale et banque du sang, Ben Arous, Tunisia
Correspondence: Karim Mechri (karimmechri91@gmail.com)
P-179 Community infection at Staphylococcus aureus with Panton Valentine Leucocidin in new caledonia polyvalent ICU : a descriptive study
Florent Vincent, Benoit Marot, Pauline Genieys
CHT Gaston Bourret, Noumea, France
Correspondence: Florent Vincent (vincent.florent.bis@gmail.com)
P-180 Evaluation of intubating conditions using stylet by conventional through-tube technique and through Murphy’s eye in patients with high Mallampati scores
Haider Abbas
King George’s Medical University, Lucknow, India
Correspondence: Haider Abbas (haiderup@gmail.com)
P-181 Ultrasound sliding lung in confirming absence of selective endotracheal intubation: An ancillary study from the prospective multicenter trial EPIC
Vanessa Jean-Michel1, Gwenael Prat2, Pierre Bailly2, James Benis3, Montaine Lefevre4, Pierre-Yves Egreteau4, Christophe Giacardi5, Cécile Aubron2, Erwan L’Her2
1CH de Tourcoing, Tourcoing, France; 2CHRU de la Cavale Blanche, Brest, France; 3CH de Quimper, Quimper, France; 4CH de Morlaix, Morlaix, France; 5HIA Clermont Tonnerre, Brest, France
Correspondence: Vanessa Jean-Michel (vanessa.jeanmichel@gmail.com)
P-182 Submandibular sonography in predicting difficult airway in anesthesia
Wejden Yacoubi, Faten Haddad, Asma Ben Souissi, Skander Naimi, Sahar Abdallah, M’hamed Sami Mebazaa
Mongi Slim teaching hospital, Tunis, Tunisia
Correspondence: Wejden Yacoubi (wejden.8988@yahoo.com)
P-183 Transcutaneous PCO2 monitoring during intubation in critically ill patients : descriptive study and assessment of the link between PCO2 variations and postintubation hypotension
Aurélien Frérou, Adel Maamar, Sonia Rafi, Claire Lhommet, Pierre Phelouzat, Emmanuel Pontis, Florian Reizine, Mathieu Lesouhaitier, Christophe Camus, Yves Le Tulzo, Jean-Marc Tadié, Arnaud Gacouin
CHU Rennes, Rennes, France
Correspondence: Aurélien Frérou (aurelien.frerou@chu-rennes.fr)
P-184 National survey of intubation practice in French intensive care units
Maelle Martin, Paul Decamps, Jean Reignier, Jean-Baptiste Lascarrou
Medecine Intensive Reanimation, CHU Nantes, Nantes, France
Correspondence: Maelle Martin (maelle.martin@chu-nantes.fr)
P-185 Impact of videolaryngoscopy expertise on intubation first attempt success in critically ills
Matthieu Amalric1, Romaric Larcher1, Vincent Brunot1, Fanny Garnier1, Audrey De Jong2, Laura Platon1, Noémie Besnard1, Delphine Daubin1, Valérie Moulaire Rigollet1, Philippe Corne1, Kada Klouche1, Boris Jung1
1Medical Intensive Care Unit, Montpellier University and Montpellier University Health Care Center, Montpellier, France; 2Saint Eloi Department of Anesthesiology and Critical Care Medicine, Montpellier University and Montpellier University Health Care Center, Montpellier, France
Correspondence: Matthieu Amalric (amalric.matthieu@gmail.com)
P-186 Impact of tracheostomy timing on prognosis in intensive care unit
Hatem Ghadhoune1, Jihene Guissouma1, Sourour Belhaj Youssef 2
1Hospital of Bizerte, University Elmanar Tunis, Faculty of Medicine Tunis, Bizerte, Tunisia; 2Faculty of medecine Monastir, Monastir, Tunisia
Correspondence: Hatem Ghadhoune (ghadhoune@yahoo.fr)
P-187 Tracheotomy in intensive care
Sabah Benhamza, Mohamed Lazraq, Youssef Miloudi, Abdelhak Bensaid, Najib El Harrar
Réanimation de l’Hôpital du 20 Août, Casablanca, Morocco
Correspondence: Sabah Benhamza (benhamzasabah5@gmail.com)
P-188 High flow nasal cannula oxygenation (HFNCO) effects assessed by electric impedance tomography: a physiologic observation in healthy subjects
Charlotte Porte, Geoffroy Hariri, Jean-Rémi Lavillegrand, Naike Bige, Jean-Luc Baudel, Hafid Ait-Oufella, Eric Maury
Hôpital Saint-Antoine, Paris, France
Correspondence: Charlotte Porte (charlotte.porte@hotmail.fr)
0L/min | 35L/min | 70L/min | |
---|---|---|---|
Supine | 100 | ||
Open mouth | + 1.2 | − 0.6 | |
Closed mouth | + 12.5* | + 18 * | |
Semi recumbent | +7 | ||
Open mouth | + 2.1 | − 3.8 | |
Closed mouth | + 9.3* | + 25*$ |
P-189 Nasal high flow oxygen can be used in hypercapnic respiratory failure due to COPD exacerbation without increase in PaCO2
Lise Piquilloud1, Francois Beloncle2, Pierre-Yves Olivier2, Alain Mercat2
1Adult Intensive Care and Burn Unit, University Hospital and University of Lausanne, Lausanne, Switzerland; 2Medical Intensive Care Department, University Hospital of Angers, Angers, France
Correspondence: Lise Piquilloud (lise.piquilloud@chuv.ch)
P-190 Atypical micro-organisms in acute exacerbation of chronic obstructive pulmonary disease: incidence and outcomes
Gharbi Rim, Sioud Imen, Oussama Jaoued, Sik Ali Habiba, Kheder Mohamed, Ben Haj Khalifa Anis, Fekih Hassen Mohamed, Elatrous Souheil
1Hôpital Taher Sfar, Mahdia, Tunisia
Correspondence: Gharbi Rim (rimgharbi2008@gmail.com)
P-191 Non-invasive ventilation use at Emergency Department during acute exacerbations of chronic obstructive pulmonary disease: Clinical outcomes and predictors of failure
Hadil Mhadhbi, Yosra Yahya, Khedija Zaouche, Abdelwahab Mghirbi, Kamel Majed
Emergency Department la Rabta, Tunis, Tunisia
Correspondence: Hadil Mhadhbi (hadil.mhadhbi@gmail.com)
P-192 Predictive factors of non-invasive ventilation failure in elderly patients with acute respiratory failure at Emergency Department
Yosra Yahya, Abdelwahab Mghirbi, Khedija Zaouche, Ramla Baccouche, Hadil Mhadhbi, Nadia Zaouak, Hamida Maghraoui, Kamel Majed
Emergency Department of La Rabta teaching Hospital, Tunis, Tunisia
Correspondence: Yosra Yahya (yosrayahia@gmail.com)
P-193 ECCO2R as salvage therapy in acute severe asthma: insights from the great Paris area register
Jean-Loup Augy1, Nadia Aissaoui1, Yves Cohen2, Muriel Fartoukh3, Nicholas Heming4, Eric Maury5, Johanna Oziel2, Guillaume Voiriot6, Jean-Luc Diehl1
1AP-HP, Hôpital Européen Georges Pompidou, Service de Médecine Intensive Réanimation, Paris, France; 2AP-HP, Hôpital Avicenne, Service de Réanimation Polyvalente, Bobigny, France; 3AP-HP, Hôpital Tenon, Service de Réanimation Polyvalente, Paris, France; 4AP-HP, Hôpital Raymond Poincaré, Service de Réanimation Polyvalente, Garches, France; 5AP-HP, Hôpital Saint-Antoine, Service de Médecine Intensive Réanimation, Paris, France; 6AP-HP, Hôpital Tenon, Service de Réanimation Polyvalente, Paris, France
Correspondence: Jean-Loup Augy (augyjeanloup@hotmail.com)
Before ECCO2R | One day after ECCO2R initiation | p | |
---|---|---|---|
pH PaCO2 (mmHg) PaO2 (mmHg) | 7.26 (IC: 7.20–7.27) 68.5 (IC: 63–71.5) 73 (IC: 68–94) | 7.4 (IC: 7.37–7.41) 47.5 (IC: 45–59) 82 (IC: 58.5–102) | 0.009 0.30 1 |
P-194 Acute exacerbations of chronic obstructive pulmonary disease requiring invasive ventilation: factors predicting mortality
Jihene Guissouma, Hatem Ghadhoune, Habib Brahmi, Sourour Belhaj Youssef, Meriem Ksouri, Hana Benali, Yesmine Garbaa
Hôpital Bougatfa, Bizerte, Tunisia
Correspondence: Jihene Guissouma (bahri.jihene@yahoo.fr)
P-195 Infections due to hypermucoviscous Klebsiella pneumoniae in intensive care : clinical présentation in New Calédonia, 2017–2019
Pierre Tailpied1, Julien Colot2, Mathieu Série2
1CHT, Noumea, France; 2Institut Pasteur de Nouvelle Calédonie, Nouméa, France
Correspondence: Pierre Tailpied (pierre.tailpied@gmail.com)
P-196 Infectious complications following snakebite by bothrops lanceolatus in martinique: a retrospective case series
Dabor Resiere1, Hossein Mehdaoui1, André Cabie2, Remi Neviere1, Bruno Mégarbane3, Hatem Kallel4
1Department of Critical Care, University Hospital of Martinique, Fort-de-France, France; 2Department of Infectious Diseases, University Hospital of Martinique, INSERM CIC 1424, Antilles University EA4537, F-97200, Fort-de-France, France; 3Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Paris-Diderot University, INSERM UMRS1144, Paris, France; 4Intensive Care Unit, Cayenne General Hospital, Cayenne, 97300 French Guiana, France, Cayenne, GUYANA
Correspondence: Dabor Resiere (dabor.resiere@chu-martinique.fr)
P-197 Hemophagocytic lymphohistiocytosis secondary to sepsis: a monocentric retrospective study in medical intensive care unit; evolution comparison with a control cohort of sepsis
Diane Ducloux, Maximilien Grall, Steven Grange, Fabienne Tamion
CHU Rouen, Rouen, France
Correspondence: Diane Ducloux (diane.ducloux@gmail.com)
P-198 Serum and peritoneal exudate concentrations after high doses of ß-lactams in critically ill patients with severe intra-abdominal infections: an observational prospective study
Lisa Leon, Philippe Guerci, Elise Pape, Nathalie Thilly, Amandine Luc, Adeline Germain, Anne-Lise Butin-Druoton, Marie-Reine Losser, Julien Birckener, Julien Scala Bertola, Emmanuel Novy
CHRU Nancy, Vandoeuvre Les Nancy, France
Correspondence: Lisa Leon (lisaleon1307@gmail.com)
P-199 Epidemiology and prognosis of intensive care unit acquired bacteremia in French Guiana
Hatem Kallel1, Roy Michaela1, Claire Mayence1, Cyrille Mathien1, Stephanie Houcke1, Dabor Resiere2, Hommel Didier1
CH Cayenne, Cayenne, France; 2CHU martinique, Fort De France, France
Correspondence: Hatem Kallel (hatem.kallel@ch-cayenne.fr)
P-200 Assessing and applying individualized treatment for group A streptococcal necrotizing soft-tissue infection is possible
Tomas Urbina1, Camille Hua2, Romain Bosc3, Françoise Tomberli4, Raphael Lepeule5, Jean-Winoc Decousser6, Armand Mekontso Dessap1, Olivier Chosidow2, Nicolas De Prost1
1Service de réanimation médicale, Hôpital Henri Mondor, APHP, Paris, France; 2Service de Dermatologie, Hôpital Henri Mondor, APHP, Paris, France; 3Service de chirurgie plastique, Hôpital Henri Mondor, APHP, Paris, France; 4Service de réanimation chirurgicale, Hôpital Henri Mondor, APHP, Paris, France; 5Unité transverale de traitement des infections, Labratoire de bactériologie-virologie, Hôpital Henri Mondor, APHP, Paris, France; 6Labratoire de bactériologie-virologie, Hôpital Henri Mondor, APHP, Paris, France
Correspondence: Tomas Urbina (tomasurbina75@hotmail.com)
Available data | Overall (n = 224) | Gas (n = 60) | Others (n = 164) | p (univariate)a | Adjusted ORb | p (multivariate)b | |
---|---|---|---|---|---|---|---|
Demographical data | |||||||
Age, years, median (IQR) | 224 | 64.00 [53.00–74.25] | 60.00
[50.00–72.00] | 65.00 [55.50–75.00] | 0.083 | ||
Male gender, n (%) | 224 | 127 (56.7) | 31 (51.7) | 96 (58.5) | 0.443 | ||
Comorbidities, n (%) | |||||||
Diabetes mellitus | 224 | 83 (37.1) | 18 (30.0) | 65 (39.6) | 0.244 | ||
Immunodeficiency | 224 | 58 (25.9) | 6 (10.0) | 52 (31.7) | 0.002 | 0.29 [0.10–0.74] | < 0.015 |
HIVc infection | 224 | 2 (0.9) | 0 (0.0) | 2 (1.2) | 0.954 | ||
Cancer | 224 | 21 (9.4) | 0 (0.0) | 21 (12.8) | 0.008 | ||
Corticosteroids | 224 | 36 (16.1) | 6 (10.0) | 30 (18.3) | 0.197 | ||
Obliterating arteritis of the lower limbs | 224 | 24 (10.7) | 5 (8.3) | 19 (11.6) | 0.651 | ||
Liver cirrhosis | 224 | 9 (4.0) | 0 (0.0) | 9 (5.5) | 0.142 | ||
Chronic kidney disease | 224 | 25 (11.2) | 4 (6.7) | 21 (12.8) | 0.293 | ||
Chronic alcohol consumption | 224 | 27 (12.1) | 5 (8.3) | 22 (13.4) | 0.422 | ||
Obesity | 224 | 57 (25.4) | 13 (21.7) | 44 (26.8) | 0.54 | ||
Prior to admission | |||||||
Time from first symptom, days, median (IQR) | 224 | 5.00 [2.00–9.75] | 5.00 [2.00–7.25] | 5.00 [2.00–10.00] | 0.599 | ||
Antibiotic treatment, n (%) | 221 | 137 (61.2) | 30 (50.8) | 107 (66.0) | 0.057 | ||
NSAIDd use, n (%) | 222 | 46 (20.5) | 19 (31.7) | 27 (16.7) | 0.024 | – | 0.122 |
Presentation upon admission | |||||||
Nosocomial infection, n (%) | 222 | 45 (20.1) | 4 (6.7) | 41 (25.3) | 0.004 | – | 0.197 |
Abdominoperineal infection, n (%) | 223 | 38 (17.0) | 1 (1.7) | 37 (22.7) | < 0.001 | 0.06 [0.00–0.30] | 0.007 |
Shock, n (%) | 220 | 91 (40.6) | 21 (35.6) | 70 (43.5) | 0.369 | ||
Creatininemia, µmol/L, median [IQR] | 210 | 112.50 [69.00–171.25] | 123.00 [71.25–187.25] | 109.50 [67.25–167.75] | 0.571 | ||
Uremia, mmol/L, median [IQR] | 207 | 78.00 [40.50–109.00] | 10.25 [5.45–18.02] | 9.80 [5.20–19.10] | 0.966 | ||
Plasma bicarbonate, mmol/L, median [IQR] | 193 | 57.00 [34.00–86.00] | 22.70 [20.10–26.00] | 23.00 [19.50–27.05] | 0.943 | ||
Blood leucocytes 103/mm3, median [IQR] | 219 | 14 .4 [9.5, 21.6] | 17.2 [12.4, 22.5] | 13.6 [9–21] | 0.016 | – | 0.067 |
Platelets 103/mm3, median [IQR] | 189 | 217 [153–329] | 224 [181–313] | 207 [144–344] | 0.45 | ||
Hemoglobinemia, g/dL, median [IQR] | 215 | 30.00 [12.00–62.00] | 11.05 [10.15–12.50] | 10.60 [9.35–12.10] | 0.171 | ||
Arterial lactates-mmol/L-median [IQR] | 146 | 20.50 [9.00–34.75] | 2.10 [1.50–3.60] | 2.00 [1.20–3.40] | 0.677 |
P-201 Dosage of cefotaxim in patients with sickle cell patients and acute chest syndrome receiving continuous infusion versus intermittent bolus administration
Keyvan Razazi1, Enora Berti1, Jerome Cecchini2, Guillaume Carteaux1, Nicolas De Prost1, Anoosha Habibi3, Anne Hulin4, Armand Mekontso Dessap1
1Service de réanimation médicale, Hôpital Henri Mondor, Créteil, France; 2Service de réanimation, centre hospitalier intercommunal de Créteil, Créteil, France; 3Unité des Maladies Génétiques du Globule Rouge, Hôpital Henri Mondor, Créteil, France; 4Laboratoire de Pharmacologie-Toxicologie, Hôpital Henri Mondor, Créteil, France
Correspondence: Keyvan Razazi (keyvan.razazi@aphp.fr)
P-202 The outcome of TBI patients with acute diabetes insipidus in the ICU
Mariem Dlela, Olfa Turki, Rezk Gorbel, Najeh Baccouche, Mounir Bouaziz
Habib Bourguiba Hospital, Sfax, Tunisia
Correspondence: Mariem Dlela (mariem241090@gmail.com)
P-203 Acute glucocorticoid deficiency following traumatic brain injury
Mariem Dlela, Rania Ammar Zayani, Abir Bouattour, Najeh Baccouche, Mounir Bouaziz
Habib bourguiba hospital, Sfax, Tunisia
Correspondence: Mariem Dlela (mariem241090@gmail.com)
P-204 Thyrotropic dysfunction following traumatic brain injury
Mariem Dlela, Rezk Gorbel, Olfa Turki, Najeh Baccouche, Mounir Bouaziz
Habib Bourguiba Hospital, Sfax, Tunisia
Correspondence: Mariem Dlela (mariem241090@gmail.com)
P-205 Transcranial Doppler (DTC) predictive of complication after a serious cranial trauma (TCG)
Souhila Sadat, Dalila Zeghdoud, Dalila Bougdal, Kamel Guenane
EHS salim zemirli, Alger, Algeria
Correspondence: Souhila Sadat (sadatsouhila@hotmail.fr)
P-206 Prevalence, characteristics, risk factors, and short-term consequences of hyponatremia in intensive care unit patients with post-traumatic brain injury
Olfa Turki, Amal Triki, Najeh Baccouche, Karama Bouchaala, Yousfi Mounir, Mabrouk Bahloul, Mounir Bouaziz
Habib Bourguiba University Hospital, Sfax, Tunisia
Correspondence: Olfa Turki (olfa.turki.rea@gmail.com)
P-207 Post traumatic epilepsy: about 32 cases
Kamilia Chtara, Hasna Bouchiira, Wiem Ben Amor, Rania Ammar Zayani, Sabrine Bradai, Mabrouk Bahloul, Mounir Bouaziz
University of Sfax, Sfax, Tunisia
Correspondence: Kamilia Chtara (kamilia.chtaraelaoud@gmail.com)
P-208 Hydroelectrolytic disorders in brain injury -Intensive care Unit A1-
Ihssan Mehrez, Abdelkrim Shimi, Ali Derkaoui, Mohammed Khatouf
CHU HASSAN II FES-intensive care A1, Fes, Morocco
Correspondence: Ihssan Mehrez (mehrez.ihssan@gmail.com)
P-209 Decompressive craniectomy in traumatic brain injury: about 147 cases
Karama Bouchaala, Rania Ammar Zayani, Sabrine Bradai, Kamilia Chtara, Chokri Ben Hamida, Mounir Bouaziz
Faculty of Medecine,University of Sfax, Sfax, Tunisia
Correspondence: Karama Bouchaala (karamamnif@gmail.com)
P-210 Gastrointestinal bleeding in immunocompromised patients in the ICU
Jennifer Catano, Virginie Lemiale, Eric Mariotte, Sandrine Valade, Michaël Darmon, Elie Azoulay, Lara Zafrani
Hôpital Saint Louis, Paris, France
Correspondence: Jennifer Catano (jcatano@hotmail.fr)
P-211 Risk factors for delayed defecation and impact on outcome in critically ill patients: a multicenter prospective non-interventional study
Benoît Painvin1,*, Arnaud Gacouin2, Antoine Roquilly3, Claire Dahyot-Fizelier4, Sigsimond Lasocki5, Chloe Rousseau6, Denis Frasca7, Philippe Seguin8
1Anesthésie-Réanimation/CHU RENNES, Rennes, France; 2Réanimation Médicale/CHU RENNES, Rennes, France; 3Réanimation Chirurgicale/CHU NANTES, Nantes, France; 4Réanimation chirurgicale/CHU POITIERS, Poitiers, France; 5Anesthésie-Réanimation/CHU ANGERS, Angers, France; 6Centre investigation clinique/CHU RENNES, Rennes, France; 7Anesthésie-Réanimation/CHU POITIERS, Poitiers, France; 8Réanimation chirurgicale/CHU RENNES, Rennes, France
Correspondence: Benoît Painvin (painvinbe@gmail.com)
P-212 Bacterial ecology of intra-abdominal sepsis
Khalid Khaleq, Asmaa Ouchane, Aziz Bouhouri, Khalid Zerouali
Faculté de médecine et de pharmacie / CHU Ibnou Rochd, Casablanca, Morocco
Correspondence: Khalid Khaleq (khaleq20@gmx.fr)
P-213 Nutritional management in medical intensive care unit: a Tunisian national survey
Samia Ayed1, Amira Jamoussi1, Rania Ammar Zayani2, Mounir Bouaziz2, Amel Mokline3, Amenallah Messaadi3, Dhouha Lakhdhar1, Oussema Jaoued4, Souheil Elatrous4, Hela Maamouri5, Nozha Brahmi5, Imen Ben Saida6, Mohamed Boussarsar6, Ines Fathallah7, Nedia Kouraichi7, Jihene Guissouma8, Hatem Ghadhoune8, Dorra Sakis9, Foued Daly9, Salah Ben Lakhal9, Kais Ben Romdhane10, Takoua Merhabene11, Houda Mateur12, Youssef Zied Elhechmi13, Zouheir Jerbi13, Jalila Ben Khelil1, Mohamed Besbes1
1Abderrahmen Mami Hospital, Ariana, Tunisia; 2Habib Bourguiba Hospital, Sfax, Tunisia; 3Burns And Traumatology Hospital, Ben Arous, Tunisia; 4Taher Sfar Hospital, Mahdia, Tunisia; 5Department Of Intensive Care And Toxicology, Tunis, Tunisia; 6Farhat Hached Hospital, Sousse, Tunisia; 7Yassminet Regional Hospital, Ben Arous, Tunisia; 8Habib Bougatfa Regional Hospital, Bizerte, Tunisia; 9Larabta Hospital, Tunis, Tunisia; 10Carthagene Private Hospital, Tunis, Tunisia; 11Regional Hospital Of Zaghouan, Zaghouan, Tunisia; 12Regional Hospital Of Tozeur, Tozeur, Tunisia; 13Habib Thameur Hospital, Tunis, Tunisia
Correspondence: Samia Ayed (samia.ayed@yahoo.fr)
P-214 Stochastic Targeted (STAR) glycemic control: improved performances and safety for all
Vincent Uyttendaele1, Jennifer L. Knopp2, Marc Pirotte3, Philippe Morimont3, Geoffrey M. Shaw4, J. Geoffrey Chase2, Thomas Desaive1, Benoit Misset3, Bernard Lambermont3
1GIGA-In silico Medicine, University of Liège, Liège, Belgium; 2Department of Mechanical Engineering, University of Canterbury, Christchurch, New-Zealand; 3Department of Intensive Care, University Hospital of Liège, Liège, Belgium; 4Department of Intensive Care, Christchurch Hospital, Christchurch, New-Zealand
Correspondence: Vincent Uyttendaele (vincent.uyttendaele@uliege.be)
STAR | SP | |
---|---|---|
#Patients | 10 | 20 |
Total hours | 455 | 5006 |
Average measurements per day | 12 | 7 |
Median [IQR] BG (mg/dL) | 118 [109 129] | 139 [117 160] |
Median [IQR] insulin rate (U/h) | 3.0 [2.0 4.0] | 2.5 [2.0 3.0] |
Median [IQR] dextrose rate (g/h) | 7.0 [4.7 8.2] | 9.8 [8.6 11.5] |
%BG in 80–145 mg/dL | 89 | 55 |
%BG in 145–180 mg/dL | 9 | 31 |
%BG in 100–150 mg/dL | 83 | 54 |
%BG > 180 mg/dL | 2 | 13 |
%BG < 80 mg/dL | 0.5 | 1 |
%BG < 72 mg/dL | 0.5 | 0.5 |
%BG < 40 mg/dL | 0 | 0 |
P-215 Gastrectomy in intensive care: prognostic factors
Adnane Janati, Amine Raja, Aziz Bouhouri
CHU IBN Rochd, Casablanca, Morocco
Correspondence: Adnane Janati (adnanjanati@gmail.com)
P-216 Efficacy of multiple second line agents in refractory status epilepticus in a pediatric intensive care unit
Lea Savary, Claire Le Reun
CHU Tours, Tours, France
Correspondence: Lea Savary (lea.savary@hotmail.com)
P-217 Management of drowning in pediatric intensive care
Samira Kalouch, Wissal Aissaoui, Khalid Yakini, Abdelaziz Chlilek
Chu Ibn Rochd Casablanca, Casablanca, Morocco
Correspondence: Samira Kalouch (dr.kalouch@gmail.com)
P-218 Epidemiology of severe pediatric trauma following winter sport accidents in the Northern French Alps
Emilien Maisonneuve1, Nadia Roumeliotis2, Pierre Bouzat1, Guillaume Mortamet1
1CHU Grenoble, Grenoble, France; 2CHU Sainte-Justine, Montréal, Canada
Correspondence: Emilien Maisonneuve (emilienmaisonneuve@orange.fr)
P-219 Severe traumatic brain injury in pediatric intensive care unit: study of management practices in French-speaking pediatric intensive care units. PTBIS Protocol-Pediatric Traumatic Brain Injury Survey
Manon Denis1, Benjamin Lauzier2, Etienne Javouhey3, David Brossier4
1Department of Pediatrics, Caen University Hospital, Caen, France; 2L’institut du thorax, INSERM, CNRS, UNIV Nantes, Nantes, France; 3Pediatric Intensive Care Unit, Lyon University Hospital, Bron, Lyon, France; 4Pediatric Intensive Care Unit, Caen University Hospital, Caen, France
Correspondence: Manon Denis (denis.manon89@gmail.com)
P-220 Ingestion of a button cell in children
Choubeila Guetteche
CHU Constantine, Constantine, Algeria
Correspondence: Choubeila Guetteche (cguetteche@gmail.com)
P-221 Anesthesia for extraction of foreign bodies from the airways in children
Yacine Benhocine
University Hospital Center Nedir Mohamed, Tizi-Ouzou, Algeria
Correspondence: Yacine Benhocine (yacine001@yahoo.fr)
P-222 Non-invasive neurally adjusted ventilatory assist (NAVA) in infants with bronchiolitis: a retrospective cohort study
Alex Lepage-Farrell, Sally Al Omar, Atsushi Kawaguchi, Sandrine Essouri, Philippe Jouvet, Guillaume Emeriaud
CHU Sainte Justine, Université de Montréal, Montréal, Canada
Correspondence: Alex Lepage-Farrell (alex.lepage-farrell@umontreal.ca)
Variables | n | 2 h before NIV-NAVA | 2 h after NIV-NAVA | P |
---|---|---|---|---|
mWCAS | ||||
All patients | 47 | 3.0 (2.75–3.5) | 2.5 (2.0–3.0) | < 0.001 |
When baseline Edi < 20 | 20 | 3.0 (2.5–3.25) | 2.5 (2.0–2.5) | < 0.01 |
When baseline Edi > 20 | 21 | 3.5 (2.5–3.6) | 2.5 (2.0–3.0) | < 0.01 |
Inspiratory Edi, μV | ||||
All patients | 57 | 21.4 (9.9–45.9) | 20.1 (16.6–32.3) | < 0.05 |
When baseline Edi < 20 | 27 | 9.8 (5.1–14.8) | 11.6 (6.8–19.2) | 0.18 |
When baseline Edi > 20 | 30 | 43.7 (32.1–54.6) | 29.1 (19.8–36.8) | < 0.01 |
Vital signs | ||||
Heart rate | 62 | 149 (141–160) | 144 (133–157) | < 0.001 |
Respiratory rate | 62 | 43 (35–48) | 41 (33–46) | 0.05 |
Oxygenation | ||||
FiO2, % | 59 | 35 (25–40) | 30 (28–45) | 0.22 |
SpO2, % | 62 | 98 (96–100) | 98 (97–99) | 0.15 |
SpO2/FiO2 index | 59 | 2.8 (2.0–3.8) | 3.2 (2.2–3.5) | 0.06 |
Capillary blood gas | ||||
pH | 24 | 7.27 (7.24–7.30) | 7.32 (7.29–7.34) | < 0.001 |
CO2 | 24 | 63 (53–69) | 57 (47–64) | 0.002 |
HCO3 | 24 | 28 (24–31) | 28 (26–30) | 0.59 |
FLACC Score | 18 | 1.5 (0.0–3.0) | 0 (0.0–2.0) | 0.61 |
P-223 State of transfusion practices at the pediatric intensive care unit Canastel, Oran, Algeria
Amel Zerhouni1, Wahiba Djebbari2, Lahcen Senhadji1, Nabil Tabet-Aoul3, Nabil Aouffen3, Amine Benhamed1
1CHUO, Oran, Algeria; 2Faculté de médecine Sidi Bel Abbes, Sidi Bel Abbes, Algeria; 3Ehs CANASTEL, Oran, Algeria
Correspondence: Amel Zerhouni (azerhouni2000@yahoo.fr)
P-224 Antibiotic resistance of nosocomial infections in an intensive care unit
Sabah Benhamza, Mohamed Lazraq, Youssef Miloudi, Abdelhak Bensaid, Najib El Harrar
Réanimation de l’hôpital 20 Août, CHU Ibn Rochd, Casablanca, Morocco
Correspondence: Sabah Benhamza (benhamzasabah5@gmail.com)
P-225 Impact of the Accelerate Pheno™ system for rapid antimicrobial susceptibility testing in intensive-care patients with Gram-negative bloodstream infections
Nabil Gastli1, Guillaume Savary2, Paul Jaubert3, Déborah Hirt4, Claire Poyart1, Jean-Paul Mira3, Helene Poupet1, Solen Kerneis5
1Service de Bactériologie, APHP.CUP, Site Cochin, Paris, France; 2Intensive, Paris, France; 3Medical Intensive Care Unit, Cochin Hospital, APHP.Centre–Université de Paris, Paris, France; 4Service de Pharmacologie, APHP.CUP, Site Cochin, Paris, France; 5Equipe Mobile d’Infectiologie, APHP.CUP, Site Cochin, Paris, France
Correspondence: Nabil Gastli (nabil.gastli@aphp.fr)
P-226 Use of Accelerate PhenoTest Blood Culture Kit for rapid microbiological documentation (90 min) and antibiotic susceptibility testing (+5 h) of positive blood cultures in the ICU and hematology units : an observational study
Jean-Luc Baudel1, Jacques Tankovic1, Redouane Dahoumane1, Jean-Remy Lavillegrand2, Razach Abdallah2, Geoffroy Hariri2, Naike Bige2, Hafid Ait-Oufella2, Nicolas Veziris1, Eric Maury2, Bertrand Guidet2
1Service Bactériologie, Hôpital Saint-Antoine, Paris, France; 2Service Réanimation Médicale, Hôpital Saint-Antoine, Paris, France
Correspondence: Jean-Luc Baudel (jean-luc.baudel@aphp.fr)
P-227 Bacterial lung microbiota under mechanical ventilation a pilot study
Mélanie Fromentin, Antoine Bridier-Nahmias, Constance Vuillard, Jean-Damien Ricard, Damien Roux
INSERM UMR 1137 IAME Infection Antimicrobials Modelling Evolution, Paris, France
Correspondence: Mélanie Fromentin (mel.fromentin@wanadoo.fr)
P-228 Lung bacterial microbiome and virome in intensive care a pilot study
Mélanie Fromentin1, Jean-Damien Ricard1, Julien Do Vale1, Antoine Bridier-Nahmias1, Severine Mercier2, Noemie Ranger3, Antonio Alberdi4, Damien Roux1
1Inserm UMR 1137 Iame “Infection Antimicrobials Modelling Evolution” University of Paris, Paris, France; 2”INSERM U 976 HIPI “Human Immunology, Paris, France; 3Inserm UMR 976 HIPI “Human Immunology, Pathophysiology & Immunotherapy” University of Paris, Paris, France; 4Plateforme technologique Institut de Recherche Saint Louis, Université de Paris, Paris, France
Correspondence: Mélanie Fromentin (mel.fromentin@wanadoo.fr)
P-229 Current state of colistin resistance in a burn intensive care unit in Tunisia
Sonia Ben Behi1, Sarra Dhraief1, Amel Mokline2, Lilya Debbiche2, Amenallah Messaadi2, Lamia Thabet1
1Centre de Traumatologie et des Grands Brûlés de Ben Arous-Laboratoire de biologie médicale et banque du sang, Ben Arous, Tunisia; 2Centre de Traumatologie et des Grands Brûlés de Ben Arous-Service de réanimation des brûlés, Ben Arous, Tunisia
Correspondence: Sonia Ben Behi (benbehi.sonya@gmail.com)
P-230 Mediastinitis complicating cervico-facial cellulitis
Mohamed Lazraq, Sabah Benhamza, Youssef Miloudi, Abdelhak Bensaid, Najib Elharrar
Réanimation Hôpital 20 Août 1953, Casablanca, Morocco
Correspondence: Mohamed Lazraq (mohamed_lz@hotmail.com)
P-231 Early- and late-onset pneumonia: myth or reality?
Sana Kharrat, Hatem Ghadhoune, Jihene Guissouma, Sadok Bougharriou, Habib Brahmi, Meriem Ksouri
Hospital of Bizerte, University Elmanar Tunis, Faculty of Medecine Tunis, Bizerte, Tunisia
Correspondence: Sana Kharrat (sanakharrat15@hotmail.com)
Disclosure of conflicts of interest
-
AARAB Yassir: Research support/Scientific studies : SuperSonic Imagine S.A. (Aix-en-Provence, France)
-
ABARDAZZOU Abir: No disclosure
-
ABBAS Haider: No conflict of interest
-
ABDALLAH Razach: No disclosure
-
ABDALLAH Sahar: No disclosure
-
ABDEJABBAR Maghfour: No disclosure
-
ABDEL-NABEY Moustafa: No conflict of interest
-
ABDELLATIF Sami: No conflict of interest
-
ABDENNEBI Cyrine: No conflict of interest
-
ABID Selma: No conflict of interest
-
ABIDI Ameni: No conflict of interest
-
ABOAB Jérôme: No conflict of interest
-
ABOUELHASSAN Taoufik: No conflict of interest
-
ABOUQAL Redouane: No conflict of interest
-
ABRAHAM Paul: No conflict of interest
-
ABROUG Fekri: No conflict of interest
-
ACHOURI Abderrahim: No conflict of interest
-
ACHREF Laajili: No disclosure
-
ADDA Melanie: No disclosure
-
ADDA Mireille: No disclosure
-
ADNANE Janati: No disclosure
-
ADNOT Pauline: No conflict of interest
-
ADRIE Christophe: No disclosure
-
AEGERTER Philippe: No conflict of interest
-
AGBAKOU Maïté: No conflict of interest
-
AGERON Francois-Xavier: No conflict of interest
-
AGUERSIF Amazigh: No conflict of interest
-
AHO Serge: No disclosure
-
AISSAOUI Nadia: Trainings, Teaching: ASTRA-ZENECA, MEDTRONIC; Invitation to national or international congresses: ASTRA-ZENECA, ABIOMED, THORATEC, MEDTRONIC
-
AISSAOUI Wissal: No conflict of interest
-
AIT-HAMOU Zakaria: No conflict of interest
-
AIT-OUFELLA Hafid: No conflict of interest
-
AKROUR Yanis: No conflict of interest
-
AL HARRAR Rachid: No disclosure
-
AL OMAR Sally: No conflict of interest
-
ALAMOWITCH Sonia: No disclosure
-
ALBERDI Antonio: No conflict of interest
-
ALBUISSON Eliane: No conflict of interest
-
ALI Deeba: No conflict of interest
-
ALLALI William: No conflict of interest
-
ALLOUACHE Christophe: No disclosure
-
ALLOUCHE Hend: No conflict of interest
-
ALVES Barbara: No conflict of interest
-
AMALRIC Matthieu: Invitation to national or international congresses: Sanofi
-
AMENGLE Albert Ludovic: No disclosure
-
AMEYE Lieveke: No conflict of interest
-
AMIEL Jean-Bernard: No conflict of interest
-
AMIOT Aurélien: No conflict of interest
-
AMMAR Wessem: No disclosure
-
AMMAR ZAYANI Rania: No conflict of interest
-
AMOURA Zahir: No disclosure
-
AMOUYAL Elsa: No conflict of interest
-
ANDRE Cécile: No disclosure
-
ANGUEL Nadia: No disclosure
-
ANIS Ben Haj Khalifa: No conflict of interest
-
ANNANE Djillali: No conflict of interest
-
ANOTA Amélie: Consultancy, Expert: Roche, Astrazeneca; Trainings, Teaching: BMS
-
ANSELMI Luciano: No conflict of interest
-
ANTONELLI Massimo: No disclosure
-
AOUFFEN Nabil: No disclosure
-
APPERT-DECLE Alexandra: No conflict of interest
-
ARAFA Meher: No conflict of interest
-
ARGAUD Laurent: No conflict of interest
-
ARMAND-LEFREVRE Laurence: Trainings, Teaching: Biomerieux-non-paid internal symposium
-
ARNAL Jean-Michel: Research support/Scientific studies: Hamilton Medical; Consultancy, Expert: Hamilton Medical, Resmed, Breas Medical
-
AROICHANE Nadine: No conflict of interest
-
ARRESTIER Romain: No conflict of interest
-
ARTRU Florent: No disclosure
-
ARTZNER Thierry: No conflict of interest
-
ASEHNOUNE Karim: No disclosure
-
ASFAR Pierre: Consultancy, Expert: Expert activity for Banque Publique d’Investissement (French government Agency)
-
ASLANIAN Pierre: No conflict of interest
-
AUBART Melodie: No conflict of interest
-
AUBRON Cécile: Invitation to national or international congresses: Pfizer
-
AUDIBERT Juliette: No conflict of interest
-
AUGUSTO Jean-François: No conflict of interest
-
AUGY Jean-Loup: No conflict of interest
-
AXUS Marina: No disclosure
-
AYARI Ahmed: No conflict of interest
-
AYED Samia: No conflict of interest
-
AZOULAY Elie: Research support/Scientific studies: Pfizer, Ablynx; Consultancy, Expert: Lectures for Baxter, Pfizer and Gilead; Invitation to national or international congresses: Gilead 2018
-
BABOI Loredana: No disclosure
-
BACCARI Amal: No conflict of interest
-
BACCOUCHE Najeh: No conflict of interest
-
BACCOUCHE Ramla: No conflict of interest
-
BACHASSON Damien: Research support/Scientific studies: Fondation EDF, Association Française Contre les Myopathies; Patent or product inventor: Institut de Myologie, Paris, France
-
BACHELLIER Philippe: No disclosure
-
BADAOUI Karim: No conflict of interest
-
BADER-MEUNIER Brigitte: Research support/Scientific studies: Novartis, Roche, Pfizer; Invitation to national or international congresses: Novartis
-
BAGATE François: Invitation to national or international congresses: Orkyn
-
BAHLOUL Mabrouk: No conflict of interest
-
BAILLEUL Clotilde: No disclosure
-
BAILLY Pierre: No conflict of interest
-
BAISSE Arthur: No conflict of interest
-
BALIK Martin: Trainings, Teaching: Fresenius Medical Care; Patent or product inventor: GML Czech Republic
-
BANYDEEN Rishika: No conflict of interest
-
BAPTISTE Amandine: No conflict of interest
-
BAPTISTE Olivier: No conflict of interest
-
BARBAR Saber Davide: No disclosure
-
BARBIER François: No disclosure
-
BARBIER Louise: Trainings, Teaching: Ethicon, Astellas; Invitation to national or international congresses: Sandoz, Astellas
-
BARNERIAS Christine: No disclosure
-
BARON Aurore: No disclosure
-
BARON Elodie: No conflict of interest
-
BARRATT-DUE Andreas: No disclosure
-
BARRAU Stephanie: No disclosure
-
BARRAUD Damien: No disclosure
-
BARRAUD Helene: No disclosure
-
BARROIS Brigitte: No conflict of interest
-
BARUCHEL André: No disclosure
-
BASTIDE Marie Anaïs: No conflict of interest
-
BAUDEL Jean-Luc: No conflict of interest
-
BAUDIN Florent: Invitation to national or international congresses: Dr Baudin has received speaking fees from Maquet Critical Care (EPNV, Montreux May 2016)
-
BAUDRY Thomas: Trainings, Teaching: Gilead, Pfizer; Invitation to national or international congresses: Pfizer
-
BAUER Philippe: No conflict of interest
-
BAYAT Sam: Research support/Scientific studies: Fisher & Paykel
-
BEAUCOURT Camille: Trainings, Teaching: Gallia 100 euros
-
BEAUFILS Fabien: Consultancy, Expert: Astra Zeneca; Invitation to national or international congresses: Astra Zeneca
-
BEDHAIFI Amir: No disclosure
-
BEDOS Jean-Pierre: Consultancy, Expert: Pfizer/Correvio; Invitation to national or international congresses: Correvio
-
BEDUNEAU Gaetan: Research support/Scientific studies: SRLF; Association Départementale d’Aide aux Insuffisants Respiratoires (76); Trainings, Teaching: Drager; Invitation to national or international congresses: MSD; Hill Rom
-
BEGANTON Frankie: No conflict of interest
-
BEGOT Erwan: No disclosure
-
BEINSE Guillaume: Research support/Scientific studies: Association pour la Recherche contre le Cancer; La Ligue contre le Cancer; LeoPharma; Invitation to national or international congresses: Pharmamar
-
BELAID Imtinene: No conflict of interest
-
BELAYACHI Jihane: No conflict of interest
-
BELE Nicolas: No conflict of interest
-
BELHAJ YOUSSEF Sourour: No conflict of interest
-
BELLIEN Jeremy: No disclosure
-
BELLUT Hugo: No conflict of interest
-
BELMEKADEM Said: No conflict of interest
-
BELONCLE Francois: No conflict of interest
-
BEN AHMED Hedia: No disclosure
-
BEN AHMED Tarek: No conflict of interest
-
BEN ALI Yosri: No conflict of interest
-
BEN AMOR Wiem: No conflict of interest
-
BEN BEHI Sonia: No conflict of interest
-
BEN HADJ SALEM Omar: No conflict of interest
-
BEN HAMIDA Chokri: No conflict of interest
-
BEN ISMAIL Khaoula: No conflict of interest
-
BEN JABALLAH Nejla: No conflict of interest
-
BEN KHELIL Jalila: No conflict of interest
-
BEN LAKHAL Salah: No conflict of interest
-
BEN LAMINE Farah: No conflict of interest
-
BEN ROMDHANE Kais: No disclosure
-
BEN SAAD Manel: No conflict of interest
-
BEN SAIDA Imen: No conflict of interest
-
BEN SALAH Adel: No disclosure
-
BEN SALAH Amina: No conflict of interest
-
BEN SOUISSI Asma: No conflict of interest
-
BEN ZARROUK Sarra: No disclosure
-
BENABOUD Sihem: No disclosure
-
BENAIS Morgan: No conflict of interest
-
BENALI Hana: No conflict of interest
-
BENARD Matthieu: No conflict of interest
-
BENBERNOU Soumia: No conflict of interest
-
BENETAZZO Lucie: No conflict of interest
-
BENGHANEM Sarah: No conflict of interest
-
BENGONO BENGONO Roddy Stephan: No conflict of interest
-
BENHAMED Amine: No disclosure
-
BENHAMZA Sabah: No conflict of interest
-
BENHOCINE Yacine: No conflict of interest
-
BENICHOU Nicolas: Research support/Scientific studies: SFNDT (société francophone de néphrologie dialyse et transplantation)—Master 2 scholarship
-
BENIS James: No conflict of interest
-
BENNETT Gavin: No disclosure
-
BENOIT Dominique: Research support/Scientific studies: Gilead, Astellas, Fisher-Paykel, Baxter, Alexion and Fresenius Kabi
-
BENSAID Abdelhak: No disclosure
-
BENSARDI Fatimazahra: No disclosure
-
BENYAMINA Mourad: No disclosure
-
BENZERARA Laurent: Patent or product inventor: aphp
-
BENZERDJEB Nazim: Research support/Scientific studies: AMARAPE, iCAP; Consultancy, Expert: ALPHASIGHTS, MSD; Trainings, Teaching: MSD
-
BEQIRI Erta: No disclosure
-
BÉRANGER Agathe: No conflict of interest
-
BERARD Emilie: No conflict of interest
-
BERDAI Adnane: No disclosure
-
BERGER Patrick: No disclosure
-
BERNAL William: No disclosure
-
BERNARDIN Gilles: No disclosure
-
BERRADA Lina: No conflict of interest
-
BERTHAUD Romain: No conflict of interest
-
BERTHET Guillaume: No conflict of interest
-
BERTI Enora: No conflict of interest
-
BERTOLI Sarah: No disclosure
-
BERTRAND Pierre-Marie No conflict of interest
-
BESBES Lamia: No disclosure
-
BESBES Mohamed: No conflict of interest
-
BESCH Camille: Invitation to national or international congresses: Abbvie, Novartis
-
BESCH Guillaume: No conflict of interest
-
BESNARD Noémie: No conflict of interest
-
BESSET Sebastien: No disclosure
-
BETTON Delphine: No conflict of interest
-
BEURET Pascal: No conflict of interest
-
BEURTON Alexandra: No conflict of interest
-
BEUVON Clément: No conflict of interest
-
BIEDERMANN Sebastien: Invitation to national or international congresses: Vifor Pharma
-
BIGE Naike: No conflict of interest
-
BIGNON Anne: No conflict of interest
-
BIGRAT Vincent: No conflict of interest
-
BIHAN Kevin: Research support/Scientific studies: Pitié-Salpêtrière hospital; Trainings, Teaching: Sorbonne University
-
BILLE Emmanuelle: No disclosure
-
BIRCKENER Julien: No conflict of interest
-
BIRONNEAU Vanessa: Trainings, Teaching: ARAIR; Invitation to national or international congresses: Alize Santé, SOS oxygène, ANTADIR
-
BISBAL Magali: No conflict of interest
-
BISTON Patrick: No disclosure
-
BITKER Laurent: No conflict of interest
-
BLANC-BRUDE Olivier: No disclosure
-
BLATEAU Alain: No disclosure
-
BLOCH-LAINE Emmanuel: No conflict of interest
-
BLUM Laurene: No disclosure
-
BOCCARA Johanna: No conflict of interest
-
BOCCI Maria grazia: Trainings, Teaching: Catholic University of Rome
-
BOCHUD Pierre-Yves: No disclosure
-
BODEMER Christine: No disclosure
-
BODENES Laetitia: No conflict of interest
-
BODET-CONTENTIN Laetitia: No conflict of interest
-
BOGGIAN Katia: No conflict of interest
-
BOIGE Valérie: Research support/Scientific studies: Merck Serono; Consultancy, Expert: Bayer, Merck Serono, Eisai, Ipsen; Trainings, Teaching: Ipsen, Amgen; Invitation to national or international congresses: Roche, Sanofi, Merck Serono, Bayer
-
BOILÈVE Alice: No conflict of interest
-
BOISSEAU Chloé: No disclosure
-
BOISSEL Nicolas: No disclosure
-
BOISSIER Florence: No conflict of interest
-
BOIVIN Alexandra: No conflict of interest
-
BONACORSI Stéphane: No conflict of interest
-
BONGIOVANNI Filippo: No conflict of interest
-
BONNARDEL Eline: No conflict of interest
-
BONNEFOY-CUDRAZ Eric: No disclosure
-
BONNET Sixtine: No conflict of interest
-
BONNEVIE Tristan: Research support/Scientific studies: Fisher & Paykel
-
BONTEN Marc: No disclosure
-
BORCOMAN Edith: No disclosure
-
BORDES Julien: No conflict of interest
-
BORDET Fabienne: No conflict of interest
-
BORDET Jeanne: No conflict of interest
-
BORGI Aïda: No conflict of interest
-
BORIES Phuong-Nhi: No conflict of interest
-
BORRHOMÉE Suzanne: No conflict of interest
-
BORTOLOTTI Perrine: No conflict of interest
-
BOSC Romain: No disclosure
-
BOSIO Silvia: No conflict of interest
-
BOST-BRU Cécile: No disclosure
-
BOTTE Astrid: No conflict of interest
-
BOUADMA Lila: Research support/Scientific studies: Thermo Fisher Scientific
-
BOUATTOUR Abir: No conflict of interest
-
BOUAZIZ Mounir: No conflict of interest
-
BOUAZZA Naïm: No conflict of interest
-
BOUBAKER Ghalia: No conflict of interest
-
BOUBAKER Radhia: No conflict of interest
-
BOUBECHE Samia: No disclosure
-
BOUCHAALA Karama: No conflict of interest
-
BOUCHIIRA Hasna: No conflict of interest
-
BOUDON Marc: Invitation to national or international congresses: EUMEDICA
-
BOUGDAL Dalila: No conflict of interest
-
BOUGHANMI Hatem: No conflict of interest
-
BOUGHARRIOU Sadok: No conflict of interest
-
BOUGOUIN Wulfran: Consultancy, Expert: Withings
-
BOUHARAOUA Sihem: No disclosure
-
BOUHEMAD Belaid: No conflict of interest
-
BOUHOURI Aziz: No disclosure
-
BOUIDIR Youssef: No conflict of interest
-
BOUKARI Madjid: No disclosure
-
BOUKOUB Naila: No conflict of interest
-
BOULAFTALI Yacine: No conflict of interest
-
BOULAIN Thierry: Invitation to national or international congresses: Pfizer
-
BOULANGER Eric: Consultancy, Expert: Roquette SA; Invitation to national or international congresses: SFGG and EUGMS
-
BOULARAN Josiane: No disclosure
-
BOUNES Vincent: No disclosure
-
BOURCIER Simon: No disclosure
-
BOURDIN Gaël: No conflict of interest
-
BOUREL Claire: No conflict of interest
-
BOURENNE Jeremy: No disclosure
-
BOURGOIN Pierre: Research support/Scientific studies: ORIONPAHARMA in 2018 and MEDTRONIC in 2017
-
BOURMAUD Aurelie: No conflict of interest
-
BOURSIER Simon: No conflict of interest
-
BOUSBIA Soulef: No conflict of interest
-
BOUSSARSAR Mohamed: No disclosure
-
BOUSTA Medhi: No disclosure
-
BOUTIN Emmanuelle: No disclosure
-
BOUTONNET Mathieu: No conflict of interest
-
BOUZAT Pierre: No conflict of interest
-
BOUZBIB Charlotte: Consultancy, Expert: Gilead; Invitation to national or international congresses: Gilead
-
BOUZIANE Mohammed: No disclosure
-
BOUZIRI Asma: No conflict of interest
-
BOYER Alexandre: Trainings, Teaching: Basilea
-
BOYER Déborah: No conflict of interest
-
BRADAI Sabrine: No conflict of interest
-
BRAHMI Habib: No conflict of interest
-
BRAHMI Nozha: No disclosure
-
BRASSART Benoit: No conflict of interest
-
BRASSIER Anais: No disclosure
-
BREBION Amélie: Invitation to national or international congresses: bioMérieux, Hologic, Janssen
-
BRECHOT Nicolas: No conflict of interest
-
BREDIN Swann: No conflict of interest
-
BRETAGNOL Anne: No disclosure
-
BREUREC Sébastien: No conflict of interest
-
BRIDIER-NAHMIAS Antoine: No conflict of interest
-
BRISARD Laurent: Research support/Scientific studies: BAXTER (Grant Research)
-
BROCHARD Laurent: No disclosure
-
BROCHON Sandie: No disclosure
-
BROSSIER David: No conflict of interest
-
BROWN Delphine: No conflict of interest
-
BRUEL Cedric: No disclosure
-
BRULE Noelle: No disclosure
-
BRUNEEL Fabrice: Invitation to national or international congresses: PFIZER, GILEAD, MSD
-
BRUNOT Vincent: Invitation to national or international congresses: Fresenius Kabi and Fresenius Medical Care
-
BUCUR Petru: No disclosure
-
BUETTI Niccolo: Research support/Scientific studies: Swiss National Science foundation research grant and bangerter rhyner foundation supporting my postdoc
-
BUI Hoang-Nam: No disclosure
-
BURELLI Gabrielle: No conflict of interest
-
BURGEL Pierre-Régis: No disclosure
-
BURGHI G: No conflict of interest
-
BUSTARRET Olivier: No conflict of interest
-
BUTIN-DRUOTON Anne-Lise: Invitation to national or international congresses: Astellas
-
CABIE André: No disclosure
-
CABRE Philippe: No conflict of interest
-
CABRIO Davy: No conflict of interest
-
CADOZ Cyril: No disclosure
-
CALANDRA Thierry: No disclosure
-
CALLOT Delphine: No conflict of interest
-
CALLY Radj: No conflict of interest
-
CALVAT Sylvie: No conflict of interest
-
CAMPFORT Maëva: No conflict of interest
-
CAMUS Christophe: No conflict of interest
-
CANET Emmanuel: Consultancy, Expert: Gilead
-
CANNET Floriane: No conflict of interest
-
CANOUI-POITRINE Florence: Research support/Scientific studies: Abbvie
-
CAPDEVILA Xavier: No conflict of interest
-
CAPELLIER Gilles: Consultancy, Expert: Baxter; Invitation to national or international congresses: Asten
-
CAPITO Carmen: No conflict of interest
-
CAPLAN Morgan: No conflict of interest
-
CAPLIN Cecile: No disclosure
-
CARFANTAN Cyril: No conflict of interest
-
CARIOU Alain: Consultancy, Expert: Bard
-
CARLES Michel: Invitation to national or international congresses: SOS Oxygène
-
CARPENTIER Dorothée: No disclosure
-
CARRIÉ Cédric: No disclosure
-
CARTEAUX Guillaume: Consultancy, Expert: Air Liquide Medical Systems; Trainings, Teaching: Air Liquide Medical Systems
-
CARVAL Thibaut: No conflict of interest
-
CASSIBBA Julie: No conflict of interest
-
CASSINA Tiziano: No conflict of interest
-
CASSIR Nadim: Invitation to national or international congresses: Pfizer, MSD, Eumedica
-
CASTANARES Diego: No conflict of interest
-
CASTELAIN Vincent: Invitation to national or international congresses: Pfizer; Astellas; Philips
-
CASTILLO Jean-Marie: No disclosure
-
CATANO Jennifer: No conflict of interest
-
CAVAILLE Guilhem: No disclosure
-
CAVAILLON Jean-Marc: No disclosure
-
CECCHINI Jerome: No conflict of interest
-
CERASUOLO Damiano: No conflict of interest
-
CERUTI Samuele: No conflict of interest
-
CHABARTIER Cyrille: Invitation to national or international congresses: FRESENIUS
-
CHABERT Paul: No conflict of interest
-
CHAFFAUT Cendrine: No conflict of interest
-
CHAILLOU Delphine: Consultancy, Expert: Novartis; Invitation to national or international congresses: Novartis
-
CHAMPION Suzanne: No disclosure
-
CHAMPY Pauline: No disclosure
-
CHANOINE Sébastien: Consultancy, Expert: AstraZeneca; Invitation to national or international congresses: Astellas, LFB, Novartis, MSD, Actelion
-
CHAPALAIN Xavier: No conflict of interest
-
CHAPEAU David: No conflict of interest
-
CHAPLAIN Agathe: No disclosure
-
CHARBIT Jonathan: No disclosure
-
CHARDOT Christophe: No conflict of interest
-
CHAREYRE Judith: No conflict of interest
-
CHARPENTIER Julien: Trainings, Teaching: MSD; Invitation to national or international congresses: PFIZER; CORREVIO
-
CHARRA Boubaker: No disclosure
-
CHARRON Cyril: No disclosure
-
CHARUE Dominique: No disclosure
-
CHARUEL Jean-luc: No disclosure
-
CHASE J. Geoffrey: Research support/Scientific studies: Tiro Medical, Medtronic Inc; Consultancy, Expert: Tiro Medical, Medtronic Inc; Stock shareholder: Tiro edical; Patent or product inventor: Tiro Medical, Medtronic Inc
-
CHATZIANTONIOU Christos: No conflict of interest
-
CHAUVELOT Louis: Invitation to national or international congresses: Laidet médical
-
CHAZOT Guillaume: No conflict of interest
-
CHELBI Rym: No conflict of interest
-
CHELLY Jonathan: Consultancy, Expert: Hamilton Medical; Invitation to national or international congresses: Hamilton medical
-
CHEMLI Wael: No conflict of interest
-
CHENOUARD Alexis: No conflict of interest
-
CHERKAB Rachid: No conflict of interest
-
CHEVRET Sylvie: No disclosure
-
CHHUN Stephanie: No conflict of interest
-
CHICHE Jean-Daniel: No disclosure
-
CHICOISNEAU Maxence: No conflict of interest
-
CHLILEK Abdelaziz: No disclosure
-
CHOCRON Richard: Consultancy, Expert: ASPEN
-
CHOMMELOUX Juliette: No conflict of interest
-
CHOMTON Maryline: No conflict of interest
-
CHOSIDOW Olivier: No disclosure
-
CHOUCHANA Laurent: No conflict of interest
-
CHOUCHENE Imed: No disclosure
-
CHOUKROUN Gérald: No conflict of interest
-
CHTARA Kamilia: No conflict of interest
-
CICCONE Camille: No conflict of interest
-
CINOTTI Raphaël: No conflict of interest
-
CLAIR Bernard: No disclosure
-
CLAUDINON Aurore: No conflict of interest
-
CLAUSSE Darless: No conflict of interest
-
CLAVIER Thomas: No disclosure
-
CLEMENT Nicolas: No conflict of interest
-
CLEUZIOU Pierre: Invitation to national or international congresses: Eisai
-
CLOUZEAU Benjamin: No conflict of interest
-
COCCINI Coralie: No disclosure
-
COGO Adrien: No disclosure
-
COHEN Johana: No disclosure
-
COHEN Laure: No conflict of interest
-
COHEN Yves: No conflict of interest
-
COIFFARD Benjamin: No conflict of interest
-
COINTAULT Olivier: No disclosure
-
COIRIER Valentin: No conflict of interest
-
COITEUX Valerie: No disclosure
-
COLARDELLE Philippe: No disclosure
-
COLIN Gwenhael: Consultancy, Expert: Combioxin
-
COLOMB Benoit: No conflict of interest
-
COLOMBANI Sarah: No conflict of interest
-
COLOMBANI Sylvie: No conflict of interest
-
COLOT Julien: No disclosure
-
COMBAUX Danièle: No conflict of interest
-
COMBES Alain: Research support/Scientific studies: GETINGE; Consultancy, Expert: GETINGE, BAXTER, XENIOS; Trainings, Teaching: GETINGE, BAXTER, XENIOS; Invitation to national or international congresses: GETINGE, BAXTER, XENIOS
-
COMBRET Yann: No conflict of interest
-
COMMEREUC Morgane: No disclosure
-
CONIA Alexandre: No disclosure
-
CONSTANTIN Jean-Michel: No disclosure
-
CONTAL Olivier: No disclosure
-
CONTOU Damien: No conflict of interest
-
CORNE Philippe: No disclosure
-
CORNET Muriel: Research support/Scientific studies: Pfizer; Consultancy, Expert: Pfizer; Trainings, Teaching: Gilead Science; Invitation to national or international congresses: Gilead Sciences, Pfizer
-
COSTE Joël: No disclosure
-
COSTES Nicolas: No conflict of interest
-
COUDROY Rémi: Research support/Scientific studies: European Respiratory Society, SRLF
-
COUPEZ Elisabeth: No disclosure
-
COUR Martin: No conflict of interest
-
COURCELLE Romain: No conflict of interest
-
COURET David: No conflict of interest
-
COURTEILLE Benoit: No disclosure
-
COUSEIN Etienne: Consultancy, Expert: Becton Dickinson, LFB; Invitation to national or international congresses: Novartis
-
COUSIN Nicolas: No conflict of interest
-
COUSSEMENT Julien: Consultancy, Expert: SANOFI; Invitation to national or international congresses: EUMEDICA
-
COUTANCE Guillaume: Research support/Scientific studies: Biotest; Consultancy, Expert: Biotest; Invitation to national or international congresses: Sanofi, Biotest
-
COUTEAU-CHARDON Amélie: No conflict of interest
-
CRACCO Christophe: No conflict of interest
-
CREMER Olaf: No disclosure
-
CRETEUR Jacques: No conflict of interest
-
CROISIER Jean-Louis: No conflict of interest
-
CROSBY Laura: No conflict of interest
-
CRULLI Benjamin: No conflict of interest
-
CZOSNYKA Marek: No disclosure
-
D’HUMIERES Camille: Research support/Scientific studies: Université de Paris; Trainings, Teaching: Université de Paris
-
DA SILVA Daniel: Research support/Scientific studies: Fresenius Medical Care; Consultancy, Expert: Fresenius Medical Care; Invitation to national or international congresses: Xenios Novalung, Heilbronn, Germany
-
DACHRAOUI Fahmi: No disclosure
-
DAHOUMANE Redouane: No conflict of interest
-
DAHYOT-FIZELIER Claire: No disclosure
-
DAIX Thomas: No conflict of interest
-
DALY Foued: No conflict of interest
-
DAMONTI Lauro: No conflict of interest
-
DANTAN Etienne: No conflict of interest
-
DARMON Michaël: Research support/Scientific studies: MSD, Astute Medical; Consultancy, Expert: Gilead-Kite; Trainings, Teaching: MSD, Astelas, Gilead-Kite
-
DARMONT Michael: No disclosure
-
DAS Vincent: No disclosure
-
DAUBIN Cedric: No conflict of interest
-
DAUBIN Delphine: No conflict of interest
-
DAUDON Michel: No disclosure
-
DAUFRESNE Pierre: No conflict of interest
-
DAUGER Stéphane: No conflict of interest
-
DAVIET Florence: Invitation to national or international congresses: sandosz
-
DE COURSON Hugues: No conflict of interest
-
DE JONG Audrey: Trainings, Teaching: Baxter, Medtronic; Invitation to national or international congresses: Astellas
-
DE LONLAY Pascale: Research support/Scientific studies: INSERM; Trainings, Teaching: Diplome inter-universitaire maladies héréditaires du métabolisme; Invitation to national or international congresses: Plusieurs congrès; Patent or product inventor: brevet académique
-
DE MONTMOLLIN Etienne: No conflict of interest
-
DE PROST Nicolas: No conflict of interest
-
DE ROUX Quentin: No conflict of interest
-
DE SAINT-BLANQUAT Laure: No conflict of interest
-
DE VITA Nello: No conflict of interest
-
DEBATY Guillaume: Consultancy, Expert: Zoll Medical
-
DEBBICHE Lilya: No conflict of interest
-
DEBOCK Romain: No disclosure
-
DEBRAY Dominique: Consultancy, Expert: ALEXION,; Trainings, Teaching: VERTEX; Invitation to national or international congresses: ASTELLAS and SANOFI
-
DEBUREAUX Pierre-Edouard: No conflict of interest
-
DECAMPS Paul: No conflict of interest
-
DECLERCQ Pierre-Louis: Invitation to national or international congresses: Isis Médical, Pfizer
-
DECORMEILLE Guillaume: Trainings, Teaching: CHU TOULOUSE; Invitation to national or international congresses: SFAR-SRLF
-
DECOUSSER Jean-Winoc: Invitation to national or international congresses: MOBIDIAG
-
DEHO Anna: No conflict of interest
-
DEKEYSER Thibault: No conflict of interest
-
DEL BELLO Arnaud: No disclosure
-
DELANNOY Pierre-Yves: No conflict of interest
-
DELASTRE Olivier: No disclosure
-
DELEMAZURE Julie: Trainings, Teaching: cardioSleep
-
DELHAES Laurence: No disclosure
-
DELIGNETTE Marie-charlotte: No conflict of interest
-
DELLAMONICA Jean: Trainings, Teaching: Medtronic; Invitation to national or international congresses: MSD, General Electrics
-
DELPIERRE Clément: No conflict of interest
-
DELVILLE Marianne: No conflict of interest
-
DEMAILLY Zoé: Research support/Scientific studies: SRLF
-
DEMAREST Elsa: No disclosure
-
DEMARET Pierre: No conflict of interest
-
DEMISELLE Julien: No conflict of interest
-
DEMONDION Pierre: No conflict of interest
-
DEMOULE Alexandre: Research support/Scientific studies: Drager, Philips; Consultancy, Expert: Baxter, Respinor, LungPacer; Trainings, Teaching: Fisher & Paykel, Hamilton, Baxter; Invitation to national or international congresses: Fisher & Paykel
-
DENIS Manon: No conflict of interest
-
DEPEYRE Fanny: Invitation to national or international congresses: Pfizer
-
DEPLANTE Yvon: No conflict of interest
-
DEQUIN Pierre-François: Research support/Scientific studies: MedImmune Combioxin Ferring Pharmaceuticals A/S Asahi Kasei Pharma America Corporation
-
DERAUGLAUDRE Lucie: No conflict of interest
-
DERBEL Karim: No disclosure
-
DERKAOUI Ali: No disclosure
-
DERVIN Krystel: No conflict of interest
-
DESAIVE Thomas: No conflict of interest
-
DESGUERRE Isabelle: Research support/Scientific studies: Ptc inc, Avexis; Consultancy, Expert: Avexis, PTC inc, Biogene; Trainings, Teaching: roche, PTC inc, Avexis; Invitation to national or international congresses: sarepta, biogen, Avexis, Biomarin
-
DESNOS Cyrielle: No conflict of interest
-
DESROYS DU ROURE François: No conflict of interest
-
DETOLLENAERE Charles: No conflict of interest
-
DEVAQUET Jérôme: Invitation to national or international congresses: MSD France
-
DEVILDER Mathieu: No conflict of interest
-
DEVOS Philippe: No conflict of interest
-
DEVROEY Marianne: No conflict of interest
-
DEYE Nicolas: Invitation to national or international congresses: Zoll, Bard
-
DHONNEUR Gilles: No disclosure
-
DHRAIEF Sarra: No conflict of interest
-
DI MEGLIO Lucas: Research support/Scientific studies: PhD grant from “la fondation de l’avenir pour la recherche médicale”
-
DIANA Jean-Sebastien: Trainings, Teaching: PARIS DESCARTES (PARIS 5); Invitation to national or international congresses: EBMT, ESID workshop, ASCA, SFP, SHIP
-
DIDIER Hommel: No conflict of interest
-
DIEHL Jean-Luc: Research support/Scientific studies: Alung, General Electric HealthCare, Fresenius Medical Care; Consultancy, Expert: Fresenius Medical Care; Invitation to national or international congresses: Fresenius Medical Care, General Electric HealthCare
-
DINA Julia: No disclosure
-
DJEBLI Houria: No conflict of interest
-
DJIBRE Michel: No conflict of interest
-
DLELA Mariem: No conflict of interest
-
DO VALE Julien: No conflict of interest
-
DOGHRI Hamdi: No disclosure
-
DOIT Catherine: No disclosure
-
DOLLAT Camille: No conflict of interest
-
DOLOU Julien: No conflict of interest
-
DONETTI Laurence: No conflict of interest
-
DOURTHE Marie-Emilie: Invitation to national or international congresses: Novartis
-
DOYEN Denis: No conflict of interest
-
DRES Martin: Consultancy, Expert: Lungpacer; Invitation to national or international congresses: Lungpacer
-
DREYFUSS Didier: Research support/Scientific studies: Grant from French Ministry of Health
-
DROUOT Xavier: No disclosure
-
DU CHEYRON Damien: No conflict of interest
-
DUBÉ Bruno-Pierre: Consultancy, Expert: Novartis, GSK
-
DUBERT Marie: No conflict of interest
-
DUBOST Baptiste: No conflict of interest
-
DUBOST Jean-Louis: No conflict of interest
-
DUBURCQ Thibault: No conflict of interest
-
DUCHEMANN Boris: Consultancy, Expert: BMS, MSD, Roche; Invitation to national or international congresses: ROCHE, OXYVIE, PFIZER, Astra zeneca
-
DUCLOUX Diane: No conflict of interest
-
DUCREUX Michel: No disclosure
-
DUFLOT Thomas: No conflict of interest
-
DUFOSSEZ Marie-Christine: No conflict of interest
-
DUFOUR Nicolas: Consultancy, Expert: Agence Nationale de Sécurité du Médicament et des produits de santé
-
DUMAS Florence: No conflict of interest
-
DUMAS Guillaume: No conflict of interest
-
DUMONTET Erwan: No conflict of interest
-
DUPEYRAT Julien: No conflict of interest
-
DUPIC Laurent: Invitation to national or international congresses: ESPNIC
-
DUPLAND Pierre: No conflict of interest
-
DUPONT Axelle: No conflict of interest
-
DUPONT Damien: Trainings, Teaching: Pfizer; Invitation to national or international congresses: MSD
-
DUPONT Sébastien: No conflict of interest
-
DUPONT Thibault: No conflict of interest
-
DUPUIS Claire: No conflict of interest
-
DUPUY Caroline: No disclosure
-
DURAND Francois: No disclosure
-
DUREUIL Bertrand: No disclosure
-
DURRBACH Antoine: No disclosure
-
ECKERT Philippe: No conflict of interest
-
ECOLLAN Patrick: Trainings, Teaching: ASTRA ZENECA; LILLY
-
EDDOUISSI Wafaa: No disclosure
-
EGBOHOU Pilakimwe: No disclosure
-
EGO Anne: No disclosure
-
EGRETEAU Pierre-Yves: No conflict of interest
-
EHRMANN Stephan: Research support/Scientific studies: Aerogen Ltd, Fisher & Paykel, Hamilton; Consultancy, Expert: Aerogen Ltd, La Diffusion Technique Française; Trainings, Teaching: Aerogen Ltd, Fisher & Paykel; Invitation to national or international congresses: Fisher & Paykel, Aerogen Ltd; Patent or product inventor: Brevet européen; Jet aerosol dispenser brevet EP17305015
-
EL BEKI Nabil: No conflict of interest
-
EL FAKHR Kaoutar: No conflict of interest
-
EL HADHRI Asma: No conflict of interest
-
EL HAJ Tayssir: No disclosure
-
EL HARRAR Najib: No disclosure
-
EL HARRAR Rachid: No disclosure
-
EL IDRISSI Mouna: No disclosure
-
EL KALIOUBIE Ahmed: No conflict of interest
-
EL KETTANI Chafik: No disclosure
-
EL KOUARI Fadwa: Invitation to national or international congresses: Celgene
-
ELAIASSI Mohamed: No disclosure
-
ELATROUS Souheil: Invitation to national or international congresses: Medis Tunisie
-
ELHADRAMI Reda: No disclosure
-
ELHAMMOUDI Driss: No disclosure
-
ELHAMZAOUI Hamza: No disclosure
-
ELHARRAR Najib: No disclosure
-
ELHECHMI Youssef zied: No disclosure
-
ELIE Caroline: No conflict of interest
-
ELODIE Baron: No disclosure
-
ELOUARDI Youssef: No disclosure
-
EMERIAUD Guillaume: Research support/Scientific studies: Maquet Critical Care
-
EMNA Abid: No conflict of interest
-
ENAUD Raphaël: Research support/Scientific studies: VERTEX; Consultancy, Expert: BIOCODEX; Invitation to national or international congresses: NESTLE, NUTRICIA
-
ENNOURI Emna: No conflict of interest
-
ENSER Maya: No conflict of interest
-
EPAILLARD Nicolas: No disclosure
-
ERNON Ludovic: No conflict of interest
-
ESCALARD Clément: No conflict of interest
-
ESIENE Agnès: No disclosure
-
ESSOURI Sandrine: No conflict of interest
-
ETIENNE Manuel: Invitation to national or international congresses: Gilead (SFLS 2019); Pfizer (ECCMID 2019), MSD (JNI 2019), MSD (JNI 2018), ASTELLAS (ECCMID 2018), CORREVIO (RICAI 2017), GILEAD (JNI 2017)
-
ETIENNE Pascal: No disclosure
-
EVRARD Bruno: Invitation to national or international congresses: Pfizer
-
FADIL Aziz: No disclosure
-
FADLALLAH Jehane: No disclosure
-
FAGOT-GANDET Florence: No conflict of interest
-
FAGUER Stanislas: Research support/Scientific studies: Astellas; Consultancy, Expert: Vifor Pharma; Invitation to national or international congresses: Astellas
-
FAIN Olivier: No disclosure
-
FAITOT Francois: Invitation to national or international congresses: Astellas, Novartis, Sandoz, Bayer
-
FALAHI Fahimeh: No disclosure
-
FALEH Kawther: No conflict of interest
-
FALQUE Loic: No conflict of interest
-
FARTOUKH Muriel: Research support/Scientific studies: Biomérieux, MSD; Consultancy, Expert: Biomérieux; Advertising documents: Biomérieux; Trainings, Teaching: Biomérieux; Invitation to national or international congresses: Biomérieux
-
FATHALLAH Ines: No conflict of interest
-
FATNASSI Meriem: No conflict of interest
-
FAUCONNIER Jeremy: No conflict of interest
-
FAVORY Raphael: Research support/Scientific studies: La Jolla (CA) ATHOS 3 study
-
FAVRE Mathieu: No conflict of interest
-
FEDOU Anne-laure: No conflict of interest
-
FELIX Arthur: No conflict of interest
-
FERGE Jean-louis: No conflict of interest
-
FERNANDEZ Audrey: No conflict of interest
-
FERNANDEZ FERNANDEZ Elena: Research support/Scientific studies: Aerogen Ltd.
-
FERRE Alexis: No conflict of interest
-
FERREIRA Luis: No conflict of interest
-
FERRIÈRE Nicolas: Invitation to national or international congresses: ORKYN
-
FERRONI Agnès: No disclosure
-
FEUILLET Fanny: No conflict of interest
-
FEYDEAU Pauline: No conflict of interest
-
FIANCETTE Maud: Research support/Scientific studies: AKPA
-
FIESCHI Claire: No disclosure
-
FIHMAN Vincent: No conflict of interest
-
FILLATRE Pierre: Research support/Scientific studies: Agence de Biomédecine
-
FINEBERG David: Research support/Scientific studies: I am a full time employee of Asahi Kasei Pharma America, the research sponsor
-
FIORE Antonio: No conflict of interest
-
FITTING Catherine: No conflict of interest
-
FLATRES Aurelien: Research support/Scientific studies: SuperSonic Imagine S.A. (Aix-en-Provence, France)
-
FLECHELLES Olivier: No disclosure
-
FLECHER Erwan: No disclosure
-
FLORENTIN Jonathan: No disclosure
-
FOLLIET Laure: No conflict of interest
-
FONTAINE Candice: No conflict of interest
-
FOREL Jean-Marie: No disclosure
-
FORFAIT Carole: No conflict of interest
-
FORT Clémentine: No conflict of interest
-
FOSSÉ Quentin: No conflict of interest
-
FOUCHER Yohann: No conflict of interest
-
FOUDHAILI Nassereddine: No conflict of interest
-
FOURNIER Alicia: No conflict of interest
-
FOURNIER Clement: No disclosure
-
FRAJ Nesrine: No conflict of interest
-
FRANCHINEAU Guillaume: No conflict of interest
-
FRANCOIS Bruno: Research support/Scientific studies: Asahi Kasei Pharma America
-
FRANCOZ Claire: Invitation to national or international congresses: Biotest, Chiesi, Gilead
-
FRANGE Pierre: Research support/Scientific studies: French Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS), Shire, Chimerix; Consultancy, Expert: MSD France; Trainings, Teaching: MSD France, Janssen-Cilag, Gilead Sciences, Medtronic; Invitation to national or international congresses: Gilead Sciences, Janssen-Cilag, MSD France, Pfizer, Astellas
-
FRASCA Denis: No conflict of interest
-
FRAT Jean-Pierre: Research support/Scientific studies: french ministry of health; Consultancy, Expert: Fisher and Paykel Healthcare, SOS oxygène; Invitation to national or international congresses: Fisher and Paykel Healthcare, SOS oxygène
-
FREDJ Hana: No conflict of interest
-
FRÉROU Aurélien: No conflict of interest
-
FRITZ Caroline: No disclosure
-
FROMENTIN Mélanie: Research support/Scientific studies: MSD; Invitation to national or international congresses: MSD
-
FROUIN Antoine: No conflict of interest
-
FRUGIER Alexandre: No disclosure
-
GABORIAU Louise: No conflict of interest
-
GACI Rostane: Invitation to national or international congresses: BARD
-
GACOUIN Arnaud: No disclosure
-
GADDAS Mehdi: No conflict of interest
-
GAILLARD Arnaud: Trainings, Teaching: Zoll Medical
-
GAIMARD Sophie: No conflict of interest
-
GAINNIER Marc: No conflict of interest
-
GALBOIS Arnaud: No conflict of interest
-
GALERNEAU Louis-Marie: Invitation to national or international congresses: Agir À Domicile
-
GALICIER Lionel: Consultancy, Expert: NOVARTIS, EUSAPHARMA; Trainings, Teaching: Baxalta, PFIZER; Invitation to national or international congresses: JANSSEN, NOVARTIS, SHIRE
-
GALLAH Salah: No conflict of interest
-
GAMON Lucie: No conflict of interest
-
GANA Inès: No conflict of interest
-
GANDJBAKHCH Estelle: No disclosure
-
GANSTER Frédérique: No disclosure
-
GANTOIS Guillaume: No conflict of interest
-
GARBAA Yesmine: No conflict of interest
-
GARBEZ Nicolas: No conflict of interest
-
GARNIER Fanny: No conflict of interest
-
GARRET Charlotte: No disclosure
-
GARRIGUES Eve: No conflict of interest
-
GARROUSTE Maïté: No conflict of interest
-
GASRI Bahija: No conflict of interest
-
GASTINNE Thomas: No disclosure
-
GASTLI Nabil: No conflict of interest
-
GAUBERTI Maxime: No conflict of interest
-
GAUDEL Myrtille: Trainings, Teaching: Getinge France; Invitation to national or international congresses: Drager Médical SAS
-
GAUDRY Stéphane: Trainings, Teaching: ZAMBON
-
GAVAUD Ariane: No conflict of interest
-
GAVELLI Francesco: No conflict of interest
-
GEERAERTS Thomas: No conflict of interest
-
GELEE Bruno: No conflict of interest
-
GENEIX Mario: No conflict of interest
-
GENIEYS Pauline: No conflict of interest
-
GENNISSON Jean-Luc: Consultancy, Expert: supersonic imagine
-
GENUINI Mathieu: No conflict of interest
-
GEORGES Hugues: No conflict of interest
-
GERI Guillaume: No conflict of interest
-
GERMAIN Adeline: No conflict of interest
-
GESLAIN Guillaume: No conflict of interest
-
GETTE Sébastien: No disclosure
-
GHADHOUNE Hatem: No conflict of interest
-
GHEERBRANT Hubert: No conflict of interest
-
GHOMARI Nabil: No conflict of interest
-
GHRENASSIA Etienne: No disclosure
-
GIABICANI Mikhael: No conflict of interest
-
GIACARDI Christophe: No conflict of interest
-
GIAJ LEVRA Matteo: No conflict of interest
-
GIBELIN Aude: No conflict of interest
-
GILIBERTO Jean-Pierre: No disclosure
-
GINGUAY Antonin: No conflict of interest
-
GIRARD Muriel: No conflict of interest
-
GIRAUDEAU Bruno: No conflict of interest
-
GIRAULT Christophe: No conflict of interest
-
GIRY Marion: No conflict of interest
-
GISBERT-MORA Chloé: No conflict of interest
-
GLAVNIK Boris: No disclosure
-
GLENISSON Jean: No disclosure
-
GODEAU Elise: No disclosure
-
GOETZ Christophe: No disclosure
-
GOLDGRAN-TOLEDANO Dany: No disclosure
-
GOLDWIRT Lauriane: No conflict of interest
-
GONTIER Olivier: No disclosure
-
GONZALEZ Frederic: No conflict of interest
-
GORBEL Rezk: No conflict of interest
-
GORO Seydou: No conflict of interest
-
GOUDELIN Marine: No conflict of interest
-
GOULMANE Mourad: Research support/Scientific studies: Oran hospital and university center; Trainings, Teaching: Faculty of Medicine of Oran ALGERIA; Invitation to national or international congresses: french language reanimation company
-
GOURSAUD Suzanne: No conflict of interest
-
GOUTAY Julien: No conflict of interest
-
GOYER Isabelle: No conflict of interest
-
GRALL Maximilien: No disclosure
-
GRALL Nathalie: Invitation to national or international congresses: Da Volterra
-
GRAMMATICO-GUILLON Leslie: No conflict of interest
-
GRANDMOUGIN Daniel: No conflict of interest
-
GRANGÉ Steven: Consultancy, Expert: Alexion, Sanofi; Invitation to national or international congresses: Alexion, Sanofi, Octapharma
-
GRAS-LEGUEN Christèle: No disclosure
-
GRAVIER Francis-Edouard: No conflict of interest
-
GREGNON Marion: No conflict of interest
-
GREGOIRE Murielle: No conflict of interest
-
GRIETEN Jef: No conflict of interest
-
GRIMALDI David: Trainings, Teaching: Alexion; Invitation to national or international congresses: MSD
-
GRIMAUD Marion: No conflict of interest
-
GRIMBERT Philippe: No disclosure
-
GRISOTTO Coline: No conflict of interest
-
GRONDELAERS Jill: No conflict of interest
-
GROS Antoine: No disclosure
-
GRUSON Didier: No conflict of interest
-
GUENANE Kamel: No conflict of interest
-
GUERCI Philippe: Invitation to national or international congresses: SFAR, ESICM
-
GUERIN Emmanuelle: No conflict of interest
-
GUÉRIN Claude: No conflict of interest
-
GUÉROT Emmanuel: No conflict of interest
-
GUERVILLY Christophe: No disclosure
-
GUETTECHE Choubeila: No conflict of interest
-
GUEYE Papa: No conflict of interest
-
GUIDET Bertrand: Research support/Scientific studies: Grifols; Invitation to national or international congresses: Grifols
-
GUILLOIS Bernard: No disclosure
-
GUILLON Antoine: Consultancy, Expert: Becton Dickinson
-
GUILLON Benoit: No disclosure
-
GUILLOT Camille: No conflict of interest
-
GUINAULT Damien: Consultancy, Expert: SANOFI, ASTELLAS; Invitation to national or international congresses: NOVARTIS
-
GUIOT Julien: No conflict of interest
-
GUISSOUMA Jihene: No conflict of interest
-
GUITTON Christophe: Invitation to national or international congresses: Fisher & Paykel, Pfizer
-
GUNTZ Julien: No conflict of interest
-
HABIBA Sik Ali: No conflict of interest
-
HABIBI Anoosha: Research support/Scientific studies: addmedica, agios; Consultancy, Expert: Bluebird, Pfizer; Trainings, Teaching: Novartis; Invitation to national or international congresses: Addmedica
-
HABRE Walide: No disclosure
-
HADCHOUEL Juliette: No conflict of interest
-
HADDAD Faten: No conflict of interest
-
HADJ Mathilde: No conflict of interest
-
HADJ HASSINE Shatila: No conflict of interest
-
HAGUI Mounir: No conflict of interest
-
HAJJI Ahmed: Invitation to national or international congresses: société tunisienne de pédiatrie
-
HAKIMI Abdelmalek: No disclosure
-
HAMDI Aicha: No conflict of interest
-
HAMIDFAR Rebecca: No conflict of interest
-
HAMMAMI Emna: No conflict of interest
-
HAMMAMI Maha: No conflict of interest
-
HAMMAMI Zouhir: No disclosure
-
HAMMOUDA Zeineb: No conflict of interest
-
HAMROUN Aghiles: No conflict of interest
-
HAMROUNI Mouldi: No disclosure
-
HAMZAOUI Olfa: Trainings, Teaching: Cheetah Compagny
-
HANTSON Philippe: No conflict of interest
-
HARANDOU Mustapha: No disclosure
-
HARIRI Geoffroy: No conflict of interest
-
HAUDEBOURG Anne-Fleur: No disclosure
-
HEATON Nigel: No disclosure
-
HEKIMIAN Guillaume: No conflict of interest
-
HELMS Julie: Invitation to national or international congresses: MSD France, Pfizer PFE France, Diagnostica Stago
-
HEMAMID Habiba: No conflict of interest
-
HEMING Nicholas: No conflict of interest
-
HENNEQUIN Carole: No conflict of interest
-
HENRY Amandine: No conflict of interest
-
HERBEZ Emilie: No conflict of interest
-
HERBRECHT Jean-Etienne: Trainings, Teaching: Gilead
-
HERMANN Bertrand: No conflict of interest
-
HERNANDEZ PADILLA Ana catalina: No conflict of interest
-
HERRMANN Sofia: Consultancy, Expert: Abbvie; Advertising documents: Humira; Invitation to national or international congresses: Abbvie, Janssen, Fresenius, Kabi, Cook
-
HERTIG Alexandre: Consultancy, Expert: SANOFI GENZYME, HANSA; Trainings, Teaching: ASTELLAS; Invitation to national or international congresses: SANOFI GENZYME, ASTELLAS, SHIRE
-
HILFIKER Roger: Research support/Scientific studies: Swiss Cancer Research
-
HILLAIRE-BUYS Dominique: No conflict of interest
-
HINAUT Ronan: No conflict of interest
-
HIRT Déborah: No conflict of interest
-
HO TIN NOE Benoit: Research support/Scientific studies: INSERM Fondation pour la Recherche Médicale InCa; Invitation to national or international congresses: GRC conferences
-
HODJAT-PANAH Kyann: No disclosure
-
HOGREL Jean-Yves: Consultancy, Expert: Biogen, Sarepta; Invitation to national or international congresses: Sanofi; Patent or product inventor: Ateliers Laumonier, Valotec
-
HOLLEBECQUE Antoine: No disclosure
-
HOLLEVILLE Mathilde: No conflict of interest
-
HOPPE Marie-Anne: No disclosure
-
HOUCKE Stephanie: No conflict of interest
-
HOULI Rawnak: No conflict of interest
-
HOUNAIN Taha: No disclosure
-
HOURCASTAGNOU Edith: Invitation to national or international congresses: MSD, PFIZER
-
HOURI Fadoua: No conflict of interest
-
HOURIA Djebli: No disclosure
-
HOURMANT Yannick: No conflict of interest
-
HRAIECH Sami: No conflict of interest
-
HUA Camille: No conflict of interest
-
HUANG Florent: Invitation to national or international congresses: Bristol Meyers Squibb
-
HUET Olivier: Consultancy, Expert: EDWARDS LIFE SCIENCE
-
HUGUET Francoise: No disclosure
-
HULIN Anne: Research support/Scientific studies: Bayer; Trainings, Teaching: Université Paris Descartes; Université Paris-Est Créteil
-
HYVERNAT Hervé: No conflict of interest
-
ICHAÏ Philippe: No conflict of interest
-
IMEN Sioud: No conflict of interest
-
IOOS Vincent: No disclosure
-
ISERIN Franck: No disclosure
-
ISSA Nahema: No conflict of interest
-
JABER Samir: Consultancy, Expert: drager, Fisher-Paykel; Medtronic; Baxter; Xenios Fresenius; Trainings, Teaching: Drager, Fisher-Paykel; Medtronic; Baxter; Xenios Fresenius; Invitation to national or international congresses: Drager, Fisher-Paykel; Medtronic; Baxter; Xenios Fresenius
-
JABI Rachid: No conflict of interest
-
JACQ Gwenaëlle: No conflict of interest
-
JACQUET Emmanuelle: Research support/Scientific studies: Unicancer (ESME and STORM studies); Invitation to national or international congresses: Pfizer; Patent or product inventor: Pfizer, Roche, Lilly
-
JACQUIER Sophie: No conflict of interest
-
JAFFRO Marion: No disclosure
-
JAMI Imen: No conflict of interest
-
JAMME Matthieu: Consultancy, Expert: Alexion
-
JAMOUSSI Amira: No conflict of interest
-
JANATI Adnane: No disclosure
-
JANSSEN-LANGENSTEIN Ralf: Invitation to national or international congresses: Pfizer
-
JAOUED Oussama: No conflict of interest
-
JARRAYA Fatma: No conflict of interest
-
JARRIGE Bruno: No conflict of interest
-
JAUBERT Paul: No conflict of interest
-
JAVAUD Nicolas: No conflict of interest
-
JAVOUHEY Etienne: Research support/Scientific studies: CSL Behring; La jolla
-
JAY Guillaume: No disclosure
-
JEAN-MICHEL Vanessa: No conflict of interest
-
JEMMELI Rim: No disclosure
-
JENKINS Emily: No conflict of interest
-
JERBI Zouheir: No disclosure
-
JESTIN Matthieu: No conflict of interest
-
JIVANJEE Mufaddal: No conflict of interest
-
JOFFRE Jérémie: No conflict of interest
-
JOLAINE Valerie: No conflict of interest
-
JOLY Bérangère: No conflict of interest
-
JONATHAN Florentin: No disclosure
-
JORAM Nicolas: No conflict of interest
-
JORET Aurelie: No disclosure
-
JORIS Jean: No disclosure
-
JOSEPH Adrien: No conflict of interest
-
JOST Daniel: No conflict of interest
-
JOUAN Youenn: No conflict of interest
-
JOUFFROY Romain: Invitation to national or international congresses: SRLF 2018
-
JOURDAIN Cecile: No disclosure
-
JOURDAIN Merce: No disclosure
-
JOURNOIS Didier: No disclosure
-
JOUVEN Xavier: No disclosure
-
JOUVET Philippe: Research support/Scientific studies: Air Liquide Santé; Invitation to national or international congresses: Air Liquide Santé
-
JOYCE Mary: Research support/Scientific studies: Aerogen; Advertising documents: Aerogen; Patent or product inventor: Aerogen
-
JOZWIAK Mathieu: No conflict of interest
-
JUNG Boris: Research support/Scientific studies: APARD; Invitation to national or international congresses: Sedana
-
KAIDOMAR Michel: No disclosure
-
KALFON Pierre: Consultancy, Expert: GENERAL ELECTRIC HEALTHCARE; Invitation to national or international congresses: Fresenius
-
KALLAL Hela: No conflict of interest
-
KALLEL Aicha: No conflict of interest
-
KALLEL Hatem: No conflict of interest
-
KALLEL Kalthoum: No disclosure
-
KALLEL Myriam: No disclosure
-
KALOUCH Samira: Trainings, Teaching: faculte de médecine et pharmacie casablanca
-
KAMAR Nassim: Research support/Scientific studies: Astellas; Consultancy, Expert: Abbvie, Amgen, Astellas, Chiesi, Gilead, Fresenius Medical care, Merck Sharp and Dohme, Neovii, Novartis, Roche, Sanofi, and Shire; Invitation to national or international congresses: Abbvie, Amgen, Astellas, Chiesi, Gilead, Fresenius Medical care, Merck Sharp and Dohme, Neovii, Novartis, Roche, Sanofi, and Shire
-
KAMEL Toufik: Research support/Scientific studies: Benefit-to-risk balance of bronchoalveolar lavage in the critically ill. A prospective, multicenter cohort study
-
KAMINSKI Dominique: No conflict of interest
-
KAMMOUN Yassmine: No conflict of interest
-
KARRAY Narjess: No conflict of interest
-
KAWAGUCHI Atsushi: Research support/Scientific studies: Fonds de la recherche en sante du Quebec
-
KAYANOKI Toshihiko: Research support/Scientific studies: Asahi Kasei Pharma America Corporation
-
KELLENS Isabelle: No conflict of interest
-
KERNEIS Mathieu: Research support/Scientific studies: Institut Servier, FFC; Consultancy, Expert: Bayer, Sanofi, Servier; Invitation to national or international congresses: Sanofi
-
KERNEIS Solen: Research support/Scientific studies: bioMérieux; Consultancy, Expert: Accelerate Diagnostics, bioMérieux
-
KHALED Ameni: No conflict of interest
-
KHALEQ Khalid: No conflict of interest
-
KHALLOUKI Mohamed: No disclosure
-
KHANNA Nina: No conflict of interest
-
KHARRAT Sana: No conflict of interest
-
KHATOUF Mohammed: No disclosure
-
KHEDHER Sana: No conflict of interest
-
KHZOURI Takoua: No disclosure
-
KIPNIS Eric: No disclosure
-
KLAII Salma: No conflict of interest
-
KLEIN Thomas: No conflict of interest
-
KLOUCHE Kada: Invitation to national or international congresses: PFIZER
-
KNOPP Jennifer l.: No conflict of interest
-
KOSSOROTOFF Manoëlle: No conflict of interest
-
KOUATCHET Achille: No disclosure
-
KOURAICHI Nedia: Trainings, Teaching: Faculty of medecin Tunis
-
KOUTSOUKOU Antonia: No conflict of interest
-
KRID Saoussen: No conflict of interest
-
KRINGS Adrien: No conflict of interest
-
KSOURI Meriem: No conflict of interest
-
KUBIS Nathalie: Invitation to national or international congresses: LFB; Patent or product inventor: brevet (22nd March 2018; FR 18 52473), not yet licensed
-
L’HER Erwan: Research support/Scientific studies: Oxynov Inc, Québec, QC, CA, General Electrics Healthcare; Consultancy, Expert: Oxynov Inc, Québec, QC, CA, Smiths Medical, General Electrics Healthcare; Invitation to national or international congresses: General Electrics Healthcare; Stock shareholder: Oxynov Inc, Québec, QC, CA; Patent or product inventor: Université de Bretagne Occidentale, Université Laval-Qc-CA
-
LABBE Vincent: No disclosure
-
LABRO Laura: No disclosure
-
LACAILLE Florence: No conflict of interest
-
LACAMPAGNE Alain: No disclosure
-
LACAN Claire: No conflict of interest
-
LACHERADE Jean-Claude: No conflict of interest
-
LADJEMI Maha-Zohra: No conflict of interest
-
LAFON Charles: No conflict of interest
-
LAFON Marie-Edith: No disclosure
-
LAFON Thomas: No conflict of interest
-
LAGACHE Laurie: Invitation to national or international congresses: ASTEN
-
LAHMAR Manel: No disclosure
-
LAHMER Basma: No conflict of interest
-
LAHOUCINE Barrou: No disclosure
-
LAINE Laurent: No conflict of interest
-
LAISSI Mohamed: No conflict of interest
-
LAKHDHAR Dhouha: No disclosure
-
LALLOZ Amandine: Invitation to national or international congresses: Stryker
-
LAMBERMONT Bernard: Research support/Scientific studies: Maquet, Cytosorbents; Trainings, Teaching: Drager; Invitation to national or international congresses: Orion, Acertys, Drager
-
LAMBERT Jerome: No disclosure
-
LAMBIOTTE Fabien: No conflict of interest
-
LAMBOTTE Olivier: Research support/Scientific studies: Gilead; Consultancy, Expert: BMS, Astra Zeneca, MSD, Incyte, Janssen; Invitation to national or international congresses: BMS
-
LAMER Antoine: No conflict of interest
-
LAMHAUT Lionel: Research support/Scientific studies: Getinge; Trainings, Teaching: Stryker,Zoll, Getinge; Invitation to national or international congresses: Zoll, Astra Zeneca, Getinge; Patent or product inventor: Neckpure, SAUV Life
-
LAMIA Bouchra: Research support/Scientific studies: Bayer, MSD, Vivisol, Asten, Philips; Consultancy, Expert: Bayer, MSD, Chiesi, Novartis, Lowenstein, Philips,Vivisol/Advertising documents: Philips; Trainings, Teaching: Novartis, GSK, Astra Zeneca, Boeringher; Invitation to national or international congresses: Chiesi, Astra Zeneca, SOS oxygene, Novartis, Boeringher
-
LAMOTH Frédéric: Consultancy, Expert: Gilead, MSD, Basilea; Invitation to national or international congresses: MSD, Gilead
-
LANCEL Steve: No conflict of interest
-
LANCELOT Aymeric: No disclosure
-
LANGERON Olivier: No conflict of interest
-
LAPIDUS Nathanael: No disclosure
-
LARAMAS Mathieu: Consultancy, Expert: Astra-Zeneca; Sanofi; Trainings, Teaching: NOVASRTIS; BAYER; AMGEN; JANSSEN; Invitation to national or international congresses: SANOFI; PFIZER; ASTELLAS
-
LARCHER Romaric: Trainings, Teaching: MSD, PFIZER; Invitation to national or international congresses: MSD, PFIZER
-
LARDE Julie: No disclosure
-
LASCARROU Jean-Baptiste: Consultancy, Expert: Asahi Kasei
-
LASOCKI Sigsimond: No disclosure
-
LASSALLE Thibault: No conflict of interest
-
LATERRE Pierre-François: Consultancy, Expert: Ferring, Adrenomed, Inotrem
-
LAUNAY Elise: No disclosure
-
LAUNEY Yoann: No conflict of interest
-
LAUNOIS Amélie: No conflict of interest
-
LAURENT Alexandra: No conflict of interest
-
LAURENT Raynaud: No disclosure
-
LAURENT Virginie: No conflict of interest
-
LAURIOUX Flavie: No disclosure
-
LAUTRETTE Alexandre: Invitation to national or international congresses: Hemotec
-
LAUZIER Benjamin: No conflict of interest
-
LAVAYSSIERE Laurence: No disclosure
-
LAVIGNE Flavie: No conflict of interest
-
LAVILLEGRAND Jean-Rémi: No conflict of interest
-
LAZARESCU Alina: No disclosure
-
LAZRAQ Mohamed: No conflict of interest
-
LE BARS Didier: Consultancy, Expert: NucAdvisor
-
LE BERRE Nicolas: No disclosure
-
LE BIHAN Clément: No conflict of interest
-
LE BORGNE Pierrick: No disclosure
-
LE BOUAR Gurvan: No conflict of interest
-
LE BOURGEOIS Amandine: No disclosure
-
LE BOURGEOIS Fleur: Invitation to national or international congresses: Fresenius Kabi France
-
LE CORRE Marine: No conflict of interest
-
LE GOIC Maeva: No conflict of interest
-
LE GOUGE Amélie: No conflict of interest
-
LE GOUILL Steven: No disclosure
-
LE GUENNEC Loïc: No conflict of interest
-
LE GUYADER Maxence: No disclosure
-
LE NEINDRE Aymeric: Trainings, Teaching: Health Impact; Invitation to national or international congresses: SIFR, SRLF
-
LE NIGER Catherine: No conflict of interest
-
LE REUN Claire: No conflict of interest
-
LE TACON Serge: No disclosure
-
LE TERRIER Christophe: No conflict of interest
-
LE TULZO Yves: No conflict of interest
-
LE-LILLO LOUËT Agnès: No disclosure
-
LEBERT Christine: No disclosure
-
LEBIHAN Clement: No disclosure
-
LEBLANC Sarah: Research support/Scientific studies: Cook; Consultancy, Expert: Norgine; Trainings, Teaching: Fujifilm, Boston Scientific
-
LEBRETON Guillaume: No disclosure
-
LEBRUN-VIGNES Benedicte: Research support/Scientific studies: NOVARTIS; Consultancy, Expert: ANSM
-
LEBUFFE Gilles: No disclosure
-
LECLERC Maxime: No conflict of interest
-
LÉCLUSE Aldéric: Research support/Scientific studies: PGRX AVC study; Consultancy, Expert: BMS-Pfizer, Boerhinger Ingelheim, Bayer; Invitation to national or international congresses: BMS-Pfizer, Boerhinger Ingelheim
-
LEDOUX Didier: No disclosure
-
LEFEBVRE Francois: No conflict of interest
-
LEFEVRE Montaine: No conflict of interest
-
LEFRANT Jean-Yves: Invitation to national or international congresses: PFIZER
-
LEFRERE Francois: Consultancy, Expert: NOVARTIS; Trainings, Teaching: NOVARTIS; Invitation to national or international congresses: NOVARTIS
-
LEGARCON Vincent: No conflict of interest
-
LEGER Julie: No conflict of interest
-
LEGER Maxime: No conflict of interest
-
LEGER Pierre-Louis: No conflict of interest
-
LEGOUIS David: No conflict of interest
-
LEGOUY Camille: No conflict of interest
-
LEGRAND Matthieu: No disclosure
-
LEGRAS Annick: No conflict of interest
-
LEGRIEL Stéphane: Invitation to national or international congresses: London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures
-
LEJEUNE Manon: No disclosure
-
LEMAITRE Caroline: No conflict of interest
-
LEMAITRE Elise: No conflict of interest
-
LEMAITRE Florian: Research support/Scientific studies: Astellas, MSD, Janssen, Sandoz; Consultancy, Expert: Janssen; Invitation to national or international congresses: Gilead
-
LEMARIE Jeremy: No disclosure
-
LEMERLE Marie: No conflict of interest
-
LEMIALE Virginie: Trainings, Teaching: Gilead, Astellas, Alexion, Pfizer, MSD; Invitation to national or international congresses: Pfizer, Biomerieux
-
LEMTIRI Justine: No conflict of interest
-
LENGLINE Etienne: Invitation to national or international congresses: Gilead EHA 2019
-
LENZOTTI Anne-marine: No disclosure
-
LEON Lisa: No conflict of interest
-
LEON Rusel: No disclosure
-
LEPAGE-FARRELL Alex: No conflict of interest
-
LEPELTIER Hélène: No conflict of interest
-
LEPETIT Arnaud: No disclosure
-
LEPEULE Raphael: Invitation to national or international congresses: MSD, Pfizer, Eumedica
-
LEPRETRE Anne-Claire: No conflict of interest
-
LERMUZEAUX Mathilde: No conflict of interest
-
LEROY Christophe: Invitation to national or international congresses: PFIZER
-
LEROY Dorian: No conflict of interest
-
LEROY Olivier: No disclosure
-
LESAGE Anne: No disclosure
-
LESAGE Fabrice: No conflict of interest
-
LESENNE Anouk: No conflict of interest
-
LESOUHAITIER Mathieu: No conflict of interest
-
LETAVERNIER Emmanuel: No disclosure
-
LETOCART Philippe: No disclosure
-
LEVESQUE Eric: No disclosure
-
LEVRAT Albrice: No conflict of interest
-
LEVY Michaël: No conflict of interest
-
LÉVY Bruno: Research support/Scientific studies: Gettinge, Amomed; Consultancy, Expert: Orion, Amomed, novartis; Invitation to national or international congresses: Pfizer
-
LÉVY Raphaël: No conflict of interest
-
LHEUREUX Florent: No conflict of interest
-
LHOMMET Claire: No disclosure
-
LIENARD Hélène: No conflict of interest
-
LIET Jean-Michel: No conflict of interest
-
LIFERMANN François: No conflict of interest
-
LIM Pascal: No disclosure
-
LIPMAN Jeffrey: No disclosure
-
LIU Vincent: No conflict of interest
-
LIU Yihua: No disclosure
-
LLITJOS Jean-François: No conflict of interest
-
LOGRE Elsa: No conflict of interest
-
LORTON Fleur: Research support/Scientific studies: Groupe de pathologie infectieuse pédiatrique; Groupe Francophone de Réanimation et Urgences Pédiatriques; Société Française de Pédiatrie-Pampers
-
LOSSER Marie-Reine: Invitation to national or international congresses: Pfizer Esicm 2019
-
LOUATI Assaad: No conflict of interest
-
LOUIS Bruno: Research support/Scientific studies: Fondation pour la Recherche Médicale; Fédération ANTADIR; Agence Nationale de la Recherche
-
LOUIS Guillaume: No conflict of interest
-
LOUNDOU Anderson: No disclosure
-
LSTIBUREK Laura: No conflict of interest
-
LU Chen: No disclosure
-
LUC Amandine: No conflict of interest
-
LUCET Jean-Christophe: No conflict of interest
-
LUFT Antoine: No conflict of interest
-
LUIS David: No disclosure
-
LUPERTO Marta: No conflict of interest
-
LUYT Charles-Edouard: Research support/Scientific studies: Bayer Healthcare, Faron, AstraZenecca; Consultancy, Expert: Bayer Healthcare, Faron, ThermoFischer Brahms, Carmat; Trainings, Teaching: Merck Sharp & Dohme, Biomérieux
-
MAAMAR Adel: No conflict of interest
-
MAAMOURI Hela: No conflict of interest
-
MAAREK Alizee: Invitation to national or international congresses: SANDOZ
-
MAAROUFI Sara: No disclosure
-
MAATOUG Samir: No conflict of interest
-
MAATOUK Syrine: No conflict of interest
-
MAATOUK Yed: No disclosure
-
MAAYOUFI Houda: No conflict of interest
-
MABROUKI Asma: No conflict of interest
-
MACLOUGHLIN Ronan: Research support/Scientific studies: Aerogen Ltd; Patent or product inventor: Aerogen Ltd
-
MADANI Naoufel: No conflict of interest
-
MAGHRAOUI Hamida: No conflict of interest
-
MAHAMANE RABIOU Habibou Hassane: No conflict of interest
-
MAHAUX Pedro: No conflict of interest
-
MAILLOUX Arnaud: No disclosure
-
MAISONNEUVE Emilien: No conflict of interest
-
MAIZEL Julien: No conflict of interest
-
MAJED Kamel: Trainings, Teaching: ERC, faculté de médecine de tunis
-
MAKOUDI Sarah: No conflict of interest
-
MALACRINO Dominique: No conflict of interest
-
MALKA David: No disclosure
-
MALLARD Jeremy: No conflict of interest
-
MALLET Vincent: No disclosure
-
MAMZER Marie france: No disclosure
-
MANCEAU Sandra: No conflict of interest
-
MANEN Séverine: No disclosure
-
MANSUY Jean-Michel: No disclosure
-
MARC Julien: No conflict of interest
-
MARCHAL Jean-Claude: No disclosure
-
MARCHETTI Oscar: No disclosure
-
MARCOTTE Guillaume: Consultancy, Expert: LFB Biomédicament; Trainings, Teaching: LFB Biomédicament
-
MARHFOUR Abdeljabbar: No conflict of interest
-
MARI Arnaud: No conflict of interest
-
MARIE Damien: No conflict of interest
-
MARIJON Eloi: No disclosure
-
MARIOTTE Eric: Consultancy, Expert: Sanofi-aventis
-
MARJANOVIC Nicolas: No disclosure
-
MARJANOVIC Zora: No disclosure
-
MARONI Arielle: No conflict of interest
-
MAROT Benoit: No conflict of interest
-
MARQUE Sophie: No conflict of interest
-
MARTI Pierre-Emmanuel: No conflict of interest
-
MARTIN Clémence: Consultancy, Expert: Zambon; Trainings, Teaching: Zambon, Chiesi; Invitation to national or international congresses: Chiesi
-
MARTIN Lucile: No conflict of interest
-
MARTIN Maelle: No conflict of interest
-
MARTIN DELGADO Maria Cruz: No conflict of interest
-
MARTIN LOECHES Ignacio: Consultancy, Expert: Msd, gilead
-
MARTINO Frédéric: No conflict of interest
-
MARTIS Nihal: Trainings, Teaching: Octapharma; Invitation to national or international congresses: Merck, Octapharma, Sanofi, AddMedica, Novartis, LeoPharma; Stock shareholder: Merck
-
MARZOUK Mehdi: No conflict of interest
-
MASI Paul: No conflict of interest
-
MASSION Paul: No disclosure
-
MASSON Gabriel: Research support/Scientific studies: SRLF Bourse Mobilité
-
MASSON Mathilde: No conflict of interest
-
MASSRI Alexandre: No disclosure
-
MATECKI Stefan: No disclosure
-
MATEUR Houda: No disclosure
-
MATHIEN Cyrille: No conflict of interest
-
MATHIEU Daniel: No conflict of interest
-
MATUSIK Elodie: No conflict of interest
-
MAUCHIEN Benedicte: No conflict of interest
-
MAURY Eric: Research support/Scientific studies: Doran International, Drager; Trainings, Teaching: Vygon
-
MAXIME Virginie: No conflict of interest
-
MAYAUX Julien: Invitation to national or international congresses: Gilead
-
MAYENCE Claire: No disclosure
-
MAYEUR Jeanne: No disclosure
-
MAZIGHI Mikael: No disclosure
-
MBATCHI Litaty: No conflict of interest
-
MCLEAN Anthony: No disclosure
-
MEAUDRE Eric: Invitation to national or international congresses: LFB
-
MEBAZAA M’hamed Sami: No conflict of interest
-
MECHRI Karim: No conflict of interest
-
MEDDEB Khaoula: No conflict of interest
-
MEDIOUNI Karim: No conflict of interest
-
MEDRANO Chloé: No disclosure
-
MEDRINAL Clement: Invitation to national or international congresses: ASTEN SANTE
-
MEERT Anne-Pascale: No conflict of interest
-
MEFFRE Sarah: No conflict of interest
-
MEGARBANE Bruno: No conflict of interest
-
MEHDAOUI Hossein: No disclosure
-
MEHDI Asma: No disclosure
-
MEHDI Somai: No disclosure
-
MEHREZ Ihssan: Research support/Scientific studies: CHU HASSAN II FES
-
MEHTA Geeta: No conflict of interest
-
MEISTELMAN Claude: No disclosure
-
MEKONTSO DESSAP Armand: Research support/Scientific studies: Fischer and Paykel, Philips, Ferring, GSK; Consultancy, Expert: Baxter, Air Liquide, Amomed; Trainings, Teaching: Getingue, AddMedica
-
MELKI Isabelle: No conflict of interest
-
MELLATI Nouchan: No conflict of interest
-
MELLEBEEK Evi: No conflict of interest
-
MEMAIN Nathalie: No conflict of interest
-
MENG Paris: No disclosure
-
MENGELLE Catherine: No disclosure
-
MENIF Khaled: No conflict of interest
-
MENTEC Hervé: Invitation to national or international congresses: ISIS Normandie, MSD France; Stock shareholder: Tanderev; Patent or product inventor: Tanderev
-
MERCAT Alain: Research support/Scientific studies: Fisher-Paykel, General Electric; Consultancy, Expert: Faron Pharmaceuticals, Air Liquide Medical System; Trainings, Teaching: Medtronic, Fisher-Paykel, Dräger Medical; Patent or product inventor: Covidien
-
MERCERON Sybille: No conflict of interest
-
MERCIER Emmanuelle: No conflict of interest
-
MERCIER Romain: No disclosure
-
MERCIER Severine: No conflict of interest
-
MERCIER-DES-ROCHETTES Emmanuelle: No disclosure
-
MERHABENE Takoua: No conflict of interest
-
MERLE Jean-claude: No disclosure
-
MESOTTEN Dieter: No conflict of interest
-
MESSAADI Amenallah: No conflict of interest
-
MESSIKA Jonathan: Invitation to national or international congresses: CSLBehring; Fisher&Paykel
-
METAXA Victoria: No disclosure
-
METOGO MBENGONO Junette arlette: No conflict of interest
-
MEUNIER Anne: No conflict of interest
-
MEURICE Jean-claude: No disclosure
-
MEYBECK Agnes: Consultancy, Expert: Janssen, Gilead; Invitation to national or international congresses: Janssen, Viiv, Gilead
-
MEYER Pascal: No disclosure
-
MEZIANI Ferhat: Research support/Scientific studies: STAGO
-
MEZIDI Mehdi: Research support/Scientific studies: GE Healthcare
-
MGHIRBI Abdelwahab: No conflict of interest
-
MHADHBI Hadil: No conflict of interest
-
MIAILHE Arnaud-Félix: No conflict of interest
-
MICHAELA Roy: No conflict of interest
-
MICHARD Baptiste: No disclosure
-
MICHEL Philippe: No conflict of interest
-
MICHOT Jean-Baptiste: No conflict of interest
-
MICHOT Jean-Marie: No disclosure
-
MIGUERES Helene: No conflict of interest
-
MILOUDI Youssef: No disclosure
-
MIMOZ Olivier: Research support/Scientific studies: BD, 3 M; Consultancy, Expert: BD, 3 M, Sanofi; Invitation to national or international congresses: 3 M, BD, Sanofi
-
MINOTTI Bruno: No conflict of interest
-
MIRA Jean-Paul: Consultancy, Expert: ASAHI KASEI; Trainings, Teaching: MSD; Invitation to national or international congresses: ESTOR
-
MIROUSE Adrien: No conflict of interest
-
MISSET Benoit: Research support/Scientific studies: Bactiguard; Invitation to national or international congresses: Astellas
-
MNIF Basma: No conflict of interest
-
MOAL Valérie: No conflict of interest
-
MOHAMADOU Inna: No conflict of interest
-
MOHAMED Fekih hassen: No conflict of interest
-
MOHAMED Kheder: No disclosure
-
MOHAMED AMINE Amine: No disclosure
-
MOHTY Mohamad: No disclosure
-
MOINE Pierre: No disclosure
-
MOJOLI Francesco: No disclosure
-
MOKART Djamel: No conflict of interest
-
MOKLINE Amel: No conflict of interest
-
MOLINARI Nicolas: No disclosure
-
MOLLIERE Chloe: No conflict of interest
-
MONCHI Merad: No disclosure
-
MONGARDON Nicolas: No conflict of interest
-
MONGODI Silvia: No conflict of interest
-
MONNET Xavier: Consultancy, Expert: Pulsion Médical Systems; Advertising documents: Cheetah medical; Trainings, Teaching: Pulsion Medical Systems
-
MONTERO Santiago: Trainings, Teaching: ESC Clinical Training Grant in 2016
-
MONTINI Florent: No conflict of interest
-
MONTRAVERS Philippe: Research support/Scientific studies: Pfizer, MSD; Consultancy, Expert: Pfizer, MSD, Menarini, Tetraphase, Parexel, Bayer
-
MORANDEAU Valentin: No conflict of interest
-
MORAWIEC Elise: No conflict of interest
-
MOREAU Anne-Sophie: No conflict of interest
-
MOREL Guillaume: No conflict of interest
-
MOREL Jerome: No conflict of interest
-
MOREL Johanna: No conflict of interest
-
MORIMONT Philippe: No conflict of interest
-
MORO-SIBILOT Denis: No disclosure
-
MORTAMET Guillaume: No conflict of interest
-
MOSBAH Nabil: No conflict of interest
-
MOSCHIETTO Sebastien: No conflict of interest
-
MOUCADEL Virginie: Research support/Scientific studies: bioMérieux
-
MOULAIRE RIGOLLET Valérie: No disclosure
-
MOULIADE Charlotte: No conflict of interest
-
MOULIN Florence: No disclosure
-
MOUNIR Yousfi: No conflict of interest
-
MOURABIT Karima: No disclosure
-
MOURVILLIER Bruno: Trainings, Teaching: MSD; Invitation to national or international congresses: Pfizer, MSD
-
MOUSSA Mouhammed: No disclosure
-
MOUSSAFEUR Amina: No disclosure
-
MOUSSAID Fahd: No conflict of interest
-
MOUZOU Tabana: Invitation to national or international congresses: labo ACUPAN
-
MULLER Gregoire: Trainings, Teaching: Astra-Zeneca; Invitation to national or international congresses: Pfizer
-
MULLER Laurent: No disclosure
-
MULLER Michel: No conflict of interest
-
MUNTING Aline: No conflict of interest
-
MURGIER Martin: No conflict of interest
-
MURPHY Barry: Research support/Scientific studies: Aerogen; Advertising documents: Aerogen; Patent or product inventor: Aerogen
-
MUSIARI Michele: No conflict of interest
-
N’GUYEN Quang-thang: No conflict of interest
-
N’GUYEN Tran: No disclosure
-
NABIL Mosbah: No disclosure
-
NACCACHE Lionel: No disclosure
-
NAIMI Skander: No conflict of interest
-
NAKAA Sabrine: No disclosure
-
NALLET-AMATE Megan: No conflict of interest
-
NATALIS Eloïse: No disclosure
-
NAUDIN Jérôme: Invitation to national or international congresses: Novartis
-
NAY Mai-Anh: No conflict of interest
-
NEMLAGHI Safaa: No conflict of interest
-
NEOFYTOS Dionysios: Research support/Scientific studies: MSD; Consultancy, Expert: MSD, Gilead, Pfizer; Invitation to national or international congresses: Gilead, Pfizer
-
NESSELER Nicolas: No conflict of interest
-
NEVIERE Remi: No disclosure
-
NGUYEN Alexandre: No disclosure
-
NGUYEN KHOA Thao: No conflict of interest
-
NICOLAU-TRAVERS Marie-Laure: No disclosure
-
NIÉRAT Marie cécile: No conflict of interest
-
NIESZKOWSKA Ania: No disclosure
-
NIGEON Olivier: No conflict of interest
-
NITEL Gautier: No conflict of interest
-
NODEA Elena Madalina: No conflict of interest
-
NOEL Marine: No conflict of interest
-
NOGIER Marie-béatrice: No disclosure
-
NOORAH Zaid: No disclosure
-
NOUIRA Wiem: No conflict of interest
-
NOUMEIR Rita: Stock shareholder: Softmedical
-
NOURY Norbert: No conflict of interest
-
NOVY Emmanuel: Research support/Scientific studies: MSD; Invitation to national or international congresses: PFIZER, ASTELLAS
-
NSEIR Saad: Consultancy, Expert: MSD; Trainings, Teaching: MSD, Pfizer, Gilead, Biomérieux, Bio-Rad
-
NSIRI Afak: No disclosure
-
NSSAIR Karim: No conflict of interest
-
NYUNGA Martine: No conflict of interest
-
O’GRADY John: No disclosure
-
O’SULLIVAN Andrew: Research support/Scientific studies: Aeorgen; Advertising documents: Aerogen; Patent or product inventor: Aerogen
-
OBERIC Lucie: Consultancy, Expert: Roche, Takeda, Janssen; Trainings, Teaching: Janssen; Invitation to national or international congresses: Roche, Janssen, Servier
-
OLIVER Leopold: No disclosure
-
OLIVIER Pierre-Yves: Consultancy, Expert: Air Liquide Medical System
-
OLLIVIER Veronique: No conflict of interest
-
ONIMUS Thierry: No conflict of interest
-
OPPENHEIMER Anne: Invitation to national or international congresses: Gedeon Richter
-
ORKISZ Maciej: No conflict of interest
-
ORLIAGUET Gilles: Research support/Scientific studies: UNIVERSITÉ DE LILLE, EUROPEAN SOCIETY OF ANAESTHESIA, FONDATION ROTHSCHILD; Invitation to national or international congresses: LABORATOIRE AGUETTANT
-
ORLOWSKI Sophie: No conflict of interest
-
ORVAIN Corentin: Consultancy, Expert: Novartis, Incyte; Invitation to national or international congresses: Pfizer, JAZZ Pharmaceuticals
-
OUALHA Mehdi: Invitation to national or international congresses: SRLF
-
OUANES Islem: No disclosure
-
OUCHANE Asmaa: No disclosure
-
OUERFELLI Rim: No conflict of interest
-
OUESLATI Meriem: No conflict of interest
-
OWONO ETOUNDI Paul: No disclosure
-
OZIEL Johanna: No conflict of interest
-
OZIER Yves: Consultancy, Expert: LFB
-
PAESMANS Marianne: No conflict of interest
-
PAGANI Jean-Luc: No conflict of interest
-
PAGET Christophe: No conflict of interest
-
PAGLIARANI Pablo: Invitation to national or international congresses: Vegenat, Pfizer, Fresenius
-
PAINVIN Benoît: No conflict of interest
-
PAJOT Olivier: No conflict of interest
-
PANIS Elke: No conflict of interest
-
PAPAZIAN Laurent: No disclosure
-
PAPE Elise: No conflict of interest
-
PARLATO Mariana: No conflict of interest
-
PARMENTIER-DECRUCQ Erika: No conflict of interest
-
PARZIBUT Gilles: No conflict of interest
-
PARZY Gabriel: No conflict of interest
-
PASQUIER Pierre: No conflict of interest
-
PATEAU Victoire: Research support/Scientific studies: OxyNov; Patent or product inventor: OxyNov
-
PATRIER Juliette: No conflict of interest
-
PAUGAM Catherine: No disclosure
-
PAUL Marine: No conflict of interest
-
PAUL-BELLON Rachel: No disclosure
-
PAULO Nicolas: No conflict of interest
-
PAVOT Arthur: Invitation to national or international congresses: Fresenius Medical Care France
-
PEHLIVAN Jonathan: No conflict of interest
-
PEIGNE Vincent: Invitation to national or international congresses: Air liquide
-
PÉJU Edwige: No conflict of interest
-
PENE Frédéric: Consultancy, Expert: Alexion
-
PÉPIN-LEHALLEUR Adrien: Invitation to national or international congresses: Chiesi
-
PERE Morgane: No conflict of interest
-
PEREIRA Bruno: No disclosure
-
PEREZ Didier: No disclosure
-
PEREZ Pierre: No disclosure
-
PEREZ Yonatan: No conflict of interest
-
PERIER François: No disclosure
-
PERIN Nicolas: No conflict of interest
-
PERIOT-JARRY Mathilde: No conflict of interest
-
PERNER Anders: No disclosure
-
PERNY Jessica: No disclosure
-
PEROZZIELLO Anne: No conflict of interest
-
PERREIN Adeline: No disclosure
-
PERRIAT Sophie: No disclosure
-
PERRIN Clémence: No conflict of interest
-
PERRIN Gilles: No disclosure
-
PERSICHINI Romain: No conflict of interest
-
PESCHAUD Frédérique: No conflict of interest
-
PESKINE Anne: No conflict of interest
-
PETERS-SENGERS Hessel: Trainings, Teaching: Amsterdam UMC-masterclass experimental nephropathology; Invitation to national or international congresses: 15th Congress of the International Society for Organ Donation and Procurement (ISODP)
-
PETIT Matthieu: No conflict of interest
-
PETITDEMANGE Lucie: No conflict of interest
-
PEZZATO Stefano: No conflict of interest
-
PHELOUZAT Pierre: No conflict of interest
-
PHILIPPART Francois: No conflict of interest
-
PHILIPPE Goutorbe: No disclosure
-
PHILIPPE Pascal: No conflict of interest
-
PIAGNERELLI Michael: No conflict of interest
-
PICARD Muriel: No conflict of interest
-
PICARD Yoann: No disclosure
-
PICHEREAU Claire: No conflict of interest
-
PICHON Nicolas: No conflict of interest
-
PICKKERS Peter: No disclosure
-
PIN Isabelle: Advertising documents: GSK, AZ, NOVARTIS; Trainings, Teaching: GSK, AZ, NOVARTIS; Invitation to national or international congresses: AZ, NOVARTIS
-
PINETON DE CHAMBRUN Guillaume: Consultancy, Expert: Abbvie, Takeda, Pfizer, Janssen; Trainings, Teaching: Abbvie, MSD, Tillots Pharma, Takeda, Janssen, Pfizer, Hospira; Invitation to national or international congresses: Abbvie, Amgen, Takeda, Pfizer, MSD
-
PINETON DE CHAMBRUN Marc: Invitation to national or international congresses: LFB
-
PIQUILLOUD Lise: No conflict of interest
-
PIRANI Tasneem: No conflict of interest
-
PIRIOU Vincent: No disclosure
-
PIROTTE Marc: No conflict of interest
-
PITON Gaël: Trainings, Teaching: FRESENIUS France
-
PLACIER Sandrine: No conflict of interest
-
PLANTEFEVE Gaëtan: Consultancy, Expert: Panacea Conseil; Trainings, Teaching: Panacea Conseil
-
PLATON Laura: Invitation to national or international congresses: EBMT, SFGMTC
-
PODREZ Kevin: No disclosure
-
POIROUX Laurent: Trainings, Teaching: Fisher & Paykel, Doran
-
POISSY Julien: Research support/Scientific studies: SRLF, CHRU Lille; Invitation to national or international congresses: Pfizer, MSD, Eumédica
-
PONCELET Géraldine: No conflict of interest
-
PONS Bertrand: No conflict of interest
-
PONSIN Pauline: No disclosure
-
PONTIS Emmanuel: No conflict of interest
-
POPOFF Benjamin: No conflict of interest
-
PORTEAUD Jordan: No disclosure
-
POTIER Pierre: No disclosure
-
POTTECHER Julien: Research support/Scientific studies: Ambu; Invitation to national or international congresses: Amomed
-
POULAIN Daniel: No conflict of interest
-
POULARD Thomas: No conflict of interest
-
POUPET Helene: No conflict of interest
-
POYART Claire: No disclosure
-
PRADAT-DIEHL Pascale: No conflict of interest
-
PRAT Gwenael: No conflict of interest
-
PREAU Sebastien: No conflict of interest
-
PREDA Gabriel: No conflict of interest
-
PREISER Jean-Charles: No conflict of interest
-
PRESTIFILIPPO Alessia: No disclosure
-
PREVEDELLO Danielle: No conflict of interest
-
PRÉVEL Renaud: Invitation to national or international congresses: Pfizer (ECCMID Madrid 2018)
-
PRIEUR Guillaume: Trainings, Teaching: Health Impact
-
PRIGENT Amélie: No disclosure
-
PRIM Benjamin: No disclosure
-
PROTIN Caroline: No disclosure
-
PRUD’HOMME Eloi: No conflict of interest
-
PUISSET Florent: No disclosure
-
PUYMIRAT Etienne: No disclosure
-
QUENOT Jean-Pierre: No conflict of interest
-
QUINTARD Hervé: No disclosure
-
RABEONY Tioka: No disclosure
-
RABODONIRINA Meja: No disclosure
-
RACHID Alharrar: No disclosure
-
RADFORD Amanda: Research support/Scientific studies: I am a full time employee at Asahi Kasei Pharma America, the research sponsor
-
RAFFOUX Emmanuel: No disclosure
-
RAFI Sonia: No disclosure
-
RAHMANI Imen: No conflict of interest
-
RAIMBAULT Mélina: No conflict of interest
-
RAJA Amine: Research support/Scientific studies: A.JANNATI; Consultancy, Expert: A.BOUHOURI; Advertising documents: R.HARRAR; Trainings, Teaching: R.HARRAR; Invitation to national or international congresses: R.HARRAR; Stock shareholder: R.HARRAR; Patent or product inventor: R.HARRAR
-
RAMBAUD Jerome: No conflict of interest
-
RAMBAUD Thomas: No conflict of interest
-
RANGER Noemie: Research support/Scientific studies: Pathoquest (Paris)
-
RAUCOULES Marc aimé: No disclosure
-
RAULT Christophe: No disclosure
-
RAZACH Idriss: No disclosure
-
RAZAZI Keyvan: Invitation to national or international congresses: Réanimation 2020
-
REBIERE Vincent: No conflict of interest
-
RECHER Christian: No disclosure
-
REGAIEG Kais: No conflict of interest
-
REGNIER Jean: No disclosure
-
REHOUMA Haythem: No disclosure
-
REIGNIER Jean: No conflict of interest
-
REIZINE Florian: No conflict of interest
-
RELLO Jordi: No conflict of interest
-
RENALDO Florence: No conflict of interest
-
RENAUDIER Marie: No conflict of interest
-
RENAULT Anne: Trainings, Teaching: Université de Bretagne occidentale; Invitation to national or international congresses: Fresenius
-
RENOLLEAU Sylvain: No conflict of interest
-
REPESSÉ Xavier: No conflict of interest
-
RESCHE-RIGON Matthieu: No conflict of interest
-
RESIERE Dabor: No conflict of interest
-
REUTER Danielle: No disclosure
-
REYNAUD Faustine: No disclosure
-
REYNAUD Marie: No conflict of interest
-
RHANEM Toufiq: No disclosure
-
RIAD Zakaria: No disclosure
-
RIAUD Charline: No conflict of interest
-
RICARD Cécile: No conflict of interest
-
RICARD Jean-Damien: Invitation to national or international congresses: Fisher&Paykel
-
RICCI Jean-Ehrland: No conflict of interest
-
RICHARD Jean-Christophe: Research support/Scientific studies: Hamilton
-
RICHARD Régine: No conflict of interest
-
RICHARD Vincent: No disclosure
-
RICHECOEUR Jack: Trainings, Teaching: Massimo
-
RICOME Sylvie: No conflict of interest
-
RIGAUD Jean-Philippe: No conflict of interest
-
RIM Gharbi: No conflict of interest
-
RIMMELE Thomas: No disclosure
-
ROBERT Alexandre: No conflict of interest
-
ROBERT Blandine: No disclosure
-
ROBERT René: Research support/Scientific studies: Fisher and Paykel; Invitation to national or international congresses: Fresenius Medical Care
-
ROBERT Tiphaine: No conflict of interest
-
ROBERTS Jason A.: Research support/Scientific studies: MSD, Biomerieux; Consultancy, Expert: MSD, Accelerate diagnostics, Biomerieux
-
ROBIN Emmanuel: No conflict of interest
-
ROBIN Nicolas: No disclosure
-
ROBINEAU Olivier: No disclosure
-
ROCH Antoine: No disclosure
-
ROCHE Anne: No conflict of interest
-
ROGER Claire: Consultancy, Expert: PFIZER, FRESENIUS MEDICAL CARE; Invitation to national or international congresses: MSD,PFIZER
-
ROLLE Amélie: No conflict of interest
-
RONDEAU Eric: No disclosure
-
RONZIÈRE Thomas: No disclosure
-
ROQUILLY Antoine: No disclosure
-
ROSSELLI Sylvène: No disclosure
-
ROUBY Jean-Jacques: No disclosure
-
ROUIS Sana: No conflict of interest
-
ROULEAU Stéphane: No conflict of interest
-
ROULET Sylvie: No disclosure
-
ROULLAND Charlotte: No disclosure
-
ROUMELIOTIS Nadia: No conflict of interest
-
ROUSSE Natacha: No disclosure
-
ROUSSEAU Anne-Françoise: Invitation to national or international congresses: Orion
-
ROUSSEAU Chloe: No disclosure
-
ROUSSEAU Christophe: No conflict of interest
-
ROUSSET David: No disclosure
-
ROUSTAN Jerome: No disclosure
-
ROUX Damien: Consultancy, Expert: Astellas
-
ROUZE Anahita: No disclosure
-
ROZENBERG Emmanuel: No conflict of interest
-
ROZIER Romain: Invitation to national or international congresses: SFAR, ARCOTHOVA
-
RUCKLY Stephane: Research support/Scientific studies: Pfizer
-
RUDLER Marika: No disclosure
-
SAADE Anastasia: No conflict of interest
-
SABA Makni: No conflict of interest
-
SABIA Marie: No disclosure
-
SABRINA Chaoueh: No conflict of interest
-
SACCHERI Clément: No disclosure
-
SACLEUX Sophie-Caroline: No conflict of interest
-
SADAT Souhila: No conflict of interest
-
SAGARDOY Thomas: No disclosure
-
SAGNIER Anne: No disclosure
-
SAILLARD Colombe: Trainings, Teaching: Amgen, Novartis; Invitation to national or international congresses: Amgen
-
SAINT-SARDOS Pierre: No disclosure
-
SAKIS Dorra: No conflict of interest
-
SALAME Ephrem: No disclosure
-
SALEM Joe Elie: No conflict of interest
-
SALEM Mohamed: No disclosure
-
SALIBA Faouzi: Research support/Scientific studies: Novartis, Astellas, Chiesi, Baxter; Consultancy, Expert: Novartis, Baxter, Vital therapies; Invitation to national or international congresses: Gilead, Abbvie, Novartis, Astellas, Pfizer, Chiesi
-
SALOMON Elsa: No conflict of interest
-
SALOMON Remi: No disclosure
-
SALVADOR Elodie: No conflict of interest
-
SALVI Nadege: No disclosure
-
SAMUEL Didier: Consultancy, Expert: Intercept, Biotest gilead sciences, abbvie
-
SAN Sovannarith: No disclosure
-
SANGLA Frédéric: No conflict of interest
-
SAPORITO Andrea: Consultancy, Expert: BBraun, Sintetica; Invitation to national or international congresses: Sintetica; Patent or product inventor: Lightsens
-
SAUNEUF Bertrand: No conflict of interest
-
SAUTHIER Michael: Research support/Scientific studies: Fonds de recherche en santé du Québec (gouvernement)
-
SAUVAGE Brice: No conflict of interest
-
SAVARY Guillaume: No conflict of interest
-
SAVARY Lea: No conflict of interest
-
SAVOYE COLLET Celine: No conflict of interest
-
SAZIO Charline: No disclosure
-
SBOUI Sajida: No conflict of interest
-
SCALA BERTOLA Julien: No conflict of interest
-
SCHELLONGOWSKI Peter: Consultancy, Expert: Getinge, Novartis, Gilead, Astro Pharma, Shire, Astellas, Basilea, Baxter
-
SCHENCK Maleka: No conflict of interest
-
SCHMIDT Aline: No disclosure
-
SCHMIDT Matthieu: Consultancy, Expert: Getinge, Drager
-
SCHMITT Johan: Invitation to national or international congresses: Société Francaise d’Anesthésie Réanimation; Congrès Anesthésie Réanimation Urgentistes Militaires
-
SCHNEIDER Francis: No conflict of interest
-
SCHNELL David: No conflict of interest
-
SCHNITZLER Béatrice: No disclosure
-
SCHORTGEN Frédérique: Trainings, Teaching: ESICM, SRLF, IHTMS, CREUF, AFIB; Invitation to national or international congresses: ESICM, SRLF, IHTMS, CREUF, AFIB
-
SCHUGHART Klaus: No disclosure
-
SCHULTZ Marcus: No conflict of interest
-
SCHWEBEL Carole: Invitation to national or international congresses: Pfizer
-
SCICLUNA Brendon: No disclosure
-
SCULIER Jean-Paul: No conflict of interest
-
SEE Perrine: No conflict of interest
-
SEGHBOYAN Jean-marie: No disclosure
-
SEGUIN Amelie: No conflict of interest
-
SEGUIN Philippe: Consultancy, Expert: LFB; Invitation to national or international congresses: Astellas
-
SEJOURNE Caroline: No conflict of interest
-
SELLAMI Walid: No conflict of interest
-
SENDID Boualem: Research support/Scientific studies: AllFun project, FP7 European Commission; Invitation to national or international congresses: Pfizer
-
SENHADJI Lahcen: No conflict of interest
-
SERBOUTI Rita: Research support/Scientific studies: Fresenius Medical Care; Consultancy, Expert: Fresenius Medical Care; Trainings, Teaching: Fresenius Medical Care; Invitation to national or international congresses: Fresenius Medical Care
-
SERFATY Lawrence: No disclosure
-
SÉRIE Mathieu: No conflict of interest
-
SHAW Geoffrey M.: No conflict of interest
-
SHI Rui: No conflict of interest
-
SHIMI Abdelkrim: No disclosure
-
SHOJAEI Maryam: No disclosure
-
SI-TAHAR Mustapha: Consultancy, Expert: Cynbiose Respiratory; Stock shareholder: Cynbiose respiratory
-
SIAMI Shidasp: No conflict of interest
-
SILVA Daniel: Research support/Scientific studies: Fresenius Medical Care France; Consultancy, Expert: Fresenius Medical Care France; Invitation to national or international congresses: Xenios Novalung, Heilbronn, Germany
-
SILVA Stein: No disclosure
-
SIMILOWSKI Thomas: Research support/Scientific studies: Lungpacer; Consultancy, Expert: ADEP Assistance, AstraZeneca, Chiesi France, GSK France, Lungpacer Inc., KPL consulting, TEVA; Trainings, Teaching: Chiesi France, GSK France, Novartis France; Invitation to national or international congresses: Novartis France; Patent or product inventor: Air Liquide Medical Systems, MyBrain Technology
-
SIMON Marie: Trainings, Teaching: Fresenius, Pfizer, Gilead, MSD; Invitation to national or international congresses: Pfizer, MSD
-
SIMON-PIMMEL Jeanne: No conflict of interest
-
SIRAULT Bruno: No disclosure
-
SIRODOT Michel: No disclosure
-
SLAMA Michel: No disclosure
-
SLIM Amine: No disclosure
-
SMIELEWSKI Peter: No disclosure
-
SOARES Marcio: Stock shareholder: Epimed Solutions; Patent or product inventor: Epimed Solutions
-
SOLO NOMENJANAHARY Mialitiana: No conflict of interest
-
SOMMET Julie: No conflict of interest
-
SONNEVILLE Romain: Research support/Scientific studies: French ministry of Health, SRLF, ESICM; Consultancy, Expert: Baxter; Trainings, Teaching: Panacea
-
SONZINI Roberta: No conflict of interest
-
SORTAIS Clara: No conflict of interest
-
SOUBRANE Olivier: No disclosure
-
SOUHEIL Elatrous: No disclosure
-
SOULIGNAC Chloe: No disclosure
-
SOUWEINE Bertrand: Consultancy, Expert: MSD; Trainings, Teaching: Gilead; Invitation to national or international congresses: Pfizer
-
SPAGNOLETTI Marco: No conflict of interest
-
STECKELMACHER Claire: No disclosure
-
STOCKX Luc: Research support/Scientific studies: Phenox, Medtronic; Consultancy, Expert: Phenox; Trainings, Teaching: Phenox; Invitation to national or international congresses: Phenox
-
STOCLIN Annabelle: No conflict of interest
-
SUBRA Gilles: No disclosure
-
SULTANIK Philippe: Invitation to national or international congresses: ABBVIE, GILEAD, BIOTEST
-
SUZANNE Marie: Invitation to national or international congresses: NOVARTIS PHARMA SAS
-
SZTRYMF Benjamin: No conflict of interest
-
TABET-AOUL Nabil: No conflict of interest
-
TABRA Cécilia: No conflict of interest
-
TACCONE Fabio: No disclosure
-
TADIÉ Jean-Marc: No conflict of interest
-
TAILPIED Pierre: No conflict of interest
-
TAJELLIJITI Nissrine: No conflict of interest
-
TAMION Fabienne: No conflict of interest
-
TANAKA Kosuke: Research support/Scientific studies: I am a full time employee of Asahi Kasei Pharama America, the reserch sponsor.
-
TANAKA Sébastien: No conflict of interest
-
TANDJAOUI-LAMBIOTTE Yacine: Trainings, Teaching: Gambro
-
TANG Benjamin: No disclosure
-
TANKOVIC Jacques: No conflict of interest
-
TARTE Karin: No disclosure
-
TATHAM Amy: No disclosure
-
TATTEVIN Pierre: Research support/Scientific studies: Astellas, Biomérieux, Gilead, Pfizer, et MSD; Consultancy, Expert: Gilead, Astellas, Coreviome, MSD, Mylan, Shionogi, et Pfizer,; Invitation to national or international congresses: Mylan, MSD, Pfizer, Biomérieux, Gilead, et Astellas
-
TAVITIAN Suzanne: No disclosure
-
TCHETIKE Pikabalou: No disclosure
-
TEBOUL Jean-Louis: Consultancy, Expert: Getinge
-
TEITEN Christelle: No conflict of interest
-
TEIXEIRA Luis: No disclosure
-
TEMIME Johanna: No conflict of interest
-
TERNACLE Julien: No disclosure
-
TERREAUX Jeremy: No disclosure
-
TERZI Nicolas: Invitation to national or international congresses: Boehringer Ingelheim
-
THABET Lamia: No conflict of interest
-
THABUT Dominique: No conflict of interest
-
THENOT Victoire: No conflict of interest
-
THEOCHARIDOU Eleni: No disclosure
-
THEODOSE Igor: No conflict of interest
-
THEPOT-SEEGERS Valérie: No conflict of interest
-
THEVENIN Didier: No conflict of interest
-
THIEBLEMONT Catherine: No disclosure
-
THIERY Guillaume: Consultancy, Expert: Gilead, advisory board, CAR-T Cells; Trainings, Teaching: Amgen, lecture CAR-T cells
-
THILLE Arnaud: Research support/Scientific studies: Fisher&Paykel; Trainings, Teaching: Fisher&Paykel, GE Healthcare, Maquet - Getinge, Covidien; Invitation to national or international congresses: Fisher&Paykel, GE Healthcare, Maquet - Getinge, Covidien
-
THILLY Nathalie: No conflict of interest
-
THIREAU Jerome: No conflict of interest
-
THIRION Marina: Trainings, Teaching: Panacéa Conseil & Formation Santé; Invitation to national or international congresses: Pfizer (congrès SRLF 2019)
-
THIRY Eric: No disclosure
-
THOMAS Laure: No conflict of interest
-
THY Michael: No conflict of interest
-
TIMSIT Jean-François: Research support/Scientific studies: Merck, bioMerieux, Pfizer; Consultancy, Expert: Nabriva, Merck, Pfizer, Bayer Pharma, Paratek; Trainings, Teaching: Gilead
-
TISSIÈRES Pierre: Research support/Scientific studies: bioMerieux; Consultancy, Expert: Sedana, Baxter
-
TOFFART Anne-Claire: Research support/Scientific studies: Roche, BMS, Astra Zeneca; Consultancy, Expert: Roche, BMS, MSD, Astra Zeneca, Vifor PharmaBoehringer Ingelheim, Pfizer; Trainings, Teaching: Roche, MSD, Astra Zeneca; Invitation to national or international congresses: Roche, BMS, MSD, Astra Zeneca, Vifor PharmaBoehringer Ingelheim, Pfizer
-
TOMBERLI Françoise: No conflict of interest
-
TOUBIANA Julie: No conflict of interest
-
TOUIL Yosr: No conflict of interest
-
TOUMI Radhouane: No conflict of interest
-
TOURTIER Jean-pierre: No disclosure
-
TRELUYER Jean-marc: No disclosure
-
TRÉLUYER Jean-Marc: Research support/Scientific studies: APHP and Université de Paris
-
TREMOLIERES Pierre: No conflict of interest
-
TRIDON Chloé: No disclosure
-
TRIFI Ahlem: No conflict of interest
-
TRIKI Amal: No conflict of interest
-
TUDESQ Jean-Jacques: Trainings, Teaching: MSD, Gilead; Invitation to national or international congresses: Pfizer
-
TUFFET Samuel: No conflict of interest
-
TURBIL Emanuele: No conflict of interest
-
TURKI Olfa: No conflict of interest
-
UHEL Fabrice: No conflict of interest
-
URBINA Tomas: No conflict of interest
-
URIEN Saïk: No conflict of interest
-
UYTTENDAELE Vincent: Research support/Scientific studies: FNRS FRIA–Fund for Research and Training in Industry and Agriculture (Belgium)
-
VALADE Sandrine: Consultancy, Expert: Sanofi; Invitation to national or international congresses: Pfizer
-
VALENTE Mélanie: No disclosure
-
VALENTINO Ruddy: No disclosure
-
VALETTE Xavier: No conflict of interest
-
VALKONEN Miia: No disclosure
-
VALLEE Barthélémy: No conflict of interest
-
VALLY Shazima: No disclosure
-
VAN BOXSTAEL Sam: Trainings, Teaching: ALSG; Invitation to national or international congresses: ZOL Genk
-
VAN CAUTER Sofie: Consultancy, Expert: Biogen; Invitation to national or international congresses: Biogen
-
VAN DE LOUW Andry: No conflict of interest
-
VAN DELDEN Christian: Consultancy, Expert: Astellas, Pfizer, MSD, Gilead; Trainings, Teaching: Basilea
-
VAN DER POLL Tom: No disclosure
-
VAN GRUNDERBEECK Nicolas: Research support/Scientific studies: MSD; Trainings, Teaching: Getinge group; Invitation to national or international congresses: AIr Liquide
-
VAN POUCKE Sven: No conflict of interest
-
VAN VUGHT Lonneke: No disclosure
-
VAN-GYSEL Damien: No conflict of interest
-
VANDERMEULEN Elly: No conflict of interest
-
VANDROUX David: Invitation to national or international congresses: Nordic pharma
-
VANDUEREN Charlotte: No conflict of interest
-
VANELDEREN Pascal: Research support/Scientific studies: BBraun
-
VARNOUS Shaida: No disclosure
-
VEBER Benoit: No disclosure
-
VEDRENNE-CLOQUET Meryl: Trainings, Teaching: MSD; Invitation to national or international congresses: Fresenius
-
VERGEZ François: No disclosure
-
VERLHAC Camille: Research support/Scientific studies: Fresenius kabi; Invitation to national or international congresses: Hospal
-
VERRIER Nathalie: No disclosure
-
VEYRADIER Agnès: No conflict of interest
-
VEZIRIS Nicolas: Research support/Scientific studies: Accelerate Diagnostic et Curetis; Consultancy, Expert: becton dickinson; Invitation to national or international congresses: otsuka
-
VIALLARD Marcel Louis: No conflict of interest
-
VICAIRE Hugues: No conflict of interest
-
VIEILLARD-BARON Antoine: Research support/Scientific studies: GSK
-
VIGNERON Clara: No conflict of interest
-
VIGNON Philippe: No conflict of interest
-
VILLA Elodie: No conflict of interest
-
VILLENEUVE Laurent: No disclosure
-
VIMEUX Sylvie: No conflict of interest
-
VIMPERE Damien: No conflict of interest
-
VINCENT Arthur: No conflict of interest
-
VINCENT Florent: Trainings, Teaching: SANOFI
-
VINCENT Francois: No disclosure
-
VINCENT Jean-Louis: No disclosure
-
VINCENTELLI André: Consultancy, Expert: Abbott; Medtronic; Trainings, Teaching: Abbott; Invitation to national or international congresses: Abott
-
VINETTI Marco: Research support/Scientific studies: Combacte, Adrenomed AG, Inotrem, Artisan Pharma, Sepcell; Consultancy, Expert: Orion
-
VINSONNEAU Christophe: No conflict of interest
-
VISSAC Camille: No conflict of interest
-
VIVIEN Benoit: No conflict of interest
-
VIVIER Emmanuel: No conflict of interest
-
VOIRIOT Guillaume: Research support/Scientific studies: Biomérieux, SOS oxygène, Janssen; Consultancy, Expert: Biomérieux; Invitation to national or international congresses: Biomérieux
-
VON KIETZELL Matthias: Invitation to national or international congresses: Gilead, Viif, MSD, Pfizer
-
VUILLARD Constance: No disclosure
-
VUNDELINCKX Joris: Research support/Scientific studies: Interreg Euregio Maas-Rijn, European goverment
-
VUOTTO Fanny: No conflict of interest
-
WAINTRAUB Xavier: Research support/Scientific studies: Medtronic, Abbott, Sorin; Consultancy, Expert: Boston, Abbott, Biosense Webster; Trainings, Teaching: Boston; Invitation to national or international congresses: Medtech
-
WALLET Florent: Consultancy, Expert: Novartis Gilead Kite; Invitation to national or international congresses: Gilead Kite
-
WALLIS Steven c.: No conflict of interest
-
WEISS Emmanuel: Consultancy, Expert: MSD; Invitation to national or international congresses: MSD
-
WEISS Nicolas: Consultancy, Expert: Med Day pharmaceuticals
-
WIBAIL Alain: No disclosure
-
WIESEN Patricia: No conflict of interest
-
WITTEBOLE Xavier: Research support/Scientific studies: Investigator fee paid to the hospital by AKPA; Consultancy, Expert: AKPA
-
WORMSER Johan: No conflict of interest
-
WOUTERS Patrick: Research support/Scientific studies: Fresenius; Consultancy, Expert: aguettant; Invitation to national or international congresses: Vifor
-
YACOUBI Wejden: No conflict of interest
-
YAGER Hélène: No conflict of interest
-
YAHYA Yosra: No conflict of interest
-
YAKINI Khalid: No disclosure
-
YAKOUBEN Karima: No disclosure
-
YONIS Hodane: Invitation to national or international congresses: LVL medical et Pfizer
-
YOUNAN Romy: No conflict of interest
-
YOUSSOUFA Atika: No disclosure
-
ZACHARIA Mahi: No disclosure
-
ZAFRANI Lara: Research support/Scientific studies: Jazz Pharmaceuticals
-
ZAMBON Olivier: No disclosure
-
ZAOUAK Nadia: No conflict of interest
-
ZAOUCHE Khedija: No conflict of interest
-
ZARROUGUI Wafa: No conflict of interest
-
ZE MINKANDE Jacqueline: No disclosure
-
ZEGHDOUD Dalila: No disclosure
-
ZERBIB Yoann: No conflict of interest
-
ZERHOUNI Amel: No conflict of interest
-
ZERHOUNI Amine: No conflict of interest
-
ZERIMECH Farid: No conflict of interest
-
ZEROUALI Khalid: No disclosure
-
ZHENG Yi: No conflict of interest
-
ZIMMERLI Stefan: Research support/Scientific studies: MSD, Pfizer, Gilead; Consultancy, Expert: MSD, Pfizer; Trainings, Teaching: Gilead; Invitation to national or international congresses: Gilead
-
ZOUAOUI BOUDJLETIA Karim: No disclosure
-
ZOUARI Farah: No conflict of interest
-
ZOUARI Fatma: No conflict of interest
-
ZOUARI Hager: No conflict of interest
-
ZRIBI Malek: No conflict of interest
-
ZUBER Benjamin: Invitation to national or international congresses: Oxyvie